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Abstract 
 
Chitin is the second most abundant biopolymer in the natural world and is 
hydrolysed through the action of chitinases and chitobiases. The hydrolysis of 
chitin yields commercially important products such as chito-oligosaccharides and 
N-acetylglucosamine. The hydrolysis of chitin waste is also a major industry. 
Enzymatic hydrolysis of chitin is the best and most environmentally friendly 
method of chitin breakdown. There is a constant demand for easy to produce, 
fast-performing, reliable chitinolytic enzymes.   
 
This study identified and investigated a chitobiase (Chb) from Photorhabdus 
luminescens. The Chb enzyme was cloned, expressed, purified and its activity 
characterised. The proposed catalytic residues were mutated and the catalytic 
activity removed to (i) highlight their importance in catalysis and (ii) ascertain 
whether the specific GlcNAc binding is retained. The binding abilities of this 
catalytically inactive carbohydrate-binding protein were investigated to 
determine if it could be used as a “lectin” for the analysis of glycan patterns on 
glycoproteins.  Residues were selected in the active site for site-directed 
mutagenesis to study their effect on catalytic activity. Three mutants were 
generated that exhibited enhanced catalytic activity as well as enhanced pH and 
temperature stability in comparison with the wildtype Chb. HPLC analysis was 
performed investigating the hydrolytic breakdown of various length chito-
oligosaccharides by the Chb enzyme. The results highlighted that the Chb 
enzyme and subsequent mutant enzymes are industrially applicable for chitin 
hydrolysis and the production of the biologically relevant sugar N-
acetylglucosamine. 
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Chapter 1 
 
Introduction 
 
 2 
1.1 Chitin 
 
Chitin is the second most abundant biopolymer in the natural world. It has an annual 
turnover of approximately 10 gigatons, a total only exceeded by cellulose (Meibom et 
al., 2004). Due to its inflexible nature chitin is a structural polysaccharide found in a 
variety of different organisms, from the exoskeletons of insects and the outer shells of 
crustaceans to the cell wall of fungi (Khoushab and Yamabhai, 2010; Rinaudo, 2006).  
 
1.1.1 Chitin structure 
 
Chitin is an insoluble, crystalline polysaccharide comprised of linear un-branched 
molecular chains of β1,4 linked N-D-acetylglucosamine residues. Chitin is structurally 
similar to cellulose, differing only at the C-2 of each glucose/N-acetylglucosamine 
residue. Cellulose has a hydroxyl group (OH) at this position while chitin has an N-
acetyl amino group (NHCOCH3).  
 
 
Fig 1.1: The structural differences between cellulose and chitin. The presence of 
the hydroxyl group at the C-2 position of cellulose and the N-acetyl group at the C-2 
position of chitin are highlighted in red (Kumar, 2000).  
 
In nature, chitin is found as crystalline fibrils. It is composed of chains of N-
acetylglucosamine, thousands of residues in length. These chains are held together by 
hydrogen bonds. There are two main forms of chitin: α-chitin and β-chitin. The 
various forms of chitin may be differentiated between using NMR and X-ray 
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diffraction. The different forms of chitin are categorised by how the long N-
acetylglucosamine chains are organised (Rinaudo, 2006). α-chitin is far more 
prevalent in nature than β–chitin. While α–chitin is found in an abundance of 
organisms, from insects and shrimp to fungi and bacteria, β-chitin is found only in 
squid pens and cocoons (Beckham and Crowley, 2011; Sikorski et al., 2009; Rinaudo, 
2006;). The crystal structure of α–chitin was first described by Minke and Blackwell 
(1978). They described α–chitin as having anti-parallel chains which are held together 
by hydrogen bonds, formed by interactions between the C=O group of one chain and 
the amide group of another. The anti-parallel organisation of the chains and the strong 
inter-chain hydrogen bonds allow the α–chitin chains to be arranged tightly, giving 
rise to its rigid, insoluble structure (Merzendorfer and Zimoch, 2003). The α–chitin 
structure was more recently examined by Sikorski et al., (2009) as the presence of 
anti-parallel chains was a stark contrast to the structure of naturally occurring 
cellulose, whose chains are aligned in a parallel fashion. Again, the chains were found 
to be aligned in an anti-parallel fashion and it was noted that they formed a helical 
configuration (Sikorski et al., 2009).  
 
a)               b)     
         
Fig 1.2: The structural differences between a) α–chitin and b) β–chitin.  a) The α–
chitin chains are organised in an anti-parallel fashion (Sikorski et al., 2009). b) The β–
chitin chains are organised in a parallel fashion (Nishiyama et al., 2011).  
 
In comparison with α–chitin, the rarer β-chitin chains were found to be organised in a 
parallel fashion (Sugiyama et al., 1999). The degree of hydrogen bonding between the 
chains was determined to be less than that found in α–chitin, allowing hydrogen 
bonds with water to also form. While β–chitin is also found as crystalline fibrils in 
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nature, the fibrils themselves are much weaker than in α-chitin (Merzendorfer and 
Zimoch, 2003; Sugiyama et al., 1999). Jang et al., (2004) investigated the structure of 
each form of chitin using Fourier transform infrared (FTIR) and Nuclear Magnetic 
Resonance (NMR) spectroscopy. From this study a third type of chitin, γ-chitin, was 
proposed, composed of two parallel chains and one anti-parallel chain (Jang et al., 
2004). However, the structure of γ-chitin has been debated and it has been proposed 
that it is just a mixture of α–chitin and β–chitin (Tharanathan and Kittur, 2003).  
 
1.1.2 Chitin synthesis 
 
Chitin is synthesized by the organisms in which it is a structural component and 
although the chitin synthesis pathway is slightly different in each organism the overall 
sequence is similar. Glucose is converted to UDP-N-acetylglucosamine, the building 
block of chitin, in a series of steps. Then, the chitin synthase family of enzymes 
sequentially add these activated UDP-N-acetylglucosamine residues to the growing 
chitin chain (Khoushab and Yamabhai, 2010; Merzendorfer and Zimoch, 2003; 
Tharanathan and Kittur, 2003).  
 
Fig 1.3: The conversion of glucose to UDP-N-acetylglucosamine. Glucose is 
converted to UDP-N-acetylglucosamine, the building block of chitin, through a series 
of steps. Chitin synthase then uses this substrate to synthesise chitin (Merzendorfer 
and Zimoch, 2003). 
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The production of chitin in fungi is compartmentalised. Chitin synthase is produced as 
an inactive precursor, and transported to the cell surface in vehicles known as 
chitosomes where it is then cleaved to yield the active form of the enzyme. It can then 
catalyze the formation of chitin from the readily available UDP-N-acetylglucosamine 
(Lenardon et al., 2010; Tharanathan and Kittur, 2003). It is believed that the 
production of chitin in insects needs a primer, although the exact mechanism is still 
unknown. It was proposed that an N-acetylglucosamine residue is attached to a lipid 
carrier such as dolichol phosphate to create dolichyldiphospho-N-acetylglucosamine 
which may then act as the primer for chitin synthesis (Merzendorfer and Zimoch, 
2003; Tharanathan and Kittur, 2003). 
 
1.1.3 Applications  
 
1.1.3.1 Applications of chitin 
 
Because of its wide availability and potential as a renewable bioresource, the use of 
chitin for various applications has been extensively studied. Processing of 
crustaceans, such as shrimp and crab, lead to the production of 1x10
9
 metric tons of 
chitin waste each year (Jeon et al., 2007). Chitin is relatively non-toxic and non-
reactive. Its insoluble, rigid structure allows it to be used as a platform on which to 
immobilise enzymes or whole cells. Other uses include as a wound dressing, as 
absorbable sutures, as a delivery-system for the controlled release of drugs and as a 
film/fibre. However its lack of solubility is a major limitation (Rinaudo, 2006; Dutta 
et al., 2004). A much wider variety of applications are possible for chito-
oligosaccharides and N-acetylglucosamine. These shorter polysaccharide chains have 
bioactive properties that chitin does not possess. This is due to differing physical 
characteristics, particularly the fact that they are water soluble due to their shorter 
length.  
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1.1.3.2 Applications of chito-oligosaccharides 
 
1.1.3.2.1 Potential medical applications of chito-oligosaccharides 
 
Chito-oligosaccharides possess many important biological relevant properties. Their 
anti-tumour properties have been studied since the 1970s and they have shown great 
potential as anti-cancer agents because, as opposed to conventional treatments such as 
chemotherapy, they are non-toxic and non-harmful to the patient. However, these are 
mainly cell culture and animal-based studies (Aam et al., 2010). The anti-cancer 
properties of chito-oligosaccharides are proposed to be linked with their ability to 
stimulate the immune system due to their high molecular weight (Suzuki et al., 2006). 
Shen et al., (2009) described the inhibitory properties of chito-oligosaccharides on 
tumour growth and metastasis in hepatocellular carcinoma (liver cancer). They found 
that treatment of hepatocarcinoma cells with chito-oligosaccharides reduced the rate 
of cell proliferation and the rate of DNA synthesis in vitro. Further in vivo studies 
demonstrated that chito-oligosaccharides reduced the rate of tumour growth and 
increased the rate of survival in a mouse model (Shen et al., 2009). It is believed that 
these anti-cancer effects of chito-oligosaccharides were due to the activation of an 
immune response. Chito-oligosaccharides, such as chitohexaose, were found to 
impact on the activity of intestinal intraepithelial lymphocytes. Their water-solubility 
allowed them to be readily absorbed in an in vivo mouse model, consequentially 
enhancing the natural killer activity of intestinal lymphocytes resulting in an 
inhibition of tumour growth (Maeda and Kimura, 2004). 
Chito-oligosaccharides are also known to induce apoptosis in certain cancer cells, as 
described in a study on liver cancer by Xu et al., (2008). This in vitro study on 
hepatocellular carcinoma cells discovered that the presence of chito-oligosaccharides 
caused an increase in the levels of Bax, a protein known to induce apoptosis. This 
resulted in an increase in apoptosis for the hepatocellular carcinoma cells.  
Wu et al., (2008) described the anti-angiogenesis properties of chito-oligosaccharides. 
Angiogenesis, the production of new blood vessels from older blood vessels, is the 
method by which tumours develop their own blood supply. It allows them to grow 
and metastasise. Inhibition of angiogenesis has long been a target of anti-cancer 
therapeutics. Wu et al., (1998) found that chito-oligosaccharides had the ability to 
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inhibit angiogenesis possibly through the down regulation of pro-angiogenic factors 
or through the blockage of pro-angiogenic signal transmission.  
Additionally, anti-inflammatory effects of chito-oligosaccharides have been observed. 
In vitro studies on macrophages by Lee et al., (2009) described that chito-
oligosaccharides inhibited the production of nitric oxide (NO), PGE2 IL-6 and TNF-α 
(all pro-inflammatory mediators) via the down-regulation of their transcription.  Yang 
et al., (2010) also noted the inhibition of the expression of various inflammatory 
mediators, again including NO and PGE2, in chito-oligosaccharide treated 
macrophages.  
 
1.1.3.2.2 Potential anti-bacterial/anti-fungal applications of chito-
oligosaccharides 
 
Chito-oligosaccharides have also been shown to possess certain anti-bacterial and 
anti-fungal properties.  A critical step in bacterial colonisation is the adherence of the 
bacterium to the host cell, frequently involving glycan epitopes. Chito-
oligosaccharides have been found to bind these bacterial carbohydrate binding 
proteins, therefore inhibiting adhesion to host cells (Aam et al., 2010). Chito-
oligosaccharides were found to inhibit the binding of certain intestinal bacterial 
strains to colorectal cells. Binding of pathogenic E. coli strains was observed to be 
inhibited, however Lactobacillus casei and L. gasseri strains were unaffected. This 
demonstrated the use of chito-oligosaccharides as a selective anti-adhesion therapy 
(Rhoades et al., 2006).  
The use of chito-oligosaccharides as chitinase inhibitors has been described (Aam et 
al., 2010). Plasmodium, the causative bacteria of malaria, requires entry into the 
mosquito gut as part of its infective life-cycle. To do this the bacteria must first 
breakdown the chitin-containing periotrophic membrane, and Plasmodium expresses 
and secretes chitinases for this purpose. Chito-oligosaccharides may therefore be used 
as chitinase inhibitors to prevent infection of the mosquito by Plasmodium (Aam et 
al., 2010).  
Park et al., (2008) demonstrated the anti-fungal activity of chito-oligosaccharides. 
Using confocal microscopy it was observed that an association between the chito-
oligosaccharides and lipids in the fungal plasma membrane caused a disruption in this 
membrane. While lysis was not observed, morphological changes to the fungus did 
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occur. Chito-oligosaccharides can also be used as anti-fungal treatment for plants. The 
presence of these oligosaccharides causes the induction of various plant chitinases 
which break down the fungal cell wall (Tharanathan and Kittur, 2003).  
Chito-oligosaccharides have also been used in cosmetics, in food (as an anti-microbial 
and preservative agent), in the treatment of hypocholesterolemia and to increase the 
absorption of iron and calcium in vivo (Xia et al., 2011).  
 
1.1.3.3 Potential applications of N-acetylglucosamine 
 
N-acetylglucosamine, the smallest unit of the chitin polymer, is also a biologically 
important monosaccharide. Complexed with N-acetylmuramic acid, N-
acetylglucosamine forms murein, a constituent of bacterial cell walls (Chen et al., 
2010). Hyaluronic acid, composed of N-acetylglucosamine and glucuronic acid, is a 
large component of the extracellular matrix, while also being a major part of cartilage, 
connective tissue and synovial fluid. Cell surface N-acetylglucosamine plays a role in 
signal transduction, antibody recognition and cell-cell interactions (Ashry and Aly, 
2007). Just as there are a large variety of biologically relevant functions of N-
acetylglucosamine, there are also a large number of applications for this important 
monosaccharide.  
Glucosamine and N-acetylglucosamine are both used for the treatment of 
degenerative joint disorders such as osteoarthritis. Osteoarthritis is a type of arthritis 
where the cartilage around the joints gradually deteriorates over time and the synovial 
membrane becomes inflamed. The general course of treatment is the management of 
symptoms with the use of pain-management drugs such as analgesics and anti-
inflammatory drugs. However, glucosamine and N-acetylglucosamine are proposed to 
slow the progression of the disease. Both are components of cartilage and synovial 
fluid (Shikhman et al., 2005; Moskowitz, 2001). N-acetylglucosamine was patented 
as a therapeutic for the treatment of joint disorders such as arthritis in 1972 (Rovati et 
al., 1972). Glucosamine has been found to reduce the progression of the narrowing of 
the joints in patients and therefore slow the progression of the disorder (Reginster et 
al., 2001). The ability of N-acetylglucosamine versus glucosamine to inhibit the 
production of pro-inflammatory mediators was examined by Shikman et al., (2001). 
N-acetylglucosamine was observed to be a more potent inhibitor of IL1β production 
by chondrocytes than glucosamine. They furthered this work in 2004 when they found 
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that N-acetylglucosamine reduced levels of cartilage deterioration in rabbits with 
experimental osteoarthritis. They also observed anti-inflammatory effects with levels 
of synovial membrane inflammation reduced (Shikhman et al., 2004). Tamai et al., 
(2003) studied the affect of N-acetylglucosamine on cartilage injury in rabbits. 
Administration of N-acetylglucosamine was found to cause an increase in 
proliferation of chondrocytes around the damaged cartilage, in turn leading to 
enhanced regeneration of the cartilage in comparison with the controls (Tamai et al., 
2003). N-acetylglucosamine now plays a huge role in the functional foods market. It 
is widely taken as a nutritional supplement for joint stiffness, joint pain and 
management of disorders such as arthritis. 
N-acetylglucosamine has also shown positive results in the treatment of Irritable 
Bowel Syndrome. In 1993 it was patented as a gastroprotective agent (Burtan and 
Freeman, 1993). Burtan found that individuals with inflammatory bowel disease 
lacked N-acetylglucosamine which, as an amino sugar, is part of the protective layer 
of glycosaminoglycans in the intestinal mucosa. Rhodes (1996) proposed that one of 
the causes of inflammatory bowel disease was a change in mucosal glycosylation. 
Salvatore et al., (2000) examined the effect of N-acetylglucosamine in paediatric 
inflammatory bowel disease. It was found that supplementation of N-
acetylglucosamine resulted in an increase in glycosaminoglycans at mucosal surfaces 
such as the epithelia which resulted in improved patient symptoms.  
N-acetylglucosamine has also been used topically in cosmetics (Bissett, 2006). 
Hyaluronic acid, a glycosaminoglycan comprised of N-acetylglucosamine and 
glucuronic acid, is a component of connective tissue. Due to its effect on cell 
proliferation, migration and angiogenesis it is known to promote wound healing. It 
hydrates the skin and improves its’ elasticity, reducing the formation of wrinkles. As a 
component of hyaluronic acid, N-acetylglucosamine was examined as a cosmetic 
supplement and was been found to also increase skin hydration and stimulate the 
healing of wounds (Bissett, 2006). Bissett et al., (2006) also found that the application 
of N-acetylglucosamine to the skin reduced facial hyperpigmentation. It was proposed 
that this was through its inhibition of the production of tyrosinase, an oxidase that 
catalyses a step in the formation of melanin.  
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1.1.4 Industrial chitin hydrolysis for the production of chito-oligosaccharides and 
N-acetylglucosamine 
 
Industrial chitin hydrolysis may be achieved through a number of different methods 
including physical, chemical and enzymatic breakdown (Prashanth and Tharanathan, 
2007).  
 
1.1.4.1 Chemical hydrolysis of chitin 
 
Chitin may be hydrolysed into smaller length chito-oligosaccharides using chemical 
means. Acid hydrolysis is one of the most common chemical industrial methods for 
chitin breakdown (Aam et al., 2010). There are many steps to this process; removal of 
contaminants, removal of minerals, acid hydrolysis, neutralisation, fractionation of 
products and lyophilisation. Chitin is derived from shrimp and crab waste for this 
purpose. This chitin waste also includes numerous contaminants such as proteins, 
lipids and minerals which need to be removed prior to chitin hydrolysis. A low 
concentration of sodium hydroxide (3% NaOH) is added to the chitin waste to 
eliminate any protein present followed by the addition of a low concentration of acid 
such as 3% HCl, to remove any minerals, such as calcium, present. Chitin may then 
either be de-acetylated to produce chitosan through the addition of a higher 
concentration of NaOH (40%) or immediately treated with a strong acid (up to 40% 
HCl) to produce various length chito-oligosaccharides through hydrolysis of the 
glycosidic bond. The temperature and acid concentration must be cautiously chosen to 
ensure breakdown to chito-oligosaccharides and N-acetylglucosamine without 
degradation of the final product (Jeon et al., 2000; Kim and Rajapakse, 2005; 
Prashanth and Tharanathan, 2007; Chen et al., 2010). While chemical hydrolysis is 
commonly used as it a relatively quick process, there are many disadvantages. The 
final product is a random mixture of various length chito-oligosaccharides and N-
acetylglucosamine monomers. The yields also tend to be quite low, with the 
production of large amounts of toxic waste leading to environmental concerns 
(Prasanth and Tharanathan, 2007).  
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1.1.4.2 Physical hydrolysis of chitin 
 
Radiation methods have been used as a method for the hydrolysis of chitin. This 
method was proposed as a way of reducing the toxic waste produced by the chemical 
hydrolysis of chitin. Radiation is applied to chitin in an acetic acid solution to 
hydrolyse the glycosidic linkages and generate shorter length chito-oligosaccharides. 
The use of ultrasound and thermal treatments have also been proposed as physical 
methods for the hydrolysis of chitin (Prashanth and Tharanathan, 2007). 
 
1.1.4.3 Enzymatic hydrolysis of chitin 
 
The enzymatic hydrolysis of chitin has many advantages over the chemical hydrolysis 
methods. It gives a more defined product and is a more controlled process. There is 
very little if any toxic waste generated and therefore it is a more environmentally 
friendly process than chemical/acid hydrolysis. Enzymatic hydrolysis of chitin yields 
the most specific length chito-oligosaccharide chains and the purest form of N-
acetylglucosamine. However, it is a much costlier process. The re-use and 
immobilisation of the chitinolytic enzymes has been found to reduce this cost 
(Prashanth and Tharanathan, 2007; Kim and Rajapaske, 2005). 
The β-1,4 glycosidic bond between the N-acetylglucosamine residues is hydrolysed 
through the action of enzymes called chitinases and chitobiases. There are two types 
of chitinase: endo-acting and exo-acting. The choice of enzyme depends on the final 
product required. For example, to generate N-acetylglucosamine from chitin, exo-
acting chitinases and chitobiases would primarily be used.  In comparison, the 
generation of mid-length chito-oligosaccharides would demand the use of endo-acting 
chitinases rather than exo-acting chitinases (Dahiya et al., 2006). The reaction 
conditions, such as incubation time, temperature and enzyme components may be 
tailored to generate an optimal yield of the specific length chito-oligosaccharides 
required (Patil et al., 2000). Initially, the enzymatic hydrolysis of chitin was 
performed in batch reactors. This was a costly process, which did not allow the re-use 
of the hydrolytic enzymes. The length of chito-oligosaccharides produced was also 
found to be not tightly controlled. These problems have been solved by enzyme 
immobilisation, which has allowed the re-use of enzymes. This has significantly 
reduced the cost of this process and has also facilitated more control over the reaction. 
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Hydrolysis may be stopped immediately and therefore the length of chito-
oligosaccharides generated can be more easily regulated (Kim and Rajapaske, 2005). 
Ramirez-Coutino et al., (2006) demonstrated the use of chitinases from Lecanicillium 
fungicola in the production of chito-oligosaccharides. They found that these endo-
acting chitinases had a higher preference for α-chitin over β–chitin and preferred the 
de-acetylated form over the acetylated form showing the importance of starting 
material and enzyme choice in the hydrolysis of chitin. de Assis et al., (2010) 
employed a fungal chitinase (from Metarhizum anisopliae) for the hydrolysis of 
chitin. This fungal chitinase produced chito-oligosaccharides ranging from 2-6 
residues in chain length.  
 
1.1.4.4 Purification and characterisation of chito-oligosaccharides 
 
The final product of hydrolysed chitin is usually a composition of various length 
chito-oligosaccharides which need to be characterised and separated based on their 
chain length. The ideal end product is a series of separate fractions, each composed of 
one specific length chito-oligosaccharide. Various methods have been employed for 
the separation of chito-oligosaccharides based on size, including filtration methods 
such as ultrafiltration, mass spectrometry and also chromatographic methods such as 
Size Exclusion Chromatography (SEC). The chito-oligosaccharides can then be 
characterised using Nuclear Magnetic Resonance (NMR) or Mass Spectrometry (MS). 
NMR can elucidate the degree of acetylation of the oligosaccharides while MS can 
also elucidate the chain length (Aam et al., 2010). Sorbotten et al., (2005) 
successfully used Size Exclusion Chromatography (SEC) to separate the different 
length chito-oligosaccharides generated from the enzymatic hydrolysis of chitosan by 
a chitinase from S. marcescens. Ultra-filtration was successfully used by Ngo et al., 
(2009) to separate chito-oligosaccharides based on their molecular weight.  
 
1.1.5 Chitin active enzymes 
 
1.1.5.1 Chitin Synthase 
 
Chitin synthases are part of the glycosyltransferase family. Glycosyltransferases are 
involved in the formation of glycosidic bonds through the transfer of a sugar donor to 
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a sugar acceptor, generally resulting in the formation of a sugar chain 
(polysaccharide). In other cases, they can catalyse the transfer of a sugar donor to 
non-sugar acceptor such as a lipid or a protein (Henrissat and Davies, 2000). Chitin 
synthases are grouped together based on the fact that they synthesise chitin, generally 
through the addition of the activated donor sugar UDP-N-acetylglucosamine to an N-
acetylglucosamine acceptor (Imai et al., 2003). Glycosyltransferases such as chitin 
synthase can exhibit a modular nature due to the presence of two independent 
domains; a catalytic domain and a binding domain. While the catalytic domain is 
involved in the synthesis of glycosidic bonds, the function of the binding domain is to 
bind insoluble substrates like chitin. The function of this will be explained more under 
carbohydrate binding proteins (see Section 1.1.5.3). Glycosyltransferases have been 
industrially useful for the production of oligosaccharides (Palcic, 2011; Merzendorfer, 
2006; Henrissat and Davies, 2000). 
 
 
Fig 1.4: Chitin synthase catalysed reaction of chitin synthesis. UDP-N-
acetylglucosamine is added to the non-reducing end of the growing chitin chain (Imai 
et al., 2003).  
 
1.1.5.2 Chitin Deacetylase 
 
Chitin deacetylases are found in fungi, insects and particularly marine bacteria. They 
catalyse the removal of the N-acetyl group from N-acetylglucosamine residues in 
chitin, releasing acetic acid. This is critical in the conversion of chitin to chitosan, a 
deacetylated form of chitin. Chitin deacetylases identify a sequence of four 
consecutive N-acetylglucosamine residues as their substrate, with one residue then 
deacetylated. The residue deacetylated depends on the type of deacetylase involved as 
chitin deacetylases can be endo- or exo-acting. The biological function of chitin 
deacetylases is to produce chitosan for incorporation into the cell wall and as a 
defence mechanism (Ghormade et al., 2010). Industrially chitosan has been produced 
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from chitin using a combination of thermal and chemical methods. However, these 
conditions tend to be very harsh and damage the final product. Therefore, there is 
more interest in the use of chitin deacetylases for the commercial generation of 
chitosan. Chitosan has a variety of applications in the biotechnological industry. For 
example it has been used as a scaffold for enzyme immobilisation, it has been used in 
food additives, cosmetics, as a drug delivery system and as a wound dressing 
(Ghormade et al., 2010; Zhao et al., 2010). 
 
Fig 1.5: Deacetylation of chitin to produce chitosan. Chitin deacetylase removes 
the N-acetyl group from chitin to produce chitosan (Tran et al., 2011). 
 
1.1.5.3 Chitin-Binding Protein 
 
Carbohydrate-binding proteins (CBPs) belong to seven families in the CAZy database 
(1, 2, 12, 14, 18, 19, and 37). The CBPs from families 14 and 18 exist as distinct 
independent proteins with no catalytic activity, while the CBPs belonging to the 
remaining families exist as domains of larger enzymes, thought to increase the 
catalytic activity of the enzyme as well as increase the affinity of the enzyme for the 
substrate (Vaaje-Kolstad et al., 2005). CBPs from families 14 and 18 are chitin-
binding proteins that have been found to have certain anti-fungal activity. One of the 
most characterised CBPs is CBP21 from S. marcescens. This CBP works in synergy 
with the chitinases from S. marcescens to enhance the rate of chitin hydrolysis, 
through the binding of chitin and the subsequent disruption of its’ structure, allowing 
the chitinase enzymes easier access to the chitin substrate. Chitin-binding proteins 
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have other numerous functions, from defence in plants to cell-wall degradation by 
bacteria (Vaaje-Kolstad et al., 2005).  
 
1.1.5.4 Chitin Hydrolase 
 
Chitin hydrolases are classified as glycosyl hydrolases and are also known as 
chitinases or chitobiases. Chitinases and chitobiases are found in all organisms. In 
fungi and invertebrates they play a role in morphogenesis and promoting the structural 
integrity of the organism. However, in plants they act in a defensive role against 
fungal pathogens, in vertebrates they are present in the digestive tract where they also 
play a defensive role, while in bacteria they primarily undertake a nutritional role 
(Ubhayasekera, 2011). As already mentioned in Section 1.1.4.3 chitinases and 
chitobiases form a chitinolytic system comprising endo- and exo-acting enzymes that 
work synergistically in the hydrolysis of chitin. Firstly, endo-acting enzymes cleave 
chitin internally generating various length chito-oligosaccharides. Exo-acting 
chitinases such as chitobiosidases may then break down these chito-oligomers to 
chitobiose (a dimer of N-acetylglucosamine). Finally exo-acting chitobiases (N-
acetylglucosaminidases) hydrolyze chitobiose to single N-acetylglucosamine residues 
(Bhattacharya et al., 2007; Sahai and Manocha, 1993). Chitinases are divided into two 
families; Family 18 and Family 19 based on sequence similarity of the catalytic 
domain. However, each family has structural and mechanistic differences. Chitobiases 
are part of Family 20 (Synstad et al., 2004). 
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Fig 1.6: The step-wise hydrolysis of chitin. A mixture of endo- and exo-acting 
enzymes hydrolyse chitin chains to shorter chito-oligosaccharide chains and N-
acetylglucosamine monomers. Image obtained from Sigma Aldrich 
(www.sigmaaldrich.com).  
 
1.2 The Glycosyl Hydrolases (Chitinases and Chitobiases) 
 
1.2.1 Classification - CAZy database – a resource for carbohydrate active 
enzymes 
 
The huge array of naturally occurring carbohydrates is mirrored by the large variety 
of enzymes available for their hydrolysis. These enzymes are classified as glycosyl 
hydrolases in the CAZy database (http://www.cazy.org/). Glycosyl hydrolases are 
enzymes that catalyse the hydrolysis of glycosidic linkages through the addition of a 
water molecule. This CAZy database (Carbohydrate-Active Enzymes database) acts 
as a resource for all carbohydrate active enzymes and classifies these enzymes into 
families based on amino acid similarity. This takes the structural similarities of the 
enzymes into account. This system has moved away from the IUB Enzyme 
Nomenclature system which classifies enzymes based on the type of reaction they 
catalyse but gave no indication of the structural features of the enzymes or their 
evolutionary history (Henrissat, 1991; Cantarel et al., 2008). Before entry into the 
CAZy database the sequences of prospective proteins, obtained from Genbank, are 
compared and analysed using tools such as BLAST and HMMER. They are 
categorised into families based on sequence similarities, generally of the catalytic or 
carbohydrate-binding domains. Once in the database, information is available on the 
 17 
sequence, structure and function of the protein. Five main types of proteins are 
covered in this database, all with different activities on carbohydrates; Glycosyl 
hydrolases, Glycosyltransferases, Polysaccharide lyases, Carbohydrate esterases and 
Carbohydrate-binding modules. While glycosyl hydrolases are involved in the 
cleavage of glycosidic linkages, glycosyltransferases are involved in the synthesis of 
glycosidic bonds. Polysaccharide lyases are also involved in the cleavage of 
glycosidic bonds, however, with a different mechanism than glycosyl hydrolases. 
Where glycosyl hydrolases cleave glycosidic linkages through hydrolysis, 
polysaccharide lyases act on carbohydrates composed of uronic acid and cleave the 
linkages through a β-elimination mechanism. Carbohydrate esterases are involved in 
the cleavage of ester-containing groups on polysaccharides. Finally, carbohydrate-
binding modules are the only proteins covered in this database with no enzymatic 
activity. They are involved in the binding of carbohydrates, and through this 
interaction assist the enzymes in carbohydrate hydrolysis. These carbohydrate-binding 
modules can be found independently or as a domain in a carbohydrate-active enzyme 
(Cantarel et al., 2008). There are currently 131 families of glycosyl hydrolases in the 
CAZy database (Cantarel et al., 2008; Henrissat 1991).  
 
1.2.2 General mechanism of action of Glycosyl Hydrolases 
 
X-ray crystallography and site-specific mutagenesis has allowed the study of the 
catalytic mechanism of these enzymes (Rye and Withers, 2000). The catalytic 
mechanism of glycosyl hydrolases has been elucidated through the crystallisation of 
enzyme-substrate and enzyme-inhibitor complexes. The functions of critical residues 
have been elucidated through the generation of mutants via site-specific mutagenesis 
(Rye and Withers, 2000). The glycosidic linkage is known to be one of the most 
durable linkages in nature. Glycosyl hydrolases are extremely adept enzymes, capable 
of catalysing the hydrolysis of glycosidic linkages up to 10
17
 times faster than would 
happen naturally (Davies and Henrissat, 1995). Despite the large number and diverse 
nature of glycosyl hydrolases available, they all have the same general acid-catalysis 
mechanism of action, requiring two critical residues in their active site for hydrolysis 
of the glycosidic bond. These residues act as a proton donor and a nucleophile (a 
general acid and a general base). Hydrolysis of the glycosidic bond can result in one 
of two outcomes; inversion or retention of the anomeric configuration (Davies and 
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Henrissat, 1995). Inverting glycosyl hydrolases result in inversion of the 
stereochemistry of the anomeric carbon, whereas retaining glycosyl hydrolases 
maintain the linkage type. The first glycosyl hydrolase to be structurally characterised 
and its mechanism deciphered was lysozyme (Matthews and Remington, 1975; Blake 
et al., 1965). In the following years, the catalytic mechanism of many other glycosyl 
hydrolases has been elucidated along with the residues critical for catalysis (Davies 
and Henrissat, 1995).  
 
1.2.2.1 Inverting glycosyl hydrolases 
 
Inverting glycosyl hydrolases catalyse the hydrolysis of substrates with the inversion 
of the anomeric configuration in a single-displacement reaction. Hydrolysis is carried 
out via a one-step mechanism that involves the creation of an oxocarbenium ion 
transition state. This mechanism requires a general acid (proton donor) and a general 
base (nucleophile) that are located approximately 10.5 Å apart. The general acid 
donates a proton to the anomeric carbon of the sugar (C1). The general base activates 
the water molecule through the removal of a proton. The nucleophile is a good 
distance away from the proton donor as it must allow space for the water molecule. 
The nucleophilicity of the water is then increased, allowing an attack on the anomeric 
carbon to occur, splitting the glycosidic linkage (Vuong and Wilson, 2010; Zechel and 
Withers, 2000; Davies and Henrissat, 1995). The mechanism is explained in the 
diagram below (see Figure 1.7).  
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Fig 1.7: Catalytic mechanism of a β-inverting glycosyl hydrolase. The glycosidic 
bond is cleaved by the glycosyl hydrolase with inversion of the anomeric carbon. 
Image obtained from CAZypedia. 
(http://www.cazypedia.org/images/a/a0/Inverting_glucosidase_mechanism.png) 
 
1.2.2.2 Retaining glycosyl hydrolases 
 
The main structural difference between inverting and retaining glycosyl hydrolases is 
the distance between the catalytic residues in the active site. In both types the proton 
donor occupies the same position (Zechel and Withers, 2000). In inverting glycosyl 
hydrolases these groups are approximately 10.5 Å apart. In retaining glycosyl 
hydrolases these groups are much closer together, approximately only 5.5 Å apart. 
Hydrolysis by retaining glycosyl hydrolases proceeds with retention of the anomeric 
configuration. It involves a double-displacement mechanism with the creation of a 
covalent glycosyl-enzyme intermediate. The first step is the attack of the anomeric 
carbon by the nucleophile which forms the glycosyl intermediate. The other catalytic 
residue acts as the proton donor and donates a proton to the glycosidic oxygen bond. 
The second step involves the hydrolysis of the glycosyl-enzyme intermediate with 
water, followed by the deprotonation of the water molecule by the catalytic residue 
(Vuong and Wilson, 2010; Zechel and Withers, 2000; Davies and Henrissat, 1995). 
The mechanism is explained in the diagram below (see Figure 1.8).  
 
.  
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Fig 1.8: Catalytic mechanism of a β-retaining glycosyl hydrolase. The glycosidic 
bond is cleaved by the glycosyl hydrolase with retention of the anomeric carbon. 
Image obtained from CAZypedia. 
(http://www.cazypedia.org/images/7/7f/Retaining_glycosidase_mechanism.png) 
 
1.2.2.3 Substrate-assisted glycosyl hydrolases 
 
Substrate-assisted catalysis is an occurrence in glycosyl hydrolases that hydrolyse 
substrates containing an N-acetyl group at the C-2 position. These enzymes generally 
have only a proton donor and no nucleophilic residue. This reaction also proceeds via 
a double-displacement mechanism, however it is the N-acetyl group that acts as the 
nucleophile and leads to the formation of an oxazolinium intermediate. The 
mechanism detailed in the diagram below (see Figure 1.9).  
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Fig 1.9: Catalytic mechanism of the substrate-assisted glycosyl hydrolases. Image 
obtained from CAZypedia. 
(http://www.cazypedia.org/images/0/0c/Hex_neighboring_mechanism.png) 
 
1.2.3 General topology of the active site of the glycosyl hydrolases 
 
There are three main folds observed in the active site of glycosyl hydrolases; a 
pocket/crater, a cleft/groove and a tunnel (Davies and Henrissat, 1995). The pocket 
shape is optimal for the binding of the non-reducing ends of sugars and therefore 
more favourable towards hydrolysis of shorter chain polysaccharides. It is often 
observed in exo-acting enzymes. The cleft and groove structures favour the hydrolysis 
of longer-chain polysaccharides. The accessible cleft site is primarily observed in 
endo-acting enzymes such as chitinases. The tunnel is less accessible than the cleft 
fold, and is less common. It has so far only been observed in cellobiohydrolases 
where the polysaccharide chain is fed through the tunnel and the hydrolysis products 
are released (Davies and Henrissat, 1995).  
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a)    b)    c) 
 
Fig 1.10: The three main folds observed in the glycosyl hydrolase active site a) 
crater, b) cleft and c) tunnel. The catalytic residues are highlighted in red (Davies 
and Henrissat, 1995). 
 
1.2.4 Families of the Glycosyl Hydrolases 
 
1.2.4.1 Family 18 Chitinases 
 
Family 18 chitinases are retaining glycosyl hydrolases involved in the breakdown of 
chitin and chito-oligosaccharide chains. They are found in bacteria, fungi, insects but 
more interestingly are found in mammals that are not known to possess chitin 
synthesis and metabolism machinery (Funkhouser and Aronson Jr, 2007). Family 18 
glycosyl hydrolases consist of five separate domains. An N-terminal signal peptide is 
present which transports the enzyme to the periplasm where it is cleaved by 
peptidases, followed by secretion of the enzyme. The catalytic domain is made up of 
an (α/β)8 barrel containing the active site in a cleft/groove. This groove is largely 
composed of aromatic residues such as tryptophan, which are important for substrate 
binding (see Figure 1.10b). A glutamate residue present in the active site is proposed 
as the catalytically critical proton donor. Unlike the majority of glycosyl hydrolases, 
there is no nucleophilic residue present. It is believed to catalyse the hydrolysis of 
chitin in the same substrate-assisted mechanism described in Section 1.2.2.3) (Sorlie 
et al., 2012; Perrakis et al., 2004; Synstad et al., 2004). There is also a chitin-binding 
domain that functions in the binding of the insoluble chitin substrate which enhances 
catalytic activity, a serine/threonine-rich region, and a C-terminal region (Perrakis et 
al., 2004).  
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1.2.4.2 Family 19 Chitinases  
 
The first family 19 chitinases to be classified were found in plants. Now, however 
they have been found in other species such as bacteria, viruses and fungi. Plant family 
19 chitinases play a defensive role, while bacterial family 19 chitinases play a role in 
nutrition with fungal family 19 chitinases playing a developmental and structural role 
(Ubhayasekera, 2011). In comparison with family 18 chitinases, family 19 chitinases 
are inverting glycosyl hydrolases. There are two glutamate residues present in the 
active site required for catalysis, one acting as a general acid and the other acting as a 
general base (Brameld and Goddard III, 1998). The majority of family 19 chitinases 
are comprised of an N-terminal signal peptide, a carbohydrate-binding module and a 
catalytic domain. The carbohydrate-binding module is attached to the rest of the 
molecule via a linker. These chitinases display an “α-helical bi-lobed” structure, with 
the active site contained within a wide groove (Ubhayasekera, 2011). Due to their 
differences in mechanism the family 18 and family 19 chitinases give rise to different 
hydrolysis products; the family 18 chitinases yield a β-anomer while the family 19 
chitinases yield an α-anomer.  
 
 
Fig 1.11: The “bi-lobed” structure of the family 19 chitinase. The active site cleft 
can clearly be seen between the two “lobes” of the family 19 chitinase structure 
(Ubhayasekera, 2011). 
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1.2.4.3 Family 20 Chitobiases 
 
Family 20 glycosyl hydrolases encompass enzymes with three different activities; N-
acetylhexosaminidases, lacto-N-biosidases and chitobiases (N-
acetylglucosamindases). N-acetylhexosaminidases catalyse the hydrolysis of N-
aceylglucosamine residues from chitobiose and longer-length chito-oligosaccharides. 
Lacto-N-biosidases catalyse the hydrolysis of lacto-N-biose (a dimer of galactose and 
N-acetylglucosamine) from longer oligosaccharides such as lacto-N-tetraose, lacto-N-
hexaose etc. While chitinases hydrolyse chitin and chito-oligosaccharide chains, 
chitobiases hydrolyse chitobiose (a dimer of N-acetylglucosamine) to release two N-
acetylglucosamine residues (Intra et al., 2008).  Family 20 glycosyl hydrolases are 
widely found in nature, from bacteria and fungi to insects, plants and mammals. N-
acetylhexosaminidases are known to play crucial roles in mammals, as mutations in 
the HEX genes cause lysosomal storage disorders such as Tay Sachs disease and 
Sandhoff disease (Tews et al., 1996). In insects they play a role in structural 
remodelling, in bacteria and fungi they play a role in chitin metabolism while in 
plants they play a role in defence (Tews et al., 1996). Family 20 glycosyl hydrolases 
are generally composed of four domains and an N-terminal signal peptide. Functions 
have been designated to two of the domains; a catalytic domain and a chitin binding 
domain. The catalytic domain, a (βα)8 barrel, contains the active site which is 
contained in a deep crater. These enzymes have a slightly unusual mechanism of 
catalysis, a substrate-assisted mechanism, requiring a proton donor such as a 
glutamate residue in the active site, while the N-acetyl group of the sugar acts as the 
nucleophile (Prag et al., 2000; Tews et al., 1996).  
 
1.3 Bacterial Chitinases 
 
Chitinolytic systems are found in a variety of bacterial species with the most well 
characterised system being that from S. marcescens. The structures and mechanisms 
of its chitinases and chitobiases have been well studied.  
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1.3.1 Serratia marcescens 
 
1.3.1.1 S. marcescens overview 
 
S. marcescens is an opportunistic pathogen causing nosocomial infections. It is a gram 
negative, saprophytic bacteria belonging to the genus Serratia and is a member of the 
Enterobacteriaceae family (Hejazi & Falkiner, 1997).  Some strains are red-coloured 
due to the production of a red-pigmented secondary metabolite known as prodigiosin. 
In nature S. marcescens is found primarily in water and soil. In humans the bacteria 
rarely infects healthy individuals, preferring immuno-compromised individuals as its 
host (Grimont & Grimont, 2006). S. marcescens may cause a number of infections, 
ranging from sinusitis, urinary tract infections and wound infections to the more lethal 
pneumonia and septicaemia (Hejazi & Falkiner, 1997). S. marcescens is resistant to 
many commonly used antibiotics including ampicillin, tetracycline, and first and 
second generation cephalosporins (Grimont & Grimont, 2006; Hejazi & Falkiner, 
1997). S. marcescens contains many virulence factors that help it to evade the 
immune system, colonise the host and cause damage. These factors include the 
production of powerful siderophores for iron aquisition, the production of hemolysin 
(a molecule capable of lysing host erythrocytes) and the secretion of proteases which 
can cause tissue damage. Certain strains of S. marcescens can even be resistant to the 
bacteriolytic activity of serum (Grimont & Grimont, 2006).  
 
 
Fig 1.12: The red colour of Serratia marcescens due to the presence of the 
pigment, prodigiosin. Image obtained from: 
http://faculty.ccbcmd.edu/courses/bio141/labmanua/lab2/sminsol.html 
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1.3.1.2 The chitinolytic system from S. marcescens 
 
S. marcescens was discovered to be an extremely efficient chitin-degrading 
bacterium, producing more chitinolytic enzymes than all those tested alongside it 
(Monreal & Reese, 1969). It was found that S. marcescens produced a total of five 
proteins associated with chitin degradation, all of which have different molecular 
weights (Fuchs et al., 1986). Further studies deduced that S. marcescens contains 
three chitinases, named ChiA, ChiB and ChiC, a chitobiase and a protein associated 
with binding chitin named CBP21 (Brurberg et al., 2001). These enzymes comprise 
the chitinolytic system of S. marcescens and their production is induced by the 
presence of chitin in the environment. All three chitinases are exported, with varying 
degrees of processing prior to secretion. ChiA contains an N-terminal signal peptide 
that is cleaved before secretion, ChiB is not processed before secretion and the ChiC 
N-terminal signal peptide is non-specifically cleaved at various residues to generate 
various forms of ChiC before secretion (Brurberg et al., 2001). These enzymes each 
exhibit a modular structure, with one domain designated as a catalytic domain and a 
second designated as a binding domain. Functions were assigned to the various 
domains based on sequence homologies with various other enzymes (Brurberg et al., 
2001). While ChiA, ChiB and ChiC belong to the family 18 glycosyl hydrolases, the 
chitobiase belongs to the family 20 glycosyl hydrolases. The chitobiase enzyme also 
undergoes processing before secretion i.e. the cleavage of its N-terminal signal 
peptide. The final protein involved in the S. marcescens chitinolytic system has no 
enzymatic function. It is a chitin-binding protein that also has an N-terminal signal 
peptide cleaved before secretion thought to have a role in disrupting the crystalline 
structure of chitin and promoting hydrolysis by making enzyme access easier 
(Brurberg et al., 2001).  
 
1.3.1.3 Chitin hydrolysis by S. marcescens 
 
ChiA is the most studied chitinase from S. marcescens with its crystal structure being 
described by Perrakis et al., in 1994. It was found to contain three domains; a β-barrel 
domain, a β-strand domain and a domain containing a mixture of α and β folds. The 
structure of the chitinase associated with a chito-oligosaccharide substrate was also 
studied and this led to the assignment of the β-barrel as the catalytic domain (Perrakis 
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et al., 1994). Both ChiA and ChiB contain N-terminal signal peptides and are 
exported proteins. The active site of both ChiA and ChiB is located in a deep cleft in 
the catalytic domain surrounded by aromatic residues for substrate binding. The main 
difference in ChiA and ChiB structure is the position of their respective active sites 
which are located on opposite sides of the catalytic domain, suggesting that they each 
bind in a different orientation to the chitin substrate (Brurberg et al., 2001). Brurberg 
et al. (1996) studied the catalytic properties of a ChiA and ChiB from S. marcescens 
BLJ200. Incubation of ChiA with (GlcNAc)1-6 yielded (GlcNAc)2 and GlcNAc 
hinting at an exo-chitobiohydrolase activity. Incubation of ChiB with (GlcNAc)1-6 
also yielded (GlcNAc)2 and GlcNAc. There was no hydrolysis of (GlcNAc)2. 
Chitobiose ((GlcNAc)2) is then hydrolysed by chitobiases to yield the final N-
acetylglucosamine product (Prag et al., 2000; Tews et al., 1996). The hydrolysis of 
chitin by ChiA and ChiB is enhanced by the action of CBP21, a chitin-binding 
protein. This protein binds to the insoluble chitin substrate disrupting its structure and 
thus making it more accessible for the ChiA and ChiB enzymes to bind and hydrolyse 
the substrate (Vaaje-Kolstad et al., 2005).  
 
1.3.1.4 Mechanism of action of the chitobiase from S. marcescens 
 
Drouillard et al., (1997) first described the nature of chitobiose hydrolysis by the 
chitobiase from S. marcescens. They found that the reaction was catalysed with 
retention of the anomeric configuration. They also proposed a substrate-assisted 
mechanism of catalysis for this chitobiase. They suggested that the chitobiase 
employed the N-acetyl group of the sugar as the nucleophile, due to the absence of a 
conveniently located nucleophile in the active site.  Tews et al., (1996) also proposed 
a substrate-assisted mechanism of hydrolysis where Glu 540 acted as the proton donor 
while the N-acetyl group of the sugar substrate acted as the nucleophile resulting in 
retention of the anomeric configuration. Prag et al., furthered this work in 2000 when 
they performed site-directed mutagenesis on the supposed catalytically important 
residues. They confirmed that Glu 540 acted as the proton donor while the Asp 
residue at position 539 held the N-acetyl group of the sugar substrate in place while it 
acted as the nucleophile. This unusual mechanism of action involving the sugar 
substrate as the nucleophile is also found in lysozyme and another family 20 enzyme, 
namely, the N-acetyl-β-hexosaminidase (Rye & Withers, 2000; Drouillard et al., 
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1997). Davies and Henrissat (1995) described the topology of the active site of 
chitobiases. The active site is shaped like a pocket or crater. This shape is favourable 
for the binding of the reducing end of sugars such as that found in chitobiose. This 
shape is not optimal for the binding of longer-chain polysaccharides due to the lack of 
available reducing ends. 
 
1.3.2 Photorhabdus luminescens 
 
This study has identified a chitobiase enzyme from P. luminescens which shows 
significant similarities with that of the well characterised S. marcescens chitobiase 
(see Section 3.2).  
 
1.3.2.1 P. luminescens overview 
 
The genre of bacteria, Photorhabdus, is a member of the Enterobacteriaceae family. 
Fischer et al., (1999) were the first group to classify Photorhabdus into three distinct 
genomic species, Photorhabdus luminescens, Photorhabdus temperata and 
Photorhabdus asymbiotica, based on numerous studies including 16S rRNA 
sequencing, ∆Tm measurements to determine DNA relatedness and phenotypic 
characterizations. P. luminescens was used in this study and therefore will be the only 
Photorhabdus species discussed further.  
Photorhabdus luminescens is a gram negative, motile, facultative anaerobe that forms 
a symbiotic relationship with soil residing, entomopathogenic nematodes from the 
Heterorhabditidae family. P. luminescens has a life cycle composed of two phases, 
symbiosis and virulence. During symbiosis P. luminescens may be found dwelling in 
the gut of the nematode during its infective juvenile (IJ) stage (Waterfield et al., 2009; 
Forst et al., 1997). Infective juvenile nematodes are characterized by the fact that their 
development is arrested and that they are searching for insect hosts. Infection of the 
insect by the nematode can be through the digestive tract, respiratory tract or through 
penetration of the outer skin. The final destination of the nematode is the hemocoel of 
the insect, a cavity containing blood and hemolymph. Once in the hemocoel, the 
nematodes release the virulent bacteria present in their system which kills the insect 
host by inducing septicaemia (Waterfield et al., 2009; Forst & Nealson, 1996). 
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However, before killing the insect host the bacteria is confronted by the insects’ 
immune system. P. luminescens secretes virulence molecules such as toxins in order 
to evade this immune response. It secretes toxins such as Tcd and Mcf1 which are 
involved in breaking down the gut epithelium and inducing apoptosis in cells 
respectively (Waterfield et al., 2009). It also secretes a molecule known as LopT 
which inhibits uptake and consequently phagocytosis by macrophages. In order to 
prevent other bacteria and fungi from colonising the insect cadaver, P. luminescens 
secretes various anti-microbial molecules such as the toxic S-type pyocins. Tca is an 
orally toxic molecule secreted by P. luminescens to deter larger animals from eating 
the insect cadaver (Waterfield et al., 2009). 
 
 
Fig 1.13: The life cycle of P. luminescens. The life cycle of the P. luminescens 
bacteria includes two main stages; symbiosis and virulence (Williamson and Kaya, 
2003).  
 
The insect carcass plays host to the nematode and bacteria. P. luminescens secretes 
lipases and proteases which breakdown the insect cadaver providing nutrients for the 
nematodes, allowing them to feed and reproduce. Approximately two weeks post 
infection, the nematodes, in their infective juvenile stage and in symbiosis again with 
the bacteria, leave the insect carcass to seek out new prey, repeating the cycle all over 
again (Forst et al., 1997; Forst & Nealson, 1996;).  
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Fig 1.14: Nematode from the Heterorhabditidae family infected with 
Photorhabdus luminescens The glow from the insect is due to the bioluminescent 
properties of the P. luminescens bacteria (University of Bath, 2004).  
 
1.3.2.2 Chitinase activity of P. luminescens 
 
Chen et al., (1996) examined the chitinase activity in Xenorhabdus and Photorhabdus 
species through the use of N-acetylglucosamine, chitotriose and chitin substrates. 
They were found to have both endo- and exo-chitinase activity. From a literature 
search carried out it was observed that there has been very little work carried out on 
specific chitinases and chitobiases from P. luminescens.  Part of the P. luminescens 
life cycle involves the killing of the insect host and subsequent colonization of its 
cadaver. This requires the degradation of the insect cadaver to provide nutrients for 
the nematode. The outer shell of insects contains chitin as a structural component. 
Presumably, P. luminescens secretes chitinases and chitobiases to aid in the 
degradation of the insect cadaver, before symbiosis can take place. These chitinases 
and chitobiases could also play a defensive role during colonisation of the insect, 
having anti-fungal and anti-microbial effects, preventing colonisation of the insect by 
other bacteria and fungi (Chen et al., 1996).  
 
The first objective of this work was to carry out a detailed study of the chitobiase 
enzyme from P. luminescens. However, a second objective was also identified. 
Enzymes have two innate functions; catalysis and binding. While the first objective of 
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this study was to study the catalytic mechanism of the chitobiase enzyme, a second 
objective was to study the binding mechanism of the enzyme. Enzymes are extremely 
specific in the binding of their substrates. The substrate of the chitobiase enzyme is 
chitobiose, a dimer of N-acetylglucosamine. The chitobiase enzyme has the ability to 
specifically recognise and bind this sugar before catalysing its hydrolysis. The binding 
of this sugar by the enzyme was of interest in this study. N-acetylglucosamine is a 
sugar residue that is a component of glycans found on eukaryotic proteins. It is of 
commercial importance in the field of glycoprotein biotherapeutics where its presence 
or absence can greatly affect the pharmacokinetic properties of a biotherapeutic. The 
glycopatterns on glycoproteins and glycolipids may be analysed using carbohydrate 
binding proteins such as lectins. There is only one commercially available lectin 
capable of binding terminal GlcNAc, GSLII. This is difficult to make recombinantly 
due to its’ structural complexity (it is a glycosylated protein with disulphide bridges 
present). Alternatives are therefore needed that can be produced recombinantly. 
Recent protein structural studies have used mutagenesis as a tool to remove the 
catalytic activity of enzymes, while still allowing them to retain their unique specific 
binding abilities. The ability of the chitobiase enzyme to specifically bind to N-
acetylglucosamine is therefore of commercial interest. Therefore, the second objective 
of this work was the mutagenesis of the chitobiase enzyme in order to engineer it into 
a novel carbohydrate binding protein that could be used in the analysis of 
glycoproteins. The mechanism and significance of glycosylation, biologically and 
industrially, is discussed in detail below (see Section 1.4). 
 
1.4 Glycosylation 
 
The majority of eukaryotic proteins undergo post-translational modifications after 
synthesis that affect their structure, properties and functions. These covalent 
modifications basically regulate the proteins behaviour and extend the variety of 
functions of the proteome (Seo and Lee, 2004).  There are many different types of 
post-translational modifications, some common types include ubiquitination, 
phosphorylation, sulfation, acylation and glycosylation. While some post-translational 
modifications are common on intracellular proteins, such as phosphorylation, others 
are more common on extracellular proteins, such as glycosylation. Glycosylation is 
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one of the most prevalent and diverse post-translational modifications. It is the 
process of adding glycans to molecules to form glycoconjugates. Glycans can be 
added to a variety of molecules, such as proteins and lipids. The addition of glycans to 
lipids forms biologically important membrane glycolipids such as lipopolysaccharide 
found in bacterial cell membranes and glycosphingolipids, found in eukaryotic cell 
membranes. The addition of glycans to proteins is, however, a far more prevalent 
occurrence, with over two-thirds of human proteins being glycosylated (Apweiler et 
al., 1999). Glycosylation occurs in the Endoplasmic Reticulum (ER) and Golgi 
apparatus where specific enzymes catalyze the addition and removal of sugar residues 
to polypeptide chains. The glycosylation process is not template driven; it contains no 
proof reading machinery and depends on the physiological status of the cell. Glycans 
can combine with each other in ways that differ in chain length, sequence and 
branching points. This leads to enormous variation in the glycan structures produced. 
Laine (1997) calculated that there were 1.44 x 10
15
 possible isomers for a hexamer 
when using 20 sugars. There are two main types of glycosylation; N-linked 
glycosylation and O-linked glycosylation. Apweiler et al., (1999), through analysis of 
the SWISS-PROT database, deduced that over 90% of all glycosylated eukaryotic 
proteins are N-linked. The other 10% are O-linked. Some glycoproteins may contain 
both O-linked and N-linked glycans. 
 
1.4.1 Eukaryotic glycosylation  
 
Glycosylation is carried out by both eukaryotes and prokaryotes. However, eukaryotic 
glycosylation was discovered before prokaryotic glycosylation and is better 
understood and characterized. 
 
1.4.1.1 N-linked glycosylation 
 
Eukaryotic N-linked glycosylation is carried out in the ER and golgi apparatus of the 
cell. N-linked glycans are linked to the amide nitrogen of asparagine residues (hence 
N-linked); however the asparagine residue must be present in the following consensus 
sequence: Asn-X-Ser/Thr, where X denotes any amino acid except proline. The 
consensus sequence Asn-X-Thr is preferred over Asn-X-Ser. Glycosylation is a 
stepwise process (Varki et al., 2009). The first step is the production of a core glycan 
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structure at the membrane of the ER. This core structure is produced on a lipid 
“anchor” known as dolichol phosphate and then transferred to the nitrogen of an 
asparagine residue of the consensus sequence by a transferase enzyme, oligosaccharyl 
transferase, in the lumen of the ER. 
  
Fig 1.15: The N-linked glycosylation pathway. The stepwise construction of N-
linked glycans (Varki et al., 2008).  
 
This core glycan structure is comprised of two N-acetylglucosamine residues, nine 
mannose residues and three glucose residues. This glycan structure then undergoes 
modifications as it moves through the ER, including the removal of the three glucose 
residues through the action of a glucosidase and the removal of up to four of the 
mannose residues through the action of a mannosidase. Once correctly folded this 
new glycoprotein, with the glycan core attached, is transported to the golgi apparatus 
where the glycans are then modified resulting in the production of one of three types 
of glycan structure; high mannose, complex and hybrid (see Figure 1.16). 
Transferases are then involved in the completion of the glycan structures through the 
addition of further glycans. The addition of an N-acetylglucosamine residue catalyses 
the cleavage of two more mannose residues from the original glycan structure leaving 
a core structure common to all N-linked glycans of Manα1-6(Manα1-3)Manβ1-
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4GlcNAcβ1-4GlcNAcβ1-Asn-X-Ser/Thr. The addition of N-acetylglucosamine, 
galactose and sialic acid residues are catalysed by N-acetylglycosyltransferases, 
galactosyltransferases and sialytransferases respectively. These glycans are 
sequentially attached and can result in branched bi-, tri- and tetra-antennary 
structures. Sialic acid is generally the terminal glycan residue present on these 
structures. The complete glycoproteins are then transported from the golgi apparatus 
to carry out their functions throughout the cell (Schwartz and Aebi, 2011; Varki et al., 
2009; Burda and Aebi, 1999; Dwek, 1996).  
 
Fig 1.16: Types of N-linked glycosylation. The three main patterns of N-linked 
glycosylation are high mannose, hybrid and complex (Hossler et al., 2009). 
 
1.4.1.2 O-linked glycosylation 
 
In comparison with N-linked glycans, O-linked glycans do not share the same core 
glycan structure. A variety of structures are observed for O-linked glycosylation. O-
linked glycans are most commonly attached to the hydroxyl group (oxygen – hence 
O-linked) of a serine or threonine. They can also be attached to tyrosine, 
hydroxyproline or other hydroxylated amino acids. In contrast with N-linked 
glycosylation, no attachment consensus sequence is known, therefore the presence of 
O-linked glycan structures is difficult to predict. While N-linked glycosylation begins 
in the ER and finishes in the golgi apparatus (Varki et al., 2009), O-linked 
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glycosylation is solely carried out in the golgi apparatus. O-linked glycans are named 
by the initiating sugar, i.e. O-linked GalNAc, O-linked Fucose etc. Assembly of the 
glycan structure most commonly begins with the addition of an N-acetygalactosamine 
residue to a hydroxyl group of a serine or threonine by an N-
acetylgalactosaminyltransferase. However, other residues such as galactose, N-
acetylglucosamine, fucose, xylose and glucosamine can also be used. The initiating 
sugar is attached to a lipid carrier, undecaprenyl pyrophosphate (UDP). These glycan 
structures may then be elongated by the sequential addition of sugars by various 
glycosyl transferases and modifications such as acylation and sulfation may also take 
place. The structure of O-linked glycans is dependent on the enzymes present in the 
cell, and therefore, the cells metabolic status. Mucins are one of the most commonly 
studied O-linked glycans. Mucins are glycoproteins that are characterised by an 
abundance of O-linked glycans due to the presence of a large number of serine and 
threonine residues. These glycoproteins tend to be saturated with O-linked glycans. 
Mucins account for a large proportion of mucous, the viscous substance secreted by 
epithelial cells in areas such as the respiratory, urinary and digestive tracts. Mucin O-
linked glycans are highly sialylated which results in them being negatively charged. 
This allows them to bind water molecules and carry out their functions such as 
lubrication and acting as a protective barrier for the epithelium against chemical, 
physical and microbial threats. There are eight main types of core glycan structure, 
two of which are found commonly in mucins. These structures vary widely in size and 
composition (Varki et al., 2009; Taylor and Drikamer, 2006; Van den Steen et al., 
1998; Dwek, 1996).  
 
 
Fig 1.17: The 8 main cores of O-linked glycosylation. There are eight main types of 
O–linked glycan core which are depicted above (Hossler et al., 2009).  
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1.4.2 Prokaryotic glycosylation 
 
While eukaryotic protein glycosylation was first described in the 1930s, it wasn’t until 
the 1970s that protein glycosylation in prokaryotes was described (Baker et al., 2013). 
Until that point, it was thought that prokaryotes did not have the ability to glycosylate 
their proteins due to the lack of an ER and golgi apparatus in their cellular structure. 
Glycosylation is now accepted as a widely occurring process in prokaryotes and is 
even a more complicated process than in eukaryotes due to the larger variety of sugars 
involved. As with eukaryotes, there are two main types of glycosylation found in 
prokaryotes; N-linked and O-linked, the glycan linked to the amide nitrogen of an 
asparagine and the glycan linked to the hydroxyl oxygen of a serine or threonine 
respectively (Baker et al., 2013; Nothaft and Szymanski, 2010). O-linked 
glycosylation was the first type of glycosylation discovered in prokaryotes when it 
was noted that surface layer (S-layer) proteins of Halobacterium and Clostridium 
species were modified with O-linked glycans. These glycosylated proteins accounted 
for up to 50% of the S-layer and covered the surface of the bacterium with the glycan 
portion of the protein protruding away from the surface (Mescher and Strominger, 
1976; Sletyr and Thorne, 1976). Glycans were not only observed on S-layer proteins, 
as proteins like flagellin and pilli were also found to be extensively glycosylated. 
Prokaryotic glycosylation was generally found on extracellular proteins and was 
proposed to have a role in the virulence of the bacterium and the pathogenesis of 
disease by facilitating interactions with the host. The first comprehensive evidence of 
an N-linked glycosylation pathway was described for the bacterium Campylobacter 
jejuni by Szymanski et al., in 1999 and Young et al., in 2002.  Two proteins, PEB3 
and CgpA, were discovered to be glycosylated by this pathway. Now over 65 proteins 
are known to be glycosylated in C. jejuni in this way (Nothaft and Szymanski, 2010).  
 
1.4.3 Biological functions of glycosylation 
 
Due to their presence on the cell surface glycans have major functions in cell-cell 
interactions, cell recognition, cell signalling and cell trafficking (Dwek, 1996). They 
also play major roles in protein structure and the immune system which will be 
discussed below. 
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1.4.3.1 Structural and protective functions on glycoproteins 
 
Glycans can have profound effects on the structure of the protein and consequently 
can affect the proteins physio-chemical properties and function. It has been noted that 
glycosylated proteins have an increased stability in comparison with their non-
glycosylated forms. N-linked glycan structures are relatively large, with a sialyated 
triantennary structure having a molecular weight of around 2851 Da (Imperiali and 
O’Connor, 1999). Glycans can facilitate the correct folding of the protein in the ER 
and stabilisation of the tertiary structure. The thermostability and pH stability of a 
protein are majorly affected by the glycans on its surface. Solubility can also be 
enhanced due to the hydrophilic nature of the glycans and also their masking of 
hydrophobic amino acids of the protein. The longevity of the protein is also improved 
as the glycans cover the protein surface protecting it from proteases. The glycans also 
mask antigenic domains present on the protein, resulting in decreased 
immunogenicity (Sinclair and Elliott, 2004; Imperiali and O’Connor, 1999).  
 
1.4.3.2 Immunological functions of glycosylation 
 
Glycans play a major role in mammalian immunity, with their main function being to 
act as ligands for a variety of immunologically important receptors. Glycans act as 
ligands for a family of selectins involved in leukocyte trafficking. Selectins are 
receptors expressed on endothelial cells and leukocytes. There are different types of 
selectins, the most common being E-selectin (endothelial cells), L-selectin 
(leukocytes) and P-selectin (platelets). These selectins each recognise a specific 
glycan ligand, for example P-selectin recognises and binds sialyl-Lewis-X. During 
inflammation the expression of these receptors is up-regulated. Binding between the 
selectin and specific glycan allows the leukocytes and platelets to roll along the 
epithelium, eventually migrating through the epithelial barrier to the site of 
inflammation (Marth and Grewal, 2008).  
Macrophages are phagocytic cells involved in innate immunity. They recognise and 
engulf pathogens. One way in which they recognise pathogens is through their 
mannose receptor. As the name suggests this receptor recognises certain mannose 
patterns, specifically α-linked highly branched mannose structures. Recognition of 
this pattern, particularly on a pathogen, triggers phagocytosis of the pathogen. This 
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recognition event can also trigger the release of pro-inflammatory mediators such as 
cytokines and initiation of the adaptive immune response (Linehan et al., 2000).  
The mucous that lines the gastrointestinal tract is composed of mucins which as 
mentioned before are O-linked highly glycosylated proteins.  The glycan patterns on 
these mucins are recognised by gastrointestinal microbes, both commensal bacteria 
and pathogenic bacteria. Adhering to these glycans allows the bacteria to colonize the 
gastrointestinal tract. This is critical for pathogens to initiate an infection but also 
critical for commensals to carry out their probiotic functions. Bacteria adhere to 
glycans using adhesins such as fimbriae and pili as well as membrane and cell wall 
proteins. Mucin glycans also play a protective role in the gastrointestinal tract. Certain 
glycans have the ability to be released once bound such as those belonging to MUC1. 
This inhibits colonisation by the pathogen (Juge, 2012; Moran et al., 2011).  
Toll-like receptors (TLRs) are pattern recognition receptors. There are 10 in the 
receptor family (numbered 1-10 eg. TLR1, TLR2 etc) and they are found expressed 
on immune cells such as dendritic cells. They each recognise different patterns called 
Pathogen Associated Molecular Patterns (PAMPs). In general these patterns are 
glycans present on pathogens. After recognition of a PAMP the TLR initiates a 
signalling cascade in the cell which results in the “switching-on” of the innate 
immune system. This includes the secretion of cytokines and other pro-inflammatory 
mediators as well as the activation and differentiation of T cells (van Kooyk and 
Rabinovich, 2008).  
 
1.4.5 Aberrant glycosylation  
 
Glycosylation is essential for the survival of eukaryotes. The absence of glycosylation 
in an embryo is fatal and defects in the glycosylation pathway lead to several serious 
human diseases. In mice a defect in N-acetylglucosaminyltransferase, the enzyme 
responsible for the transfer of N-acetylglucosamine to the lipid anchor (dolichol 
phosphate), results in the death of an embryo 5 days after fertilization. This signifies 
that glycosylation is critical in embryonic development (Marek et al., 1999). Many 
human diseases of aberrant glycosylation are congenital. There are 12 congenital 
diseases connected with defects in N-linked glycosylation while there are 7 congenital 
diseases connected with O-linked glycosylation. The symptoms of these diseases can 
vary from mild to fatal, with neurological and developmental issues prevalent (Jaeken 
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and Matthijis, 2007).  One of the most studied groups of aberrant glycosylation 
related diseases are lysosomal storage diseases. These diseases affect the ability of the 
lysosomes to break down glycoconjugates, specifically a defect in glycosidases leads 
to an inability to catabolise glycoproteins. Diseases characterised by lysosomal 
storage disorders include Tay-Sachs and Sandhoff’s (Ohtsubo and Marth, 2006).  
Tay-Sachs is a genetic disease characterised by a mutation in the HEXA gene which 
causes a hexosaminidase deficiency. This enzyme breaks down Gm2 type 
gangliosides. A build-up of these sialyated glycosphingolipids can cause symptoms 
such as blindness and paralysis and even lead to death. Sandhoff disease is also 
caused by a hexosaminidase deficiency, which leads to a build-up of gangliosides and 
the aforementioned symptoms (Tews et al., 1996).  Glycosylation is crucial in the 
functioning of a normal nervous system. Neurodegenerative diseases such as 
Alzheimers and muscular degenerative diseases such as muscular dystrophy have 
been shown to have decreased glycosylation or altered glycosylation patterns 
(Kanninen et al., 2004; Muntoni et al., 2002). 
The glycosylation pattern on the surface of a cell may signify the physiological status 
of the cell. Changes in this pattern are known to be associated with certain diseases. 
Practically all cancers have been associated with early changes in glycan pattern 
(Dube and Bertozzi, 2005). Cancer is an umbrella term for a group of diseases all 
characterised by uncontrolled cell growth. This cell growth is accompanied by 
phenotypic changes that allow the cells to migrate through tissues and evade the 
immune system. One mechanism of immune evasion is the alteration of glycan 
patterns on the surface of the cell.  This is achieved by the over-expression of glycans 
and glycosylation associated enzymes such as glycosyltransferases (Ghazarian et al., 
2011). A common alteration observed is an increase in the branching of N-glycans. 
An alteration of terminal residues is also common. These alterations in glycosylation 
can act as biomarkers for the diagnosis of cancer as the presence/absence of certain 
glycans distinguishes then from healthy cells. Certain glycoproteins are also up-
regulated in cancer and the detection of these may facilitate a diagnosis. Prostate 
Specific Antigen (PSA), a glycoprotein produced by prostate cells, is up-regulated 
during prostate cancer. The diagnosis of prostate cancer now involves the 
measurement of this antigen. Ovarian cancer is characterised by an upregulation in 
CA-125, a mucin also known as MUC16. Detection of this glycoprotein can help to 
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diagnose ovarian cancer. Carcinoembryonic antigen (CEA) is a glycoprotein involved 
in cell-adhesion. It is thought to be upregulated in colon cancer. 
While it is known that altered glycosylation is a hallmark of cancer, it is not known 
whether the altered glycosylation pattern causes the cancer or is caused by the cancer 
(Ghazarian et al., 2011; Dube and Bertozzi, 2005).  
 
1.4.6 Glycoprotein therapeutics and the Biopharmaceutical Industry 
 
Originally, proteins for therapeutic use were obtained from natural sources. 
Historically insulin was obtained and purified from the pancreas of cattle and pigs, 
however due to a lack of purity, batch to batch variation and the constant risk of 
contamination this is no longer a viable option (Sethuraman and Stadheim, 2006). 
More recently, recombinant DNA technologies and protein production have been 
exploited for the production of new therapeutics. In a move away from the standard 
chemical drugs made by the pharmaceutical industry, this new industry, the 
biopharmaceutical industry, produces novel protein-based therapeutics. The industry 
is growing rapidly, with the biopharmaceutical market estimated to be now worth 
$100 billion annually. There are over 300 biopharmaceutical therapeutics currently 
approved and available for use (Langer, 2012). The first biotherapeutic produced and 
approved for human use was recombinant insulin (humulin) in 1982 (Walsh, 2010).  
All therapies based on proteins, nucleic acids, cells and tissues are included in the 
term biotherapeutics. However, only protein biotherapeutics will be discussed here. 
Protein biotherapeutics are produced recombinantly using both prokaryotic and 
eukaryotic expression systems. Prokaryotic systems include the use of bacterial cells 
such as E. coli for the over-expression of the recombinant protein. Eukaryotic systems 
include the use of cell lines such as Chinese Hamster Ovary (CHO) cells as well as 
the use of insect cell lines and yeast-based systems. Transgenic animals are used for 
the production of antibodies. Expression of recombinant proteins in prokaryotic hosts 
is relatively cheap, simple and fast with large yields of product obtained. However, 
the use of mammalian cell lines is favored due to their ability to glycosylate proteins 
in a similar fashion to the native human protein. In 2006 over 70% of therapeutic 
proteins were observed to be glycosylated (Walsh, 2006; Sinclair and Elliott, 2005). 
The correct glycosylation of these protein therapeutics is essential as they affect 
properties including stability, efficacy, immunogenicity and solubility (Werner et al., 
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2007). As already mentioned glycosylation is largely affected by the metabolic status 
of the cell. Due to pressures of high level expression and variable growth conditions 
at large scale, including fluctuations in nutrient composition of the media, 
heterogeneous glycosylation of the recombinant products often results. The difficulty 
of tightly regulating all the growth variables during large-scale expression results in a 
product containing a mixture of glycoforms, differentially glycosylated forms of the 
same protein (Werner et al., 2007; Walsh, 2006; Sinclair and Elliott, 2005). Different 
glycoforms of the same therapeutic may have very different pharmacological 
properties. Erythropoietin (EPO), a hormone involved in the production of red blood 
cells, is a glycoprotein containing three potential N-linked glycosylation sites (Asn 
24, 38, 83) and one potential O-linked glycosylation site (Ser 126) (Delorme et al., 
1992). The degree of sialylation on recombinant erythropoietin greatly affects its half-
life in vivo. Sialylated and non-sialylated versions of erythropoietin were administered 
to rodents. The sialylated version had a plasma half-life of 5-6 hours in contrast with 
the non-sialylated version which had a half-life of less than 2 minutes (Erbayraktar et 
al., 2003). An example of heterogenous glycosylation having an effect on protein 
half-life was also observed for the drug Lenercept, a “p55 tumour necrosis factor 
receptor fusion protein” (Jones et al., 2007). This therapeutic was administered 
intravenously to cynomolgus monkeys and the pharmacokinetic properties were 
analysed. Blood samples were taken intermittently and the lenercept glycoforms 
present in these samples were analysed. The glycoforms of lenercept with a high 
number of terminal GlcNAc residues were rapidly cleared from circulation. It was 
proposed that the mannose receptor selectively cleared these glycoforms (Jones et al., 
2007). N-acetylneuraminic acid, when present at the terminal end of glycan structures, 
has been shown to increase the half-life of therapeutics in circulation. Hyper-
glycosylation of therapeutics has also been shown to increase the half-life of 
therapeutics (Hossler et al., 2009). The consensus sequence for N-linked 
glycosylation may also be engineered into the protein sequence, increasing the overall 
glycosylation of the protein. This is known to increase the activity and half-life of the 
therapeutic protein. Such was the case with erythropoietin (Hossler et al., 2009).  
CHO cells may add N-glycolylneuraminic acid (NGNA) to glycoproteins, a glycan 
not present on human glycoproteins. EPO expressed from CHO cells can contain 
various amounts of NGNA. When present in low amounts, <1% of total terminal 
residues there are no adverse effects observed. However, when present in higher 
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quantities, such as >7%, immune responses have been observed (Noguchi et al., 
2005).  
Efforts have been made to alter the glycosylation system of the expression systems to 
either try ensure more homogenous glycosylation of the resulting therapeutics or to 
alter the glycosylation patterns for more favorable characteristics of the protein 
therapeutics.  In 2005 Roche bought a glycoengineering company called GlycArt for 
$190 million. This company specializes in the modification of mammalian cell lines 
for optimal glycosylation of protein therapeutics. They engineered a cell line that was 
deficient in fucosyltransferases but over produced n-acetylglycosaminyltransferases. 
When used for the production of monoclonal antibodies, an extra N-
acetylglucosamine residue was added to the Fc portion of the antibody, increasing the 
efficiency of its interaction with the Fc receptor (Sheridan, 2007).  
As the glycosylation pattern of a protein therapeutic has a significant affect on its 
immunogenicity and efficacy, regulatory bodies increasingly require the glycoproteins 
to be thoroughly characterized initially and throughout production to ensure batch to 
batch consistency. Any alteration in the manufacturing process of biotherapeutics 
requires the resulting products to be extensively characterized to ensure changes in 
glycosylation have not occurred that could result in varied efficacy and safety. This 
has led to the industry wide need for fast, high-throughput glycoprotein analysis 
techniques (Werner et al., 2007; Walsh, 2006; Sinclair and Elliott, 2005).  
 
1.4.7 Analysis of glycans 
 
Analysis of the glycan structures attached to glycoproteins is a difficult task due to the 
diversity of glycans and branched nature of the structure. There is a need for rapid and 
accurate methods for glycoprotein analysis for both the diagnostic and 
biopharmaceutical industries. There are many techniques currently used including 2-D 
Gel Electrophoresis, Mass Spectrometry (MS), High Performance Liquid 
Chromatography (HPLC), Nuclear Magnetic Resonance (NMR) and Lectin 
Microarrays. Certain techniques such as MS require enzymatic release of the glycan 
prior to analysis. Techniques that can analyse the glycoprotein as a whole, with no 
need for prior enzymatic treatment, are preferred.  
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1.4.7.1 2-D Gel Electrophoresis 
 
Two-dimensional gel electrophoresis can be used as an initial step in the analysis of 
glycoproteins. An advantage of this technique is that intact glycoproteins can be 
analysed. However, it is difficult to separate various glycoforms in a mixture. 2-D gel 
electrophoresis separates proteins based on their molecular weight and isoelectric 
point. Slight differences in glycosylation do not cause much of a change in the 
molecular weight of the protein, so these different glycoforms are not fully separated 
from each other. Sialylation has a big effect on the pI of the protein, but it is very 
difficult to separate neutral sugars. Many glycoforms could be represented by one 
spot on the gel. This method does not allow for the characterisation of glycans, it only 
acts as a representation of the various glycoforms present (Geyer and Geyer, 2006).  
 
1.4.7.2 Release of glycans from glycoproteins 
 
The majority of glycoprotein analysis techniques require the release of glycans from 
the protein or at least the hydrolysis of the protein into smaller peptide fragments. 
Glycans can be released from glycoproteins using chemical or enzymatic means. 
Enzymatic methods are more specific than chemical methods, cleaving off specific 
glycans. Enzymes allow the cleavage of peptide fragments with glycans attached, 
allowing the site of glycosylation to be deciphered. However, the use of enzymes also 
has disadvantages due to the fact that not all glycans are cleaved due to the specificity 
of the enzyme. Chemical methods are not specific and can therefore cleave all glycans 
from the glycoprotein; however the use of chemicals can also lead to the degradation 
of the protein. This results in information being lost on the number and location of 
glycosylation sites. Trypsin and PGNaseF are commonly used in the enzymatic 
treatment of N-linked glycoproteins. Trypsin cleaves the C-terminal end of a Lys-Arg 
sequence while PGNaseF cleaves the majority of N-linked glycans through the 
hydrolysis of the GlcNAc attached to the asparagine residue of the protein.  The 
release of O-linked glycans is more complicated than N-linked glycans due to the 
high variety in their structure. The enzymes used for this purpose are limited in their 
specificity, such as an O-glycanase. A commonly used chemical for glycan release is 
sodium borohydride, which results in the release of N-linked and O-linked glycans. 
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One disadvantage of this method is O-linked glycans can be damaged during this 
process (Geyer and Geyer, 2006).  
 
1.4.7.3 Mass Spectrometry (MS) 
 
MS has been used for glycoprotein analysis due to its relatively high levels of 
sensitivity and throughput. It can be used to detect different glycans in a sample as 
well as providing information on their structures. MS measures the mass of a sample 
through the measurement of its charge to mass ratio (Hitchen and Dell, 2006). The 
samples are converted to gas-phase ions in an ioniser and are accelerated to a mass 
analyzer where they are detected. This produces a mass spectrum. Glycoprotein 
analysis by MS may be carried out on intact or cleaved glycans. The mass of intact 
glycans can be deciphered. However structural analysis requires the glycans to be 
cleaved from the surface of the glycoprotein. These glycoprotein samples are subject 
to enzymatic or chemical cleavage prior to analysis. An issue with this method is that 
not all glycans will be removed from the glycan and although the structures of the 
glycans can be deciphered there is no information elucidated on the individual 
glycosylation sites (Dalpathado and Desaire, 2008; Geyer and Geyer, 2006;). Another 
disadvantage is the isomeric nature of carbohydrates. MS cannot distinguish between 
isomers due to their identical molecular mass. There is also no information on linkage 
or branching obtained (Pilobello and Mahal, 2007).  
 
1.4.7.4 High Performance Liquid Chromatography (HPLC) 
 
HPLC is a method than can separate samples in a mixture using a wide range of 
various adsorbtion and separation materials. The wide range of materials available 
allows for the separation of isomeric compounds, which is not possible using MS. 
Glycans are released from the glycoprotein for analysis. Labelling of the individual 
glycans can also be carried out which allows individual components to be quantified. 
There are a variety of different types of HPLC, each separating components based on 
different characteristics. Anion exchange chromatography separates molecules based 
on their charge. Reversed-phase HPLC (RP-HPLC) separates molecules based on 
their hydrophobicity while normal-phase HPLC (NP-HPLC) separates molecules 
based on their hydrophilicity. Both RP-HPLC and NP-HPLC also generally separate 
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the glycans by size. The structures of the glycans can be proposed when compared 
with the elution profiles of known glycans (Geyer and Geyer, 2006).  
 
1.4.7.5 Nuclear Magnetic Resonance (NMR) 
 
NMR analyses glycans based on the extent that a glycan distorts a magnetic field. This 
technique has the ability of completely characterising the entire glycan, from its mass and 
structure to its anomeric configuration and linkage. However, there are also some major 
disadvantages associated. It is an expensive technique that requires skilled personnel, 
specialised equipment and large concentrations of purified glycans. It is also better suited 
to the analysis of single glycan samples rather than mixtures (Geyer and Geyer, 2006).  
 
1.4.7.6 Analysis of glycoproteins using lectins  
 
1.4.7.6.1 Functions of lectins 
 
Lectins are carbohydrate-binding proteins (CBPs) and have been described in the 
literature since the 19
th
 century. The function of lectins depends on their source. In 
general, the main function of lectins is recognition. While plant lectins were the first 
to be discovered their exact functions are still not completely clear. Two assumptions 
made in the 1970s are still being reported and discussed today. It is widely believed 
that plant lectins play a defensive role, due to their ability to bind carbohydrates on 
the surface of invading pathogens such as bacteria and fungi. Lectins can also be 
insecticidal as they are found in large numbers in the seeds of plants that are 
poisonous to insects such as wheat germ agglutinin (WGA). The second function of 
lectins in plants is the most debated. It was proposed that lectins facilitate the binding 
of rhizobia to plants forming a symbiotic relationship. Rhizobia are nitrogen-fixing 
bacteria that can provide the leguminous plant with all its nitrogen needs. However, 
there has been conflicting evidence for this theory and it has neither been confirmed 
nor disproved. The function of microbial and viral lectins is more defined. Lectins 
facilitate the binding of microbes and viruses to host cells/tissues through recognition 
of carbohydrate patterns on their surface. The addition of an appropriate inhibiting 
sugar can block binding and therefore prevent infection. There are numerous 
functions described for animal lectins, it depends on the type of lectin. Collectins such 
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as Mannose binding proteins (MBP) turn on innate immunity through the initiation of 
the complement pathway caused by the recognition of surface mannose patterns on 
bacteria. MBPs have a modular nature; their C-terminus contains a carbohydrate 
recognition domain (CRD) which binds to the invading microbe while the N-terminus 
triggers complement activation through its interaction with the cell (Ambrosi et al., 
2005). Selectins facilitate the binding of leukocytes to blood vessels, allowing them to 
migrate into tissues to sites of inflammation (Nilsson, 2007; Sharon and Lis, 2004; Lis 
& Sharon, 1998). The family of galectins have various functions, from controlling 
development of tissues through their differential expression to regulating the immune 
system through their action on T cells (Camby et al., 2006). Expression of galectin-1 
and galectin-3 on certain tumour cells such as colon and breast has been noted, 
leading to the proposition of either as cancer biomarkers (Ambrosi et al., 2005; 
Takenaka et al., 2004).  
 
1.4.7.6.2 Lectin analysis 
 
Lectins have been exploited for the analysis of glycans due to their innate binding 
specificities. They have the ability to recognise and bind very specific glycan 
structures found on glycoproteins. Lectins can be used in a variety of ways for 
glycoprotein analysis such as Lectin Affinity Chromatography (LAC), Enzyme-
Linked Lectin Assays (ELLA) and Lectin Microarrays (Geyer and Geyer, 2006).  
LAC exploits the specificity of lectin binding. The lectins can be attached to a 
stationary phase in a column to separate a mixture of glycoproteins. The glycoproteins 
of interest may either be retained on the column, then requiring elution, or are free to 
flow through the column. This method may be used to retain the sugar of interest or to 
remove certain glycoproteins from a mixture. A series of columns with different 
specificities can be used to separate an array of glycoproteins from a mixture (Geyer 
and Geyer, 2006). ELLAs follow the same format as the commonly used ELISA. In 
this method the glycoprotein is immobilised on the surface of a 96-well plate where it 
can be probed with a selection of labelled lectins of different specificities. Binding is 
detected using colorimetric techniques (Thompson et al., 2011). A panel of lectins of 
known specificities can be used which allow the pattern of glycans on the protein to 
be elucidated. Another format in which lectins are useful in glycoanalysis is the lectin 
microarray which consists of a panel of lectins immobilised on a chip. Samples 
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containing glycoproteins, generally fluorescently tagged, are added to the chip and 
allowed to hybridise. The pattern of spots generated allows the surface glycans of the 
glycoprotein to be elucidated (Pilbello and Mahal, 2007).  
There are many advantages associated with the use of lectins for glycoprotein 
analysis. Primarily, the glycoproteins can be analysed in an intact state and there is no 
requirement for prior denaturation of the protein. Terminal glycan residues can be 
elucidated from the intact glycoprotein, while underlying residues can be exposed 
using specific enzymatic treatments, such as the use of glycosidases that remove the 
terminal glycan residues. Large concentrations of the glycoprotein are not required 
due to the specificity of the reaction. Lectins can be employed for in vitro but also in 
vivo work if conjugated to fluorescent proteins such as GFP (Varki et al., 2008; 
Pilbello and Mahal, 2007; Geyer and Geyer, 2006).  
Lectins are available from a wide-range of sources as discussed above (see Section 
1.4.7.6.3). However, lectins commercially used in glycan analysis are generally 
obtained from plants. There can be large batch-to-batch variations and limited 
availability. In 2006, there were only 60 commercially available fully characterised 
lectins (Pilobello and Mahal, 2007). A way to circumvent this issue is through the use 
of lectins from different sources. The use of recombinant lectins from microbial 
sources is fast gaining prominence. These recombinant lectins can be produced 
cheaply, quickly, in large quantities and there are no issues with batch-to-batch 
variation.  
 
1.5 Engineering of enzymes to potentially generate novel 
carbohydrate-binding proteins for glycoprotein analysis 
 
Enzymes have two major innate functions; binding and catalysis. In order to catalyse 
a reaction they must first bind the substrate. This chitobiose binding of the enzyme 
and its actions are very specific. Binding of the substrate occurs through Van der 
Waals forces along with ionic and hydrogen bonds. If the catalytically active residues 
of the enzyme are known, then, in theory, the catalytic activity of the enzyme may be 
eliminated/reduced using site-directed mutagenesis. This would potentially make a 
unique carbohydrate binding protein. Vital information for this work is the 
identification of catalytically important residues (Plapp, 1995).  
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Before the 1970s, active site residues were generally modified using chemical means 
to elucidate their function. In this way the catalytically important residues were 
discovered. Each amino acid has a different side group which can react with 
chemicals in a different way. A chemical was chosen that would affect an amino acid 
in a specific way. Modification of the amino acid would then result in catalytic 
changes depending on the function of the amino acid (Ferhst, 1999). Now techniques 
such as site-specific mutagenesis and structural modelling are used. This allows for 
the mutation of proposed catalytic residues and generation of mutants with varying 
degrees of catalytic activity (Plapp, 1995).  
The generation of lectins from enzymes exploits the specificity of the enzyme for its 
substrate. Various studies have tried to generate carbohydrate binding proteins from 
enzymes by removing their catalytic activity. Laine et al., (2007) have generated an 
inactive endoglycosidase that binds chitin while Jokilami et al., (2007) have generated 
an inactive polysialidase that binds to polysialic acid. Woods et al., have a patent 
pending on Lectenz. They are generating lectin-like proteins from carbohydrate-
processing enzymes. In silico analysis is performed to visualise and improve the 
enzyme-substrate binding using molecular dynamic simulations.  
This study attempts to generate a carbohydrate-binding protein through the 
mutagenesis of a chitobiase enzyme from P. luminescens. The main substrate of this 
enzyme is chitobiose, a dimer of N-acetylglucosamine. It was proposed that the 
removal of the catalytic activity of this enzyme would result in the generation of a 
protein capable of detecting and binding to N-acetylglucosamine. This carbohydrate-
binding protein would have huge potential in the fields of diagnostics and 
glycoanalysis due to the prevalence of N-acetylglucosamine residues on cell surfaces 
and biotherapeutics and the lack of choice in commercial GlcNAc binders available. 
This novel carbohydrate-binding protein could be incorporated or immmoblised into 
ELLAs, lectin microarrays and lectin affinity chromatography.  
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1.6 Objectives 
 
This project aimed to study a homologue of the S. marcescens chitobiase enzyme that 
was identified in Photorhabdus luminescens (Chb). There were two main objectives 
of this project. The first aim was to study the catalytic activity of the enzyme. This 
included the cloning, expression and purification of the enzyme for the first time. 
Characterisation of the physio-chemical properties of the purified recombinant 
enzyme was then carried out, including the use of oligosaccharide substrates to 
determine its kinetics.  
The second aim of this work was to take a closer look at the binding capabilities of 
the enzyme through the elimination of the catalytic activity of the enzyme using 
mutagenesis. This was in the interest of generating a protein that bound to N-
acetylglucosamine for the purpose of glycoprotein analysis. The binding abilities of 
the catalytically inactive enzyme were determined using techniques such as ELLAs. 
This mutagenesis was carried out with the goal to potentially generate a novel 
carbohydrate binding protein with important binding specificities that may have uses 
in glycoprotein analysis.  
A third and related aim was to carry out site-specific mutagenesis on the rChbL 
enzyme and rChb binding protein. In the case of the rChbL enzyme this was to 
provide information of the importance of certain chosen active site residues in 
catalysis, while also being an attempt to improve the catalytic activity of the enzyme. 
In the case of the rChb binding protein the mutagenesis was carried out on the same 
active site residues in order to determine the importance of these resdidues in 
substrate binding and to improve the binding abilities of the protein.  
Finally the catalytic activity of the rChbL enzyme was tested on natural substrates 
such as chitin to determine if it would be a viable option for commercial chitin 
breakdown.  
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2.1 Vectors, Primers, Constructs and Bacterial Strains: 
 
                    
Fig 2.1: pQE60 vector from Qiagen. This 3.4kb vector from Qiagen contains the 
following features; a multiple cloning site (MCS) followed by a His6 tag which 
enables the protein to be expressed with an N-terminal His6 tag, a T5 promoter/lac 
operon for inducible expression of the protein and ampicillin resistance in the form of 
a beta lactamase gene. The vector image was obtained from the Qiagen website 
(www.qiagen.com). 
 
Table 2.1 Primer Sequences 
Primer Name  Sequence (5′-3′) 
Cloning: 
chb+_F  GTCAGCCCATGGACAAGAAATTTAAATTGCAT 
chb+_R  GTCAGCGGATCCCTTTACATTATCAATTCG 
chb-_F   GTCAGCCCATGGCGCAGCAAGTGGTT 
chb-_R  GTCAGCGGATCCCTTTACATTATCAATTCG 
Mutagenesis: 
chb+cbp_F  [P]GGGGAGCTGACGCGAAGAA 
chb+cbp_R  [P]AAAATGCCAAGTCTCCAATGGTC 
chb+cbplnk_F  [P]GGTTCTCATCACCATCACCATCACTAAGCTTAATTA 
chb+cbplnk_R  [P]GCCACCAGATCCTGCCTTTACATTATCAATTCG 
63A_F   [P]GGGGCAGATGCGGCTAAATGTAATCG 
63A_R   [P]CAGTACCGCACAGTTAACGCCGTG   
648_F   [P]GGGACACTCTCTACGCGGGCGGC 
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648_R   [P]AAAAATTCACCCCAACGCGTTTGGTGGC  
545A_chb_F  [P]GGAGATGAAGCGGCGAATATCCGTTTG 
545A_cbp_F  [P]GGAGCTGACGCGGCGAATATCCGTTTG 
545A_R  [P]CCCAAAATGCCAAGTCTCCAATGGTG 
551A_F  [P]ATCCGTTTGGGAGCGGGATTCCAGG 
551A_chb_R  [P]ATTCTTCGCTTCATCTCCCCCAAAATG 
551A_cbp_R  [P]ATTCTTCGCGTCAGCTCCCCCAAAAT 
545A551A_chb_F [P]GGAGCGGGATTCCAGGATAAAAATGGTCCTATC 
545A551A_chb_R [P]CCTTCACTTCGCGCGTTATAGGCAAAC 
545A551A_cbp_F [P]CGTTTGGGAGCGGGATTCCAGGAT  
545A551A_cbp_R [P]GATATTCGCCGCGTCAGCTCCCCC 
*[P] denotes 5′ phosphorylation of primer 
 
 
Table 2.2 Constructs 
Construct Name  Description     Source 
pQE60    Expression vector for C-terminally tagged  Qiagen  
His6 proteins, T5 promoter/lac operon,  
amp
R
, ColE1 origin 
pQE60_Chb+   pQE60 plasmid containing chb ORF with  This work 
N-terminal signal peptide 
pQE60_Chb-   pQE60 plasmid containing chb ORF   This work 
without N-terminal signal peptide 
pQE60_Chb_CBP  pQE60 plasmid containing chb ORF with  This work 
N-terminal signal peptide with D539A and  
E540D mutations 
pQE60_Chb_CBPlnk  pQE60 plasmid containing chb ORF with  This work 
N-terminal signal peptide, D539A  
and E540D mutations and C-terminal  
linker of 3xGlycine and 1xSerine 
pQE60_Chb _63A  pQE60 plasmid containing chb ORF with  This work 
N-terminal signal peptide and W63A  
mutation 
pQE60_Chb _648A  pQE60 plasmid containing chb ORF with This work  
N-terminal signal peptide and D648A  
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mutation 
pQE60_Chb _545A  pQE60 plasmid containing chb ORF with This work  
N-terminal signal peptide and K545A  
mutation 
pQE60_Chb _551A  pQE60 plasmid containing chb ORF with  This work 
N-terminal signal peptide and D551A  
mutation 
pQE60_Chb _545A/551A pQE60 plasmid containing chb ORF with  This work 
N-terminal signal peptide and K545A  
and D551A mutations 
pQE60_Chb _CBP_63A pQE60 plasmid containing chb ORF with  This work 
N-terminal signal peptide with D539A,  
E540D and W63A mutations 
pQE60_Chb _CBP _648A pQE60 plasmid containing chb ORF with  This work 
N-terminal signal peptide with D539A,  
E540D and D648A mutations 
pQE60_Chb _CBP _545A pQE60 plasmid containing chb ORF with  This work 
N-terminal signal peptide with D539A,  
E540D and K545A mutations 
pQE60_Chb _CBP _551A pQE60 plasmid containing chb ORF with  This work 
N-terminal signal peptide with D539A,  
E540D and D551A mutations 
pQE60_Chb_CBP _  pQE60 plasmid containing chb ORF with  This work 
545A/551A   N-terminal signal peptide with D539A,  
E540D, K545A and D551A mutations 
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Table 2.3 Strains of bacteria used 
Strain   Description  Use   Source 
E. coli JM109  F∆traD36, proAB+  All purpose cloning Sigma 
lacIq, ∆lacZ M15  strain.  
endA1 recA1 hsdR17  Produces stable 
(rk-, mk+) mcrA  plasmid DNA. 
supE44 – gyrA96  
relA1 ∆ (lacproAB)  
thi-1 
E. coli XL10 Gold ∆(mcrA)183   All purpose cloning Stratagene 
∆(mcrCB-hsdSMR strain.  
-mrr)173 endA1  High transformation  
recA1 relA1 gyrA96  efficiency.  
supE44 thi-1   Produces stable plasmid 
lac[F∆proAB   DNA. 
lacIqZ∆M15 ::Tn10 
(tetR) Amy (CmR)] 
E coli KRX  traD36, ∆ampP,  Protease deficient. Promega 
proA+B+, lacIq,  High transformation  
∆(lacZ)M15] ∆ompT, efficiency.  
endA1, recA1,  Expression strain 
gyrA96 (Nalr), thi-1,  
hsdR17 (rk-mk+),  
relA1, supE44,  
∆(lac-proAB),  
∆(rhaBAD)  
::T7 RNA polymerase 
Photorhabdus  TT01 Wildtype     Dr. David Clarke 
luminescens        (UCC) 
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2.2 Microbiological Media: 
 
 Luria Broth (LB) Broth 
Tryptone  10 g/L 
Yeast Extract  5 g/L 
Sodium Chloride 10 g/L 
 
Media was autoclaved before use. 
 
 Luria Broth (LB) Agar Plates 
Tryptone  10 g/L 
Yeast Extract  5 g/L 
Sodium Chloride 10 g/L 
Agar   15 g/L 
 
Agar was autoclaved and 15 mL was poured aseptically into sterile Petri dishes.  
 
 Terrific Broth (TB) Medium 
 
Base Medium:  
Tryptone  12 g 
Yeast Extract  24 g 
Glycerol  4 mL 
 
Made up to 900 mL with dH2O and sterilised by autoclaving. 100 mL of sterile 1 M 
potassium phosphate buffer, pH 7.2, was added aseptically before use. 
 
 Potassium Phosphate Buffer (1 M) 
 
KH2PO4 (0.17 M) 23.1 g/L 
K2HPO4 (0.72 M) 12.4 g/L 
 
The buffer was sterilised by autoclaving.  
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2.3 Buffers and Solutions: 
 
 Buffers for the preparation of competent cells 
 
TBF1 : 
RBCl  100 mM 
MnCl2* 50 mM 
CaCl2  10 mM 
CH3CO2K 30  mM   
Glycerol 15% 
pH  5.8 
 
Made with ultrapure water. MnCl2 was added after adjusting pH. Solution was sterile 
filtered through a 0.45 μM filter. Stored at 4oC.  
 
TBF2: 
MOPs  10 mM 
RbCl  10 mM 
CaCl2  75 mM 
Glycerol 15% 
pH (KOH) 6.8 
 
Made with ultrapure water. Solution was sterile filtered through a 0.45 μM filter and 
stored at 4
o
C. 
 
 Phosphate Buffered Saline 10x (PBS) 
Na2HPO4 10.9 g/L 
NaH2PO4 3.2 g/L 
NaCl  90 g/L 
 
For PBST, the detergent Tween-20 was added to a final concentration of 0.1% (v/v). 
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 Tris Buffered Saline (TBS) 
Tris  20 mM 
NaCl  150 mM 
CaCl2  1 mM 
MgCl2  1 mM 
pH  7.6 
 
The pH was adjusted to 7.6 with HCl before addition of the MgCl2 for a final 
concentration of 1 mM. For TBST the detergent Tween-20 was added to give a final 
concentration of 0.1% (v/v).  
 
 SDS PAGE Buffer (5x) 
Tris  15 g/L 
Glycine 72 g/L 
SDS  5 g/L 
pH  8.3 
 
 SDS-PAGE Sample Buffer (5x)  
Glycerol  5 mL 
Tris   1.25 mL, 0.5 M pH 6.8 stock 
SDS   2 mL 10% stock 
β-mercaptoethanol 0.5 mL 
Bromophenol Blue 0.5% (w/v) 
dH20   1 mL 
 
 Coomassie Blue Stain Solution 
Methanol  40% (v/v) 
dH2O   50% (v/v) 
Acetic Acid  10% (v/v) 
Brilliant Blue  0.25% (w/v) 
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 Coomassie Blue Destain Solution 
Methanol  40% (v/v) 
dH2O   50% (v/v) 
Acetic Acid  10% (v/v) 
 
 Tris Acetate EDTA Buffer 50x (TAE) 
Tris   242 g/L 
EDTA   100 mL/L, 0.5M Stock 
Glacial Acetic Acid 57.1 mL/L 
pH   8.0 
 
 0.7% Agarose Gel 
TAE Buffer  1 L 
Agarose  7 g/L 
 
Gel was boiled until all agarose was dissolved. Stored at 60
o
C.  
 
 Agarose Gel Loading Dye 
Bromophenol Blue 0.25% (w/v) 
Xylene Cyanol 0.25% (w/v) 
Ficoll Type 100 15% (w/v) 
 
 Ethidium Bromide Stain 
A 10 mg/mL stock solution in dH2O was stored at 4ºC in the dark. For the staining of 
agarose gels, 100 μL of stock solution was mixed into 1 L of dH2O. The staining 
solution was kept in a plastic tray and covered to protect against light. Used ethidium 
bromide stain was collected and the ethidium bromide was extracted by mixing with a 
de-staining bag (GeneChoice, Gentaur) overnight. The clear liquid was disposed of 
routinely, and the ethidium bromide was incinerated.  
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 Lysis Buffer 
NaH2PO4  20 mM 
NaCl   0.5 M 
Imidazole  20 M 
pH   7.4 
 
 TMB Solution : 
Citric Acid   1.37 mL, 0.1 M Stock 
Sodium Citrate 3.63 mL, 0.1 M Stock 
dH2O   5 mL 
  
1 TMB Tablet (Sigma T3405) was dissolved in the TMB solution and 2 µl of H2O2 
was added directly before use. 
 
 1,2,3 Method 
 
Solution 1 
Glucose  0.5 M 
EDTA   0.1 M 
Tris HCl  1 M 
 
Solution 2 
NaOH   1 M 
SDS   10% 
 
Solution 3 
KOAc   3 M 
pH   4.8 
 
11.5 mL of glacial acetic acid and 28.5 mL dH2O were added to 60 mL of 5 M 
potassium acetate to give 3 M potassium and 5 M acetate.  
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 TE Buffer 
Tris   10 mM 
Na2-EDTA  1 mM 
pH    8.0 
 
 DNS Assay 
 
Solution A 
Sodium Potassium Tartrate 300 g 
 
Dissolved in 500 mL dH20 and heated to 40
o
C. 
 
Solution B 
NaOH   16 g 
DNS   10 g 
 
The NaOH was dissolved in 200 mL dH20 and heated to 90
o
C before adding the DNS. 
 
Solution A and B were mixed together and allowed to cool. Phenol was added at a 
final concentration of 0.2%. The solution was made up to 1 L with dH20 and then 
stored in the dark at room temperature.  
 
 Western blot transfer buffer 
Tris   60 mM 
Glycine  149 mM 
SDS   0.055% 
Methanol  10% (v/v) 
 
 Methanol acetate borate solution (MABS) 
Sodium acetate 240 mg 
Boric acid  200 mg 
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The chemicals were dissolved in 10 mL methanol. The solution was stored for one 
week at 4
o
C.  
 
2.4 Antibiotics: 
 
Ampicillin was prepared in dH2O at a concentration of 100 mg/mL and was stored at  
-20
0C. It was used at a working concentration of 100 μg/mL for solid and liquid 
media for growth of E. coli. 
 
2.5 Storing of Bacteria: 
 
Bacteria were stored as 33% glycerol stocks. 1 mL of an overnight culture (late log 
phase) was aseptically added to 500 μL of sterile 80% glycerol. If the bacteria 
contained a plasmid with antibiotic resistance the appropriate antibiotic was added to 
the overnight culture. These stocks were stored at -20
o
C and -80
o
C, as working stocks 
and permanent stocks, respectively. 
 
2.6 Culturing of Bacteria: 
 
A streak was taken from the working stock onto a fresh LB agar plate containing 
antibiotics, where appropriate. The plate was incubated overnight at 37
o
C. These 
could be stored at 4
o
C after growth for up to one week. 
 
2.7 Isolation of DNA: 
 
2.7.1 Isolation of Genomic DNA 
 
Genomic DNA was obtained using a Genomic DNA Purification Kit from Promega. 
The kit was used according to the manufacturer’s instructions. 1 mL of an overnight 
bacterial culture was centrifuged at 13,000 rpm for 2 minutes. The culture media was 
removed and the pellet was gently resuspended in 600 μL nuclei lysis solution. This 
was incubated at 80
o
C for 5 minutes in a heating block to lyse cells and was then 
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cooled to room temperature. 30 μL of RNase solution was added to the cell lysate and 
inverted 5 times to mix. This was incubated at 37
o
C for 30 minutes and then cooled to 
room temperature. 200 μL of protein precipitation solution was added and the solution 
was vortexed vigorously at high speed for 20 seconds. It was kept on ice for 5 minutes 
and then centrifuged at 13,000 rpm for 3 minutes. The culture media was removed 
and added extremely slowly to an eppendorf containing 600 μL room temperature 
isopropanol. This was gently mixed by inversion until strands of thread-like DNA 
could be seen. This was centrifuged at 13,000 rpm for 2 minutes. The culture media 
was removed and 600 μL of room temperature 70% ethanol was added to the pellet. 
This was gently inverted to wash the pellet. It was centrifuged at 13,000 rpm for 2 
minutes. The ethanol was aspirated off and the pellet was air dried in a vacuum at 
maximum speed for 10 minutes. 100 μL of DNA rehydration solution was added and 
it was incubated at 4
o
C overnight. The DNA was then stored at 4
o
C. 
The presence of the plasmid DNA was then verified by visualisation on a 0.7% 
agarose gel (see Section 2.8 for an example).  
 
2.7.2 Isolation of Plasmid DNA 
 
Two methods for the isolation of plasmid DNA were carried out during this work. 
The method used depended on the purpose of the experiment. The 1, 2, 3 Method first 
described by Birnboim and Doly (1979) yielded good quality DNA and was cheaper 
than the kit method; however it was more time-consuming. It was used for the 
screening of multiple clones from transformations.  
The HiYield Plamid miniprep kit (RBC Biosciences) yielded high quality, pure DNA 
and was less time-consuming. It was used for the preparation of plasmid DNA for 
transformations and sequencing. 
  
2.7.2.1 Isolation of Plasmid DNA - 1, 2, 3 Method 
 
This method allows covalently closed circular DNA to remain double stranded while 
selectively denaturing the high molecular weight chromosomal DNA with an alkaline 
treatment. Bacteria was removed from an agar plate using a sterile loop and added to 
an eppendorf containing 200 μL of Solution 1 (see Section 2.3) and resuspended. 
Solution 1 contained EDTA which had two purposes; firstly to chelate any divalent 
 63 
cations such as Mg
2+
 and Ca
2+ 
which are crucial for DNase activity and secondly to 
destabilise the bacterial membrane. Alternatively 1.5 mL of a bacterial culture was 
centrifuged at 13,000 rpm for 2 minutes and the culture media discarded. The pellet 
was resuspended in 200 μL of Solution 1. The re-suspension was left at room 
temperature for 5 minutes. 
200 μL of Solution 2 (see Section 2.3) was added to lyse the cells through the action 
of SDS and to break down any dsDNA due to the presence of NaOH. This was mixed 
by inversion for several seconds. It was then left on ice for 5 minutes. 
200 μL of Solution 3 (see Section 2.3) was added to neutralise the solution. The 
smaller plasmid DNA was able to renature and solubilises in these conditions 
however the larger chromosomal DNA and proteins precipitated out of solution. This 
solution was mixed by inversion for several seconds. It was left on ice for 10 minutes 
until a clot of chromosomal DNA formed. This was pelleted by centrifugation at 
13,000 rpm for 10 minutes.  
The following steps were performed in order to clean-up the plasmid DNA sample: 
The culture media was transferred to a fresh tube to which 450 μL of phenol 
chloroform isoamylalcohol (25:24:1) was added. This was mixed by vortexing and 
then centrifuged at 13,000 rpm for 5 minutes.  
The aqueous layer was carefully transferred to a fresh tube to which an equal volume 
of isopropanol was added. This was then mixed by inversion for several seconds and 
left on ice for 10 minutes.  
It was centrifuged at 13,000 rpm for 10 minutes to pellet the plasmid DNA. The 
culture media (isopropanol) was removed and the pellet was washed with 70% 
ethanol. The pellet was not resuspended. It was centrifuged again for 4 minutes. The 
ethanol was removed and the plasmid DNA was dried using a vacuum dryer 
(SpeedVac) for 5 minutes. The plasmid DNA was resuspended in 50 μL TE Buffer 
and was stored at 4
o
C. The presence of the plasmid DNA was then verified by 
visualisation on a 0.7% agarose gel. 
 
2.7.2.2 Isolation of Plasmid DNA - Kit Method 
 
High quality plasmid DNA was obtained using a HiYield plasmid mini kit (RBC 
Biosciences). This kit follows the same principles as the 1, 2, 3 method above and was 
used according to the manufacturers instructions. Bacteria was removed from an agar 
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plate using a sterile loop and resuspended in 200 μL PD1 buffer. Alternatively 1.5 mL 
of an overnight culture was centrifuged at 13,000 rpm for 2 minutes and the pellet was 
resuspended in 200 μL PD1 buffer. 200 μL of PD2 buffer was added to the tube re-
suspension and gently inverted to mix. This was allowed to stand at room temperature 
for 2 minutes until the lysate cleared. 300 μL of PD3 buffer was added and mixed 
immediately by inversion. This was centrifuged at 13,000 rpm for 2 minutes. The 
clear lysate was removed and added to a PD column that was placed in a 2 mL 
collection tube. This was centrifuged at 13,000 rpm for 30 seconds. The flow through 
was discarded. 600 μL of W1 buffer was added to the column and centrifuged at 
13,000 rpm for 30 seconds. The flow through was removed. 500 μL of wash buffer (+ 
ethanol) was added and centrifuged at 13,000 rpm for 30 seconds. The flow through 
was discarded. This step was repeated. The column was then centrifuged at 13,000 
rpm for 10 minutes to ensure removal of all residual ethanol. The column was 
transferred to a clean 1.5 mL eppendorf. 50 μL of elution buffer was added directly to 
the centre of the membrane and was allowed to stand for 2 minutes to ensure it was 
absorbed. The column was then spun at 13,000 rpm for 2 minutes to elute the purified 
plasmid DNA. The flow through was kept and stored at 4
o
C. 
The presence of the plasmid DNA was then verified by visualisation on a 0.7% 
agarose gel. 
 
2.8 Agarose Gel Electrophoresis: 
 
DNA was analysed by electrophoresis in BioRad gel apparatus. Agarose was made by 
adding the required concentration of agarose (between 0.7% and 2%) to 1X TAE 
Buffer (see Section 2.3) and dissolved by boiling. This solution was stored at 60
o
C. 
When needed, 30 mL-50 mL (depending on the size of the gel needed) was poured 
into the gel casing and a plastic comb was slotted on to provide wells for the addition 
of samples. This was left to set at room temperature. The set gel was then placed in 
the gel rig, 1X TAE running buffer was added and the comb was removed. Samples 
were mixed with agarose gel loading dye (see Section 2.3) in a 9:1 ratio. The loading 
dye was to facilitate the loading of samples and to give an indication of sample 
migration during electrophoresis. 6 μL of 1 Kb Plus DNA Ladder (Invitrogen) was 
added to each gel as a molecular weight marker. Gels were run at 120 volts for 20-40 
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minutes depending on the size of the gel. Gels were then removed and immersed in an 
ethidium bromide bath (see Section 2.3) for 20 minutes. The gel was then visualised 
and the image captured on a UV transilluminator coupled with an image analyser. 
a)                                                         b) 
              
Fig 2.2: a) 1 kb Molecular Marker, b) Example of an ethidium bromide stained 
agarose gel. a) The DNA ladder (Invitrogen) used as a molecular weight marker. 
Image obtained from the Invitrogen website (www.invitrogen.com). b) An example of 
a DNA agarose gel. Lane 1; Ladder, Lane 2; Plasmid sample, Lane 3; Plasmid 
sample.  
 
2.9 Gel extraction procedure for the isolation of DNA from agarose 
gels 
 
DNA was isolated from agarose gels using a Hi Yield
TM
 Gel/PCR DNA extraction kit 
from RBC Bioscience. The kit was used as per the manufacturer’s instructions. The 
gel was stained with 30 mL of Sybr Safe DNA gel stain (Invitrogen) for 30 minutes in 
the dark. The gel was then put under blue light to visualise the bands of DNA. The 
appropriate bands were excised from the gel using a scalpel and transferred to a 
centrifuge tube. 700 μL of Detergent Free (DF) buffer was added to the gel slice 
which was then mixed by vortexing. This was incubated at 55
o
C for 10-15 minutes 
until the gel slice was dissolved. A DF column was placed in a collection tube. 800 
μL of the sample mixture was added to the column and centrifuged at 13,000 rpm for 
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30 seconds. The flow through was discarded. The remainder of the sample mixture 
was added to the column and centrifuged at 13,000 rpm for 30 seconds. The flow 
through was again discarded. 600 μL of wash buffer was then added to the column 
and spun at 13,000 rpm for 30 seconds. The flow through was discarded. This wash 
step was repeated. The column was then centrifuged at 13,000 rpm for 10 minutes to 
ensure complete removal of the wash buffer as it contained ethanol. The flow through 
was discarded. The DF column was transferred to a sterile centrifuge tube. 20-50 μL 
of elution buffer was added to the column and allowed to stand for 2 minutes until all 
the buffer had absorbed. This was centrifuged at 13,000 rpm for 2 minutes. The 
purified DNA in the flow through was collected and stored at 4
o
C. 
 
2.10 DNA sequencing 
  
Recombinant clones and potential mutants were verified by DNA sequencing. 
Commercial sequencing services were provided by MWG Biotech/Eurofins and 
Source BioScience gene service. Suitable sequencing primers for standard vectors 
were sent with samples to be analysed. Samples were sent as plasmid preparations 
prepared in dH2O. 
 
2.11 PCR  
 
Standard PCR reaction mixture: 
Template DNA  1 μL  
dNTPs   1 μL  
Primers (10 μM)  1 μL of each  
Buffer (10X)  5 μL  
dH2O    40 μL  
Taq polymerase 1 μL 
 
Standard PCR programme cycle for Phusion Taq polymerase.  
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Reactions: 
Stage 1: Step 1: 95ºC for 10 minutes  
Stage 2: Step 1: 95ºC for 30 seconds  
  Step 2: Annealing temperature for 30 seconds  
  Step 3: 72ºC for 30 seconds per kb to be synthesised  
Stage 3: Step 1: 72ºC for 10 minutes 
 
2.12 Enzymatic reactions 
 
All enzymes and relevant buffers were obtained from Invitrogen Life Technologies®, 
New England Biolabs® or Sigma Corporation and were used according to the 
manufacturer’s instructions. 
 
DpnI Restriction Digest 
PCR Product   10 μL 
DpnI    2 μL 
Relevant Buffer (10X) 2 μL 
BSA (10X)   2 μL 
dH2O    4 μL 
 
The reaction mix was incubated in a 37
o
C water-bath for 16 hrs. 
  
Restriction digest 
PCR Product   15 μL 
Restriction Enzyme  3 μL 
Relevant Buffer (10X) 3 μL 
BSA (10X)   3 μL 
dH2O    6 μL 
 
The reaction mix was incubated in a 37
o
C water-bath for 16 hrs. 
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Ligation   
PCR Product   12 μL 
Vector    4 μL 
T4 DNA Ligase  1 μL 
Ligase Buffer (10X)  2 μL 
dH2O    1 μL 
 
The reaction was left to incubate overnight at room temperature.  
 
2.13 Site-specific mutagenesis 
 
Mutations were introduced into open reading frames (ORF) on plasmid constructs by 
PCR amplification using complementary phosphorylated primers carrying the desired 
mutation. A standard PCR reaction mixture, as described in Section 2.11, was set up. 
The PCR was carried out using high fidelity Phusion Taq polymerase and the standard 
program cycle for Phusion Taq polymerase (see Section 2.11). An extension time of 2 
minutes was used to amplify plasmids of 3.5-4 kb. The template DNA was then 
eliminated by digestion with DpnI restriction endonuclease (see Section 2.12). DpnI 
selectively digests the template DNA from dam+ E.coli strains over the newly 
synthesized DNA as it is biased towards a methylated recognition sequence. The 
amplified plasmid, with the incorporated mutation, was circularised by ligation (see 
Section 2.12) which was facilitated by the use of phosphorylated primers.  
 
2.14 Transformations 
 
2.14.1 Preparation of highly efficient competent cells 
 
The Rubidium Chloride (RC) Method: 
This follows the method first described by Hanahan (1985). 5 mL of LB with the 
appropriate antibiotics was inoculated with a single colony of the relevant bacteria 
and allowed to grow overnight at 37
o
C in a shaking incubator at 220 rpm.  2.5 mL of 
this overnight culture was added to 250 mL LB in a 1 L flask and allowed to grow to 
an OD600 of 0.5 (early-mid exponential phase) at 37
o
C at 220 rpm. The flask was 
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placed on ice for 10 minutes to cool. All subsequent steps took place at 4
o
C. The 
culture was centrifuged to collect the cells at 3,000 rpm for 5 minutes. The culture 
media was decanted and the cell pellet was resuspended very gently in 75 mL of ice-
cold TBF1 buffer (see Section 2.3). The suspension was then left on ice for 90 
minutes. The cells were again collected by centrifugation as before. The culture media 
was again discarded and the pellet was resuspended very gently in 10 mL ice-cold 
TBF2 (see Section 2.3). The cell suspension was aliquoted (200 μL/tube) into sterile 
microfuge tubes (1.5 mL) which were then flash frozen in -80
o
C ethanol.  The 
competent cells were then stored at -80
o
C.  
 
2.14.2 Transformation of Competent Cells 
 
The competent cells were taken from the -80
oC freezer and thawed on ice. 200 μL of 
competent cells were mixed with plasmid DNA or ligation reaction. This mixture was 
kept on ice for 30 minutes. It was then heat shocked at 42
o
C in a water bath for 30 
seconds and quickly returned to ice for 2 minutes. 800 μL of LB Broth was added 
aseptically and incubated at 37
oC in a water bath for 1 hour. 200 μL was spread on 
agar plates with the appropriate antibiotics and incubated overnight at 37
o
C. The rest 
was concentrated by centrifugation at 13,000 rpm for 1 minute. The culture media 
was discarded and the pellet was resuspended in 100 μL sterile saline solution This 
was spread on an agar plate and incubated overnight at 37
o
C as previously described. 
 
2.14.3 Determination of cell efficiency 
 
Competent cell efficiency is defined in terms of the number of colony forming units 
obtained per μg of transformed plasmid DNA. A 10 ng/μl stock of pBR322 plasmid 
DNA was diluted to 1 ng/μL, 100 pg/μL and 10 pg/μL. 1 μL of each dilution was 
transformed as described above (see Section 2.14.2). The cell efficiency was 
calculated from the number of colonies obtained, taking into account the dilution 
factor and the fraction of culture transferred to the spread plate. 
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2.15 Expression 
 
Single colonies of the bacteria containing the expression plasmid of interest were 
prepared from a working glycerol stock. A single colony was selected and used to 
inoculate a sterilin containing 5 mL of LB (and antibiotic if required). The culture was 
incubated overnight at 37
o
C at 220 rpm. A 1 L baffled flask containing 500 mL TB 
media and appropriate antibiotic was inoculated with 5 mL of this overnight culture. 
The culture was grown at 37
o
C, with shaking at 220 rpm, until an OD600 of 0.5-0.6 
was reached (mid-late exponential phase). At this point IPTG was added to a final 
concentration of 100 μM to induce expression of the protein. The culture was then 
incubated at 30
o
C for a defined period of time before the cells were collected by 
centrifugation at 4,000 rpm for 20 minutes. 
At this stage the pellet can be stored at -20
o
C and the culture media can be stored at 
4
o
C depending on requirements.  
 
2.15.1 Generation of soluble and insoluble cellular fractions from expression 
cultures 
 
5 mL samples were taken from expression cultures and the absorbance was read. The 
samples were normalised to ensure a uniform number of cells present on each cellular 
sample. Each sample was centrifuged at 13,000 rpm for 10 minutes. The culture 
media was discarded and the cell pellet was resuspended in 1X lysis buffer (see 
Section 2.3). The samples were sonicated as described in Section 2.16.1 and 
centrifuged at 13,000 rpm for 10 minutes. The culture media (soluble fraction) was 
removed and 5X protein loading dye was added to it. The pellet (insoluble fraction) 
was resuspended in 1X protein loading dye and both were boiled at 100
0
C for 10 
minutes before addition to a gel. 
 
2.16 Preparation of cleared lysate for protein purification 
 
Cells can be lysed by numerous methods. The methods employed here were 
sonication, cell disruption or by the addition of lysozyme. 
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2.16.1 Cell Lysis by Sonication 
 
A cell pellet from a 500 mL expression culture was re-suspended in 50 mL lysis 
buffer containing 20 mM imidazole, pH 7.6 (see Section 2.3). The cells were 
disrupted with a 3 mm micro-tip sonicator (Sonics & Materials Inc.) using 2.5 s, 40 
kHz pulses for 60 s. The lysate was then centrifuged at 4,000 rpm for 20 minutes at 
4ºC (using a Rotanta 460 R rotor) to pellet any insoluble material. The cleared lysate 
was transferred to a fresh container and passed through a 0.2 μm filter to remove any 
remaining cell debris and stored at 4°C for protein purification. 
 
2.16.2 Cell Lysis using Lysozyme 
 
A cell pellet from a 500 mL culture was resuspended in 50 mL lysis buffer containing 
20 mM imidazole, 10 mg/mL lysozyme and 10 μg/mL DNase at pH 7.6. The cells 
were incubated in a water bath at 37
o
C for 30 minutes. The cell lysate was centrifuged 
at 4,000 rpm for 20 minutes at 4
o
C to remove any insoluble debris. The lysate was 
then transferred to a fresh container and passed through a 0.2 μm filter to remove any 
remaining debris. It was then stored at 4
o
C for protein purification. 
 
2.16.3 Cell Lysis by Cell disruption 
 
A cell pellet from a 500 mL culture was resuspended in 200 mL lysis buffer 
containing 20 mM lysis buffer (see Section 2.3) and 0.01% antifoam. The cells were 
fully homogenised in this buffer until they were the consistency of yoghurt. The cells 
should be approximately 250 g/L wet weight or 25 g/L dry weight. The pressure was 
selected according to the organism being disrupted. For E. coli a pressure of 15,000 
psi was chosen. The sample reservoir was filled with lysis buffer and run through the 
system at the selected pressure. The sample was then loaded into the reservoir and 
disrupted. The disruption step could be repeated if the sample was particularly 
viscous. 20 mL of buffer was chased through the instrument at the selected pressure to 
harvest any residual sample. The unit was thoroughly cleaned after each use by 
running 150 mL of dH2O, 150 mL of ethanol followed by a final 150 mL dH2O 
through the machine. The disrupted sample was then spun at 13,000 rpm for 30 
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minutes at 4
o
C to pellet any insoluble debris. The culture media which was the cell 
lysate was stored at 4
o
C for protein purification. 
 
2.17 Preparation of culture media containing protein 
 
Conversely if the protein is secreted from the cell as was the case with the protein 
expressed in this work it can be collected straight from the culture media.  
The culture media was centrifuged again after the initial cell harvest at 13,000 rpm for 
30 minutes. The sample was then passed through a 0.2 μm filter to remove any debris 
and stored at 4
o
C for protein purification. 
 
2.18 Isolation of different cell fractions by the water lysis method 
 
This method was first described by Henderson and MacPherson (1986). The method 
was performed in this study as described by Ward et al. (2000). The cells were lysed 
using osmotic pressure. The periplasmic, cytoplasmic and membrane fractions were 
isolated in this way to determine which cellular fraction contained the most protein. 
50 mL of an expression culture was centrifuged at 4,000 rpm for 10 minutes at 10
o
C. 
The culture media was discarded and the pellet was resuspended in 10 mL 0.2 M Tris 
at pH 8.0. This re-suspension was stirred at room temperature for 20 minutes. Once 
the stirring was complete this was called Time Zero. At Time Zero 4.85 mL of 1 M 
Sucrose/0.2 M Tris/1 mM EDTA was added. At Time 1.5 minutes 65 μL of 10 
mg/mL lysozyme prepared in 1 M Sucrose/0.2 M Tris/1 mM EDTA was added. At 
Time 2 minutes 9.6 mL of dH20 was added and the mixture was allowed to stir 
constantly for 20 minutes. This mixture was spun at 18,000 rpm for 20 minutes at 
4
o
C. The culture media was retained and stored at -20
o
C. This was the periplasmic 
fraction. The pellet was resuspended in 15 mL dH2O until fully homogenised. The 
homogenised mixture was then stirred for 30 minutes at room temperature. The 
mixture was then spun at 18,000 rpm for 20 minutes at 4
o
C. The culture media was 
retained and stored at -20
o
C. This was the cytoplasmic fraction. The pellet was 
washed twice with 30 mL 0.1 M Sodium Phosphate buffer containing 1 mM 
mercaptoethanol. Each time the pellet was resuspended using a homogeniser and 
sedimented at 18,000 rpm for 20 minutes at 4
o
C. The final pellet was resuspended in 
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an ice-cold re-suspension buffer of 0.1 M Sodium Phosphate containing 1 mM 
mercaptoethanol at pH 7.2 using a 1 mL homogeniser and stored at -20
o
C. This was 
the mixed membrane fraction. 
Each fraction was analysed by SDS-PAGE as described previously to determine 
protein location. 
 
2.19 Purification of the recombinant protein 
 
Immobilised Metal Affinity Chromatography (IMAC) was used to purify the 
recombinant proteins as they contained C terminal His6 tags. IMAC is based on the 
covalent binding event between proteins and metal ions. Here a resin containing Ni
2+ 
was used, as this metal ion binds to histidine residues. Therefore the resin bound the 
His6 tagged recombinant protein.  
 
2.19.1 IMAC purification 
 
Ni-Sepharose resin (GE Healthcare) was used. 5 mL of resin was added to a 20 mL 
column. The storage buffer was allowed to flow through and was washed with 5-10 
column volumes (CV) of dH2O until all the resin had settled. The column was 
equilibrated with 10 CV of lysis buffer containing 20 mM imidazole. The cell lysate 
or filtered culture media was then added to the column and allowed to slowly flow 
over the resin to ensure optimum capture of the protein by the resin. The resin was 
subsequently washed with 10 CV of lysis buffer containing a defined concentration of 
imidazole. The recombinant protein was then eluted with a high concentration of 
imidazole (100-500 mM) and this fraction was collected. The column was then 
washed with 10 CV of dH2O followed by 5 CV of 20% ethanol in which the resin was 
then stored. Fractions were taken at each step of the process and run on SDS-PAGE as 
described before.  
 
2.19.2 Stripping and Recharging the IMAC Resin 
 
The resin was stripped and recharged prior to use. It was initially washed with 2 CV 
of dH2O followed by 2 CV of 50% ethanol. The resin was then stripped of metal ions 
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by washing with 2 CV of 100 mM EDTA, pH 8.0. Any remaining impurities were 
removed with 2 CV of 200 mM NaCl, a rinse with 2 CV of dH2O followed by a 10 
CV wash with 30% Isopropanol over 30 minutes. The resin was then washed with 10 
CVof dH2O and recharged with ½ a CV of 100 mM NiSO4. Finally the column was 
washed with 10 CV of dH2O and stored in 20% ethanol.  
 
2.20 Desalting/Buffer exchange of purified protein using a HiPrep 
26/10 desalting column 
 
The proteins discussed in this work were buffer exchanged into suitable buffers using 
a Fast Performance Liquid Chromatography (FPLC) system with a HiPrep 26/10 
desalting column. The HiPrep column is a gel filtration column that contained 
Sephadex G-25 Fine. This gel allowed the high molecular weight proteins to elute 
first as they were excluded from the gel. The smaller substances entered the gel pores 
and therefore eluted later. 
 
The FPLC back pressure limit was set to 0.35 MPa and the flow rate to 1 mL/min 
before attachment of the HiPrep 26/10 desalting column. The top of the column was 
attached to pump outlet No.1 and the bottom of the column attached to the FPLC 
using green peek tubing (0.75 mm I.D.). Before the first sample application the 
column storage buffer (water:ethanol 80:20) was removed, and the column was 
equilibrated with sample buffer. This was done by washing with 2 CV of water (106 
mL) followed by 5 CV (265 mL) of PBS. Equilibration was not necessary between 
runs using the same buffer. Washing was carried out at the flow rate intended for 
chromatography (5 mL/min). Samples were collected in 1 mL fractions in 96-well 
plates. 
 
2.21 Sodium dodecyl Sulfate PolyAcrylamide Gel Electrophoresis 
(SDS-PAGE) 
 
Gel Preparation: 
Protein samples were analysed by sodium dodecyl sulphate polyacrylamide gel 
electrophoresis (SDS-PAGE), based on the method outlined by Laemmli (1970).  
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The gels were made as per the recipes below (see Tables 2.4 and 2.5) without the 
addition of TEMED as this immediately catalyzed the polymerisation of the gel. 
When the gel apparatus was set up (Vertical mini electrophoresis system, ATTO), the 
TEMED was added to the resolving gel which was immediately poured and overlaid 
with isopropanol. After polymerisation, the isopropanol was thoroughly washed off. 
TEMED was added to the stacking gel and this was poured on top of the resolving 
gel. A comb was inserted to allow the formation of wells for the loading of samples. 
 
Table 2.4 Resolving Gel Recipe  
    7.5% 10% 12.5% 15%  
30% Acrylamide (mL) 1.875 2.5 3.12 5.0 
1.5 M Tris-HCl pH 8.8 (mL) 1.875 1.875 1.875 1.875 
10% SDS (μL)  75 75 75 75 
H2O (mL)   3.63 3.01 2.38 1.75    
10% APS (μL)   37.5 37.5 37.5 37.5 
TEMED (μL)   3.75 3.75 3.75 3.75 
 
Table 2.5 Stacking Gel Recipe 
     4%  
30% Acrylamide (μL)   325 
0.5 M Tris-HCl pH 6.8 (μL)  625   
10% SDS (μL)   25 
H2O (mL)    12.5 
10% APS (μL)   1.54 
TEMED (μL)    2.5 
 
2.21.1 Sample Preparation 
 
40 μL of sample and 10 μL of 5X SDS-PAGE sample buffer (see Section 2.3) were 
added to a microfuge tube. This mixture was boiled at 100
o
C on a heating block for 
10 minutes. They were stored on ice until loading onto the gel. 
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2.21.2 Sample Application 
 
20 μL of each sample was added to each well leaving one well spare for the relative 
molecular weight protein marker (Broad range protein marker, NEB). 20 μL of the 
ladder was added to the spare well for Coomassie Staining. If the gel was to be used 
for Western Blot analysis, the NEB pre-stained or colour plus pre-stained protein 
markers were used.  
 
The Broad range protein marker consisted of Rabbit Muscle Myosin (212 kDa), 
MBP-β-galactosidase from E.coli (158 kDa), β-galactosidase from E.coli (116 kDa), 
Rabbit muscle Phosphorylase B (97 kDa), Bovine Serum Albumin (66 kDa), Bovine 
liver Glutamic dehydrogenase (55 kDa), MBP2 from E. coli (42 kDa), Thioredoxin 
reductase from E. coli (34 kDa), Soybean Trypsin inhibitor (20 kDa), Chicken egg 
white lysozyme (14 kDa), Bovine lung Aproptinin (6.5 kDa), Bovine pancreas insulin 
(3.4 kDa) and Bovine pancreas B chain (2.34 kDa). The prestained protein marker 
consisted of MBP-β-galactosidase from E. coli (175 kDa), MBP-paramyosin from E. 
coli (80kDa), MBP-CBD from E. coli (58 kDa), CBD-Mxe Intein-2CBD from E. coli 
(46 kDa), CBDBmFKBP13 from E. coli (25kDa), Chicken egg white lysozyme (17 
kDa), Bovine lung aprotinin (7 kDa).  
 
The colour plus protein marker consisted of MBP-β-galactosidase from E. coli (175 
kDa), MBP-truncated-β-galactosidase E.coli (80 kDa), MBP-CBDE E. coli (58 kDa), 
CBD-Mxe Intein-2CBDE E. coli (46 kDa), CBD-Mxe Intein E. coli (30 kDa), CBD E. 
coli ParE (23 kDa), Chicken egg white lysozyme (17kDa), Bovine lung aprotinin (7 
kDa). 
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Fig 2.3: Broad range protein marker (NEB). Image from obtained from 
http://www.neb.com.   
 
2.21.3 Gel Visualisation 
 
Polyacrylamide gels were removed from the electrophoresis chamber and washed 
with dH2O. The gels were stained for one hour with Coomassie blue stain solution 
(see Section 2.3). The stain was removed and the gels were washed with dH2O. 
Coomassie blue destain solution was then added and left overnight to destain the gel. 
After the overnight destain it was washed again with dH2O to enhance the protein 
bands further. 
 
Silver staining was used for gels that required a higher degree of sensitivity for 
visualisation. 
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Table 2.6 Silver Staining of SDS-PAGE gels 
Step    Reagent   Time 
Fix    30% ethanol   >1 hour 
10% Acetic Acid 
Wash 1   20% Ethanol   15 minutes 
Wash 2   Water    15 minutes 
Sensitisation   0.1% Sodium Thiosulphate 1 minute 
Rinse    Water    2 x 20 seconds 
Silver Nitrate   0.1% AgNO3   30 minutes 
0.026% Formaldehyde 
Rinse    Water    2 x 20 seconds 
Development   3% Sodium Carbonate Until bands appear 
0.019% Formaldehyde 
0.002% Sodium Thiosulphate 
Stop    5% Trizma Base  1 minute 
2.5% Acetic Acid 
*50mL per gel per step 
 
2.22 Western Blot analysis 
 
SDS-PAGE gels were run as described in Section 2.21 with 20 μL of NEB pre-stained 
molecular weight ladder. Two western blot methods were employed; a dry method 
using an iBlot (Invitrogen) and a semi-dry method using an electroblotter. 
 
For the dry method an iBlot Dry Blotting System from Invitrogen was used. The gel 
was set-up as seen in Figure 2.3 and allowed to run on the machine for 7 minutes to 
allow transfer to take place.   
 
For the semi-dry method, four pieces of blotting paper and a piece of nitrocellulose 
membrane were cut to the same dimensions as the SDS-PAGE gel. The blotting 
paper, nitrocellulose and gel were then soaked in transfer buffer (see Section 2.3) and 
arranged on the semi-dry electroblotter as per Figure 2.4. Transfer then occurred at a 
constant 20 V for 15 minutes. 
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To detect the His6 tagged recombinant proteins the membrane was blocked overnight 
in 3% BSA in TBS with 0.05% tween (TBST). Afterwards the blot was washed 4 
times for 5 minutes with TBST. The blot was then incubated at room temperature for 
1 hour with a 1:10,000 anti-His antibody diluted in 1% BSA TBST. This was then 
washed 4 x 5 minutes with TBST. For visualisation one sigma fast dab tab and one 
Sigma fast urea H2O2 tab were dissolved in 15 mL dH2O. This was poured over the 
blot and soaked until bands appeared. The blot was rinsed with dH2O to stop the 
reaction.  
When detecting biotinylated proteins the same procedure was followed except that an 
anti-Biotin antibody was used in place of the anti-His antibody. 
 
 
 
Fig 2.4: Schematic of western blot layout using the iBlot (dry method). The 
apparatus was set up as in diagram. Image obtained from Invitrogen. 
(www.invitrogen.com). 
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Fig 2.5 Schematic of the western blot layout using semi-dry method. The 
apparatus was set up as in diagram.  
 
2.23 Protein quantification 
 
Protein was quantified using two methods, the Bradford Assay and by reading its 
absorbance at 280 nm. The Bradford Assay was described by Bradford (1976). It is a 
colorimetric method in which the Coomassie dye binds to the protein in an acidic 
medium and immediately a shift in absorption maximum occurs from 465 nm to 595 
nm in which a colour change takes place from brown to blue. Proteins can also be 
quantified reading their absorbance at 280 nm as proteins have the ability to absorb 
ultraviolet light in solution with the absorbance maxima at 280 nm.  
 
2.23.1 Quantification of protein using the Bradford Assay 
 
The Bradford assay using BradfordUltra
TM
 reagent (Expedeon) was used to quantify 
total protein in the range of 1 μg/mL – 1.5 mg/mL. For low range protein samples (1-
25 μg/mL) 150 μL of sample was mixed with 150 μL Bradford Ultra. For high protein 
range samples (0.1 -1.5 mg/mL) 20 μL of sample was mixed with 300 μL of 
BradfordUltraTM reagent. All samples, standards and blanks were prepared in 
triplicate. The absorbance was read at 600 nm. Bovine serum albumin (BSA) was 
used as the reference protein. BSA standards were prepared in PBS and assayed in 
triplicate to yield a standard curve. Protein concentration of samples was determined 
from this standard curve. 
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2.23.2 Quantification of protein using 280nm readings 
 
Protein samples were spun at 13,000 rpm for 10 minutes to remove any debris in the 
solution. This was to ensure nothing interfered with the absorbance readings. The UV 
lamp was set to 280 nm and was zeroed with the same buffer the protein samples were 
in. The protein samples were read in triplicate. The concentration of the protein was 
then calculated using the Beer-Lambert law: 
 
A = εcl 
Beer-Lambert law used to determine protein concentration using 280 nm 
absorbance readings. A = absorbance, ε = extinction coefficient of the protein in 
question, c = concentration (in units corresponding to ε) and l = path length (cm). 
 
2.24 Immobilisation of protein onto cyanogen bromide-activated 
sepharose 
 
The protein to be immobilised was buffer exchanged into Coupling buffer (0.1 M 
NaHCO3 with 0.5 M NaCl at pH 8.5 or PBS at pH 7.2). The capacity for the gel was 
5-10 mg per mL of gel. The cyanogen bromide-activated resin was washed and 
swelled in cold 1 mM HCl for 45 minutes at 200 mL/g of gel. The resin was washed 
with 10 CV of dH2O and then one CV of coupling buffer. The protein solution was 
immediately added at 5-10 mg of protein/mL of gel. The solution was left to mix by 
inversion overnight at 4
o
C. The gel was extensively washed with coupling buffer to 
remove any unreacted ligand. 2 CVs of 0.2 M Glycine were added to block the 
unreacted groups. This was left to mix by inversion at 4
o
C for 16 hours. This was 
washed extensively with coupling buffer and then 0.1 M acetate buffer with 0.5 M 
NaCl at pH 4.0. This wash cycle was repeated 4-5 times until the rinsings were devoid 
of protein. Resin to be used immediately was equilibrated in coupling buffer. Resin 
not immediately used was stored in 1 M NaCl at 4
o
C with a suitable bacteriostat such 
as sodium azide (2 mM).  
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2.25 Quantitative determination of reducing sugars by DNS assay 
 
Reducing sugars, under alkaline conditions, reduce 3,5-dinitrosalicylic acid to 3-
amino-5-nitrosalicylic acid. A red colour is produced on boiling, which absorbs 
maximally at 540-550 nm (Miller 1959). The DNS assay was used to quantify 
reducing sugars in the range 0.2-1 mg/mL. Standards for a standard curve were 
prepared using GlcNAc at concentrations between 0-1 mg/mL. The carbohydrate 
solutions (standards and samples) were mixed with DNS reagent (see Section 2.3) in a 
ration of 1:2. The samples were then boiled at 100
o
C for 10 minutes. The samples 
were allowed to cool and then 250 μL of each sample was aliquoted into a microtitre 
plate. All samples, standards and blanks were prepared in triplicate. The plate was 
read at 570 nm. 
 
2.26 Assay to determine activity of β-N-acetylglucosaminidase 
 
An assay had to be devised and optimised to quantitatively measure the activity of the 
enzyme on N-acetylglucosamine. 4-Nitrophenyl N-acetyl-β-D-glucosaminide (PNP-
GlcNAc) is a chromogenic substrate that can be broken down by the β-N-acetyl-
glucosaminidase enzyme (chitobiase enzyme). Upon breakdown 4-Nitrophenol is 
released, whose absorbance can be read at 405 nm. Standards in the range of 0-1 mM 
were made from 4-Nitrophenol. 210 μL of each standard was added to a NUNC 
Maxisorp 96-well plate in triplicate. 100 μL of 1 mM substrate made up in 50 mM 
Sodium Phosphate pH 8.0 was added to the wells of the 96-well plate in triplicate. 10 
μL of enzyme was added to each well containing substrate and incubated at 37oC for 
45 minutes. 100 μL of 1 M Sodium Carbonate at pH 11.5 was added to stop the 
reaction and release the product. The absorbance was read on a plate reader at 405 
nm.   
 
2.26.1 Determination of Vmax and Km  
 
The rate of catalytic activity (V) of the enzyme was measured over a range of 
increasing PNP-GlcNAc substrate concentrations. A plot of the rate of activity (V) 
versus substrate concentration (S) generated a Michaelis Menten curve. The Vmax was 
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the maximum rate of activity achieved by the enzyme. The Km was determined as the 
substrate concentration which gave rise to the half the maximum Vmax.    
Hanes-Woolf plot – A plot of S/V versus S was generated. The slope of the line gave 
1/Vmax and the x-axis intercept gave –Km. 
 
2.26.2 Assay to determine specificity of β-N-acetyl-glucosaminidase 
 
Assay as above (Section 2.26) except different 4-nitrophenyl conjugated substrates 
were used. The other substrates used were PNP-α-Glucose, PNP-α-Galactose, PNP-α-
Fucose, PNP-α-Mannose, PNP-β-Glucose, PNP-β-Galactose and PNP-Sialic Acid. 
 
2.26.3 Sugar Inhibition of β-N-acetyl-glucosaminidase 
 
Assay as above (Section 2.26) except different concentrations (0-100 mM) of free 
sugars were incubated at 37
o
C with the enzyme for 15 minutes before addition to the 
96-well plate. The sugars used were GlcNAc, glucose, galactose, lactose, fucose, 
mannose and xylose.   
 
2.27 Enzyme Linked Lectin Assay (ELLA) 
 
50 μL of a Glycoprotein solution 5 µg/ml (such as asialo agalacto fetuin) made in 
PBS was added to the wells of a NUNC Maxisorp 96 well plate and incubated 
overnight at 4
o
C. The unbound glycoprotein was then removed by inversion and the 
plate was then blocked with 200 μL of a 0.5% PVA solution for 2 hours at 25oC. The 
plate was then washed four times with TBST. 50 μL of a 5-10 μg/mL lectin solution, 
diluted in TBST was then added to the plate and incubated for an hour at 25
o
C. The 
plate was washed again four times with TBST. 50 μL of a 1:10000 HRP-labelled 
murine anti-biotin or anti-histidine antibody in TBST was added to each well. The 
plate was again incubated for 1 hour at 25
o
C. Following this incubation the plate was 
washed 4 times with TBST followed by a single PBS wash. The assay was developed 
by adding 100 μL TMB solution to each well and left to react for 10 minutes. The 
reaction was stopped by adding 50 μL of 10% H2SO4. The absorbance was read on a 
plate reader at 450 nm.  
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Fig 2.6: Schematic of an ELLA. The ELLA follows the same principle as an ELISA. 
The glycoprotein target is placed on the surface of the plate and probed with a 
labelled lectin which is detected colormetrically. Image taken from Thompson et al. 
(2011).  
 
2.28 Biotinylation of Carbohydrate Binding Protein (CBP) 
 
A biotinylation kit from Thermo Scientific (Sulfo-NHS-LC-Biotin 21327) was used 
as per the manufacturer’s guidelines. The biotin was removed from the freezer and 
equilibrated to room temperature. 180 μL of ultrapure water was added to the 1 mg 
tube of biotin to give a 10 mM biotin stock solution. The protein to be biotinylated 
was resuspended in an amine free buffer such as PBS. An aliquot of the 10 mM biotin 
stock was added to the protein solution to give a 20 fold molar excess of biotin to 
protein. The reaction was left to continue on ice for 2 hours. The sample was then 
buffer exchanged to remove any excess biotin with PD MidiTrap G-25 columns (GE 
Healthcare).  
 
 
 
2.29 Insoluble Substrate Assays 
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The method used was modified from that described by Suginta et al (2007). Chitin (α 
and β), chitosan and cellulose are all insoluble and therefore they cannot be used in an 
ELLA format. Instead this insoluble substrate assay was used which allows the 
binding of proteins to these substrates be visualised on SDS-PAGE gels. Avicel 
(crystalline cellulose), crustacean shell chitosan and chitin (α and β) were used in 
these experiments. 
 
2.29.1 Insoluble Substrate Assay –rChbL Enzyme 
 
0.05 g of the insoluble substrate was added to a 1.5 mL microfuge tube along with 1 
mL of 50 μg/mL rChbL enzyme or rChbL enzyme mutant in 50 mM sodium 
phosphate buffer pH 8.0. This was allowed to incubate for one hour at 4
o
C while 
being continuously rotated. 100 μL samples were taken at time-points (5, 15, 30 and 
60 minutes). Each sample was centrifuged at 13,000 rpm for 5 minutes. 50 μL of the 
culture media was removed and 10 μL of 5X protein sample buffer (see Section 2.3) 
was added to this. The sample was boiled at 100
o
C for 10 minutes. The insoluble 
substrate was washed twice with PBS and 50 μL of 1X protein sample buffer was 
added to it. It was also boiled at 100
o
C for 10 minutes. All samples were run on SDS-
PAGE gels as described in Section 2.21 and stained using Silver Staining as described 
in Table 2.6. 
 
2.29.2 Insoluble Substrate Assay – rChb CBP 
 
0.05 g of the insoluble substrate was added to a 1.5 mL microfuge tube along with 1 
mL of 50 μg/mL rChb CBP or rChb CBP mutant in 50 mM sodium phosphate buffer 
pH 8.0. This was allowed to incubate for one hour at 45
o
C while being continuously 
rotated. 100 μL samples were taken at time-points (5, 15, 30 and 60 minutes). Each 
sample was centrifuged at 13,000 rpm for 5 minutes. 50 μL of the culture media was 
removed and 10μL of 5X protein sample buffer (see Section 2.3) was added to this. 
The sample was boiled at 100
o
C for 10 minutes. The insoluble substrate was washed 
twice with PBS and 50 μL of 1X protein sample buffer was added to it. It was also 
boiled at 100
o
C for 10 minutes. All samples were run on SDS-PAGE gels as 
described in Section 2.21 and stained using Silver Staining as described in Table 2.6. 
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2.30 High Performance Liquid Chromatography (HPLC) to analyze 
chitin hydrolysis 
 
2.30.1 Instrumentation 
 
The chromatographic separation was performed using an Ultimate 3000 HPLC system 
from Dionex. The derivatised samples were separated on an XTerra RP18 6x150mm 
column of 3.5 μm from Waters at a flow rate of 700 μL/min. The column temperature 
was kept constant at 20
o
C using a column oven. 50 mM sodium acetate (pH 4.0) was 
used as mobile phase A while acetronitrile was used as the organic solvent (mobile 
phase B). The gradient program used was: 0-12 minutes (2% B), 12-27 minutes (2-
10% B), 27-35 minutes (10-2% B) and 35-40 minutes (2% B). The separations were 
read using a UV detector at 254 nm. Chromeleon software was used to plot the 
resulting chromatograms.  
 
2.30.2 Sample preparation 
 
Standards used were N-acetylglucosamine, Chitobiose and Chitohexose all at 1 mM. 
Hydrolysis of chitin and chito-oligosaccharides (1 mM) were performed at 37
o
C in 1 
mL reactions with 1 μg/mL enzyme in sodium phosphate buffer at pH 8.0. 200 μL 
samples were taken at time-points (0, 0.5, 1, 3, 6 and 24) and kept on ice or at 4
o
C. 
Each sample was centrifuged at 13,000 rpm for 5 minutes to remove any insoluble 
material. The samples were then run through vivaspins (Sartorius) to remove the 
enzyme present. The flow-through was retained. 100 μL of each sample was 
derivatised.  
 
2.30.3 Derivatisation of samples and standards 
 
The derivatisation reagent was composed of a methanol acetate borate solution, 
MABS (see Section 2.3). 30 mg of anthranilic acid and 20 mg of sodium 
cyanoborohydride were dissolved in 1 mL MABS prior to use. 100 μL of the samples 
and standards were mixed with 100 μL of the derivatisation agent in a 2 mL screw-top 
polypropylene plastic tube. This mixture was heated at 80
o
C for 80 minutes in a water 
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bath. After allowing the sample to cool it was diluted with 800μL Mobile phase A and 
centrifuged at 13,000 rpm for 3 minutes. 120 μL of the sample was transferred to a 
HPLC vial for analysis.  
 
2.32 Statistical Analysis and Data Analysis 
 
The student T-test was used to determine if differences measured between samples 
were significantly different from one another. The level of statistical significance was 
indicated by *(p<0.5), **(p<0.01) and ***(p<0.001).  
All experiments were carried out in triplicate. The results shown are the means ±SD 
of three samples.  
 
2.33 Data Mining and Protein Modelling 
 
To identify homologous protein and DNA sequences deposited in Genbank, the 
BLAST program available at NCBI (www.ncbi.nlm.nih.gov) was used. DNA 
sequences for the strains used were obtained from the following sequencing studies; 
Serratia marcescens (Q54468) and Photorhabdus luminescens (NP_928634.1). DNA 
and protein sequences were aligned using ClustalW available at 
http://www.ebi.ac.uk/Tools/clustalw and Genedoc program, available to download at 
http://www.nrbsc.org/. DNA sequences were analysed for restriction sites using the 
Webcutter 2.0 programme (http://rna.lundberg.gu.se/cutter2/).  
Protein modelling was carried out using Swiss-Model available from 
http://swissmodel.expasy.org/. Homology modelling was carried out using the 
automated mode to predict the structure of the P. luminescens Chb based on already 
determined crystal structures of the S. marcescens Chb. The S. marcescens structures 
can be found in the Protein Data Bank (http://www.rcsb.org/pdb/home/home.do) 
labelled 1QBA and 1QBB. Pymol from Delano Scientific was used as the protein 
imaging software, available for download at http://pymol.sourceforge.net.  
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Chapter 3: 
 
The cloning, expression, purification 
and characterisation of a chitobiase 
(rChbL) enzyme from Photorhabdus 
luminescens. 
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3.1 Overview 
 
This chapter describes the discovery, cloning, expression, purification and 
characterisation of the recombinant Chb enzyme for the first time from P. 
luminescens. As stated previously, S. marcescens is reported to be one of the most 
efficient bacteria involved in the degradation of chitin, capable of expressing at least 3 
chitinases, a chitobiase and a chitin binding protein (Brurberg et al., 2001). The 
protein sequence for the extensively characterised chitobiase (Chb) from S. 
marcescens was used as a reference sequence to investigate the presence or absence 
of a gene encoding a potential chitobiase in the genomic sequence of P. luminescens.  
 
3.2 Identification of a chitobiase from P. luminescens  
 
A BLAST search (available from www.ncbi.nlm.nih.gov ) was used to compare the S. 
marcescens Chb protein sequence with the P. luminescens proteome. The BLAST 
resulted in a list of 6 proteins showing various levels of homology to Chb. The most 
promising candidate for further study was a novel N-acetyl-β-glucosaminidase 
(NP_928634.1) that displayed 66% identity to the Chb sequence from S. marcescens. 
 
Table 3.1 Sequences producing significant alignments to the S. marcescens 
chitobiase 
Protein      Query Cover E value Max ident. 
N-acetyl-beta-glucosaminidase  99%  0.0  66% 
Hypothetical protein plu3801   7%  3.9  29% 
Hypothetical protein plu1131   11%  4.7  27% 
Hypothetical protein plu2394   3%  7.8  41% 
IS630 family transposase   7%  8.7  28% 
Hypothetical protein plu3021   8%  9.4  27% 
 
Further sequence alignments (see Figure 3.1) between the Chb protein from S. 
marcescens and ChbL from P. luminescens were performed using the online tool, 
ClustalW (available from: http://www.ebi.ac.uk/Tools/clustalw/) and the software 
program Genedoc (available to download from: http://www.nrbesc.org/). The 
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sequences were obtained from Genbank, S. marcescens (Q54468) and P. luminescens 
(NP_928634.1). 
This analysis revealed that the Chb from P. luminescens (ChbL) shared approximately 
80% sequence similarity and 66% identity with the Chb from S. marcescens. Most 
notably high levels of amino acid conservation were observed around the site of the 
catalytically important residues D539 and E540. The least sequence similarity was 
observed at the proteins N-terminus and between residues 200 and 300. The P. 
luminescens sequence was marginally longer than the S. marcescens sequence, 
comprising 891 amino acids compared to 884 amino acids. The relatively high degree 
of sequence similarity between the P. luminescens Chb and S. marcescens Chb, 
combined with the relatively high levels of conservation around the proposed active 
site, made the P. luminescens Chb (ChbL) a favourable target enzyme for further 
study.  
 
 
Fig 3.1: Sequence alignment of the well-characterised chitobiase from S. 
marcescens (SM_CHB) and the chitobiase from P. luminescens (PL_CHB). The 
sequence alignment was generated with the SM_CHB (Accession number Q54468) 
and PL_CHB (Accession number NP_928634.1) gene sequences using ClustalW 
(available from http://www.ebi.ac.uk/Tools/msa/clustalw2/) and visualised using 
Genedoc software. The catalytically important residues are highlighted in red and the 
conserved residues are highlighted in black.  
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3.3 Cloning of the chb gene from P. luminescens 
 
Overexpression of a protein of interest is usually difficult to achieve using the natural 
prokaryotic host. Typically proteins may be produced recombinantly using a number 
of different cell systems. The method chosen will depend on the protein to be 
expressed. Factors to be considered include whether or not the native protein is 
glycosylated, the size/complexity of the protein and the presence of any other post-
translational modifications.  
In this study the recombinant protein of interest was expressed in the prokaryotic host 
Escherichia coli as these cells are relatively easy and cheap to culture and grow 
rapidly. In addition, there are no complex purification steps (Baneyx, 1999).  
 
The protein of interest was produced recombinantly in E. coli as over expression in its 
native host P. luminescens was unattainable. E. coli is one of the most commonly 
used hosts for recombinant protein expression as its genetics are well defined, it 
grows rapidly, is inexpensive to culture and is amenable to large scale protein 
production (Baneyx, 1999). One of the disadvantages of the E. coli expression system, 
compared to eukaryotic cells, is its lack of a glycosylation system (Makrides, 1996). 
This can become a problem when expressing proteins of plant or human origin as they 
are generally modified post-translationally by the addition of glycans. The ChbL 
protein however is also of prokaryotic origin and was therefore suitable for over-
production in E. coli.  
 
The gene encoding the ChbL protein was identified from the NCBI database, 
accession no NC_005126.1.  
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atgaagaaatttaaattgcatacattagcagcactgactgcaactgttggacttatgggttctgcatat
gcttcccaaacagcgcagcaagtggttgatgcactgagtcaattaaaagttaattataaagttgttgat
aatcaggcaggagatcacggcgttaactgtgcggtactgggggcagattgggctaaatgtaatcgagtg
gatattactttaaccaatggtaatcaggcgattgactctattgactgggcgatttatttccacagtatt
cgtcaggtcctgagcgtggataatgaacagtttaaaatcacgcgtattacgggcgatttacatagactg
gagccaaccgaaaaattcaccggtattaaagctaatgagcaggtaaaactgccgtttattggagaatac
tggcagatttacagcactgattttctacctcgctggtatgcaacgtcgggtgatgcgaagcctaaagtg
cttgttagtacggatacagaagatctaagtcaattcttatctgctttcaccgatgatcagtggaaacgc
acacagacagataacaatattttgatgacgcctgaaaatcgttatatgaagaatttgcaggtcaaaaag
gttggatcagagaagttgcgtgggcaaattatcccgacaccaaaagaggttcagatttttcccgaggat
gctgatttatctggcggggtgagactggaattgggtggtttaaatgacgaggcagttattcttgtcaga
aaacgttttactgatcaaggcattaaattagaggatagtggttattcagttgcgacccagattatctct
tcagagtttcctggcgattggcaggttaaaggggcttaccgtctgaatgtgacccagaatggggcacaa
attgttgcttttgaccaatctggggtgttttacggtcttcaatctctgttgtcattaattcctgttgat
ggcgataggaagattgctactttgacggcaaaagatgcgccccgctttgaatatcgtggtgcactcctt
gatgtagggcgtaatttccacagtaaacaggctgttctgcgtttgcttgaccaaatggcaagttacaaa
ctgaataaactccatattcatctgtctgatgatgaaggttggcgtttggaaattcctggattacctgag
ttgacggaagttggcagccagcggtgtcatgatttaagtgaaactcaatgtttattaccacaattgggt
tcaggccccgataacaacaacatggggagcggatatttcagccgtcaagattacattgatattctgaaa
tatgctaaagctcgttatatcgacgttattcctgaaattgatatgccagcccatgctcgtgccgcggtt
gtttctatggaagcccgctataaaaaattaattgctcaggggaatgtgaaaggggcgagtgaatatcgt
ttgctcgatccaacggataccaccagagcaacatcggttcagctctatgatcgccgcagttatttgaac
ccgtgtatggattcttcaaaacggtttgttgagaaagtcataggtgaaattgctgctatgcataaagta
gcaggttcaccattggagacttggcattttgggggagatgaagcgaagaatatccgtttgggagacgga
ttccaggataaaaatggtcctatcgtaccgggtaagggcatcattgataaaagtgcggaagataaaccg
tgggctaagtctcagatttgtcagaagttgatagaacagggtgttgtgaaagacattgatcatcttgcc
agcgacttcgcaattgaagtgagcaaaattgtgaatgctaatggtatcgagaggatgcaggcatggcag
gatggtttaaaacatgctagcagtgctaaagattttgccaccaaacgcgttggggtgaatttttgggac
actctctacgatggcggctttgattcagtcaatgattgggcgaataagggctatgacgtggtgatatct
agcccagattatatttatctggatatgccatatgaagttcatccacaagaacgtggctattattgggcg
gctcgttttaacgatgaagctaagatctttagttttgcgcccaataacataccgcaaaatgctgaaact
tccgttgaccgtgatggtaatgcattcagtgcgaaaagtgataaaccgtggccgggtgcctatgggctt
tcaggtcaaggatggagtgaaacggttcggactgatgagcagatggaatatatgatttatccgcgcttg
ttgccgctagcggaacgggcatggcaccgggccggttgggagttggattatattccgggccaggtatat
aagcgtggagaaacgtataaagtcgatatagatgcgcttaatcgtgactggacccggttcgctaacctg
atagggcaacgtgagcttagtaaactggataaagcgggcattgcttaccgtctaccggttccgggggct
aaggtaaaacggggtattttgcgggctaatgttgctctgcctggattggtaatccagtattcgacggat
ggcggtcataactgggaagtttataacaaccataaacgcccaagagtgagaggtgatgtgttgatccgt
tctgtcagcccggacggtaaacgttacagtcgaattgataatgtaaaggcatga 
Fig 3.2: chbl gene sequence from P. luminescens. The P.luminescens chb gene 
sequence was obtained from Genbank (Accession number NC_005126.1). The 
proposed signal peptide is highlighted in red.  
 
Primers were designed to amplify the chbl gene from P. luminescens genomic DNA 
for ligation with the pQE60 vector from Qiagen (as described in Sections 2.11 and 
2.12). This company produce a variety of pQE vectors which enable high-level 
production of recombinant proteins. pQE vectors have numerous features that make 
them attractive for cloning. The vectors allow for the addition of N- or C-terminal 
His6 tags to the protein of interest, which facilitates downstream IMAC affinity-based 
purification. The vectors contain extensive multiple cloning sites and an optimised 
promoter sequence which includes a phage T5 transcriptional promoter and a lac 
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operon sequence for inducible expression of the protein. The pQE vectors also contain 
a β-lactamase gene that confers ampicillin resistance to the cell.  
The Chb protein from Serratia marcescens contains an N-terminal 27 amino acid 
signal peptide that is believed to be cleaved during post translational processing of the 
protein (Tews et al., 1996). The ChbL protein from P. luminescens is predicted to 
contain a signal peptide as the area was highly conserved between the two 
homologous proteins (see Figure 3.3).  
 
 
Fig 3.3: Prediction of a signal peptide sequence in the rChbL sequence. SignalP 
4.1 (available from http://www.cbs.dtu.dk/) was used to predict the presence/absence 
of a signal peptide in the ChbL protein sequence (NP_928634.1).  
 
Table 3.2 Signal Peptide Prediction 
Measure Position Value  Cutoff  Signal Peptide 
max. C  25  0.562 
max. Y 25  0.703 
max. S  12  0.946 
mean S 1-24  0.899 
D  1-24  0.796  0.570  Yes 
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A signal peptide was predicted to be present on the ChbL protein from residue 1 to 
24. The mature protein sequence was predicted to begin at residue 25. In order to 
examine the effects the signal peptide had on expression of the protein, the ChbL 
protein was amplified and cloned into the pQE60 vector both as an immature protein 
with its signal peptide (Chb+) and as a mature protein without its signal peptide  
(Chb-). The pQE60 vector was used as it adds a C-terminal His6 tag to the 
recombinant proteins. This was pertinent as Chb+ contained an N-terminal signal 
peptide which, if cleaved, would also remove the His tag.  
 
3.3.1 Cloning the immature rChbL protein (Chb+) 
 
The gene sequence was amplified as an NcoI-BamHI fragment for cloning into the 
pQE60 vector. An NcoI site was incorporated using the forward primer chb+_F. In 
the NcoI sequence the internal start codon is followed by a ‘G’ and lysine cannot be 
encoded by any codons beginning with ‘G’. Therefore, an additional codon was 
incorporated to facilitate the NcoI site. The best candidate was alanine as it is the 
smallest and simplest amino acid. It is also found at the beginning of the S. 
marcescens signal peptide, which shows a high level of similarity to that of the P. 
luminescens sequence. It was believed this would not dramatically impact the function 
of the signal peptide.  
 
         Met   Ala    Lys   Lys    Phe   Lys  Leu   His 
CC ATG GAC AAG AAA TTT AAA TTG CAT 
       NcoI 
 
Rather than the wildtype; 
 
        Met ---   Lys   Lys    Phe   Lys   Leu   His 
       ATG --- AAG AAA TTT AAA TTG CAT 
 
A BamHI restriction site was incorporated through the reverse primer chb+_R. No 
additional amino acids were required. The resultant Nco-BamHI PCR product was 
cloned into an NcoI-BglII digested pQE60 vector to make the pQE60_Chb+ 
construct. 
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3.3.2 Cloning the mature rChbL protein (Chb-) 
 
Comparison with the S. marcescens protein sequence showed high conservation 
between the sequences even in the signal peptide.  
 
 
Fig 3.4: Partial sequence alignment between the SM_CHB and the PL_CHB 
highlighting sequence similarity in the signal peptide region. The sequence 
alignment was generated using the ClustalW online tool and Genedoc software. The 
predicted signal peptide is highlighted in red. The conserved residues are highlighted 
in black. 
 
The chb- gene sequence was also amplified as an NcoI-BamHI fragment for cloning 
into the pQE60 vector. An NcoI site was incorporated using the forward primer chb-
_F. The first residue of the mature ChbL protein is a serine. In the NcoI restriction site 
the internal start codon is followed by a ‘G’. Serine cannot be encoded by any codons 
beginning with ‘G’. Therefore an additional codon was incorporated to facilitate the 
NcoI site. Again the best candidate was alanine as it is the smallest and simplest 
amino acid. The reverse primer chb-_R was the same as that used for the cloning of 
the immature Chb+ protein. The resultant NcoI-BamHI PCR product was cloned into 
an NcoI-BglII digested pQE60 vector to make the pQE60_Chb- construct.  
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Fig 3.5: Schematic describing the production of the pQE60_Chb- and 
pQE60_Chb+ constructs. These constructs were created from the primers chb+_F, 
chb+_R, chb-_F and chb-_R. The chb+ and chb- primers were used to amplify the chb 
gene with and without its signal peptide respectively, into a pQE60 vector. The gene 
was cloned as an NcoI-BamHI fragment into an NcoI-BglII digested vector. The red 
insert represents the chb gene, the yellow insert represents the β-lactamase gene, the 
green insert represents the promoter, the purple insert represents the signal peptide 
(leader sequence) and the blue insert represents the C-terminal His tag.  
PCR PCR 
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The chb gene was successfully cloned into the pQE60 vector as a mature (Chb+) and 
immature peptide (Chb-). The sequences were verified using commercial sequencing 
from Eurofins (see Section 2.10). The vector was then transformed into E. coli JM109 
cells for stable storage of the plasmid and into E. coli KRX competent cells for 
expression of the recombinant Chb protein.  
 
3.4 The effect of the signal peptide on rChbL protein expression 
 
Expression of the immature and mature rChbL proteins was undertaken to examine if 
the protein was expressed in E. coli and the effect, if any, of the signal peptide on cell 
growth and soluble protein production. The cultures were monitored using OD600nm 
readings over a 16 hour period and the soluble and insoluble protein fractions were 
analysed by SDS-PAGE to determine the extent of protein expression and solubility 
(see Figure 3.6).  
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Fig 3.6: a) Analysis of the growth rate of Chb+ (immature) and Chb- (mature) 
cultures b) Analysis of protein expression from the soluble and insoluble 
fractions from Chb+ and Chb- cultures. Cultures were grown and absorbance 
readings at 600nm were taken at different time-points. Soluble and insoluble fractions 
were prepared from Chb+ and Chb- cultures and analysed by 12.5% SDS-PAGE (see 
Section 2.15.1). Lane 1; Protein ladder Lane 2; Soluble Chb+ Lane 3; Insoluble Chb+ 
Lane 4; Soluble Chb- Lane 5; Insoluble Chb-. 
 
As seen in Figure 3.6 the growth rates of Chb+ and Chb- cultures were similar. The 
observed cell density of both Chb+ and Chb- cultures was similar at all time-points, 
suggesting that the presence/absence of the signal peptide did not affect the growth 
rate of the cells. It was evident from SDS-PAGE analysis that higher levels of rChbL 
protein expression resulted from the Chb+ construct. The majority of the Chb+ 
protein however was found in the insoluble cellular fraction, with a lesser amount 
visible in the soluble fraction. The analysis revealed very little evidence of Chb- 
protein expression in either the soluble or insoluble protein fractions. Therefore, in all 
further experiments the immature Chb+ protein was expressed and from here on will 
be referred to as rChbL.  
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3.5 Optimisation of the expression of rChbL in E. coli  
 
As reported in Section 3.4 the majority of rChbL protein expressed to the insoluble 
protein fraction. While not impossible, the purification of insoluble proteins is more 
difficult than that of soluble proteins and involves the denaturation and renaturation of 
the target protein. This can lead to large losses of protein as well as reduced protein 
activity. This section explores the optimisation of the expression of soluble rChbL. 
Time course analysis of both soluble and insoluble protein fractions was undertaken 
to determine the solubility of ChbL over the course of the expression experiment.  
 
a)      b) 
      
 
Fig 3.7: Time-course expression analysis of a) soluble and b) insoluble fractions 
from rChbL cultures. Once the culture had reached an OD600 of 0.5 and had been 
induced, 1 mL samples were taken every hour for 5 hours followed by an overnight 
sample. Samples from the soluble and insoluble cell fractions were obtained (see 
Section 2.15.1) and then analysed by 12.5% SDS-PAGE. Lane 1; Protein ladder Lane 
2, T=0 hours Lane 3, T=1 hour Lane 4, T= 2 hours Lane 5, T=3 hours Lane 6, T=4 
hours Lane 7, T=5 hours Lane 8, Overnight (T=16 hours). The largest protein 
concentration observed is highlighted by an arrow. 
 
As observed in Figure 3.7, time-course analysis revealed that the majority of the 
rChbL protein was found in the insoluble fraction. However, as observed previously 
there was also a small amount of protein present in the soluble fraction, with a similar 
 100 
level of rChbL protein observed in the soluble fraction at all time-points, while the 
highest level of protein observed in the insoluble fraction was 5 hours post induction.  
 
Knowing that rChbL was expressed to the soluble protein fraction but did not 
accumulate there over time, meant that the water lysis method (as described in Section 
2.18) was utilised to pinpoint the exact cellular location of the expressed rChbL. 
Cytoplasmic, periplasmic, outer membrane and extracellular fractions were analysed 
by SDS-PAGE following an overnight expression experiment (see Figure 3.8). 
 
 
 
Fig 3.8: Cellular compartment analysis of the soluble fraction of rChbL cultures. 
The soluble fraction from rChbL was analysed using the water lysis method (see 
Section 2.18) to examine where the recombinant protein was located in the cell. The 
culture media was also examined (see Section 2.16). The fractions were then run on a 
12.5% SDS gel. Lane 1, Protein ladder Lane 2, Culture media Lane 3, Cytoplasmic 
fraction Lane 4, Membrane fraction Lane 5, Periplasmic fraction. The largest protein 
concentration observed is highlighted by an arrow. 
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From analysis by the water lysis method (see Figure 3.8) it became apparent that that 
soluble rChbL was being transported across the cell membrane to the culture media. 
This result indicated that the protein could be purified from the culture media for 
experimental use. 
 
Expression and export of rChbL to the culture media was monitored by time-course 
analysis (see Figure 3.9). Culture media samples were taken (see Section 2.17) and 
analysed by 12.5% SDS-PAGE. The rChbL protein began to appear in the culture 
media two hours post-induction. As with the protein from the insoluble cellular 
fraction, the optimal time for protein harvest was five hours following induction.  
                                                                
 
Fig 3.9: Time-course expression analysis of the rChbL protein culture media 
samples. Recombinant protein expression was induced at OD600nm = 0.5. 5 mL 
samples were taken from the culture media every hour for five hours, following 
induction and an overnight sample was taken 16 hrs post induction (see Section 2.15). 
The samples were then analysed by 12.5% SDS-PAGE. Lane 1; Protein ladder, Lane 
2; T=0 hours, Lane 3; T=1 hour, Lane 4; T=2 hours, Lane 5; T=3 hours, Lane 6; T=4 
hours, Lane 7; T=5 hours, Lane 8; Overnight (T=16 hours). The largest protein 
concentration observed is highlighted by an arrow. 
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3.6 Optimisation of conditions for the expression of the rChbL 
protein 
 
Different culture conditions can have a huge impact on the levels of recombinant 
protein expression. Various conditions for growth, including the concentration of the 
inducer IPTG, temperature and media were examined in order to optimise the 
expression of the rChbL protein.  
 
The E. coli strains KRX, JM109 and XL10 Gold were examined in order to determine 
the most favourable expression host for the production of rChbL (see Figure 3.10). 
Gene transcription from the pQE60 plasmid is under the control of a T5 promoter/lac 
operon. This is a highly controllable expression system, in which the T5 promoter is 
repressed by the presence of a LacI protein. An inducer molecule known as Isopropyl 
β-D-1-thiogalactopyranoside (IPTG) inactivates the LacI repressor allowing 
transcription and subsequent protein translation to proceed (Reece, 2004). 
Induction of the E. coli strains KRX, JM109 and XL10 Gold, harbouring the 
pQE60_Chb+ plasmid was achieved by the addition of 100 μM IPTG. Culture media 
samples were analysed at 5 hours post-induction for the presence of rChbL (see 
Figure 3.10). While the rChbL protein was expressed in all strains tested, 
unsurprisingly, the recombinant protein was most strongly expressed in the 
endonuclease deficient E. coli KRX strain.  
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Fig 3.10: Analysis of ChbL expression in the E.coli strains KRX, JM109 and 
XL10 gold. The ChbL protein was expressed in three different strains of E. coli; 
KRX, XL10Gold and JM109. Culture media samples were taken 5 hours after 
induction (Section 2.15) and analysed by 12.5% SDS-PAGE. Lane 1; Protein ladder 
Lane 2; KRX Lane 3; XL10 Gold Lane 4; JM109. The largest protein concentration 
observed is highlighted by an arrow. The largest protein concentration observed is 
highlighted by an arrow. 
 
Further optimisation was undertaken by analysing the optimal concentration of IPTG 
for maximal recombinant protein expression in E. coli KRX (see Figure 3.11). The 
use of alternative media (see Figure 3.12) and growth temperatures (see Figure 3.13) 
were also examined.  
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Fig 3.11: Examining the effect of IPTG a) on growth rate b) on recombinant protein expression and c) concentration on rChbL protein 
expression. a) and b) IPTG was added to a 100 mL rChbL culture at a concentration of 100 μM, a second ChbL culture was left uninduced. The 
absorbance of each culture was monitored at 600 nm every hour for five hours post-induction and again following overnight incubation. The culture 
media was collected 5 hours post-induction (as described in Section 2.15) and the samples were analysed by 12.5% SDS-PAGE. Lane 1; Protein 
Ladder Lane 2; Chb not induced Lane 3; Chb induced.       
c) IPTG was added at 0, 5, 50 100, 250, 500 μM and 1M concentrations to determine the optimum IPTG concentration for maximum expression of 
ChbL. Culture media samples were collected and analysed at 16 hours post induction. Lane 1; Protein Ladder Lane 2; 0 μM Lane 3; 10 μM Lane 4; 
50 μM Lane 5; 100 μM Lane 6; 250 μM Lane 7; 500 μM Lane 8; 1 M.  
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Addition of IPTG to the rChbL culture resulted in a marginal drop in growth rate. The 
biggest difference in cell density between the two cultures was observed after 16 
hours (overnight incubation).  
 
Analysis of the effect of IPTG addition on protein expression demonstrated that 
expression of the recombinant protein could be tightly controlled. When no IPTG was 
added there was very little protein produced. However, when IPTG was added the 
protein was expressed at quite high levels. Therefore, the protein expression system 
was inducible and tightly controlled. The optimum concentration of IPTG for 
maximum protein yield was observed to be 100 μM. Higher concentrations of IPTG 
did not result in higher protein yields, therefore 100 μM IPTG was used for induction 
in all future experiments.  
 
 
Fig 3.12: Analysis of rChbL expression in different media; TB and LB. The 
rChbL protein was expressed in both TB or LB (see Section 2.3) and culture media 
samples were taken for analysis 5 hours post-induction. These samples were analysed 
by 12.5% SDS-PAGE. Lane 1; Protein ladder Lane 2; Culture media TB Lane 3; 
Culture media LB. The largest protein concentration observed is highlighted by an 
arrow. 
 106 
There was a discernible difference observed in the expression levels of rChbL 
depending on the media used (see Figure 3.12). A higher level of protein expression 
resulted from the use of TB compared to LB. TB was used in all subsequent 
experiments.  
 
 
 
Fig 3.13: Analysis of rChbL protein expression at different temperatures. The 
cultures were incubated at 37
o
C until an OD600nm of 0.5 was reached. They were 
subsequently induced with 100 μM IPTG, then incubated at either 30oC or 37oC for 5 
hours. A culture media sample was then evaluated by 12.5% SDS-PAGE. Lane 1; 
Protein ladder Lane 2; 30
0
C Lane 3; 37
0
C. The largest protein concentration observed 
is highlighted by an arrow. 
 
The study of the effect of incubation temperature on rChbL expression post induction 
(see Figure 3.13) revealed that the recombinant protein was more highly expressed 
following incubation at 30°C than at 37°C and was therefore grown at 30
o
C in all 
subsequent experiments.  
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3.7 Comparison of the rChbL protein purifications from the soluble 
cellular fraction and the culture media fraction 
 
Immobilised Metal Affinity Chromatography (IMAC) is a method used to purify a 
protein of interest from a complex mixture. It exploits the affinity between certain 
amino acids and metal ions. In this instance the strong interaction between histidine 
residues and nickel ions (Ni
2+
) was exploited (Reece, 2004). As discussed previously 
the rChbL protein was genetically tagged with 6 consecutive histidine (His6) residues 
using the pQE60 vector from Qiagen. The His6 tag which has a high affinity for Ni
2+
 
will facilitate purification by IMAC. IMAC sepharose, to which chelating groups had 
been covalently coupled
 
was purchased as slurry and charged using NiSO4. This resin 
was packed into a column (to a height of 2.5 mL) and the protein samples (100 mL) 
were passed over it slowly to ensure maximum time for binding between the His6 tag 
and the immobilised Ni
2+
. As histidine residues are often found on the surface of 
many other cellular proteins, wash steps must be employed to remove any weakly 
binding contaminants. These wash steps were performed with various concentrations 
of free imidazole, a 5-membered ring belonging to the histidine side chain. It 
facilitates the removal of any weakly bound proteins from the IMAC resin (Ni
2+
) due 
to its higher affinity for free imidazole than the weakly bound cellular proteins. 
Stringency washes composed of increasing concentrations of imidazole were 
employed to test the strength of the interaction between the protein of interest and the 
IMAC column. Imidazole washes were also used for the elution of the recombinant 
protein of interest using a much higher concentration.  
 
This section outlines the purification of protein from the culture media and from the 
soluble protein fraction to compare both yield and purity of the recombinant protein. 
IMAC optimisation was undertaken to determine which protein had superior binding 
to the Ni
2+
 resin and the wash stringencies that could be employed (see Figure 3.14). 
The optimised purification was then carried out to examine the yield and purity of the 
rChbL protein (see Figure 3.15). 
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a)                                                                          b)                                                             
 
Fig 3.14: IMAC optimisation for the purification of rChbL from a) the soluble 
protein fraction and b) the culture media. Stringency washes were performed with 
an increasing imidazole concentration gradient from 20 mM to 250 mM, to determine 
when ChbL was eluted from the IMAC column. The fractions were then examined by 
12.5% SDS-PAGE. 
a) Lane 1; Protein ladder Lane 2; Lysate Lane 3; Flow through one Lane 4; Flow 
through 2 Lane 5; 10 mM Imidazole Lane 6; 20 mM Imidazole Lane 7; 40 mM 
Imidazole Lane 8; 60 mM Imidazole Lane 9; 80 mM Imidazole Lane 10; 100 mM 
Imidazole Lane 11; 200mM Imidazole.  
b) Lane 1; Protein ladder Lane 2; Flow through Lane 3; 10 mM Imidazole Lane 4; 20 
mM Imidazole Lane 5; 40 mM Imidazole Lane 6; 60 mM Imidazole Lane 7; 80 mM 
Imidazole Lane 8; 100 mM Imidazole Lane 9; 200 mM Imidazole. 
 
The rChbL protein as isolated from the culture media displayed superior binding to 
the IMAC column over that obtained from the soluble protein fraction. It can be seen 
from Figure 3.14 that the soluble cellular protein eluted from the column upon the 
application of 10 mM imidazole. In comparison the protein isolated from the culture 
media was able to withstand imidazole washes of up to 40 mM before eluting from 
the resin.  
The ability of the culture media form of rChbL to withstand higher levels of imidazole 
in the wash buffers is very advantageous. Purification of rChbL from the soluble 
protein fraction would result in a highly contaminated product as 10 mM imidazole is 
not a strong enough concentration to wash away all contaminating proteins and to 
ensure the elution of pure protein. This capacity of the culture media form of rChbL to 
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withstand high stringency imidazole washes ensures the elution of a pure homogenous 
fraction of protein as seen in Figure 3.15. 
 
 
 
Fig 3.15: Purification of the recombinant ChbL protein from the culture media. 
The culture media was collected after cell harvest from an rChbL expression culture. 
The protein samples were run over an IMAC column, washed with 40 mM imidazole 
and eluted with 250 mM imidazole. Fractions were analysed by 12.5% SDS-PAGE.  
b) Lane 1; Protein ladder, Lane 2; Flow through, Lane 3; Wash 1 (40 mM), Lane 4; 
Wash 2 (40 mM), Lane 5; Elution one, Lane 6; Elution three, Lane 7; Elution five, 
Lane 8; Elution 8, Lane 9; Elution 11, Lane 10; Elution 14, Lane 11; Elution 18. 
 
Following the isolation of pure protein it is necessary to carry out a number of 
‘polishing’ steps to remove the imidazole and exchange the protein into a buffer 
suitable for downstream assays and storage. Two methods of buffer exchange were 
compared (see Figure 3.16). The first method involved the use of size exclusion 
membranes (vivaspins columns from Sartorius). The second method involved the use 
of the 26/10 desalting column (as described in Section 2.20) on the FPLC (see Figure 
3.17). 
 
Vivaspins are centrifugal filter units with a cellulose membrane. The membranes 
come in various sizes that allow for the removal of salts and proteins with lower 
molecular weights that the membrane cut off. If the correct membrane size is selected 
the target protein will be retained while allowing the buffer salts to flow through the 
membrane freely. This technique was utilised to dilute out the imidazole and to 
exchange the protein into a buffer of choice, which in this case was PBS. 
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From the graph below (see Figure 3.16) it can be seen that the majority of the protein 
was lost using the vivaspin columns. This was thought to be due to the protein binding 
to the cellulose membrane, possibly due to the carbo-binding properties of the protein. 
The FPLC method employed used a gel filtration column which allowed the high 
molecular weight recombinant proteins to elute first as they were excluded from the 
gel. The smaller substances such as imidazole entered the gel pores and therefore 
eluted later. The protein yield resulting from FPLC was almost three times higher than 
that obtained using the vivaspin columns so this was the method chosen for all future 
buffer exchange of the protein. 
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Fig 3.16: Comparison of the buffer exchange (desalting) of the purified rChbL 
protein using Vivaspins and FPLC. The elution fractions from the culture media 
purification containing protein as determined by absorbance readings (see Section 
2.23.2) were pooled together following IMAC purification. The pooled fractions were 
then either buffer exchanged using Vivaspins (Sartorius) or using FPLC (see Section 
2.20). The final protein concentration was determined using 280 nm readings as 
described in Section 2.23.2.  
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Fig 3.17: Desalting/Buffer exchange of purified protein using a HiPrep 26/10 
desalting column on an FPLC system. Buffer exchange was carried out as per 
Section 2.20. The first large peak in blue signifies the protein being eluted from the 
column. The other smaller peaks are impurities and smaller molecules such as the 
imidazole being removed. Fractions A2-A10 were collected and the protein quantified 
via absorbance readings (see Section 2.23.2). 
 
Approximately 5 mg per 250 mL TB culture of pure rChbL protein was obtained after 
purification and buffer exchange. This indicated that the majority of the rChbL 
protein was being secreted from the cell after production.  
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3.8 Characterisation of rChbL catalytic activity  
 
The catalytic activity of an enzyme may be determined by measuring either the rate of 
formation of a product or the rate of depletion of a substrate. The catalytic activity of 
the enzyme was determined by measuring the rate of product formation using a 
commercial synthetic chromogenic substrate, 4-Nitrophenyl N-acetyl β-D-
glucosaminide (PNP-GlcNAc) from Sigma. This compound is comprised of an N-
acetylglucosamine molecule linked to a fluorescent compound, 4-Nitrophenol. 
Enzymatic cleavage of PNP-GlcNAc releases 4-PNP, which forms the yellow 
coloured 4-Nitrophenolate under basic conditions. Na2CO3 was used to stop the 
reaction and develop the phenolate ion which was measured at 405nm. Activity on 
natural compounds such as chitobiose and other chito-oligosaccharides were explored 
using electrophoresis and HPLC assays as discussed in Chapter 6. 
  
 
Fig 3.18: 4-Nitrophenyl N-acetyl β-D-glucosaminide (PNP-GlcNAc). The synthetic 
substrate used for the chitobiase activity assay. Image obtained from Sigma Aldrich 
and modified (http://www.sigmaaldrich.com/ireland.html). 
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3.8.1 Development of the rChbL activity assay 
 
A modification of the assay was developed by examining the optimum concentration 
at which to use the rChbL enzyme (see Figure 3.20) and the time it took for the rChbL 
– PNP-GlcNAc reaction to reach completion (see Figure 3.21). A standard curve was 
developed using commercial 4-Nitrophenol to determine the amount of substrate 
cleaved in the Chb assay.  
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Fig 3.19: Standard curve of 4-Nitrophenol. A standard curve was constructed using 
4-Nitrophenol (Sigma), the chromogenic molecule that is released upon cleavage of 4-
Nitrophenyl N-acetyl β-D-glucosaminide. A range of concentrations of 4-Nitrophenol 
was made up in sodium phosphate buffer (50 mM, pH 8.0). 110 μL of each 
concentration was added to a 96-well plate in triplicate, 100 μL Na2CO3 was added to 
ionise all the 4-Nitrophenol to 4-Nitrophenolate and the absorbance was read at 405 
nm. Experiment is representative of three individual experiments. Error bars represent 
the standard deviation of three replicates.  
 
This standard curve was used to determine the millimolar (mM) concentration of 4-
Nitrophenol released through enzymatic cleavage of the PNP-GlcNAc substrate in 
further activity assays. 
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Fig 3.20: Determination of the optimum rChbL concentration for the Chb 
activity assay. The assay was carried out as described in Section 2.26 with a variety 
of enzymatic concentrations (1 ng/mL – 50 μg/mL) over a wide range of PNP-
GlcNAc concentrations (0-10 mM) to determine the optimum concentration at which 
to use the enzyme. The rate, V (mM PNP released/min/mL enzyme), of the reaction 
was plotted.  Experiment is representative of three individual experiments. Error bars 
represent the standard deviation of three replicates.  
 
There was very little catalytic activity observed when the lower concentrations of 
enzyme were used, i.e. 1 ng/mL, 100 ng/mL and 1 μg/mL. The most catalytic activity 
was observed when concentrations of 10 μg/mL and 50 μg/mL were used. When 10 
μg/mL of rChbL was used the absorbance values were in the range of 0.1-1.0 for the 
lower substrate concentrations (0-2 mM PNP-GlcNAc). This concentration achieved 
the most reliable results and was therefore used for future experiments. 
Enzymatic activity also peaked at a substrate concentration of approximately 2 mM 
over all enzyme concentrations used. A concentration of 2 mM PNP-GlcNAc was 
used in all further experiments in order to ensure substrate saturation. This was to 
guarantee that substrate was not a limiting factor in the reaction and, thus, would not 
affect the kinetic data.  
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Fig 3.21: Determination of the endpoint of the rChbL catalytic reaction. The Chb 
activity assay was carried out as described in Section 2.26 in 50 mM sodium 
phosphate at pH 8.0. It was terminated at various time-points by the addition of 1 M 
sodium carbonate to determine when the catalytic activity had been exhausted. The 
rate, V (mM PNP released/min/mL enzyme), of the reaction was plotted. Experiment 
is representative of three individual experiments. Error bars represent the standard 
deviation of three replicates.  
 
Figure 3.21 demonstrates that breakdown of the substrate peaked after approximately 
50 minutes. At 60 minutes the reaction had become saturated. No additional PNP-
GlcNAc had been broken down as signified by the lack of change in absorbance/rate 
of reaction. Therefore, 45 minutes was chosen to ensure that catalytic activity was 
measured under initial-rate conditions and the rate of product formation was linear 
throughout the duration of the assay. Catalytic activity was not limited by a lack of 
substrate.  
 
3.8.2 Characterisation of the rChbL activity assay 
 
The conditions of the assay were altered to determine the environment that optimises 
rChbL activity. The parameters of the assay examined were the pH at which the 
reaction took place (see Figure 3.22) and the temperature at which the reaction was 
carried out (see Figure 3.23). The stability of the enzyme was also determined; its 
stability at high temperatures was tested (see Figure 3.24), the half-life of the enzyme 
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was calculated (see Figure 3.25) and the long term stability of the enzyme was tested 
over a range of time-points and under various storage conditions (see Figure 3.26).  
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Fig 3.22: Determination of optimum buffer and pH conditions for the Chb 
activity assay. The Chb activity assay was carried out as described in Section 2.26 
with (a) different buffers all at a concentration of 50 mM and all at pH 8.0 and (b) in 
sodium citrate buffer (50 mM) over a wide range of pH values from 4-12. The rate, V 
(mM PNP released/min/mL enzyme), of the reaction was plotted. Experiment is 
representative of three individual experiments. Error bars represent the standard 
deviation of three replicates.  
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The highest rate of catalytic activity was observed in sodium phosphate buffer. A 
much lower rate of catalytic activity was observed in Phosphate buffered saline (PBS) 
and Tris buffered saline (TBS). The lowest rate of activity was observed in HEPES.  
A bell shaped curve was observed when catalytic activity was examined over a wide 
range of pH concentrations. There was relatively little catalytic activity observed at 
low or high pH values. The highest rate of catalytic activity was observed around 
neutral pH values. Catalytic activity peaked at approximately pH 8.0 after which the 
activity steadily declined. The optimum buffer conditions for enzyme activity were 
determined to be 50 mM sodium phosphate buffer at pH 8.0.  
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Fig 3.23: Determination of the optimum temperature for the Chb activity assay. 
The Chb activity assay was carried out as described in Section 2.26 in 50 mM sodium 
phosphate buffer at pH 8.0 over of range of temperatures, from 25
o
C to 60
o
C. The 
enzyme, substrate and buffer were all maintained at the specific reaction temperature. 
The rate, V (mM PNP released/min/mL enzyme), of the reaction was plotted. 
Experiment is representative of three individual experiments. Error bars represent the 
standard deviation of three replicates.  
 
A skewed bell-shaped curve was observed when the rate of catalytic activity was 
plotted against temperature. The rate of catalytic activity increased until it reached a 
maximum at 45
o
C after which there was a dramatic decrease in activity. The optimum 
temperature for catalytic activity was approximately 45
o
C. Under 45
o
C the enzymatic 
activity had not yet reached its peak. Over 45
o
C the catalytic activity dramatically 
decreased. Above 60
o
C there was negligible activity.
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Fig 3.24: Determination of the rChbL enzyme temperature stability at 37
o
C, 
45
o
C and 60
o
C. The rChbL enzyme was incubated at 37
o
C, 45
o
C and 60
o
C. Samples 
were taken at various time-points. The samples were allowed to cool and then the Chb 
activity assay was carried out as described in Section 2.26 under optimal conditions. 
Experiment is representative of three individual experiments. Error bars represent the 
standard deviation of three replicates.  
 
The rChbL enzyme was most stable for the longest duration when incubated at 37
o
C. 
Catalytic activity remained at 100% for almost 3 hours. It took 3 days to completely 
inactivate the enzyme. The ChbL enzyme was inactivated after 16 hours when 
incubated at 45
o
C. The most severe effect on catalytic activity was observed when the 
rChbL enzyme was incubated at 60
o
C. The enzyme was inactivated after only 15 
minutes.   
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Fig 3.25: Determination of the half-life of the rChbL enzyme at a) 37
o
C and b) 
45
o
C. Using the results from Fig 3.24, the ln(% Activity) was plotted against time to 
generate a linear graph. The slope of the line was used to calculate a half for the 
enzyme using the formula: Half-life = 0.693/k.  
 
The linear plots generated in Figure 3.24 allowed the half-life to be calculated from 
the slope of the line (k). The half-life at 37
o
C was calculated to be 35 hours. The 
enzyme retained the majority of its’ catalytic activity for up to 24 hours. Total activity 
was lost after 72 hours. The half-life at 45
o
C was calculated to be 6 hours. It took 16 
hours for the enzyme to lose all of its’ catalytic activity. 
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3.8.3 Optimisation of the stable storage of rChbL 
 
After purification proteins are no longer in their native environment and may become 
unstable, are prone to aggregation and proteolysis and may lose their structural 
integrity. Enzymes may lose their catalytic activity as structure is related to function. 
Therefore, it was critical to examine the optimal storage conditions for the enzyme to 
ensure it was kept stable and viable for as long as possible. Time-course analysis was 
carried out to determine the long-term viability of the rChbL enzyme under different 
storage conditions. Cold temperatures are generally optimal for the storage of 
proteins, as they tend to promote protein stability. When freezing proteins, their 
structure may be disrupted by the formation of ice crystals. Therefore, glycerol was 
routinely used as a cryoprotectant to prevent ice crystal formation and hence, stabilise 
the structure of the protein.  
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Fig 3.26: Examination of the long-term viability of the rChbL enzyme under 
various conditions. The purified rChbL enzyme was freshly stored at 100 μg/mL 
with and without glycerol as a cryoprotectant over a range of temperatures. The Chb 
activity assay was carried out as described in Section 2.26 at the various time-points. 
The rate, V (mM PNP released/min/mL enzyme), of the reaction was plotted against 
time (days). Experiment is representative of three individual experiments. Error bars 
represent the standard deviation of three replicates.  
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Figure 3.26 clearly highlights that storage at -20
o
C in the absence of a cryoprotectant 
was very unsuitable for the rChbL enzyme. After two days the enzyme had lost over 
half of its catalytic activity with total catalytic activity lost after a week. Storage at -
20
o
C in the presence of varying concentrations of a cryoprotectant significantly 
increased the storage life of the enzyme. In the presence of 20% glycerol, half of the 
catalytic activity was lost after 150 days while increasing the concentration of 
glycerol to 50% reduced the activity loss further with 66% of the activity still present 
after 150 days. Again, at -80
o
C it was observed that storage without a cryoprotectant 
caused a dramatic decrease in the rate of catalytic activity while addition of a 
cryoprotectant greatly protected against the loss of this activity. The difference in 
activity between these storage conditions highlighted the fact that if the rChbL 
enzyme was to be frozen it needed a cyroprotectant to protect its structural integrity 
and therefore its catalytic activity. Overall, however, the ideal condition for storage of 
the rChbL enzyme was at the milder temperature of 4
o
C. At this temperature the 
ChbL enzyme retained the most catalytic activity over the longest period of time. It 
lost roughly 20% of its activity over the first week in storage but in the following 
months the catalytic activity remained at a constant stable level. In general proteins 
are stored at high concentrations above 1 mg/mL. This is thought to prevent the 
proteins from sticking to the surface of the storage vessel and promotes the 
stabilisation of the protein structure. However, the ChbL enzyme had to be stored at a 
concentration of 100 μg/mL as higher concentrations were found to promote 
aggregation of the protein and caused precipitation of the protein from solution.  
 
3.8.4 Preliminary kinetic study of rChbL  
 
It is important to calculate the reaction rates of an enzyme so that enzymes under 
different conditions or from different sources may be compared. Parameters that can 
be measured from kinetics plots include the catalytic efficiency of the enzyme, the 
specific activity of the enzyme, the affinity of the enzyme for its substrate and the 
effect of inhibitors on the catalytic activity of the enzyme. There are many different 
plots that can be used to describe the kinetic values of an enzyme; Michaelis-Menten 
equation, Lineweaver-Burk plot and Hanes-Woolf plot. The Michaelis-Menten 
equation is the simplest way to describe the rate of a reaction. It plots the rate of the 
reaction against the substrate concentration. In this way it describes the relationship 
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between the rate of substrate conversion and the concentration of that substrate. 
Lineweaver-Burk plots are a more sophisticated version of the Michaelis-Menten 
equation. However, they tend to be unreliable. While the Michaelis-Menten equation 
uses a curve the Lineweaver-Burk plot generates a straight line. This is possible by 
plotting the inverse of the rate of the reaction against the inverse of the substrate 
concentration. The kinetic values are then calculated from the equation of the line. 
However, by plotting reciprocal values any small discrepancy in the data can result in 
large errors and therefore they will not be used in these kinetic studies. Lineweaver-
Burk plots are, however, useful when studying enzyme inhibition, allowing the 
various types of inhibitions to be distinguished. This will be discussed more in 
Section 3.87. Hanes-Woolf plots are generally regarded as the best plot to use. The 
Hanes-Woolf plot also generates a linear graph and allows the kinetic data to be 
calculated from the equation of the line. The relationship between the substrate and 
rate of the reaction (S/V) is plotted against the substrate concentration (S). Here the 
Michaelis-Menten equation and Hanes-Woolf plot were used to describe the results. 
Below are the values that can be calculated from Michaelis-Menten and Hanes Woolf 
plots: 
 
Vmax: The maximum enzyme velocity achieved in terms of substrate concentration. 
Km: The Michaelis-Menten constant. It is a measure of the affinity of the enzyme for 
the substrate. 
kcat: Turnover number (measure of the rate of product formation). 
kcat/Km: A measure of how efficiently the enzyme converts the substrate to product, 
(catalytic efficiency).  
 
The enzymatic activity was measured over a range of substrate concentrations and the 
values were determined using the above methods.  
However, these plots and calculations are only applicable to first order reactions. This 
had to be verified by determining the dependency of the catalytic activity on enzyme 
concentration (see Figure 3.27).  
 
 123 
y = 0.1466x - 0.0122
R2 = 0.9998
-0.5
0
0.5
1
1.5
2
2.5
3
3.5
4
0 5 10 15 20 25 30
Enzyme (ug/mL)
V
 
Fig 3.27: Determination of the dependency of catalytic activity on enzyme 
concentration. The Chb activity assay was carried out as described in Section 2.26. A 
constant concentration of PNP-GlcNAc was incubated with increasing concentrations 
of ChbL, from 0-25 μg/mL. The rate of the reaction, V (mM PNP released/min/mL 
enzyme), was plotted against enzyme concentration (μg/mL).  Experiment is 
representative of three individual experiments. Error bars represent the standard 
deviation of three replicates.  
 
The rate of reaction increased with enzyme concentration in a linear fashion, showing 
this to be a first order reaction.  
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Fig 3.28: rChbL kinetics were examined and compared using two different 
methods a) Michaelis-Menten curve and b) Hanes-Woolf plot. The Chb activity 
assay was performed as per Section 2.26 over a range of PNP-GlcNAc concentrations 
from 0 to 10 mM. The rChbL enzyme was used at a concentration of 10 μg/mL. The 
rate, V (mM PNP released/min/mL enzyme), of the reaction was plotted against 
substrate concentration (mM). Experiment is representative of three individual 
experiments. Error bars represent the standard deviation of three replicates.  
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Table 3.3 Kinetic values of the rChbL enzyme as determined by a Michaelis 
Menten curve and a Hanes-Woolf plot  
Rate Constants Michaelis Menten Hanes-Woolf 
Vmax (μM)  2610   1870 
Km (mM)  0.65   0.47 
kcat (s
-1
)
  
4.3x10
5  
3.1x10
5 
kcat/Km (mM
-1
.s
-1
)
 
6.6x10
5  
6.56x10
5 
SD (±)   0.00562  0.00562 
 
The kinetic values obtained from the Michaelis-Menten curve and Hanes-Woolf plot 
correlated quite closely (see Table 3.3). The high Vmax values obtained for the rChbL 
enzyme represent the high velocity reached by the rChbL enzyme. The low Km values 
observed for the ChbL enzyme demonstrate the high affinity of the rChbL enzyme for 
PNP-GlcNAc. The ChbL enzyme was discovered to be very catalytically efficient as 
described by the high kcat and kcat/Km values. 
 
3.8.5 Comparison of rChbL with a commercial chitobiase 
 
A chitobiase (β-N-acetylglucosaminidase) was obtained from New England Biolabs 
(NEB). This enzyme had been cloned from Xanthomonas manihotis and expressed in 
E. coli. The enzymatic activity was identical to that of the recombinant Chb in that it 
cleaves N-acetylglucosamine residues from the terminal non-reducing end of 
oligosaccharides. The activity of the commercial Chb was calculated (see Figure 
3.29).  
 
 
 
 
 
 
 
 126 
a)                                                                                                
0
0.5
1
1.5
2
2.5
3
3.5
0 2 4 6 8 10 12
S
V
Chb
Commercial Chb
  
b) 
y = 0.4251x + 0.4931
R2 = 0.9983
-0.5
0
0.5
1
1.5
2
2.5
3
-2 -1 0 1 2 3 4 5 6
S
S
/V
 
Fig 3.29: Commercial Chb kinetics measured using a a) Michaelis-Menten curve 
and b) Hanes Woolf plot. The Chb activity assay was performed as described in 
Section 2.26. Kinetic values were calculated and compared for both enzymes. The 
rate, V (mM PNP released/min/mL enzyme), of the reaction was plotted.  Experiment 
is representative of three individual experiments. Error bars represent the standard 
deviation of three replicates.  
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Table 3.4 Kinetic values for the commercial Chb as determined by a Michaelis-
Menten curve and Hanes-Woolf plot. 
Rate Constants Michaelis Menten Hanes Woolf 
Vmax (μM)  2856   2350 
Km (mM)  1.9   1.16 
kcat (s
-1
)  3.43x10
5  
2.82x10
5 
kcat/Km (mM
-1
.s
-1
) 1.8x10
5  
2.44x10
5 
SD (±)   0.00212  0.00212 
 
The commercial Chb was found to have a slightly higher velocity than the rChbL 
from this study. However, the Km of the commercial Chb was found to be higher, 
signifying a lower affinity for its substrate as compared with the lower Km of the 
rChbL from this study. The kcat values of both enzymes were similar; each value was 
10
5
 in magnitude. The kcat/Km values were also similar; both again were 10
5
 in 
magnitude. The rChbL from this study had slightly higher kcat and kcat/Km values than 
the commercial Chb, demonstrating a higher catalytic efficiency than the commercial 
Chb.  
 
3.8.6 rChbL Specificity 
 
A number of different PNP-linked sugar substrates were tested against the rChbL 
enzyme to investigate its specificity for PNP-GlcNAc as described in Section 2.26.2. 
The sugars used were PNP linked α-glucose, α-galactose, α-fucose, α-mannose, sialic 
acid, β-glucose and β-galactose.   
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Fig 3.30: Examination of the substrate specificity of the rChbL enzyme. The Chb 
activity assay was performed as per Section 2.26.2 using different a) PNP α -linked 
substrates and b) PNP β -linked substrates and PNP-Sialic Acid. The substrates were 
used over a concentration range from 0-10 mM. The rate V (mM PNP 
released/min/mL enzyme) of the reaction was plotted against substrate concentration 
(mM). Experiment is representative of three individual experiments. Error bars 
represent the standard deviation of three replicates.  
        
Figure 3.30 highlights the specificity of the rChbL enzyme for PNP-GlcNAc. The 
rChbL enzyme had relatively no affinity for any of the other substrates. No activity 
was expected for the α-sugars, however a small amount of activity wouldn’t have 
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been unexpected for the β-sugars as the native substrate of the rChbL enzyme is a β-
linked sugar.  
 
3.8.7 Sugar Inhibition of rChbL 
 
Various free sugars were added in increasing concentrations to the rChbL - PNP-
GlcNAc reaction to determine their inhibitory effect as described in Section 2.26.3. 
N-acetylglucosamine, glucose, galactose, lactose, mannose, fucose and xylose were 
chosen as they covered a wide variety of structures, which allowed the affinity of the 
rChbL enzyme towards PNP-GlcNAc to be tested.  
 
There are three types of reversible enzyme inhibition, competitive, non-competitive 
and uncompetitive, which may be distinguished using Lineweaver-Burk plots. 
Competitive inhibition occurs when the inhibitor binds to the active site of the 
enzyme thereby blocking this site for the substrate. The inhibitor and substrate are 
structurally similar and must compete for the same site. The 1/V intercept stays the 
same however the slope of the line increases with increasing inhibitor. Non-
competitive inhibition is when the inhibitor binds to the enzyme at a site other than 
the active site. It does not inhibit the substrate binding to the active site but has 
changed the conformation of the enzyme so it is unable to catalyse the reaction. The 
slope and 1/V intercept increase with increasing inhibitor. Uncompetitive inhibitors 
only bind to the enzyme-substrate complex. This inhibits the enzyme from catalyzing 
the reaction. The slope of this line stays the same however the 1/V intercept increases 
with increasing inhibitor.  
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Fig 3.31: The inhibitory effect of free sugars on the rate of rChbL catalytic 
activity on PNP-GlcNAc. The Chb activity assay was performed as described in 
Section 2.26 with 1 mM PNP-GlcNAc and increasing concentrations of GlcNAc, 
glucose, galactose, lactose, mannose, fucose and xylose. The catalytic rate, V (mM 
PNP released/min/mL enzyme), of the reaction was plotted against substrate 
concentration (mM). Experiment is representative of three individual experiments. 
Error bars represent the standard deviation of three replicates.  
       
High levels (100 mM) of N-acetylglucosamine (GlcNAc) demonstrated almost 
complete inhibition of rChbL activity on PNP-GlcNAc (see Figure 3.31). There was 
also inhibition observed when increasing concentrations of glucose were added. As N-
acetylglucosamine contains the basic glucose structure this was also to be expected, as 
it was similar to its natural substrate. There was relatively little inhibition observed 
when galactose was added to inhibit the reaction, however, when high concentrations 
of lactose were added there was a surprisingly high level of inhibition noted (up to 
80%). Not only is its structure very different from that of GlcNAc, but it is a dimer of 
galactose, which did not cause any inhibition. When high concentrations of mannose 
were added a high level of inhibition was also observed (up to 75%). Mannose has 
some structural similarity to GlcNAc. There was very little inhibition observed on 
rChbL enzymatic activity on PNP-GlcNAc when high concentrations of fucose and 
xylose were used. The structures of these sugars do not resemble that of GlcNAc so 
this was to be expected.  
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Fig 3.32: Lineweaver-Burk plots describing the inhibition occurring with a) 
GlcNAc, b) glucose, c) mannose and d) lactose. The Chb activity assay was 
performed as described in Section 2.26. Increasing concentrations of PNP-GlcNAc 
were incubated with a constant concentration of enzyme and either 25 mM, 50 mM or 
100 mM inhibiting sugar. The reciprocal rate of the reaction was plotted against the 
reciprocal of the substrate concentration. Experiment is representative of three 
individual experiments. Error bars represent the standard deviation of three replicates.  
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Table 3.5 Kinetic values describing the inhibition occurring between the rChbL -  
PNP-GlcNAc reaction and GlcNAc, glucose, mannose and lactose.   
   1/V intercept  Slope  
GlcNAc (No sugar) 0.646   0.187 
GlcNAc (25 mM) 0.713   2.550 
GlcNAc (50 mM) 0.705   6.190 
Glucose (No sugar) 0.464   0.338 
Glucose (25 mM) 0.673   0.329 
Glucose (50 mM) 0.884   0.352 
Mannose (No sugar) 0.634   0.206 
Mannose (25 mM) 0.573   0.628   
Mannose (50 mM) 0.614   1.134 
Mannose (100 mM) 0.542   1.956 
Lactose (No sugar) 0.477   0.300 
Lactose (25 mM) 0.993   0.529 
Lactose (50 mM) 1.747   0.466 
Lactose (100 mM) 2.956   0.550 
        
The values observed in Table 3.5 were calculated using the plots described in Figure 
3.32. Addition of an increasing concentration of GlcNAc increased the slope of the 
line but the 1/V intercept value remained similar over both concentrations. This trend 
indicated that GlcNAc was inhibiting the reaction in a competitive manner. Increasing 
the concentration of glucose resulted in the slope of the line remaining unchanged; 
however, the 1/V intercept increased signifying uncompetitive inhibition. Addition of 
an increasing concentration of mannose resulted in an increased slope of the line and a 
mainly unchanged 1/V intercept indicating that it was a competitive inhibitor of the 
reaction. Finally, when an increased concentration of lactose was added to the 
reaction the slope of the line and the 1/V intercept increased. This indicated that 
lactose was inhibiting the reaction in a non-competitive manner.  
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3.9 Immobilisation of rChbL to cyanogen bromide-activated 
sepharose 
 
Immobilised enzymes can be defined as “enzymes physically confined or localised in 
a certain defined region of space with retention of their catalytic activities, and which 
can be used repeatedly and continuously” (Katchalski-Ktazir, 1993). Advantages of 
immobilised enzymes over those in solution include increased stability of the enzyme, 
the ability to re-use the enzyme until its catalytic activity has been exhausted, the 
capacity to use the enzyme in large reactors and the absence of enzyme in the final 
product solution. One major disadvantage may be a loss of catalytic activity due to 
immobilisation (Katchalski-Ktazir, 1993). 
Insoluble, inert matrices are generally used for enzyme immobilisation. In this study 
the rChbL enzyme was immobilised on the commercially available cyanogen 
bromide-activated sepharose (Sigma). This matrix is a porous material comprised of 
cross-linked agarose beads. Cyanogen bromide reacts with the agarose hydroxyl 
group to form cyanate esters or imidocarbonates. Cyanate esters are highly reactive 
with the primary amines found on the surface of proteins forming an isourea bond 
thus coupling the enzyme to the matrix. These covalent bonds are irreversible and 
therefore the matrix was not reusable once the enzymes’ catalytic activity had been 
exhausted.  
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Fig 3.33: Reaction schematic describing the formation of the covalent bond 
during enzyme immobilisation to cyanogen bromide activated sepharose. The 
formation of the bond between the cyanogen bromide-activated sepharose and the 
primary amine of the protein under basic conditions is described in the schematic. The 
cyanate ester is highly reactive towards the primary amine of the protein compared 
with the mild reactivity of the imidocarbonate. 
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Fig 3.34: Determination of the volume of rChbL resin that exhibited the highest 
rate (V) of activity. The Chb activity assay was performed as described in Section 
2.26. Increasing volumes of resin at a concentration of 10 μg/mL (enzyme) were 
added to a constant concentration of PNP-GlcNAc. The rate, V (mM PNP 
released/min/mL enzyme), of the reaction was plotted against the resin volume (μL).  
Experiment is representative of three individual experiments. Error bars represent the 
standard deviation of three replicates.  
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The rChbL resin (1.2 mg/mL) was prepared as described in Section 2.24 and diluted 
to a concentration of 10 μg/mL for the purpose of Figure 3.34. The highest rate of 
activity was observed when 30 μL of rChbL resin was added to the PNP-GlcNAc 
substrate. This was in contrast with the native Chb whose activity was at 
approximately the same rate at 10 μL of a 10 μg/mL solution (see Figure 3.20). Three 
times as much rChbL resin was needed compared with the native rChbL to elicit the 
same reaction rate.  
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Fig 3.35: Examination of the of the immobilised rChbL kinetics using two 
different methods a) Michaelis-Menten curve and b) Hanes-Woolf plot. The 
enzyme assay was performed as described in Section 2.26 with an increasing 
concentration of PNP-GlcNAc (mM) to compare the rates of reaction between the 
immobilized rChbL and native rChbL. The rate, V (mM PNP released/min/mL 
enzyme), of the reaction was plotted against substrate concentration (mM). 
Experiment is representative of three individual experiments. Error bars represent the 
standard deviation of three replicates. 
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Table 3.6 Kinetic values for the immobilised rChbL as determined by a 
Michaelis-Menten curve and Hanes-Woolf plot 
Rate Constants  Michaelis-Menten  Hanes-Woolf                 
Vmax (μM)  3463   2070 
Km (mM)  1.7   0.49 
kcat (s
-1
)  1.92x10
5  
1.15x10
5
 
kcat/Km (mM
-1
.s
-1
) 1.13x10
5  
2.35x10
5 
SD (±)   0.00444  0.00444 
 
Table 3.6 highlights the fact that the Vmax of the immobilised enzyme was slightly 
higher than that of the native rChbL enzyme. The immobilised rChbL enzyme 
reached a higher rate than the native rChbL enzyme. There is a difference between 
both Km values so as Hanes-Woolf plots are deemed to be the most accurate only 
these values will be discussed. The Km was found to be similar to that of the native 
enzyme. Immobilisation of the enzyme to resin did not appear to change the affinity 
of the enzyme for its PNP-GlcNAc substrate. The catalytic efficiency of both the 
native rChbL and immobilised rChbL are similar, each are in the range of 10
5
.  
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Fig 3.36: Comparison of the temperature stability between the immobilised 
rChbL enzyme and the native rChbL enzyme. Samples of the immobilised and 
native enzyme were incubated at various temperatures before cooling. The enzyme 
assay was then performed as described in Section 2.26. The rate, V (mM PNP 
released/min/mL enzyme), of the reaction was plotted against increasing temperature. 
Experiment is representative of three individual experiments. Error bars represent the 
standard deviation of three replicates.  
 
As identified in Figure 3.36 the immobilised rChbL enzyme was slightly more stable 
at the higher temperature of 60
o
C than the native Chb enzyme. The native rChbL 
enzyme was inactivated after incubation at 60
o
C; however the immobilised rChbL 
retained almost half of its activity. Immobilisation of the rChbL enzyme to resin 
slightly increased its stability at higher temperatures.  
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3.10 Discussion 
 
A chitobiase enzyme (rChbL) from P. luminescens TT01 was successfully cloned, 
expressed, purified and characterised for the first time. The pQE60_Chb+ vector was 
transformed into two strains of E. coli, JM109 and KRX, and of the two strains, the 
JM109 cells stored the DNA safely for the longest period of time. The JM109 strain is 
routinely used for stable plasmid DNA storage as it contains recA1 and endA1 
mutations which minimise recombination events and promote high quality plasmid 
DNA preparations. At the end of the study these cells were still producing active and 
stable enzyme.  
 
KRX cells are a commonly used expression strain. They contain a somewhat 
defective restriction system in the form of hsd and e14 mutations and there is an 
absence of a common endonuclease (endA-). The KRX cells were discovered to be 
unsuitable for stable storage of the vector. After three months it was observed that the 
cells produced a much lower yield of enzyme that was also inactive. The 
pQE60_Chb+ vector had to be taken from plasmid stocks and re-transformed into 
fresh KRX cells every three months. This reduction in protein yield after storage 
using this strain was also reported by Vethanayagam and Flower (2005). They found 
that protein production decreased over time when utilizing the T7 
promoter/polymerase system. DNA sequencing verified that this problem did not arise 
due to mutations in the plasmid containing the gene of interest but was discovered to 
be due to the low levels of active T7 polymerase present in the cell. The T7 
polymerase lost its function due to mutations acquired on the bacterial chromosomal 
DNA. Much lower levels of protein expression were observed due to the lack of 
functional T7 promoter present in the cell (Vethanayagam and Flower, 2005). The 
decrease in rChbL protein expression in this study may also have been due to a lack of 
fully functioning polymerase. The E. coli polymerase may have picked up mutations 
during long-term storage. Lack of protein expression also signifies that there may 
have been a problem with the promoter sequence. Problems with promoter deletion 
from pQE vectors by KRX cells have been seen before within the group (unpublished 
results). To overcome this problem in future studies an alternative E. coli strain such 
as BL21 could be used. The expression levels of both strains are comparable, however 
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BL21 cells have leaky expression of the protein of interest and therefore induction 
cannot be as stringently controlled as with KRX cells. It would be advantageous in 
future studies to use BL21 cells to ensure a constant supply of protein with no risk of 
a reduction in protein expression over time or the production of inactive protein.  
 
The major issue encountered while exploring the expression of the rChbL protein was 
determining the location to which it was expressed. During initial studies it was 
observed that the enzyme was found as an insoluble protein in the cell lysate. Proteins 
can be insoluble due to misfolding of the protein or to the incorrect formation of 
disulphide bonds causing the protein to aggregate in an insoluble mass. Isolation and 
purification of insoluble proteins is difficult, time consuming and the quality of the 
protein can be compromised. Insoluble proteins can be purified in the presence of 
denaturents such as guanadine hydrochloride or urea followed by renaturation of the 
protein. Denaturation and renaturation of proteins is obviously not ideal as misfolding 
can occur which can impact on protein function. Ensuing studies investigated the 
compartmental location of any soluble protein. Using the water lysis method rChbL 
was identified in the periplasmic fraction. Following further investigation it was 
discovered that the majority of the protein was secreted from the cell into the media. 
This result was not unexpected as the enzyme contained a signal peptide and in nature 
this enzyme would be employed in the breakdown of chitin outside the cell. Signal 
peptides are generally found on the N-terminus of proteins, where they guide the 
newly synthesized immature proteins to the periplasm where the signal peptide is 
cleaved to generate the mature form of the protein (Reece, 2004). The periplasm can 
also facilitate correct protein folding with the help of molecular chaperones and 
proteases (Miot and Betton, 2004). N-terminal signal sequences and are very common 
among chitin-active proteins, which are frequently extracellular enzymes (Tews et al., 
1996).   
 
While investigating the hydrolysis of chitobiose by a chitobiase from S. marcescens 
2170, Toratani et al., (2008) discovered that the chitobiase was present not only in the 
culture medium but also in the periplasm when the bacteria was cultured in media 
containing chitin, similar to the findings of this study. Tews et al., (1996) purified a 
recombinant S. marcescens Chb homologue from the periplasm of E. coli. However, 
only 50% of the total protein was recovered. Whether the culture media was tested for 
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the presence of Chb protein was not mentioned in this paper. If protein was present in 
the culture media the isolation procedure would have been more straightforward and 
relatively little protein would have been lost in comparison. Drouillard et al., (1997) 
also purified a Chb protein from the periplasmic fraction of E. coli again with no 
mention of any secreted protein. The Chb protein purified by Tews et al., (1996) was 
sequenced and compared with the original sequence. The purified protein was 27 
amino acids shorter than the original sequence. They proposed that this was due to the 
removal of the signal peptide which was also 27 amino acids long. In the case of the 
rChbL protein, it is likely that the signal peptide guided the immature protein to the 
periplasm, where the signal peptide was removed, the protein potentially underwent 
some post-translation modification and was secreted from the cell. 
A significant finding was that the rChbL enzyme was secreted from E. coli after 
production. Previous papers investigating the Chb protein from S. marcescens 
produced in E. coli contained no mention of checking the culture media for protein. 
Instead the protein was isolated from the periplasmic fraction. Isolation from the 
culture media would be less complicated and time-consuming.  
 
Purifications of the rChbL protein from the different fractions highlighted the 
differences between the proteins’ structure. While the protein from the culture media 
had a relatively strong interaction with the nickel resin (40 mM imidazole was needed 
for elution), the cellular protein from the soluble fraction had a very weak interaction 
with the nickel (only 10 mM imidazole was needed to elute the protein). It was 
believed that the His6 tag was more accessible on the rChbL protein from the culture 
media than that isolated from the soluble cellular fraction. The His6 tag on the rChbL 
protein from the soluble cellular fraction may have been inaccessible due to the 
tertiary structure of the protein. Again, this provided some evidence that the cellular 
fraction contained the immature form of the protein which had not been fully 
processed in the periplasm. The correctly folded, fully mature form of rChbL is 
thought to be generated in the periplasm through the correct formation of disulphide 
bonds (the S. marcescens Chb contained 3 disulphide bonds) facilitated by the 
oxidising environment and the presence of enzymes such as disulphide isomerase and 
disulphide oxidoreductase. This mature form was then secreted. 
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The catalytic cleavage of natural substrates is often hard to analyse. For the purpose 
of developing a quick, reliable, efficient assay for the analysis of the catalytic activity 
of the rChbL from P. luminescens, 4-Nitrophenyl N-acetyl β–D-glucosaminide was 
used.  Most kinetic characterisation studies on glycosyl hydrolases are performed with 
synthetic substrates. Suginta et al., (2010) utilized PNP-GlcNAc as a substrate in their 
study on novel N-acetylglucosamindases from Vibrio harveyi 650, Liu et al., (2011) 
studied the catalytic activity of an insect β-N-acetyl-D-hexosaminidase on a 4-
methylumbelliferyl N-acetyl β–D-glucosaminide (4MU GlcNAc) substrate, 
Drouillard et al., (1997) studied the action of a chitobiase from S. marcescens also 
utilizing a p-Nitrophenyl N-acetyl-β-D-glucosaminide substrate, while Toratani et al., 
(2008) also studied the action of chitobiases from S. marcescens but used a 4-
methylumbelliferyl N-acetyl β–D-glucosaminide substrate. These substrates provide 
relatively quick results that are easy to read due to the presence of the linked 
molecule. However, these substrates do not entirely resemble the enzymes’ natural 
substrate due to the presence of the artificial leaving groups (see Figure 3.37). These 
leaving groups are much smaller than the natural sugar leaving group and molecules 
such as PNP and 4MU can be negatively charged at higher pHs (Krokeide et al., 
2007). 
 
a)                                                                b) 
          
Fig 3.37: Difference between (a) the natural substrate chitobiose and the (b) 
synthetic substrate PNP-GlcNAc. As demonstrated in the diagram the PNP leaving 
group is much smaller than the second GlcNAc residue present on the chitobiose 
sugar. 
 
However, investigating rChbL activity on its natural substrate (chitobiose) requires a 
lot more time and optimisation. Hydrolysis of the chitobiase sugar can be measured 
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through the use of methods such as High Performance Liquid Chromatography 
(HPLC) or Thin Layer Chromatography (TLC). The hydrolysis of chitobiose and 
other chito-oligosaccharides was investigated and reported in Chapter 6 using HPLC. 
The conditions for the PNP-GlcNAc assay had to be optimised to ensure the rChbL 
was working to its optimal potential, as enzymatic activity is sensitive to its 
environment. Enzymes are especially affected by the pH and temperature of their 
environment.  
Comparison of the optimum reaction conditions of the P. luminescens Chb with the S. 
marcescens Chb homologue revealed similarities. The optimum temperature of the P. 
luminescens Chb was identified as 45
o
C while a Chb homologue from S. marcescens 
was found to exhibit optimum catalytic activity at the higher temperature of 52
o
C 
(Tews et al., 1996). Another study conducted by Drouillard et al., (1997) determined 
the optimum temperature of a Chb from S. marcescens to be 40
o
C. The optimum 
activity of the Chb at similar temperatures is explained by the fact that P. luminescens 
and S. marcescens are both mesophilic bacteria, preferring moderate temperatures. 
Using circular dichroic spectroscopy the Tm of the S. marcescens Chb was calculated 
to be 60
o
C (Tews et al., 1996). While that technology was not available for this study, 
the P. luminescens Chb was found to be inactivated after incubation at 60
o
C. It can be 
hypothesized that Tm of the P. luminescens Chb was 60
o
C as the inactivation was 
probably due to denaturation of the enzymes’ tertiary structure.  Both the P. 
luminescens Chb and S. marcescens Chb (Tews et al., 1996; Drouillard et al., 1997) 
were most catalytically efficient in 50 mM sodium phosphate buffer. While the P. 
luminescens Chb was most catalytically active at pH 8.0 the S. marcescens Chb was 
found to be optimally catalytically active over a wider pH range, from pH 6.0 to pH 
8.0 (Tews et al., 1996). Sodium phosphate buffer is commonly used in many life 
science applications and tends to favourably suit proteins due to its neutral pH and the 
presence of salt to stabilize the protein structure. Phosphate buffers are also known to 
have a good buffering capacity, preventing fluctuations in pH that may occur during 
the enzymatic reaction.  
Comparison of the rates of activity between the rChbL from this study and from a 
commercially available Chb demonstrated the similarity of the catalytic activity of 
both enzymes. While the commercial Chb had a higher velocity than the rChbL, the 
rChbL had greater affinity for its substrate. The efficiency of both enzymes was 
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comparable, with the rChbL being slightly more efficient than the commercial 
version. This may have been due to the higher affinity for the substrate.  
 
Table 3.7 Comparison of the rate constants of chitobiase enzymes from different 
sources. 
Source               Km      kcat  kcat/Km      Reference 
    (mM)  (s
-1
) (s
-1
.mM)    
Photorhabdus luminescens 0.47          3.1x10
5
  6.56x10
5 
   This study 
Serratia marcescens        0.165               -      -       Tews (1996)  
Serratia marcescens        6.3x10
-5
    8.27x10
2
    1.3x10
4 
           Prag (2000) 
Serratia marcescens           56.7          1.11x10
2
          -            Drouillard (1997) 
Streptococcus pneumoniae     0.132            -                 -  Clarke (1995)  
Vibrio harveyi 650             0.172        0.08           4.65x10
5
         Suginta (2010) 
Ostrina furnacalis              0.107        4.35x10
2
     4.063x10
3
     Liu (2011) 
Trichoderma harzianum         0.0806           -                -  Marco (2004)  
Candida albicans                  0.77          7.4x10
2
          -  Cannon (1994) 
  
Table 3.7 highlights the wide variety in the rates of activity obtained for Family 20 
chitobiases from a variety of different sources including bacterial chitobiases, fungal 
chitobiases and an insect chitobiase. All of kinetic studies were performed with PNP-
GlcNAc. The P. luminescens Chb had a slightly higher Km than the other chitobiases 
from bacterial sources, signifying a lower affinity for its substrate. However, its Kcat 
and Kcat/Km values were much higher indicating that the Chb from P. luminescens is a 
more efficient enzyme. The P. luminescens Chb also had a lower substrate affinity 
than that of an insect chitobiase, but again it was found to be more catalytically 
efficient. Finally, the Chb from P. luminescens had a higher substrate affinity in 
comparison with one fungal chitobiase (Trichoderma harzianum) but a lower affinity 
compared with another fungal chitobiase (Candida albicans). The efficiency of the 
chitobiase from Candida albicans was lower than that of the Chb from P. 
luminescens. Overall, while not having the highest substrate affinity of the chitobiases 
investigated in other studies, the Chb from P. luminescens was much more efficient.  
 
The rChbL enzyme was found to be specific, failing to hydrolyse any of the substrates 
it encountered except its natural substrate GlcNAc. However, when inhibition studies 
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were performed, the enzyme was inhibited by a number of free sugars. Inhibition of 
catalytic activity by N-acetylglucosamine was expected, as this is a monomer of the 
rChbL enzymes’ natural substrate. This sugar was found to competitively inhibit the 
enzymes catalytic activity towards the PNP-GlcNAc substrate. Presumably, the N-
acetylglucosamine was bound to the active site of the rChbL, thereby blocking 
binding of the PNP-GlcNAc substrate. Unexpectedly, mannose was also found to 
competitively inhibit catalytic activity. The structure of mannose is slightly similar to 
that of N-acetylglucosamine, however, it has an axial –OH at C-2 rather than an 
equatorial N-acetyl group. As a competitive inhibitor it can also be presumed that it 
bound to the active site of the ChbL enzyme inhibiting its action on PNP-GlcNAc. 
Glucose was found to be an uncompetitive inhibitor of ChbL activity. N-
acetylglucosamine is a derivative of glucose, the only structural difference being an 
N-acetyl group at carbon 2. Despite the similarity glucose does not bind to the active 
site. Instead it was found to be un-competitively inhibiting the enzymes catalytic 
activity through binding to the enzyme-substrate complex. The glucose sugar bound 
to the enzyme-substrate complex in some way to cause inhibition. Most surprisingly, 
lactose was found to inhibit binding. Lactose is a dimer of galactose (which does not 
cause any inhibition). The inhibition caused was not due to a similarity in the 
structures between the natural substrate and lactose. Instead it binds to a different site 
causing a conformational change and therefore preventing the rChbL enzyme from 
cleaving its substrate.   
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a)                                        b)                                           c)             
 
d)                                         e)       
      
Fig 3.38: Sugar structures a) N-acetylglucosamine, b) glucose, c) mannose, d) 
galactose and e) lactose. The structures of the inhibiting sugars used highlighting 
their similarities and differences.  
 
Enzymes have been immobilised to different surfaces for use in bioreactors with 
various consequences on their activities and temperature stability. The immobilisation 
of a β-glucosidase on a polysullfone capillary for the breakdown of oleuropein into 
aglycon and glucose increased the enzymes affinity for its substrate (Km), albeit 
slightly decreasing the catalytic activity (Mazzei et al., 2009). Nagatomo et al., (2009) 
also immobilised a β-glucosidase, however, they immobilised it onto a gelatine gel. 
This surface was found to promote thermostability, increasing its stability at higher 
temperatures as compared with the native enzyme. The immobilised enzyme was also 
reusable and storage was improved with no decrease in activity after one month. 
Chitinases have also been immobilised to various surfaces for the large-scale 
hydrolysis of chitin. A chitinase from S. marcescens was immobilised onto a 
hydroxypropyl methylcellulose acetate succinate polymer surface by Chen et al., 
(1994). By using an immobilised enzyme that could be removed from the product 
solution by precipitation they were able to move from a batch reaction to a semi-batch 
reaction which increased product yield 1.4 fold.  
 
The purified rChbL from P. luminescens was immobilised to sepharose in this study. 
Immobilisation of the rChbL enzyme to resin was found to increase its velocity 
compared with the native rChbL. However, it was found to lower the affinity and 
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efficiency of the enzyme which is why a higher concentration of enzyme was needed 
to achieve the same catalytic rate as the native enzyme. Immobilisation on an 
alternative surface or using different immobilisation chemistry may improve the 
activity of the rChbL as there is a lysine at the binding site in S. marcescens that is 
conserved in P. luminescens. The rChbL enzyme may have been immobilised in such 
a way that it was more difficult for the substrate to access the active site. An 
advantage of the immobilisation was the increased stability of the rChbL at higher 
temperatures. While the native enzyme was catalytically inactive at 60
o
C, the 
immobilised enzyme retained some of its activity. Immobilisation increased the 
rChbL enzymes’ temperature stability which is important when using enzymes in 
bioreactor formats.  
 
A chitobiase (rChbL) enzyme from Photorhabdus luminescens has been cloned, 
expressed and purified for the first time. An activity assay has been devised and 
optimised to determine the enzymes’ catalytic activity. The rates of catalytic activity 
of the rChbL enzyme were found to be comparable with that of a commercial 
chitobiase and chitobiases from other studies. The rChbL enzyme was specific for the 
GlcNAc substrate. The rChbL has also been immobilised to a commercial sepharose 
resin with only a small loss in catalytic activity and increased temperature stability. 
The rChbL enzyme can be stored for over 6 months at 4
o
C and is stable for up to three 
days at 37
o
C. There properties make this rChbL enzyme a viable commercial 
prospect.  
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Chapter 4: 
 
Site-specific mutagenesis of the 
Photorhabdus luminescens rChbL 
enzyme to generate a novel 
Carbohydrate Binding Protein (rChb 
CBP)
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4.1 Overview 
 
As discussed previously, Tews et al., (1996) and Prag et al., (2000) have reported the 
cloning, expression, purification and characterisation of a Chb enzyme from S. 
marcescens. It was observed that mutagenesis of an aspartate residue to an alanine at 
position 539 and a glutamate residue to an aspartate at position 540 abolished all 
catalytic activity. However, this work was taken no further. The main aim of this 
chapter was to generate a novel carbohydrate binding protein (rChb CBP) from rChbL 
through mutagenesis of D539A and E540D as described by Prag et al., (2000). It was 
hypothesized that the catalytic activity would be destroyed from the rChbL enzyme in 
the same way it was abolished in the S. marcescens Chb resulting in a non-
catalytically active carbohydrate binding protein. This chapter also examines the 
protein sequence and the tertiary structure of the P. luminescens Chb more closely. 
Chitobiase sequences from a variety of different bacterial species were aligned to 
study the conservation in the sequences of these proteins. The structure of the P. 
luminescens Chb was modeled on that of the S. marcescens Chb to examine its 
tertiary structure and the effects the mutations would have on this structure.  
 
4.2 Chitobiase sequence analysis 
 
BLAST (available from www.ncbi.nlm.nih.gov ) was used to search for Family 20 
chitobiase enzymes similar to the S. marcescens and P. luminescens Chbs. A sequence 
alignment was performed with chitobiase sequences displaying high levels of 
sequence homology obtained from the BLAST search. Chb protein sequences from 
twelve bacterial sources were aligned; S. marcescens (SM), Serratia plymuthica (SP), 
P. luminescens (PL), Photorhabdus asymbiotica (PA), Xenorhabdus nematophila 
(XN), Enterobacter sp. (E), Yersinia enterocolitica (YE), Yersinia mollaretii (YM), 
Providencia stuartii (PS), Vibrio cholerae (VC), Vibrio sinaloensis (VS) and Vibrio 
furnissii (VF). The sequence alignment (see Figures 4.1 and 4.2) highlighted the high 
level of conservation occurring in these Chb enzymes. Approximately 60% similarity 
was observed. The catalytically important residues (Aspartate 539 and Glutamate 540) 
are conserved across all bacterial species examined.  
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Fig 4.1: Sequence alignment of chitobiase enzymes from 12 different bacterial 
species. The conserved residues are highlighted in black and the conserved catalytic 
residues are highlighted by a red box. The sequences used are S. marcescens (SM), 
Serratia plymuthica (SP), P. luminescens (PL), Photorhabdus asymbiotica (PA), 
Xenorhabdus nematophila (XN), Enterobacter sp. (E), Yersinia enterocolitica (YE), 
Yersinia mollaretii (YM), Providencia stuartii (PS), Vibrio cholerae (VC), Vibrio 
sinaloensis (VS) and Vibrio furnissii (VF). The sequences were obtained from 
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Genbank. The alignment was performed using ClustalW (online tool) and Genedoc 
software.  
 
4.3 Protein Modelling of the rChbL and rChb CBP  
 
The crystal structure of the S. marcescens Chb was solved by Tews et al., (1996) to a 
resolution of 1.9 Å using X-ray crystallography. The Chb was also co-crystallised 
with its substrate chitobiose. The structures can be found in the Protein Data Bank 
(available from: http://www.rcsb.org/pdb/home/home.do) labelled 1QBA and 1QBB 
respectively. The tertiary structure of the Chb from P. luminescens, however, is 
unknown. Homology modelling allows the unknown tertiary structure of a protein to 
be suggested. The ChbL tertiary structure was modelled using SWISS-MODEL 
(available from: http://swissmodel.expasy.org/workspace), with the S. marcescens 
Chb (1QBB) as the protein template.  
  
a)                                                                    b) 
                          
Fig 4.2: a) The S. marcescens Chb and b) the P. luminescens Chb. The P. 
luminescens Chb tertiary structure was modelled on that of the Chb from S. 
marcescens using Swiss-Model. The structures were visualised using Pymol software 
(available from http://www.pymol.org/).  The active site residues, D539 and E540, are 
highlighted in blue. The chitobiose sugar is highlighted in red.                              
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The active site of the Chb is located in a deep crater of the enzyme structure. The P. 
luminescens Chb may have a more accessible active site, since the homology model 
shows that there are fewer large amino acids at the site entrance.   
The mutations of the catalytic residues (D539A E540D) were modelled (see Figures 
4.5 and 4.6), allowing the interaction with the chitobiose sugar to be visualised. The 
distance between the sugar and the amino acid at position 540 (now aspartate) was 
increased and there was no contact observed with the chitobiose sugar. The aspartate 
at position 539 was mutated to the smaller amino acid alanine, leaving space in the 
active site that the side chain of the aspartate used to occupy.   
 
a)                                                                  b) 
         
Fig 4.3: Active site of the P. luminescens a) ChbL and b) Chb CBP. Image (a) 
contains residues D539 and E540 while image (b) depicts the mutations D539A and 
E540D. The images were generated using Pymol software. The mutations were also 
simulated using Pymol. The catalytic residues (D539 and E540) are highlighted in 
blue.  
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a)                                                             b) 
      
Fig 4.4: Visualisation of the interactions of a) ChbL and b) Chb CBP with 
chitobiose. The active site residues, a) D539 and E540 and b) D539A and E540D, are 
highlighted in blue. On the chitobiose sugar, the green denotes carbon, the red denotes 
oxygen, the white denotes hydrogen and the blue denotes nitrogen.  
 
The Chb from S. marcescens has been described as a monomeric protein containing 
four domains; Domain I, Domain II, Domain III and Domain IV (Tews et al., 1996). 
Domain I was assigned as the binding domain while the active site was contained in 
Domain III. There has been no function assigned to Domains II and IV, it can be 
presumed that they are purely structural. Figure 4.5 highlights the four potential 
domains of rChbL as modelled on those from the S. marcescens Chb. The conserved 
catalytic residues are present in Domain III. The rChbL protein sequence was 
analysed using the Simple Modular Architecture Research Tool (SMART) (available 
from http://smart.embl-heidelberg.de/) which assigned domains and annotations to 
ChbL based on sequence similarity to known protein domains. Domain I from ChbL 
was found to be similar to the cellulose-binding domain of cellulases, as was the S. 
marcescens Chb. Domain I of ChbL was therefore also assigned as a carbohydrate-
binding domain.  
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Fig 4.5: The four protein domains of ChbL. Domain I is highlighted in green, 
Domain II is highlighted in yellow, Domain III is highlighted in pink and Domain IV 
is highlighted in blue. The structures were visualised using Pymol software (available 
from http://www.pymol.org/).   
 
4.4 Cloning of the rChb CBP 
 
The immature Chb+ protein (rChbL) was used as the template for the construction of 
the new recombinant carbohydrate binding protein rChb CBP. The pQE60_Chb+ 
vector was used as the template to construct the new pQE60_Chb_CBP vector, 
inclusive of the signal peptide. The site-specific mutations (D539A and E540D) were 
introduced into open reading frames of the chb gene by whole vector PCR 
amplification using complementary phosphorylated primers carrying the desired 
mutations. Both mutations were introduced on the same forward primer (chb+cbp_F). 
The primers used were chb+cbp_F and chb+cbp_R (see Table 2.1). The 
pQE60_Chb_CBP vector was transformed into E. coli JM109 for stable plasmid 
(DNA) storage and E. coli KRX for recombinant protein expression. 
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                              gg gga gct gac gcg aag aa 
cca ttg gag act tgg cat ttt ggg gga gat gaa gcg aag aat atc cgt ttg 
gga gac gga ttc cag gat aaa aat ggt cct atc gta ccg ggt aag ggc 
Fig 4.6: The forward primer (chb+cbp_F) used to introduce site-specific 
mutations to the chbl gene in the construction of the pQE60_Chb_CBP vector. 
The gene sequence is shown in black, the forward primer sequence is shown in red 
and the site-specific mutations are red, underlined and bold.  
                      
4.5 Expression and purification of the rChb CBP 
 
The culture conditions as optimised in Section 3.6 for the expression of the rChbL 
enzyme were also employed here for the expression of the rChb CBP.  The rChb CBP 
was expressed in E. coli KRX, in TB, at 30
o
C and induced with 100 µM IPTG. The 
protein was harvested five hours post-induction. The rChb CBP was collected from 
the culture media (see Section 2.16) and purified via IMAC (see Section 2.19.1).   
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Fig 4.7: a) Comparison between growth rates of rChbL and rChb CBP cultures 
b) Time-course analysis of culture media samples from rChb CBP expression 
cultures. Recombinant protein expression was induced at OD600nm = 0.5. 5 mL 
samples were taken from the culture media every hour for five hours, following 
induction and an overnight sample was taken 16 hours post-induction (see Section 
2.15). The samples were then analysed by 12.5% SDS-PAGE. Lane 1, Protein ladder; 
Lane 2, T=0; Lane 3, T=1 hour; Lane 4, T=2 hours; Lane 5, T=3 hours; Lane 6, T=4 
hours; Lane 7, T=5 hours; Lane 8, Overnight (T=16 hours). 
 
The growth rate of the rChb CBP culture did not vary from that of the rChbL culture. 
The observed cell density of both rChbL and rChb CBP cultures was similar at all 
time-points, suggesting that the site-specific mutations did not affect the growth rate 
of the cells. Expression of the rChb CBP was similar with that of the native rChbL 
protein. The mutations did not affect the expression of the rChb CBP to the culture 
media. As with rChbL, the rChb CBP began to appear in the culture media two hours 
post induction. Protein production was optimal five hours after induction. The rChb 
CBP was therefore collected five hours post-induction.  
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Fig 4.8: Purification of the recombinant rChb CBP from the culture media. The 
culture media was collected after cell harvest from a rChb CBP expression culture 
(see Section 2.17). Purification was carried out as described in Section 2.19. The 
protein sample was run over an IMAC column, washed with 40 mM imidazole and 
eluted with 250 mM imidazole. Fractions were run on 12.5% SDS gels. Lane 1, 
Protein ladder; Lane 2, Flow through; Lane 3, Wash 1 (40 mM); Lane 4, Wash 2 (40 
mM); Lane 5, Elution 1; Lane 6, Elution 3; Lane 7, Elution 5; Lane 8, Elution 9; Lane 
9, Elution 12; Lane 10, Elution 15; Lane 11, Elution 18. 
 
The purification profile of the rChb CBP was similar to that of the native rChbL 
enzyme. As in the purification of rChbL rChb CBP was observed to elute from the 
resin at a 40mM concentration of imidazole concentrations but respectable yields of 
protein were recovered, as much as 5 mg per 250 mL culture.  
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4.6 Characterisation of the rChb CBP 
 
Following the successful cloning, expression and purification of rChb CBP the 
proteins catalytic activity was examined. Using the activity assay as described in 
Section 2.26 it was demonstrated that the catalytic activity was removed from the 
rChbL enzyme through the introduction of the two mutations, D539A and E540D (see 
Figure 4.9). A catalytically inactive protein had been successfully generated, rChb 
CBP.   
0
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Fig 4.9: Analysis of the catalytic activity of rChbL compared with rChb CBP. 
The activity assay was carried out as per Section 2.26 under optimum conditions (50 
mM sodium carbonate, pH 8.0) using 10 μg/mL rChbL and 10 μg/mL rChb CBP. 
Experiment is representative of three individual experiments. Error bars represent the 
standard deviation of three replicates.  
   
Although it was demonstrated that the rChb CBP was catalytically inactive, it 
remained to be determined if the rChb CBP retained its binding activity. As 
discovered in Chapter 3, rChbL was capable of cleaving PNP-GlcNAc, suggesting 
that rChb CBP may be capable of binding to GlcNAc residues on glycoproteins. The 
binding abilities of the rChb CBP were tested against a variety of glycoproteins using 
Enzyme Linked Lectin Assays (ELLAs) as described in Section 2.27. The 
glycoprotein target of interest was probed with the carbohydrate binding protein. 
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Detection of binding was facilitated by the engineered C-terminal His6 tag on the 
rChb CBP with the use of a HRP labelled anti-His antibody.  
Three glycoproteins were used in this study; fetuin, transferrin and thyroglobulin. 
Fetuin is a protein found in the blood. The fetuin utilised in this work was obtained 
from fetal calf serum. Bendiak et al., (1989) described the heterogeneous nature of the 
glycan patterns on fetuin as a mixture of bi-, tri-, tetra- and penta-sialyl patterns. The 
most common glycan pattern is shown in Figure 4.10(a). Transferrin is a glycoprotein 
involved in the transport of iron. The transferrin utilised in this work was of human 
origin. The structure of the most common glycan pattern found on transferrin was 
elucidated by Spik et al., (1975 and 1985) and is shown in Figure 4.10(b). 
Thyroglobulin is a high molecular weight thyroid glycoprotein (Spiro, 1965). The 
thyroglobulin used in this study was of porcine origin. The pattern of the most 
abundant glycan pattern on porcine thyroglobulin as elucidated by Kamerling et al., 
(1988) is shown in Figure 4.10(c). Each of these glycoproteins had varying degrees of 
glycosylation allowing the binding capabilities of the rChb CBP to be thoroughly 
examined. 
 
a)                                       b)                                c) 
               
Fig 4.10: The most common glycan patterns found on a) Fetuin b) Transferrin 
and c) Thyroglobulin. The most common glycan patterns on the glycoproteins used 
in this study.  
 
The glycoproteins described above all terminate in sialic acid. As it was hypothesised 
that rChb CBP would bind to structures with terminal GlcNAc and there was no 
access to glycoproteins naturally ending in this sugar it was therefore necessary that 
they were created. Glycosyl hydrolases are widely employed for the sequential 
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hydrolysis of glycan structures (Wongmadden and Landry, 1995). Commercially 
available glycosyl hydrolases were utilized for the sequential hydrolysis of the 
glycoproteins to expose the terminal glycan residue of interest. The glycoprotein 
remained untreated when examining binding to terminal sialic acid residues. When 
examining binding to terminal galactose residues a neuraminidase from Clostridium 
perfringens was used to cleave terminal sialic acid residues from the glycoprotein 
exposing underlying galactose residues of N-linked glycans. When analysing binding 
to terminal GlcNAc residues, a galactosidase from Bacillus fragilis was used to cleave 
terminal β-galactose residues from the glycoproteins.  
 
 
Fig 4.11: Glycan structures following sequential enzymatic hydrolysis with 
glycosyl hydrolases. This is the general pattern of N-linked glycosylation found on 
glycoproteins. The first structure is the untreated glycoprotein with terminal sialic 
acid. The second structure is the neuraminidase treated glycoprotein with terminal 
galactose (asialo glycoprotein) and the third structure is the galactosidase treated 
glycoprotein with terminal GlcNAc (asialo agalacto glycoprotein).   
 
Initially, the effectiveness of the glycoprotein treatments had to be examined to ensure 
that the correct terminal residues were being exposed. Each treated glycoprotein was 
probed with a commercially available lectin, known to be specific for the terminal 
residue of interest. SNA was used to detect terminal sialic acid, ECL was used to 
detect terminal galactose and GSLII was used to detect terminal GlcNAc.  
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Fig 4.12: Analysis of the effectiveness of glycoprotein treatments to generate a) 
terminal sialic acid b) terminal galactose and c) terminal GlcNAc. The generation 
of various terminal sugar residues on glycoproteins were examined by probing with 
specific lectins, SNA to detect terminal sialic acid, ECL to detect terminal galactose 
and GSLII to detect terminal GlcNAc. Experiment is representative of three 
individual experiments. Error bars represent the standard deviation of three replicates.  
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The binding of rChb CBP to terminal GlcNAc, galactose and sialic acid residues on 
these newly created glycoproteins was tested (see Figures 4.13, 4.14 and 4.15).  
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Fig 4.13: ELLA examining the binding of the rChb CBP to GlcNAc residues on 
asialo agalacto fetuin. An ELLA was carried out as per Section 2.27. Different 
concentrations of rChb CBP were used, from 10 ng/mL to 100 μg/mL. Commercial 
GSLII was used as a positive control and was detected using an anti-biotin antibody. 
The rChb CBP was detected using an anti-His antibody. Experiment is representative 
of three individual experiments. Error bars represent the standard deviation of three 
replicates.  
 
There was very little binding detected between the rChb CBP and GlcNAc residues in 
this ELLA format at all concentrations examined. The positive signal from GSLII 
verified the assay was working correctly. The highest absorbance obtained was 0.16 
which was negligible compared with the positive control and similar to the blank. The 
binding of rChb CBP to asialo agalatco transferrin and thyroglobulin was 
subsequently examined as they contained varying degrees of glycosylation on their 
surface (see Figures 4.14 and 4.15). Binding of the rChb CBP to terminal GlcNAc 
residues on these glycoproteins was also not observed. Binding of the rChb CBP to 
sialic acid or galactose was also not observed (see Figure 4.15). These results 
signified that either the rChb CBP was not binding to the GlcNAc residues or that its 
binding could not be detected with the anti-His antibody.  
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Fig 4.14: ELLA to investigate the binding of the rChb CBP to GlcNAc residues 
on various glycoproteins. An ELLA was carried out as per Section 2.27. rChb CBP 
was used at a concentration of 10 μg/mL. Commercial GSLII was used as a positive 
control at a concentration of 10 μg/mL and was detected using an anti-biotin antibody. 
The rChb CBP was detected using an anti-His antibody. Experiment is representative 
of three individual experiments. Error bars represent the standard deviation of three 
replicates.  
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Fig 4.15: ELLA to investigate the binding of rChb CBP to sialic acid and 
galactose residues on various glycoproteins. An ELLA was carried out as per 
Section 2.27. rChb CBP and GSLII were used at a concentration of 10 μg/mL and 
detected with anti-His and anti-Biotin antibodies respectively. Experiment is 
representative of three individual experiments. Error bars represent the standard 
deviation of three replicates.  
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4.7 Examination of the accessibility of the His6 tag on rChb CBP 
 
In order to rule out the issue of detection of the rChb CBP, the accessibility of the His 
tag was examined. Western blot analysis was carried out on the purified rChb CBP 
(see Section 2.22) using an anti-His antibody to detect the His6 tagged recombinant 
rChb CBP. Although a protein of correct molecular weight was present after IMAC 
purification no His6 tagged protein was detected on the blot. It was concluded that the 
His tag was not accessible to the anti-His antibody. The rChb CBP protein was also 
directly immobilised on an ELLA plate and probed with the anti-His antibody. The 
difficulty encountered when detecting the His6 tag on the rChb CBP was clearly 
demonstrated in Figure 4.16. Over all the concentrations examined only a very low 
signal was obtained. The His6 tag was not available to the anti-His antibody in this 
format. Measures were taken to improve the detectability of the rChb CBP via the 
His6 tag through the addition of a linker sequence (see Section 4.8). 
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Fig 4.16: Investigation of the limit of detection of the His6 tag on the rChb CBP.  
50 μL of the rChb CBP was laid down on a 96-well plate at various concentrations in 
triplicate. 50μL of a His6 tagged positive control (10μg/mL) was also laid down on the 
plate. The plate was blocked as per Section 2.27 and the protein was probed with an 
anti-His antibody. Experiment is representative of three individual experiments. Error 
bars represent the standard deviation of three replicates.  
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a)                                             b)                                            c) 
 
Fig 4.17: Chb CBP His6 tag highlighted a) front b) side and c) back view. The 
images were generated using Pymol. The catalytic residues are highlighted in blue. 
The His6 tag is highlighted in yellow.  
 
Figure 4.17 illustrates why there are issues being encountered when trying to detect 
the His6 tag in the ELLA format. The His6 tag is present on the side of the protein. If 
the rChb CBP is bound to the GlcNAc residues on the surface of the plate as in Figure 
4.17 (c), the His6 tag is hidden by the large bulky structure of the protein. The anti-His 
antibody would have difficulty accessing the tag.  
 
4.8 Addition of a linker sequence to the rChb CBP  
 
Many proteins contain multiple domains, which are often joined by short peptide 
fragments also known as linkers (George & Heringa, 2003). Linkers are made up of 
different residues depending on their function. Some contain small flexible residues 
such as serine and glycine to allow the domains to interact with one another, while 
others contain rigid residues such as prolines to keep the domains in a specific 
conformation. In recent times multi-functional proteins have been engineered 
comprising domains from different proteins. These domains are attached to one 
another via linkers. These allow each domain to act independently, hence the multi-
functional nature of the protein. 
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4.8.1 Cloning of the rChb CBP to include a linker peptide 
 
In this study a linker sequence comprising four small residues (three glycine residues 
and one serine residue) was used. This linker was genetically engineered in between 
the main protein and the His6 tag (see Figure 4.18). The objective of the linker was to 
allow the His6 tag to protrude from the protein and, therefore, facilitate detection with 
an anti-His antibody.  
 
 
Fig 4.18: Schematic of the rChb CBP DNA fragment with the linker inserted. 
The rChb CBP was amplified to include a linker which was comprised of three 
glycine residues and one serine residue.  
 
                                                                            GCT TAA CTA TTA CAT TTC CGT 
AGC CCG GAC GGT AAA CGT TAC AGT CGA ATT GAT AAT GTA AAG GCA  
CCT AGA  CCA CCG GGT TCT CAT CAC CAT CAC CAT CAC TAA GCT 
GGA TCT GGT GGC GGT TCT CAT CAC CAT CAC CAT CAC TAA GCT  
TAA TTA 
TAA TTA GCT GAG CTT GGA CTC CTG  
Fig 4.19: The linker sequence inserted into the pQE60_Chb_CBP construct. The 
linker sequence was split between the forward and reverse primers. The primers used 
were chb+cbplnk_F and chb+cbplnk_R (see Table 2.1). The gene sequence is in 
black, the reverse primer is in blue, the forward primer is in red and the linker 
sequence is bold and underlined. Again the primers were 5’ phosphorylated and whole 
vector amplification was used. The resulting construct was named 
pQE60_Chb_CBPlnk.  
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4.8.2 Expression and purification of rChb CBPlnk 
 
There was very little difference observed in the growth rates of the rChb CBP and 
rChb CBPlnk cultures. The observed cell density of both rChb CBP and rChb CBPlnk 
cultures was similar at all time-points. The addition of the linker peptide did not affect 
the cell growth rate. Once again it was noted that the protein was expressed and 
exported to the culture media. As with the other recombinant proteins (rChbL and 
rChb CBP) the optimal time to harvest the protein from the culture media was five 
hours post-induction (see Figure 4.20 (b)).  
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Fig 4.20: a) Comparison of the growth rates of rChb CBP and rChb CBPlnk 
cultures b) Time-course analysis of rChb CBPlnk protein expression from 
culture media samples. Recombinant protein expression was induced at OD600nm = 
0.5. 5 mL samples were taken from the culture media every hour for five hours, 
following induction and an overnight sample was taken 16 hours post induction 
(Section 2.16). The samples were then analysed by 12.5% SDS-PAGE. Lane 1, 
Protein ladder; Lane 2, T=0 hours; Lane 3, T=1 hour; Lane 4, T=2 hours; Lane 5, T=3 
hours; Lane 6, T=4 hours; Lane 7, T=5 hours; Lane 8, Overnight (T=16 hours).  
 
It was observed that the addition of the linker improved the ability of the protein to 
sustain imidazole wash concentrations of up to 100 mM, during IMAC purification 
(see Figure 4.21). This result highlighted that the addition of the linker sequence 
succeeded in projecting the His6 tag further from the protein surface making it more 
accessible to the IMAC column and it therefore bound more tightly. The loss of less 
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protein in the wash fractions meant that the yields of rChb CBPlnk were slightly 
higher than those of rChb CBP, approximately 5.5-6.5 mg per 250 mL culture.  
 
 
Fig 4.21: IMAC optimisation for the purification of rChb CBPlnk from the 
culture media. Stringency washes were performed with an increasing imidazole 
concentration gradient from 20 mM to 250 mM, to determine when rChb CBPlnk was 
eluted from the IMAC column. The fractions were then examined by 12.5% SDS-
PAGE. Lane 1, Protein ladder; Lane 2, Flow through; Lane 3, 20 mM Imidazole; 
Lane 4, 40 mM Imidazole; Lane 5, 60 mM Imidazole; Lane 6, 80 mM Imidazole; 
Lane 7, 100 mM Imidazole; Lane 8, 150 mM Imidazole; Lane 9, 250 mM Imidazole. 
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Fig 4.22: Purification of the recombinant rChb CBPlnk from the culture media. 
Purification was carried out as per Section 2.19. Washes were carried out with 80 mM 
imidazole and elution was carried out at 250mM imidazole. Lane 1, Protein ladder; 
Lane 2, Flow through; Lane 3, Wash; Lane 4, Elution 1; Lane 5, Elution 2; Lane 6, 
Elution 3; Lane 7, Elution 4; Lane 8, Elution 5; Lane 9, Elution 6; Lane 10, Elution 7. 
 
In order to confirm that the His tag was more accessible a western blot on both rChb 
CBP and rChb CBPlnk was carried out. The rChb CBP and rChb CBPlnk samples 
were analysed under native conditions by SDS-PAGE to allow the proteins to retain 
their natural conformation. β-mercaptoethanol was not added to the sample buffer and 
the samples were not boiled prior to addition to the gel. This was to ensure that the 
proteins were detected as they would be in the ELLA format, if the proteins were 
denatured then the results would not reflect the ease of detection of the His6 tag of 
each protein. It was clear from the blot result (see Figure 4.23) that the linker 
sequence dramatically increased the ability of the rChb CBPlnk to be detected by an 
anti-His antibody while the rChb CBP was not so easily detected. Similarly it was 
hypothesised that the linker allowed the anti-His antibody more access to the His6 tag 
on rChb CBPlnk.  
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Fig 4.23: Western blot analysis comparing the detection of rChb CBP and rChb 
CBPlnk. 12.5% SDS gels were run as per Section 2.22 with two exceptions, β-
mercaptoethanol was not added to the sample buffer and the samples were not boiled 
prior to addition to the gel. Western blotting was carried out as per Section 2.22. Lane 
1; rChb CBP Lane 2; rChb CBP Lane 3; Blank Lane 4; rChb CBPlnk Lane 5; rChb 
CBPlnk. 
 
4.8.3 Characterisation of the binding ability of the rChb CBPlnk 
 
Once it had been confirmed that the addition of the linker sequence significantly 
improved the detectability of the rChb CBPlnk proteins His6 tag, ELLA analysis was 
again undertaken. First, it was confirmed if direct detection of the rChb CBPlnk was 
possible (see Figure 4.24). It was observed that the limit of detection was slightly 
improved with the addition of the linker peptide. 10 μg/mL of rChb CBPlnk allowed 
the highest level of detection. However the signal was still relatively low. It was 
unknown whether any potential glycoprotein binding would be detectable in an 
ELLA.  
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Fig 4.24: Comparison of the limit of detection of the His6 tag between the rChb 
CBP and rChb CBPlnk. 50 μL of the rChb CBP and rChb CBPlnk were laid down 
on a 96-well plate at various concentrations (0-50 μg/mL) in triplicate. The plate was 
blocked as per Section 2.27 and the proteins were detected with an anti-His antibody. 
Experiment is representative of three individual experiments. Error bars represent the 
standard deviation of three replicates. An unpaired T-test was used to determine if the 
difference in detection was significant (***p<0.0003). 
 
The binding of the rChb CBPlnk to GlcNAc, galactose and sialic acid terminal 
residues was examined over an array of glycoproteins, as previous, to investigate 
whether the linker improved detection of the rChb CBP in an ELLA format (see 
Figure 4.25). Binding was again determined using a HRP labelled anti-His antibody.   
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Fig 4.25: ELLA investigating the binding of rChb CBP and rChb CBPlnk to 
GlcNAc residues on an array of glycoproteins. An ELLA was performed as per 
Section 2.27. rChb CBP and rChb CBPlnk were used at a concentration of 10 μg/mL. 
Fetuin, transferrin and thyroglobulin were treated to expose GlcNAc residues. GSLII 
was detected with an anti-Biotin antibody while rChb CBP and rChb CBPlnk were 
detected with an anti-His antibody. Experiment is representative of three individual 
experiments. Error bars represent the standard deviation of three replicates.  
 
No binding of rChb CBP or rChb CBPlnk to GlcNAc residues was observed for any 
of the glycoproteins tested. The absorbance values received were as low as those of 
the blanks. Very little difference was observed between the signals from rChb CBP 
and rChb CBPlnk. This may be as a result of no rChb CBP binding to the exposed 
GlcNAc residues or it could potentially still be a problem of detection. Further testing 
was subsequently carried out against a synthetic GlcNAc substrate and bovine serum 
mucin. Commercial BSA-GlcNAc contains a much higher concentration of GlcNAc 
residues on its surface than enzymatically treated fetuin, transferrin or thyroglobulin. 
The GlcNAc residues are separated from the BSA by a 14-atom spacer. Bovine mucin 
contains only O-linked glycans, with up to 80% of the proteins weight account for by 
sugars. It was anticipated that higher levels of glycosylation, specifically with more 
exposed terminal GlcNAc, would result in more of an opportunity for binding 
between the rChb CBPlnk and the GlcNAc residues. However, while the commercial 
plant lectin GSLII bound very well to these substrates no binding of rChb CBP was 
detected (see Figure 4.26).  
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Fig 4.26: ELLA investigating the binding of rChb CBP and rChb CBPlnk to 
BSA-GlcNAc and Bovine Serum Mucin. An ELLA was carried out as described in 
Section 2.27. A commercial BSA-GlcNAc conjugate and bovine serum mucin 
(Sigma) were used. GSLII, rChb CBP and rChb CBPlnk were used at a concentration 
of 10 μg/mL. GSLII was detected using an anti-biotin antibody and rChb CBP and 
rChb CBPlnk were detected using an anti-His antibody. Experiment is representative 
of three individual experiments. Error bars represent the standard deviation of three 
replicates.  
 
4.9 Indirect ELLA methods 
 
Due to the difficulties encountered with the detection of the rChb CBP protein, 
alternative indirect detection methods using the ELLA were employed to definitively 
conclude if the rChb CBP molecule could act as a GlcNAc binding protein. These 
methods included the use of a competitive ELLA and a sandwich ELLA.  
 
The competitive ELLA was used to study the effective competition between the 
binding of rChb CBP and GSLII to exposed terminal GlcNAc on asialo agalacto 
fetuin. Asialo agalacto fetuin was immobilised on a Nunc maxisorp plate and the plate 
was blocked. Subsequently an increasing gradient of rChb CBP was added to the 
wells containing glycoprotein and incubated at 24
o
C for 30 minutes, followed by the 
addition of a set concentration of GSLII. Bound GSLII was detected using an anti-
biotin antibody. If rChb CBP was binding to the glycoprotein it was expected that the 
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binding signal for GSLII would decrease as the concentration of bound rChb CBP 
increased. Figure 4.27 highlights that binding of rChb CBP to GlcNAc was observed 
from the competitive ELLA. The higher the concentration of rChb CBP there was 
present, the less signal observed from GlcNAc bound GSLII. This was thought to be 
due to rChb CBP binding to the terminal GlcNAc residues, however it may also have 
been due to some interaction between the rChb CBP and GSLII.  
 
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0 1 2 3 4 5 6 7 8 9 10
Concentration Chb CBP (ug/mL)
A
b
s
o
rb
a
n
c
e
 4
5
0
n
m
 
Fig 4.27: Competitive ELLA between rChb CBP and GSLII investigating 
binding to GlcNAc residues. Asialo agalacto fetuin was used. Increasing 
concentrations of rChb CBP (from 0.5 μg/mL to 10 μg/mL) were added to the plate 
and incubated at 24
o
C for 30 minutes before addition of a constant concentration of 
GSLII (10 μg/mL). GSLII was detected using an anti-biotin antibody. Experiment is 
representative of three individual experiments. Error bars represent the standard 
deviation of three replicates.  
 
The sandwich assay involved the capture of asialo agalacto fetuin by plate 
immobilised rChbCBP, with the detection of bound glycoprotein using GSLII.  
Simply, rChb CBP was laid down on a Nunc 96 well plate which was subsequently 
blocked. Asialo agalacto fetuin was then added and allowed to bind with the rChb 
CBP. Finally biotinylated GSLII was added and allowed to interact with any bound 
fetuin creating a sandwich structure. Anti-biotin antibody was used to detect the 
GSLII and a signal was expected to only be obtained if both the rChb CBP/WGA and 
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GSLII bound to the asialo agalacto fetuin. Figure 4.28 demonstrates that a signal was 
obtained for the rChb CBP–GSLII sandwich but not for the WGA-GSLII sandwich. 
WGA is a plant lectin characterised as capable of binding to GlcNAc and chitobiose. 
It was expected that this would act as a positive control for the assay however no 
signal was obtained for this sandwich.  
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Fig 4.28: Sandwich ELLA between rChb CBP and GSLII investigating binding 
to GlcNAc residues. rChb CBP was laid down on the plate which was then blocked 
as per Section 2.27. Asialo agalacto fetuin was then added and incubated for 60 
minutes at 24
o
C. GSLII was added and also incubated at 24
o
C for 60 minutes. Finally 
an anti-biotin antibody was added and the ELLA was completed as per Section 2.27. 
Experiment is representative of three individual experiments. Error bars represent the 
standard deviation of three replicates.  
 
As a result of the observations made from the experimental results shown in Figures 
4.27 and 4.28 further investigation was undertaken to determine whether the results 
obtained were due to an interaction between the rChb CBP and the glycoprotein or the 
rChb CBP and GSLII. In order to do this the sandwich assay was repeated with the 
inclusion of free GlcNAc during the incubation of the asialo agalacto fetuin. It was 
hypothesised that the addition of free sugar would inhibit the binding of rChb CBP to 
the glycoprotein resulting in a decrease in the amount of bound GSLII. If there was no 
observed decrease in bound GSLII signals between sugar replete and deplete samples 
then it could be concluded that rChb CBP was interacting directly with the GSLII.  
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The addition of increasing concentrations of free GlcNAc (sugar) did not result in less 
bound GSLII. Only a slight loss of signal was observed at the high end of the GlcNAc 
concentrations (see Figure 4.29). As stated previously this observation implied that 
there was an interaction occurring between both carbohydrate-binding proteins rather 
than between the carbohydrate-binding proteins and the glycoprotein.  
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Fig 4.29: Examining the specificity of the sandwich ELLA. rChb CBP was laid 
down on the plate which was then blocked as per Section 2.27. Asialo agalacto fetuin 
was then added, along with increasing concentrations of free GlcNAc and incubated 
for 60 minutes at 24
o
C. GSLII was added and also incubated at 24
o
C for 60 minutes. 
Finally an anti-biotin antibody was added and the ELLA was completed as per 
Section 2.27. Experiment is representative of three individual experiments. Error bars 
represent the standard deviation of three replicates.  
 
To definitively prove that the interaction was taking place between the two 
carbohydrate-binding proteins, rChb CBP and GSLII, an ELLA was carried out as 
described in Figure 4.30. rChb CBP was laid down on the plate and probed with 
GSLII. In the absence of any glycoprotein a signal was obtained for bound 
biotinylated GSLII, as the concentration of rChb CBP increased so did the amount of 
bound GSLII.  Therefore it was concluded that an interaction was occurring between 
the rChb CBP and GSLII. GSLII itself is glycosylated, hinting that the rChb CBP may 
have been binding to glycans on its surface.  
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Fig 4.30: Interaction between rChb CBP and GSLII. Increasing concentrations of 
rChb CBP was immobilized on the plate which was then blocked as per Section 2.27. 
The rChb CBP was probed with GSLII and incubated at 24
o
C for 60 minutes. Finally 
an anti-biotin antibody was added and the ELLA was completed as per Section 2.27. 
Experiment is representative of three individual experiments. Error bars represent the 
standard deviation of three replicates.  
 
As chitobiose was thought to be the natural substrate of rChbL, ELLA analysis was 
undertaken using a biotinylated PAA-chitobiose substrate. Binding between the rChb 
CBP and chitobiose was examined via the immobilisation of rChb CBP and detection 
of any bound biotinylated chitobiose. A definite interaction between rChb CBP and 
the chitobiose substrate was observed (see Figure 4.31).  
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Fig 4.31: ELLA examining the binding of rChb CBP to chitobiose. A constant 
concentration of rChb CBP was laid down on the plate at 10 μg/mL. An increasing 
concentration of biotinylated chitobiose was added and probed for with an anti-biotin 
antibody as described in Section 2.27. Experiment is representative of three individual 
experiments. Error bars represent the standard deviation of three replicates.  
 
4.10 Biotinylation of the rChb CBPlnk 
 
A final effort was made to enable direct detection of the rChb CBPlnk in an ELLA 
format. This was to ensure that detection of the rChb CBPlnk was not the issue and 
that the problem was due to a lack of interaction between the rChb CBP and GlcNAc 
residues. As manipulation of the His6 tag did not drastically improve its accessibility 
an alternative system of protein labelling and detection was investigated. A 
commercial biotinylation kit was used to label the rChb CBPlnk which could then be 
detected using an anti-Biotin antibody. The biotin molecules are functionalised to 
contain NHS esters, which are highly reactive towards the primary amine groups 
found in lysine side-chains, allowing the biotin molecules to covalently link to the 
rChb CBP surface. 
 
It was observed (in Figures 4.32 and 4.33) that the biotinylated rChb CBP was readily 
detectable with an anti-Biotin antibody. Figure 4.32 highlights the ability to detect the 
rChb CBP protein on a PVDF membrane but more importantly it can be seen from 
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Figure 4.33 that the biotinylated protein could be directly detected in the ELLA 
format.   
 
Fig 4.32: Detection of biotinylated rChb CBP on a PVDF membrane. 1 μL of the 
biotinylated rChb CBPlnk was spotted onto a PVDF membrane at a concentration of 
10 μg/mL and allowed to dry. This was repeated three times. 10 μg/mL GSLII was 
used as a positive control. The PVDF membrane was then washed with TBST, probed 
with an anti-Biotin antibody and visualised as in Section 2.22. Lane 1; biotinylated 
rChb CBPlnk Lane 2; biotinylated GSLII (positive control).  
 
0
0.2
0.4
0.6
0.8
1
1.2
GSLII Biotinylated Chb CBP
A
b
s
o
rb
a
n
c
e
 4
5
0
n
m
 
Fig 4.33: Detection of the biotinylated rChb CBPlnk. 50 μL of the rChb CBPlnk 
was laid down on a 96-well plate a concentration of 10 μg/mL in triplicate. The plate 
was blocked as per Section 2.27 and the proteins were detected with an anti-Biotin 
antibody. GSLII at a concentration of 10 μg/mL was used as a positive control and 
was also detected with an anti-Biotin antibody. Experiment is representative of three 
individual experiments. Error bars represent the standard deviation of three replicates.  
 181 
As it had now been shown that it was possible to directly detect the biotinylated rChb 
CBP in the ELLA format, the glycoprotein binding assays were repeated. The 
biotinylated rChb CBP was tested for binding against exposed terminal GlcNAc 
residues on the various glycoproteins (fetuin, transferrin and thyroglobulin), the BSA-
GlcNAc conjugate and bovine serum mucin. The background signal from the 
biotinylated protein was relatively high in comparison with the GSLII blank. The 
signal obtained from the rChb CBP, when tested against asialo agalacto fetuin, 
transferrin and thyroglobulin, was similar to the blank. There was no binding detected 
between the biotinylated rChb CBP and GlcNAc residues (see Figures 4.34 and 4.35). 
The high background was probably due to the presence of residual biotin in the 
sample. Biotin is generally removed using centrifugal units (vivaspins) to filter out the 
biotin, however this was not possible with the rChb CBP, as large volumes were lost 
when previously using vivaspins, presumably due to binding to the cellulose 
membrane (see Figure 3.16). Instead, gel filtration units were used which allowed the 
larger rChb CBP to flow through the gel while retaining the smaller biotin molecules. 
These were not very efficient for this purpose as residual biotin was still present in the 
sample, resulting in a high background signal. 
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Fig 4.34: ELLA investigating the binding of the biotinylated rChb CBPlnk to 
GlcNAc residues on different glycoproteins. An ELLA was performed as per 
Section 2.27. Biotinylated rChb CBPlnk was used at a concentration of 10 μg/mL. 
Asialo agalacto Fetuin, transferrin and thyroglobulin were used. GSLII (10 μg/mL) 
was used as a positive control. Both proteins were detected with an anti-Biotin 
antibody. Experiment is representative of three individual experiments. Error bars 
represent the standard deviation of three replicates.  
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Fig 4.35: ELLA investigating the binding of the biotinylated rChb CBP to BSA-
GlcNAc and bovine serum mucin. An ELLA was performed as per Section 2.27. 
Biotinylated rChb CBPlnk was used at a concentration of 10 μg/mL. GSLII (10 
μg/mL) was used as a positive control. Both proteins were detected with an anti-
Biotin antibody. Experiment is representative of three individual experiments. Error 
bars represent the standard deviation of three replicates.  
 
Although the problems with direct detection of the rChb CBP protein were overcome 
through biotinylation there was still no binding detected between rChb CBP and any 
of the glycoproteins tested nor the BSA-GlcNAc conjugate. The rChb CBPlnk has 57 
lysines present in its structure. However, the number of residues that were surface 
accessible for biotin conjugation was unknown. The location of potentially surface 
exposed primary amines on the rChb CBP molecule were examined and are 
highlighted in Figure 4.36. While the lysine residues appear to be distributed evenly 
over the protein surface there are two possible biotinylation sites located very close to 
the active site/binding pocket. The presence of the small biotin molecule in these 
positions would not interfere with direct detection of the rChb CBP protein in the 
ELLA format but could have rendered the protein incapable of binding to its natural 
substrate by blocking access to the active/binding site. Therefore binding of the rChb 
CBP to GlcNAc residues was still not conclusively ruled out.  
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a)           b) 
       
Fig 4.36: Possible biotinylation sites on the Chb CBPlnk a) Front view and b) 
Back view. The lysine residues are highlighted in red. The active site residues are 
highlighted in blue. The image was visualised using Pymol software (available from 
http://www.pymol.org/).   
 
4.11 Immobilised rChb CBP 
 
An alternative method for detecting an interaction between the rChb CBP and 
GlcNAc residues was employed. The rChb CBP was immobilised on cyanogen 
bromide-activated sepharose as previously described in Section 3.9. The final 
concentration of the immobilised rChb CBP was 1.5 mg/mL. The resin was then 
diluted to 10 μg/mL for the purpose of this experiment. This resin was mixed with 
BSA-GlcNAc in a column format and the unbound fractions were collected. The resin 
was washed with five CV of PBS. The resin was then boiled for 10 minutes in 1X 
protein sample buffer to remove any bound BSA-GlcNAc. The unbound, washed and 
bound fractions were analysed by SDS-PAGE. It was evident from Figure 4.37 that 
the rChb CBP resin did not bind to any BSA-GlcNAc, all BSA-GlcNAc passed over 
the column. As this chemistry was the same as the biotinylation – i.e. primary amines 
may have immobilised via the same residues surrounding the active site, these may 
have inhibited binding.  
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Fig 4.37: Examination of the binding between immobilised rChb CBP and BSA-
GlcNAc. Lane 1, Protein Ladder; Lane 2, BSA-GlcNAc sample; Lane 3, Flow 
through; Lane 4, Wash; Lane 5, Elution 1; Lane 6, Elution 2; Lane 7, Bound Fraction. 
   
4.12 Activity of the ChbL enzyme on glycoproteins 
 
The ability of the rChbL enzyme to cleave GlcNAc residues from glycoproteins was 
investigated (see Figure 4.38). This was to test the cleavage ability of the rChbL 
enzyme against GlcNAc residues on glycoproteins, to ensure that the mutations of the 
catalytic residues (D539A and E540D) to remove the catalytic activity did not affect 
the proteins ability to interact with its substrate. Various asialo agalacto glycoproteins 
were treated with either rChbL or a commercial N-acetylglucosamindase. The 
efficiency of the removal of GlcNAc residues was measured via the use of the ELLA 
and GSLII. The less signal observed for bound GSLII the more efficient the enzyme 
was at removing GlcNAc residues. 
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Fig 4.38: Comparison of rChbL and commercial N-acetylglucosaminidase 
treatment of glycoproteins to remove GlcNAc residues. Asialo agalacto fetuin, 
asialo agalacto transferrin and asialo agalacto thyroglobulin were treated with either 
10 μg/mL of rChbL or a commercial glycosidase (Sigma). The resultant glycoproteins 
were probed with GSLII which binds to GlcNAc residues. Binding was detected with 
an anti-biotin antibody. Experiment is representative of three individual experiments. 
Error bars represent the standard deviation of three replicates.  
 
A high signal was observed when the rChbL treated glycoproteins were probed with 
GSLII. This meant that the rChbL enzymatic treatment was not successful. The 
terminal GlcNAc residues were not removed from the glycoprotein. A much lower 
signal was observed when GSLII was used to probe the commercial N-
acetylglucosaminidase treated glycoproteins, meaning it effectively cleaved the 
terminal GlcNAc residues from the glycoproteins tested.  
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4.13 Discussion 
 
Family 20 glycosyl hydrolases are ubiquitously found in plants, animals, fungi and 
bacteria. Chitobiases are assigned to Family 20 based on amino acid similarity. 
Family 20 chitobiase protein sequences from many different bacterial species were 
aligned and were found to have large regions of conservation. High levels of 
homology were observed in the residues surrounding the catalytic site. The amino 
acids critical for catalytic activity were observed to be conserved across all 
chitobiases examined. The least conservation between sequences was observed at the 
beginning of the sequence in the signal peptide sequence region. This was to be 
expected as each species of bacteria has their own recognizable signal peptide 
sequence characteristics. Low levels of homology were also observed between 
residues 200 and 300. This region of sequence was described as Domain II by Prag et 
al., (1996) however no function has been assigned to it. The active site and critical 
catalytic residues were conserved in the ChbL protein sequence as compared with the 
Chb from S. marcescens.  
 
Homology modelling allowed a possible structure of rChbL to be assigned. This 
model was used to great advantage allowing for the study of the structural 
implications of amino acid mutations surrounding the binding pocket. It was 
envisioned that a successful mutagenesis strategy of residues present in the catalytic 
site would generate a catalytically inactive chitobiase similar to the S. marcescens 
Chb generated by Prag et al., (2000). While there is no report of further examination 
into the binding capabilities of this inactive enzyme, other studies have described the 
mutagenesis of enzymes and the generation of novel carbohydrate binding proteins 
with functional applications. Laine et al., (2005) utilized catalytically inactive 
endoglycosidases for the detection of fungal and bacterial species. The 
endoglycosidases bound specifically and with high affinity to chitin present in their 
structure/cell wall. They generated a fusion protein composed of the chitin-binding 
domain from an inactive chitinase from Bacillus circulans linked to GFP, which is 
now commercially available and used in human diagnostics for fungal testing. 
Jokilammi et al., (2005) isolated inactive endosialidases from bacteriophages. These 
enzymes were unable to carry out their normal function of cleaving polysialic acid 
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present on the surface of E. coli K1 however, they still retained their polysialic acid 
binding capabilities. They exploited this polysialic acid binding specificity for a 
variety of applications; through fusion to GFP this mutant enzyme was used for the 
detection of bacterial pathogens with surface polysialic acid such as Neisseria 
meningitidis and Moraxella nonliquefaciens, the GFP-endosialidase fusion protein 
was also used as a diagnostic tool for the detection of neuroblastoma tumors as they 
have high levels of polysialic acid expression.  
 
The catalytically important residues, D539 and E540 are present in all bacterial 
homologues examined in this study. Chitobiases have human homologues, know as β-
hexosaminidases. These are lysosomal enzymes that cleave terminal GlcNAc from 
glycoconjugates using the retaining acid hydrolysis mechanism. The acidic residues 
employed in this mechanism were elucidated by Fernandes et al., (1997). They 
proposed a glutamate at position 323 as a catalytically important residue, as mutation 
of this residue dramatically reduced catalytic activity. Through predictive modelling 
of the hexosamindase protein structure they identified the glutamate at position 540 in 
the S. marcescens Chb was the residue corresponding to the glutamate at position 323 
in the hexosaminidase enzyme thus cementing the importance of this acidic residue in 
the catalytic mechanism of certain chitobiase enzymes.   
 
The generation of an inactive enzyme from the P. luminescens Chb required two 
mutations, D539A (aspartate to alanine) and E540D (glutamate to aspartate). The 
study of the S. marcescens Chb demonstrated that one of the functions of the aspartate 
at position 539 was to hold the glutamate and N-acetyl group of the sugar in place for 
the duration of catalysis. Prag et al., (2000) observed that when this residue was 
mutated to the neutral amino acid alanine, the position on the sugar substrate 
remained the same. However, the N-acetyl group of the sugar twisted 175
o
. It 
inhabited the space that had previously been occupied by the side chain of the 
aspartate. The mutation at residue 540 acted directly on the catalytic activity of the S. 
marcescens Chb. This study also found a mutation to residue 540 of the P. 
luminescens Chb acted directly on catalytic activity. Glutamate and aspartate are 
amino acids with similar properties; both are acidic with a carboxylic acid side-chain. 
The major difference is the presence of an extra -CH2 group in the side chain of 
glutamate. Mutating the glutamate at position 540 to aspartate (a residue with a 
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slightly smaller side-chain) increased the distance between the amino acid and the 
non-reducing end of the sugar. While the nature of the side chain remained unchanged 
the increased distance between the carboxylic acid and the N-acetyl group of the sugar 
prevented any proton donation occurring and therefore, removed the catalytic activity 
of the rChbL enzyme.  
 
  a)        b) 
 
Fig 4.39: (a) Aspartate and (b) Glutamate structures. The similarity between the 
two acidic amino acids is clear.  
 
Upon the creation of the catalytically inactive rChbL protein rChb CBP the next step 
was to examine its binding abilities. An Enzyme Linked Lectin Assay (ELLA) was 
used (as described in Section 2.27). In 1994, Duk et al., first described an enzyme-
linked lectin assay in the format that was used in this study. They used biotinylated 
lectins to detect Tf and Tn receptors from glycophorin in a microwell plate format. 
The treated glycophorin was immobilised on a microwell plate and probed with 
biotinylated lectins such as peanut agglutinin (PNA) and jacalin (AIA). The wells 
were incubated with ExtrAvidin alkaline phosphatase solution after which the p-
nitrophenyl phosphate substrate was added, the absorbance of which could be read at 
405 nm. This study also immobilised the treated glycoprotein on the surface of a 
microwell plate. Polyvinyl alcohol (PVA) was used as a blocking solution to prevent 
any non-specific interactions. PVA was found to be an optimum blocker in ELLAs in 
a study by Thompson et al., (2011). Bovine serum albumin (BSA) and carbo-free 
blocker were also tested, however PVA generated the results with the lowest 
background signal and highest positive signal. The commercial lectins used were 
biotinylated and detected with an anti-Biotin antibody, however, the recombinant Chb 
CBP was His6 tagged and detected with an anti-His antibody. The chromogenic 
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substrate used in the ELLAs in this study was TMB, which was broken down in the 
presence of horseradish peroxidise conjugated to the anti-Biotin and anti-His 
antibodies. The absorbance of the results was also read, however at 450 nm.  
 
The first attempts at examining the binding abilities of the rChb CBP in an ELLA 
format were unsuccessful. It was thought that the lack of signal was due to a difficulty 
in detecting the His6 tag rather than no binding occurring between rChb CBP and it’s 
target glycoprotein. Modeling of the protein structure revealed that the His6 tag was 
probably hidden by the rest of the protein structure. In order to overcome this problem 
an amino acid linker sequence was genetically engineered between the His6 tag and 
the protein to allow the tag to protrude from the protein structure and therefore 
facilitate detection through the use of an anti-His antibody. The linker improved the 
purification of the rChb CBP resulting in higher yields of pure protein. It also allowed 
the rChb CBP to be detected on a western blot. The linker did not, unfortunately, 
improve detection of the protein in the ELLA format. In this instance the His6 tag was 
present on the C-terminus of the protein. His6 tags can also be engineered at the N-
terminus of a protein. However, as this protein contained a signal peptide that was 
cleaved the His6 tag would also have been removed. The addition of internal His6 tags 
are possible however this may have disrupted the structure of the protein. Since ELLA 
detection of the protein was not feasible via the His6 a different method of detection 
had to be devised.  
 
The rChb CBP contains a large number of primary amine containing residues (lysine), 
distributed evenly throughout the proteins surface. Therefore biotinylation was chosen 
as the next labeling method of choice. The biotinylated rChb CBP was detectable in 
the ELLA format, however there was no binding detected between the rChb CBP and 
the glycoproteins. However, it was noted that there were lysine residues present in the 
binding pocket of the rChb CBP. These may have hindered binding between the 
protein and GlcNAc residues.  
 
Indirect ELLA methods were then employed to test the ability of rChb CBP to bind to 
asialo agalacto glycoproteins but the only signals observed were due to interactions 
between the GSLII and rChb CBP. GSLII is a glycoprotein itself (Goldstein, 1983). 
However it was unknown if the interaction was occurring due to the rChb CBP 
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binding to sugar residues on the surface of GSLII or due to non-specific interactions 
between the two proteins. The rChb CBP was also tested against a biotinylated 
chitobiose substrate. A low but definite signal was observed so it was concluded that 
there was some interaction taking place. The low signal may have been due to the fact 
that the rChb CBP was immobilized non-specifically on the plate. The orientation of 
the protein is unknown and the active site/binding pocket may have been inaccessible. 
While obtaining an affirmative result for an interaction between rChb CBP and 
chitobiose was positive, terminal chitobiose structures are not found on glycoproteins. 
The problem with the detection of terminal GlcNAc by rChb CBP on glycoproteins 
still remained.  
 
Finally the rChb CBP was immobilised on cyanogen bromide activated resin and 
tested for binding to BSA-GlcNAc; again, no binding was detected. There are other 
types of affinity tags that can be engineered in a protein to allow purification and 
detection of the protein such as GST tags, Arg tags or MBP tags when problems with 
His6 tags are encountered (Walls and Loughran, 2011). However at this point it had 
been concluded with relative certainty that the rChb CBP could not bind to any glycan 
residues on glycoproteins.  
 
The rChbL enzymes ability to cleave GlcNAc residues from the surface of 
glycoproteins was also examined to ensure that the mutations to remove catalytic 
activity did not also remove the rChbLs binding ability. The rChbL enzyme was not 
able to cleave GlcNAc residues from the glycoproteins. This suggests that the 
mutations did not affect the natural binding abilities of the rChb CBP as both the 
enzyme and binding protein were unable to interact with the glycoprotein targets.  
 
 The structure of the rChb CBP was examined to explain why binding might not be 
occurring. The natural substrate of the Chb is chitobiose which is a small sugar 
composed of two N-acetylglucosamine residues. The rChb CBP was shown to bind to 
this substrate in the ELLA format. The glycoproteins used for analysis in this study 
are large bulky structures. The active site of the ChbL is relatively deep in the protein 
and has many over-hanging residues. It was hypothesized that steric hindrance was 
occurring; the protein was unable to access the GlcNAc residues due to both its bulky 
structure and the bulky structure of the glycoproteins. As the rChb CBP was generated 
 191 
for the final application of detecting GlcNAc residues on glycosylated 
biopharmaceuticals, methods to overcome this steric hindrance issue had to be 
examined. The active site of the rChb CBP was examined in depth in Chapter 5 and 
site-specific mutagenesis was carried out in an attempt to open up the binding pocket 
and allow binding to glycoproteins to take place.  
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Chapter 5 
 
Site-specific mutagenesis of the rChb 
CBP and rChbL enzyme 
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5.1 Overview 
 
Homology modelling of the rChb CBP structure showed an active site deep in the 
structure of the protein with many over-hanging residues. It was thought that these 
residues may be interfering with binding between the rChb CBP and glycoproteins. 
Tews et al., (1996) previously examined the structure of the Chb protein from S. 
marcescens and the amino acids involved in the catalytic mechanism of the Chb 
enzyme. A series of residues were proposed to interact directly with the chitobiose 
sugar. It was discovered that a collection of tryptophans in the pocket of the active site 
interacted with the hydrophobic surface of the chitobiose sugar, holding it in place 
during catalysis, namely Trp639, Trp685 and Trp737. An arginine at position 349 
formed hydrogen bonds with the non-reducing end of the sugar, keeping it stabilised 
during catalysis. This arginine was held in position through polar interactions with 
other residues in the active site, specifically Asp346, Asp378, Asp 379 and Glu380.  
Figure 5.1 shows the interaction between these residues and the chitobiose sugar as 
modelled by Tews et al., (1996). Figure 5.2 shows the position of the analogous 
residues in the modelled active site of the rChb from P. luminescens. These residues 
were conserved in the P. luminescens Chb and are considered essential for binding 
and therefore were not targeted for mutagenesis.  
 
a)                                                   b) 
       
Fig 5.1: Important residues involved in binding of the chitobiose by the Chb 
from S. marcescens. Image (a) highlights the tryptophan residues involved in holding 
the chitobiose in place while image (b) shows the arginine at position 349 also 
involved in holding the chitobiose in place. Image obtained from Tews et al., (1996).  
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Fig 5.2: Important residues involved in binding of the chitobiose by the Chb 
from P. luminescens. The catalytic residues are highlighted in blue, the important 
tryptophans are highlighted in red while the arginine and associated residues are 
highlighted in yellow. The image was generated using Pymol (available from 
http://www.pymol.org/).   
 
5.2 Site-specific mutagenesis of rChb CBP 
 
It was believed that the inability of rChb CBP to bind to the glycoprotein structures 
tested was an issue with steric hindrance due to the large bulky nature of the 
glycoproteins.  The active site of the P. luminescens Chb was closely examined and 
five residues were chosen for site-specific mutagenesis in an effort to allow rChb CBP 
to bind to GlcNAc residues on the surface of glycoproteins. W63, D648, K545 and 
D551 were all chosen as they were projecting out over the active site of the protein 
(see Figure 5.3). Alanine scanning mutagenesis was carried out on the four residues, 
W63, D648, K545 and D551, resulting in four mutants named W63A, D648A, 
K545A and D551A. The predicted structural modifications are highlighted in Figures 
5.4, 5.5, 5.6, 5.7 and 5.9. The primers used are shown in Figures 5.10 to 5.13. A 
tryptophan at position 689 was also mutated. As tryptophan is such a large amino acid 
it was thought that mutagenesis of this residue may open up the active site. However, 
as previously discussed this tryptophan has an important role in maintaining the 
chitobiose position during catalysis. It was believed that mutagenesis of this position 
to alanine would result in an extensive change to an important amino acid that would 
possibly result in a complete loss of function. Therefore the tryptophan at position 689 
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was mutated to a tyrosine which has a similar ring structure, generating a mutant 
named W689Y. The predicted structure of this mutant is shown in Figure 5.8. The 
primers used are shown in Figure 5.14. The new molecular weight, extinction 
coefficient and pI for each new rChb CBP is shown in Table 5.1.  
 
5.2.1 Structural modelling of the rChb CBP site-specific mutants  
 
                                           
 
                                             
Fig 5.3: Residues chosen for site-specific mutagenesis in the P. luminescens rChb 
CBP active site. The mutagenesis was performed and visualised in Pymol. The 
mutated catalytic residues (D539A and E540D) are highlighted in blue. The other 
residues chosen for mutagenesis are highlighted in green, W63, K545, D551, D648 
and W689. Images were generated using Pymol (available from 
http://www.pymol.org/).   
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a)                                                                    b) 
  
Fig 5.4: Active site of a) Chb CBP and b) Chb CBP W63A. The catalytic residues, 
D539A and E540D, are highlighted in blue and residue 63 is highlighted in green. The 
image was generated using Pymol software. Mutations were also carried out and 
visualised in Pymol (available from http://www.pymol.org/).  
 
a)                                                                      b) 
                                                                       
Fig 5.5: Active site of a) Chb CBP and b) Chb CBP K545A. The catalytic residues, 
D539A and E540D, are highlighted in blue and residue 545 is highlighted in green. 
The image was generated using Pymol software. Mutations were also carried out and 
visualised in Pymol (available from http://www.pymol.org/).    
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a)                                                                 b) 
  
Fig 5.6: Active site of a) Chb CBP and b) Chb CBP D551A. The catalytic residues, 
D539A and E540D, are highlighted in blue and residue 551 is highlighted in green. 
The image was generated using Pymol software. Mutations were also carried out and 
visualised in Pymol (available from http://www.pymol.org/).    
 
a)                                                              b) 
  
Fig 5.7: Active site of a) Chb CBP and b) Chb CBP D648A. The catalytic residues, 
D539A and E540D, are highlighted in blue and residue 648 is highlighted in green. 
The image was generated using Pymol software. Mutations were also carried out and 
visualised in Pymol (available from http://www.pymol.org/).    
 
 
 
 
 
 
 
 198 
a)                                                               b) 
  
Fig 5.8: Active site of a) Chb CBP and b) Chb CBP W689Y. The catalytic 
residues, D539A and E540D, are highlighted in blue and residue 689 is highlighted in 
green. The image was generated using Pymol software. Mutations were also carried 
out and visualised in Pymol (available from http://www.pymol.org/).    
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Fig 5.9: Mutated residues chosen in the active site of rChb CBP. The mutated 
catalytic residues (D539A and E540D) are highlighted in blue. The other mutated 
residues are highlighted in green, W63A, K545A, D551A, D648A and W689Y. The 
image was generated and the mutations were performed using Pymol (available from 
http://www.pymol.org/).   
 
5.2.2 Site-specific mutagenesis of the rChb CBP mutants 
 
Whole vector amplification was used to introduce the specific point mutations into the 
molecules DNA sequence. This was carried out as outlined in Section 2.13.  
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                                                                                                               GTG CCG CAA 
GTT AAT TAT AAA GTT GTT GAT AAT CAG GCA GGA AGT CAC GGC GTT  
TTG ACA CGC CAG GCA GGG GCA GAT GCG GCT AAA TGT AAT CG 
AAC TGT GCG GTC CGT GGG GCA GAT TGG GCT AAA TGT AAT CGA GTG  
 
Fig 5.10: Primers used for the construction of rChb CBP mutant W63A. Outline 
of the position of the primers used for the mutation of the rChb CBP at residue 63. 
The forward primer 63A_F is shown in red and the reverse primer 63A_R is shown in 
green. The mutated residue is underlined and in bold.  
 
                                                                                               GT GGT AAC CTC TGA 
GGT GAA ATT GCT ATG CAT AAA GTA GCA GGT TCA CCA TTG GAG ACT 
ACC GTA AAA CCC GGA GCT GAC GCG GCG AAT ATC AGT TTG 
TGG CAT TTT GGG GGA GCT GAC GCG AAG AAT ATC AGT TTG GGA GAC 
 
Fig 5.11: Primers used for the construction of rChb CBP mutant K545A. Outline 
of the position of the primers used for the mutation of the rChb CBP at residue 545. 
The forward primer 545A_F is shown in red and the reverse primer 545A_R is shown 
in green. The mutated residue is underlined and in bold.  
 
                 GTA AAA CCC CCT  CGA CTG  CGC  TTC  TTA ATC CGT TTG GGA 
ACT TGG CAT TTT GGG GGA GCT GAC GCG AAG AAT ATC CGT TTG GGA 
GCG GGA TTC CAG G 
GAC GGA TTC CAG GAT AAA AAT GGT CCT ATC GTA CCG GGT AAG  
 
Fig 5.12: Primers used for the construction of rChb CBP mutant D551A. Outline 
of the position of the primers used for the mutation of the rChb CBP at residue 551. 
The forward primer 551A_F is shown in red and the reverse primer 551A_R is shown 
in green. The mutated residue is underlined and in bold.  
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                                                                                                                                 CGG 
TGG CAG GAT GGT TTA AAA CAT GCT AGC AGT GCT AAA GAT TTT GCC                                                                                                                                                                                                              
TGG TTT GCG CAA CCC CAC TTA AAA AGG GAC ACT CTC TAC GCG GGC 
ACC AAA CGC GTT GGG GTG AAT TTT TGG GAC ACT CTC TAC GAT GGC  
GGC  
GGC TTT GAT TCA GTC AAT GAT TGG GCG AAT AAG GGC TAT GAC GTG  
 
Fig 5.13: Primers used for the construction of rChb CBP mutant D648A. Outline 
of the position of the primers used for the mutation of the rChb CBP at residue 648. 
The forward primer 648A_F is shown in red and the reverse primer 648A_R is shown 
in green. The mutated residue is underlined and in bold. 
 
                                                                  TA TAC GGT ATA CTT CAA GTA GGT 
AGC CCA GAT TAT ATT TAT CTG GAT ATG CCA TAT GAA GTT CAT CCA  
GTT  CTT  CGT GGC TAT TAT TGT GCG GCT CGT TTT 
CAA GAA CGT GGC TAT TAT TGG GCG GCT CGT TTT AAC GAT GAA GCT  
 
Fig 5.14: Primers used for the construction of rChb CBP mutant W689Y. Outline 
of the position of the primers used for the mutation of the rChb CBP at residue 689. 
The forward primer is shown in red and the reverse primer is shown in green. The 
mutated residue is underlined and in bold. 
 
Table 5.1: Properties of the rChb CBP mutants. 
  Molecular Weight (kDa) Extinction Coefficient  pI 
Chb CBP 99.91    1.602    6.66 
W63A  99.79    1.548    6.66 
K545A 99.85    1.602    6.53 
D551A 99.86    1.602    6.81 
D648A 99.86    1.602    6.81  
W689Y 99.88    1.562    6.66  
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5.3 Expression and purification of the rChb CBP mutants 
 
The rChb CBP mutants were transformed into E. coli JM109 cells for stable storage of 
the plasmid DNA and E. coli KRX cells for the expression of the mutant proteins. The 
optimised culture conditions for the expression of the rChbL enzyme (see Section 3.6) 
were also employed here for the expression of the rChb CBP mutants. The rChb CBP 
mutants were expressed in E. coli KRX, in TB, at 30
oC and induced with 100 μM 
IPTG. The expression of the rChb CBP mutant proteins in the cellular fraction and to 
the culture media was examined (see Figures 5.16 and 5.17). The rChb CBP mutant 
proteins were collected from the culture media and purified via IMAC (see Figure 
5.18) as previously described for the rChbL enzyme (see Section 3.7).   
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Fig 5.15: Comparison between the growth rates of the rChb CBP mutants. 
Recombinant protein expression was induced at OD600nm = 0.5. 1 mL samples were 
taken from the cultures every hour for five hours, following induction and an 
overnight sample was taken 16 hours post induction (see Section 2.15). Absorbance 
readings were taken at the different time-points. The logAbs was plotted against time.  
 
The growth rates of each of the rChb CBP mutant cultures were similar to the rChb 
CBP growth rate (see Figure 4.7). The growth rates of all the rChb CBP mutant 
cultures were quite similar to each other. The observed cell density of the W63A, 
D648A and K545A cultures was similar at all time-points, suggesting that these site-
specific mutations did not affect the growth rate of the cells. The growth rate of the 
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W689Y mutant culture was marginally slower while the cell density of the D551A 
culture at all time-points was lower than all the other mutants.  
 
a)                                              b)                                          c) 
 
d)                                              e) 
 
Fig 5.16: Time-course analysis of culture media samples from rChb CBP mutant 
expression cultures a) W63A b) K545A c) D551A d) D648A and e) W689Y. 
Recombinant protein expression was induced at OD600nm = 0.5. 5 mL samples were 
taken from the culture media every hour for five hours, following induction and an 
overnight sample was taken 16 hours post-induction (see Section 2.17). The samples 
were then analysed by 12.5% SDS-PAGE. Lane 1, Protein ladder; Lane 2, T=0; Lane 
3, T=1 hour; Lane 4, T=2 hours; Lane 5, T=3 hours; Lane 6, T=4 hours; Lane 7, T=5 
hours; Lane 8, Overnight (T=16 hours). 
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a)                                       b)                                          c) 
      
d)                                        e) 
 
Fig 5.17: Time-course expression analysis of the cellular fractions from rChb 
CBP mutant cultures a) W63A b) K545A c) D551A d) D648A and e) W689Y. 
Once the cultures had reached an OD600 of 0.5 and had been induced, 1mL samples 
were taken every hour for 5 hours followed by an overnight sample. Samples from the 
cellular fractions were obtained (see Section 2.16) and then analysed by 12.5% SDS-
PAGE. Lane 1, Protein ladder; Lane 2, T=0 hours; Lane 3, T=1 hour; Lane 4, T= 2 
hours; Lane 5, T=3 hours; Lane 6, T=4 hours; Lane 7, T=5 hours; Lane 8, Overnight 
(T=16 hours). 
 
All of the rChb CBP mutant proteins expressed. Expression of the rChb CBP mutants 
was similar with that of the native rChbL protein and rChb CBP. Again protein was 
found in the insoluble cellular fraction and the culture media. As with rChbL and 
rChb CBP, the rChb CBP mutant proteins began to appear in the culture media two 
hours post induction. Protein production was optimal five hours after induction. The 
rChb CBP mutant proteins were therefore collected five hours post-induction. There 
was a similar level of protein expression observed for all rChb CBP mutants, except 
W689Y. This mutant protein had a much lower level of expression and the most 
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protein expression was observed after an overnight incubation (16 hours). This protein 
was therefore harvested following an overnight incubation. 
 
  a)                                            b)                                            c)    
 
 d)                                             e) 
                                                                                                                                                                                                                                                                  
Fig 5.18: Purification of the rChb CBP mutants from the culture media fraction 
a) W63A b) K545A c) D551A d) D648A and e) W689Y. The culture media was 
collected after cell harvest from the mutant rChb CBP expression cultures. These were 
then run over separate IMAC columns, washed with 40 mM imidazole and eluted 
with 250 mM imidazole. Fractions were run on 12.5% SDS gels.  
Lane 1, Protein ladder; Lane 2, Lysate; Lane 3, Flow through; Lane 4, Wash; Lane 5, 
Elution one; Lane 6, Elution two; Lane 7, Buffer-exchanged sample. 
 
Purification of the rChb CBP mutant proteins was similar to that of the native rChbL 
enzyme and rChb CBP. Protein was still eluted from the resin at low imidazole 
concentrations during the washes (40 mM). Yields of protein comparable with the 
rChbL enzyme and rChb CBP were achieved (approximately 5 mg/250 mL). The 
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most protein was obtained from the D648A culture while the least protein was 
obtained from the W689Y culture.  
 
5.4 Characterisation of the rChb CBP mutants 
 
Initially, the ability to detect the rChb CBP mutants in the ELLA format was tested. 
Access to the His6 tag was initially tested and unsurprisingly detection was not 
successful (see Figure 5.19). The mutants were then biotinylated, after which 
detection with an anti-Biotin antibody was successful (see Figure 5.19). The ability of 
the rChb CBP mutants to bind glycoproteins was then examined using ELLAs as 
previously described in Section 2.27. The rChb CBP mutants were tested against 
GlcNAc residues on asialo agalacto fetuin and also against BSA-GlcNAc. The 
biotinylated rChb CBP mutants were used in all subsequent ELLAs.  
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Fig 5.19: Detection of rChb CBP mutants via their His-tag and biotinylation. 50 
μL of each mutant protein was laid down on a 96-well plate at 10 μg/mL in triplicate. 
The plate was blocked as per Section 2.27 and the protein was probed with either an 
anti-His or anti-Biotin antibody. Experiment is representative of three individual 
experiments. Error bars represent the standard deviation of three replicates.  
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Fig 5.20: ELLA to investigate the binding of the rChb CBP mutants to GlcNAc 
residues. An ELLA was carried out as per Section 2.27. The rChb CBP mutants were 
used at a concentration of 10 μg/mL. Commercial GSLII was used as a positive 
control at a concentration of 10 μg/mL and was detected using an anti-biotin antibody. 
The rChb CBP mutants were also detected using an anti-Biotin antibody. Experiment 
is representative of three individual experiments. Error bars represent the standard 
deviation of three replicates. An unpaired T-test was used to determine if the increases 
in binding capabilities were significant in comprison with the rChb CBP (K545A - 
*p<0.0115, D551A - **p<0.009). 
 
Differences in the binding abilities of the rChb CBP mutants were observed. Similarly 
to the rChb CBP, mutants W63A, D648A and W689Y did not bind to GlcNAc 
residues on asialo agalacto fetuin, BSA-GlcNAc or bovine mucin. However, a 
significant increase in binding to BSA-GlcNAc and bovine mucin was observed for 
two of the mutants, K545A and D551A. The signal from the mutants in comparison 
with rChb CBP was three-fold higher. A slightly higher signal was obtained from 
D551A than K545A. The signal obtained from GSLII, the positive control, was two-
fold higher than the mutants’ signal. Binding to asialo agalacto fetuin was also 
observed, however to a lesser extent. The signal obtained from the mutants was two-
fold higher than that of rChb CBP. The binding abilities of K545A and D551A were 
then tested against increasing concentrations of BSA-GlcNAc. The rChb CBP mutants 
bound to BSA-GlcNAc in a concentration dependent manner. A slightly higher signal 
was obtained with D551A (see Figure 5.21). The binding of the rChb CBP mutants 
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was sugar dependent as inclusion of free GlcNAc sugar (100mM) inhibited binding 
(see Figure 5.22). 
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Fig 5.21: ELLA to investigate the binding of the rChb CBP mutants to increasing 
concentrations of BSA-GlcNAc. An ELLA was carried out as per Section 2.27. 
BSA-GlcNAc was immobilised at increasing concentrations from 0 – 10 μg/mL. The 
rChb CBP mutants and commercial GSLII were used at a concentration of 10 μg/mL 
and detected using an anti-Biotin antibody. Experiment is representative of three 
individual experiments. Error bars represent the standard deviation of three replicates.  
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Fig 5.22: Examination of the inhibition of binding to GlcNAc residues with free 
GlcNAc sugar. An ELLA was carried out as per Section 2.27. BSA-GlcNAc was 
immobilised at increasing concentrations of 10 μg/mL. The rChb CBP mutants and 
commercial GSLII were used at a concentration of 10 μg/mL and incubated with 100 
mM free GlcNAc for 30 minutes before addition to the plate. They were detected 
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using an anti-Biotin antibody. Experiment is representative of three individual 
experiments. Error bars represent the standard deviation of three replicates.  
 
5.5 Construction of a double rChb CBP mutant, K545A D551A 
 
As two of the individual site-specific mutations increased the binding abilities of the 
rChb CBP separately, the next step was to combine these mutants to investigate how 
the double mutation would affect the binding ability of rChb CBP. While the single 
mutations may be individually beneficial, the effect of the combination of these 
mutants is unknown. When mutations are combined the affect on the protein may be 
synergistic or may be antagonistic (Mildvan et al., 1992). The double mutant structure 
was modelled (see Figure 5.23) and was constructed using the primers depicted in 
Figure 5.24. The new mutant, titled K545A D551A, was transformed into E. coli 
JM109 cells for stable storage of the plasmid DNA and E. coli KRX cells for 
expression of the protein.  
 
5.5.1 Structural modelling of the rChb CBP double mutant 
 
a)                                                              b) 
  
Fig 5.23: Active site of a) rChb CBP and b) rChb CBP double mutant K545A 
D551A. The catalytic residues, D539A E540D, are highlighted in blue and residues 
545 and 551 are highlighted in green. The image was generated using Pymol software 
(available from http://www.pymol.org/). Mutations were also carried out and 
visualised in Pymol.  
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5.5.2 Site-specific mutagenesis of the rChb CBP double mutant 
 
The site-specific mutations were introduced using whole vector amplifications with 
the desired mutations encoded on the forward primer. PCR was carried out as 
discussed in Section 2.11. 
 
CCT  CGA CTG CGC  GCG TTA TAG GCA AAC GGA GCG GGA TTC CAG                                                                               
GGA GCT GAC GCG AAG AAT ATC CGT TTG GGA GAC GGA TTC CAG  
GAT AAA AAT GGT CCT ATC 
GAT AAA AAT GGT CCT ATC 
 
Fig 5.24: Primers used for the construction of rChb CBP double mutant K545A 
D551A. Outline of the position of the primers used for the mutation of the rChb CBP 
at residues 545 and 551. The forward primer 551A_F is shown in red and the reverse 
primer 551A_R is shown in green. The mutated residue is underlined and in bold.  
 
Table 5.2 Properties of the rChb CBP double mutant K545A D551A 
                                  Molecular Weight (kDa) Extinction Coefficient            pI 
Chb CBP   99.91    1.602              6.66 
K545A D551A 99.80    1.603              6.66 
 
 
5.6 Expression and purification of the rChb CBP double mutant 
K545A D551A 
 
The rChb CBP double mutant K545A D551A was expressed and purified as 
previously described for the rChb CBP single mutants. The construct was transformed 
into E. coli JM109 cells for storage of the plasmid DNA and E. coli KRX cells for the 
expression of the mutant protein. The cells were grown in TB, at 30
o
C and induced 
with 100 μM IPTG. Both the cellular fraction and culture media of these expression 
cultures were examined for protein (see Figure 5.25). The protein was purified from 
the culture media fraction via IMAC (see Figure 5.26) and buffer exchanged into PBS 
using FPLC. The binding abilities of the double mutant were then examined (see 
Section 5.7).  
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Fig 5.25: a) Analysis of the growth rate of rChb CBP double mutant K545A D551A b) and c) Time-course analysis of rChb CBP double 
mutant K545A D551A expression culture samples from the culture media (b) and the cellular fraction (c). a) Recombinant protein 
expression was induced at OD600nm = 0.5. 1 mL samples were taken from the cultures every hour for five hours, following induction and an 
overnight sample was taken 16 hours post induction. Absorbance readings were taken at the different time-points. The logAbs was plotted against 
time (hours). b) and c) Recombinant protein expression was induced at OD600nm = 0.5. 5 mL samples were taken from the culture every hour for 
five hours, following induction and an overnight sample was taken 16 hours post induction. Cellular fraction samples (see Section 2.15) and 
culture media samples (see Section 2.17) were obtained. The samples were then analysed by 12.5% SDS-PAGE. Lane 1, Protein ladder; Lane 2, 
T=0; Lane 3, T=1 hour; Lane 4, T=2 hours; Lane 5, T=3 hours; Lane 6, T=4 hours; Lane 7, T=5 hours; Lane 8, Overnight (T=16 hours). 
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The growth rate of the rChb CBP double mutant culture was slightly lower than the 
rChb CBP growth rate (see Figure 5.25). The observed cell density of the double 
mutant culture was lower at all time-points, however this did not affect the expression 
of the rChb CBP double mutant. Expression of the rChb CBP double mutant was 
similar with that of the native rChbL protein, rChb CBP and other rChb CBP mutants. 
Again, protein was found in the cellular fraction and the culture media. As with 
rChbL, rChb CBP, and the rChb CBP mutant proteins, the rChb CBP double mutant 
protein began to appear in the culture media two hours post induction. Protein 
production was optimal after an overnight incubation (16 hours). The rChb CBP 
double mutant protein were therefore collected 16 hours post-induction. The level of 
protein produced was similar to the other rChb CBP mutants.  
 
 
Fig 5.26: Purification of the rChb CBP double mutant K545A D551A from the 
culture media fraction. The culture media was collected after cell harvest from the 
rChb CBP double mutant expression cultures. These were then run over separate 
IMAC columns, washed with 40 mM imidazole and eluted with 250 mM imidazole. 
Fractions were run on 12.5% SDS gels. Lane 1, Protein ladder; Lane 2, Lysate; Lane 
3, Flow through; Lane 4, Wash; Lane 5, Elution one; Lane 6, Elution two; Lane 7, 
Buffer-exchanged sample.  
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Purification of the rChb CBP double mutant K545A D551A protein was similar to 
that of the native rChbL protein, the rChb CBP and the other rChb CBP mutants. 
Protein was still eluted from the resin at low imidazole concentrations during the 
washes (40 mM). Relatively high yields of protein comparable with the rChbL protein 
and rChb CBP were achieved (approximately 6 mg/250 mL).  
 
5.7 Characterisation of the rChb CBP double mutant K545A D551A 
 
The binding ability of the double mutant was examined using ELLAs as described 
previously (see Section 2.27). The ability to detect the K545A D551A double mutant 
was examined via the His tag and biotinylation of the protein (see Figure 5.27). The 
binding of the K545A D551A double mutant was tested against asialo agalacto fetuin, 
BSA-GlcNAc and Bovine Mucin (see Figure 5.28).  
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Fig 5.27: Detection of the rChb CBP double mutant K545A D551A via its’ His-
tag and biotinylation. 50 μL of the double mutant protein was immobilised on a 96-
well plate at 10 μg/mL in triplicate. The plate was blocked as per Section 2.27 and the 
protein was probed with either an anti-His or anti-Biotin antibody. Experiment is 
representative of three individual experiments. Error bars represent the standard 
deviation of three replicates.  
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Fig 5.28: ELLA to investigate the binding of the rChb CBP double mutant 
K545A D551A to GlcNAc residues. An ELLA was carried out as per Section 2.27. 
Asialo agalacto fetuin, BSA-GlcNAc and Bovine Mucin were immobilised on the 
plate at 10 μg/mL. The rChb CBP double mutant and commercial GSLII were used at 
a concentration of 10 μg/mL and were detected using an anti-biotin antibody. 
Experiment is representative of three individual experiments. Error bars represent the 
standard deviation of three replicates. An unpaired T-test was used to determine if the 
increases in binding capabilities were significant in comprison with the rChb CBP 
(K545A D551A - ***p<0.0001). 
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Fig 5.29: ELLA to investigate the binding of the rChb CBP double mutant 
K545A D551A to increasing concentrations of BSA-GlcNAc. An ELLA was 
carried out as per Section 2.27. BSA-GlcNAc was immobilised at increasing 
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concentrations from 0 – 10 μg/mL. The rChb CBP double mutant and commercial 
GSLII were used at a concentration of 10 μg/mL and were detected using an anti-
biotin antibody. Experiment is representative of three individual experiments. Error 
bars represent the standard deviation of three replicates.  
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Fig 5.30: Examination of the inhibition of binding of the rChb CBP mutant to 
GlcNAc residues with free GlcNAc sugar. An ELLA was carried out as per Section 
2.27. BSA-GlcNAc was immobilised at increasing concentrations of 10 μg/mL. The 
rChb CBP double mutant and commercial GSLII were used at a concentration of 10 
μg/mL and incubated with 100mM free GlcNAc for 30 minutes before addition to the 
plate. They were detected using an anti-biotin antibody. Experiment is representative 
of three individual experiments. Error bars represent the standard deviation of three 
replicates.  
 
The rChb CBP double mutant K545A D551A was not detectable via its’ His6 tag as 
with the other rChb CBPs, however it was detectable after biotinylation (see Figure 
5.27). The biotinylated double mutant protein was therefore used in all subsequent 
ELLAs. Binding to asialo agalacto fetuin was not noticeably improved. The mutations 
to the rChb CBP were found to work additively as they significantly increased the 
binding of the rChb CBP to BSA-GlcNAc and bovine mucin almost two-fold (see 
Figure 5.28), compared with the single mutations. Binding to asialo agalacto fetuin 
was not improved. The binding to BSA-GlcNAc was sugar dependent as a high 
concentration of free GlcNAc sugar inhibited binding (see Figure 5.30).  
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5.8 Site-specific mutagenesis of the rChbL enzyme 
 
Following the successful mutagenesis of the rChb CBP molecule and the discovery 
that the K545A and D551A mutations resulted in an increased ability of the protein to 
bind to GlcNAc epitopes on glycoproteins, the effects of the site-specific mutations on 
the catalytic activity of the rChbL enzyme was also examined.  
The same five site-specific mutations were also carried out on the rChbL enzyme. The 
residues to be mutated were all present in close proximity to the catalytic site. These 
residues were mutated to discover more about the catalytic site of the enzyme and to 
determine which, if any, of these residues had an importance in catalysis. 
The site-specific mutations were introduced as previously (see Section 5.8.2); 
however this time the rChbL enzyme construct pQE60_Chb+ was used as a template. 
The potential structural effects of the introduced mutations were visualised using 
Pymol in Figures 5.31 to 5.36.  
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5.8.1 Structural modelling of the rChbL site-specific mutants  
                                                                                     
                                              
                                
Fig 5.31: Residues chosen for site-specific mutagenesis of the rChbL active site. 
The catalytic residues, D539 and E540, are highlighted in blue. The residues chosen 
for mutagenesis, W63, K545, D551, D648 and W689, are highlighted in green. 
Images were generated using Pymol (available from http://www.pymol.org/). The 
mutagenesis was performed and visualised in Pymol.  
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a)                                                                  b) 
                                                                     
Fig 5.32: Active site of a) rChbL and b) rChbL W63A. The catalytic site residues, 
D539 and E540, are highlighted in blue and residue 63 is highlighted in green. The 
image was generated using Pymol software (available from http://www.pymol.org/). 
 
a)                                                                  b) 
   
Fig 5.33: Active site of a) rChbL and b) rChbL K545A. The catalytic site residues, 
D539 and E540, are highlighted in blue and residue 545 is highlighted in green. The 
image was generated using Pymol software (available from http://www.pymol.org/).  
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a)                                                                  b) 
   
Fig 5.34: Active site of a) rChbL and b) rChbL D551A. The catalytic site residues, 
D539 and E540, are highlighted in blue and residue 551 is highlighted in green. The 
image was generated using Pymol software (available from http://www.pymol.org/).  
 
a)                                                                  b) 
   
Fig 5.35: Active site of a) rChbL and b) rChbL D648A. The catalytic site residues, 
D539 and E540, are highlighted in blue and residue 648 is highlighted in green. The 
image was generated using Pymol software (available from http://www.pymol.org/).  
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a)                                                                  b) 
   
Fig 5.36: Active site of a) rChbL and b) rChbL W689Y. The catalytic site residues, 
D539 and E540, are highlighted in blue and residue 689 is highlighted in green. The 
image was generated using Pymol software (available from http://www.pymol.org/).  
 
5.8.2 Site-specific mutagenesis of the rChbL mutants 
 
                                                                                                              GTG CCG CAA 
GTT AAT TAT AAA GTT GTT GAT AAT CAG GCA GGA AGT CAC GGC GTT  
TTG ACA CGC CAG GCA GGG GCA GAT GCG GCT AAA TGT AAT CG 
AAC TGT GCG GTC CGT GGG GCA GAT TGG GCT AAA TGT AAT CGA GTG  
 
Fig 5.37: Primers used for the construction of rChbL mutant W63A. Outline of 
the position of the primers used for the mutation of the rChbL enzyme at residue 63. 
The forward primer 63A_F is shown in red and the reverse primer 63A_R is shown in 
green. The mutated residue is underlined and in bold.  
 
                                                                                               GT GGT AAC CTC TGA 
GGT GAA ATT GCT ATG CAT AAA GTA GCA GGT TCA CCA TTG GAG ACT 
ACC GTA AAA CCC GGA GAT GAA GCG GCG AAT ATC AGT TTG 
TGG CAT TTT GGG GGA GAT GAA GCG AAG AAT ATC AGT TTG GGA GAC  
 
Fig 5.38: Primers used for the construction of rChbL mutant K545A. Outline of 
the position of the primers used for the mutation of the rChbL enzyme at residue 545. 
The forward primer 545A_chb_F is shown in red and the reverse primer 545A_R is 
shown in green. The mutated residue is underlined and in bold. 
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                 GTA AAA CCC CCT  CTA CTT  CGC  TTC  TTA ATC CGT TTG GGA 
ACT TGG CAT TTT GGG GGA GAT GAA GCG AAG AAT ATC CGT TTG GGA 
GCG GGA TTC CAG G 
GAC GGA TTC CAG GAT AAA AAT GGT CCT ATC GTA CCG GGT AAG  
 
Fig 5.39: Primers used for the construction of rChbL mutant D551A. Outline of 
the position of the primers used for the mutation of the rChbL enzyme at residue 551. 
The forward primer 551A_F is shown in red and the reverse primer 551A_chb_R is 
shown in green. The mutated residue is underlined and in bold. 
 
                                                                                                                                CGG 
TGG CAG GAT GGT TTA AAA CAT GCT AGC AGT GCT AAA GAT TTT GCC                                                                                                                                                                                                              
TGG TTT GCG CAA CCC CAC TTA AAA AGG GAC ACT CTC TAC GCG GGC 
ACC AAA CGC GTT GGG GTG AAT TTT TGG GAC ACT CTC TAC GAT GGC  
GGC  
GGC TTT GAT TCA GTC AAT GAT TGG GCG AAT AAG GGC TAT GAC GTG  
 
Fig 5.40: Primers used for the construction of rChbL mutant D648A. Outline of 
the position of the primers used for the mutation of the rChbL enzyme at residue 648. 
The forward primer 648A_F is shown in red and the reverse primer 648A_R is shown 
in green. The mutated residue is underlined and in bold. 
 
                                                                   TA TAC GGT ATA CTT CAA GTA GGT 
AGC CCA GAT TAT ATT TAT CTG GAT ATG CCA TAT GAA GTT CAT CCA  
TTC TTG   CGT GGC TAT TAT TGT GCG GCT CGT TTT 
CAA GAA CGT GGC TAT TAT TGG GCG GCT CGT TTT AAC GAT GAA GCT  
 
Fig 5.41: Primers used for the construction of rChbL mutant W689Y. Outline of 
the position of the primers used for the mutation of the rChbL enzyme at residue 689. 
The forward primer is shown in red and the reverse primer is shown in green. The 
mutated residue is underlined and in bold. 
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Table 5.3 Properties of the rChbL mutants. 
  Molecular Weight (kDa) Extinction Coefficient  pI 
rChbL  99.93    1.601    6.53 
W63A  99.84    1.547    6.53 
K545A 99.91    1.602    6.42 
D551A 99.92    1.601    6.66  
D648A 99.92    1.601    6.66  
W689Y 99.94    1.561    6.53 
 
 
5.9 Expression and purification of the rChbL site-specific mutants 
 
After successful cloning of the rChbL site-specific mutant constructs, the plasmids 
were transformed into E. coli JM109 cells for stable storage of the plasmid DNA and 
E. coli KRX cells for expression of the mutant proteins. The optimised culture 
conditions for the expression of the rChbL enzyme (see Section 3.6) that were used 
for the expression of the rChb CBP mutants were also employed here for the 
expression of the rChbL mutant proteins (see Figures 5.42, 5.43 and 5.44). The rChbL 
mutants were expressed at 30
o
C in TB, in E. coli KRX cells and induced with 100 μM 
IPTG. The expression of the rChbL mutants in the cellular fraction and the culture 
media were examined (see Figures 5.42 and 5.43). The mutant proteins were purified 
via IMAC (see Figure 5.44) and buffer exchanged into PBS using FPLC. The protein 
was quantified and yields were compared. The catalytic activity of the mutant 
enzymes was then examined and compared with the rChbL enzyme along with their 
physical properties.   
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Fig 5.42 Comparison of the growth rates of the rChbL mutants. Recombinant 
protein expression was induced at OD600nm = 0.5. 1 mL samples were taken from the 
cultures every hour for five hours, following induction and an overnight sample was 
taken 16 hours post induction (see Section 2.16). Absorbance readings were taken at 
the different time-points. The logAbs was plotted against time.  
 
The growth rates of the rChbL mutants were similar to each other (see Figure 5.42) 
and also to rChbL (see Figure 3.6). The cell densities at each time-point were 
relatively similar apart from that of D551A. This mutant had a slower rate of growth, 
with lower cell densities observed from 2 to 5 hours. The final cell density was, 
however, similar to that of the other rChbL mutants after an overnight incubation.  
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a)                                             b)                                         c) 
  
d)                                              e) 
 
 
Figure 5.43: Time-course analysis of culture media samples from rChbL mutant 
expression cultures a) W63A b) K545A c) D551A d) D648A and e) W689Y. 
Recombinant protein expression was induced at OD600nm = 0.5. 5 mL samples were 
taken from the culture media every hour for five hours, following induction and an 
overnight sample was taken 16 hours post-induction (see Section 2.17). The samples 
were then analysed by 12.5% SDS-PAGE. Lane 1, Protein ladder; Lane 2, T=0; Lane 
3, T=1 hour; Lane 4, T=2 hours; Lane 5, T=3 hours; Lane 6, T=4 hours; Lane 7, T=5 
hours; Lane 8, Overnight (T=16 hours). 
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a)                                            b)                                       c) 
  
d)                                            e) 
   
Figure 5.44: Time-course expression analysis of the insoluble cellular fraction 
from rChbL mutant cultures a) W63A b) K545A c) D551A d) D648A and e) 
W689Y. Once the cultures had reached an OD600 of 0.5 and had been induced, 1 mL 
samples were taken every hour for 5 hours followed by an overnight sample. Samples 
from the cellular fractions were obtained (see Section 2.16) and then analysed by 
12.5% SDS-PAGE. Lane 1, Protein ladder; Lane 2, T=0 hours; Lane 3, T=1 hour; 
Lane 4, T= 2 hours; Lane 5, T=3 hours; Lane 6, T=4 hours; Lane 7, T=5 hours; Lane 
8, Overnight (T=16 hours). 
 
The rChbL enzyme mutant proteins were found expressed both in the insoluble 
cellular fraction and in the culture media. The levels of mutant protein expression to 
the culture media were similar whether the culture was incubated for five hours or 
incubated overnight. Protein started appearing in the culture media two hours post-
induction. Protein was present in the insoluble cellular fraction one hour post-
induction. More protein was found in the cellular fraction as was the same with the 
rChbL, however, protein was again collected from the culture media due to ease of 
purification and quality of protein obtained.   
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a)                                            b)                                         c)                                     
 
d)                                            e) 
        
Figure 5.45: Purification of the rChbL mutants from the culture media fraction 
a) W63A b) K545A c) D551A d) D648A and e) W689Y. The culture media was 
collected after cell harvest from the mutant rChbL expression cultures. These were 
then run over separate IMAC columns, washed with 40 mM imidazole and eluted 
with 250 mM imidazole. Fractions were run on 12.5% SDS gels. Lane 1, Protein 
ladder; Lane 2, Lysate; Lane 3, Flow through; Lane 4, Wash; Lane 5, Elution one; 
Lane 6, Elution two; Lane 7, Buffer-exchanged sample 
 
All rChbL mutant proteins were successfully purified and buffer-exchanged. Similar 
levels of protein were obtained for each mutant. Approximately 6 mg/250 mL culture 
was obtained for each mutant.  
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5.10 Characterisation of the rChbL site-specific mutants  
 
The catalytic activity and properties of each of the rChbL mutants was thoroughly 
examined. The kinetics of each was compared with the rChbL. The specificity of each 
mutant was examined along with inhibition by various free sugars. Differences in 
thermodynamic properties were also examined. The Chb assay was carried out as 
previously described (see Section 2.26) under optimum conditions, 50 mM sodium 
phosphate pH 8.0, at 37
o
C for 45 minutes.  
 
5.10.1 Preliminary kinetic characterisation of the rChbL mutants 
 
The kinetics of each mutant was examined using the Michaelis Menten and Hanes-
Woolf plots. Each plot was used to calculate the rates of catalytic activity (Vmax, Km, 
kcat and kcat/Km). 
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Fig 5.46: Activity assay comparing the rate of catalytic activity between the 
rChbL and rChbL mutants. The Chb activity assay was performed as per Section 
2.26. The rChbL enzyme and rChbL mutant enzymes were used at a concentration of 
10 μg/mL. The PNP-GlcNAc substrate was present at 2 mM. The rate, V (mM 
PNP/min/mL enzyme), of the reaction was plotted. Experiment is representative of 
three individual experiments. Error bars represent the standard deviation of three 
replicates. An unpaired T-test was used to determine if the increases in catalytic 
activity were significant (K545A - ***p<0.0001, D551A - ***p<0.0001).  
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Figure 5.46 demonstrates that the mutations all had very different effects on the 
catalytic activity of the rChbL enzyme. While mutations W63A, D648A and W689Y 
reduced the catalytic activity of the rChbL enzyme, mutations K545A and D551A 
significantly increased the rate of catalytic activity two- fold. 
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Fig 5.47: Kinetic analysis of the rChbL mutant W63A. The Chb activity assay was performed as per Section 2.26 over a range of substrate 
concentrations from 0 to 10 mM. The rate, V (mM PNP/min/mL enzyme), was plotted against substrate concentration (S).  
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Fig 5.48: Kinetic analysis of the rChbL mutant K545A. The Chb activity assay was performed as per Section 2.26 over a range of substrate 
concentrations from 0 to 10 mM. The rate, V (mM PNP/min/mL enzyme), was plotted against substrate concentration (S). 
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Fig 5.49: Kinetic analysis of the rChbL mutant D551A. The Chb activity assay was performed as per Section 2.26 over a range of substrate 
concentrations from 0 to 10 mM. The rate, V (mM PNP/min/mL enzyme), was plotted against substrate concentration (S). 
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Fig 5.50: Kinetic analysis of the rChbL mutant D648A. The Chb activity assay was performed as per Section 2.26 over a range of substrate 
concentrations from 0 to 10 mM. The rate, V (mM PNP/min/mL enzyme), was plotted against substrate concentration (S). 
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Fig 5.51: Kinetic analysis of the rChbL mutant W689Y. The Chb activity assay was performed as per Section 2.26 over a range of substrate 
concentrations from 0 to 10 mM. The rate, V (mM PNP/min/mL enzyme), was plotted against substrate concentration (S). Experiment is 
representative of three individual experiments. Error bars represent the standard deviation of three replicates.  
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Fig 5.52: Comparison of the catalytic activity of all the rChbL mutants with the 
rChbL and a commercial Chb. The Chb activity assay was performed as per Section 
2.26 over a range of substrate concentrations from 0 to 10 mM. The rate, V (mM 
PNP/min/mL enzyme), was plotted against substrate concentration (mM). Experiment 
is representative of three individual experiments. Error bars represent the standard 
deviation of three replicates.  
 
Figures 5.47 to 5.52 demonstrate the differences in catalytic activity between the 
rChbL enzyme, rChbL mutants and a commercial Chb. The differences in kinetic 
values are shown in Tables 5.4, 5.5 and 5.6. Mutants W63A, D648A and W689Y 
reduced catalytic activity in comparison with the native rChbL. Mutants K545A and 
D551A increased catalytic activity in comparison with the native rChbL. They also 
had increased catalytic activity in comparison with the commercial Chb.  
 
It can be observed from Table 5.4 that the mutants displaying reduced catalytic 
activity had a lower Vmax and higher Km, calculated using a Michaelis Menten curve. 
The mutants with increased activity had a higher Vmax and lower Km than the rChbL 
enzyme. The kcat and kcat/Km of the more active mutants were two orders of magnitude 
higher than rChbL, while the same values for the less active mutants were slightly 
lower than the rChbL.   
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Table 5.4 Michaelis-Menten values for the rChbL mutants. 
Michaelis W63A    K545A    D551A    D648A    W689Y 
Menten       
Vmax (μM) 327  5300  7420  263  370  
Km (mM) 1  0.22  0.4  2  1.18 
kcat (s
-1
) 3.24x10
5 
5.25x10
7
 7.35x10
7
 2.60x10
5
 3.66x10
5
 
kcat/Km  3.24x10
5
 2.39x10
8
 1.84x10
8
 1.30x10
5
 3.10x10
5
 
(mM
-1
.s
-1
) 
SD (±)  0.02066 0.04327 0.07082 0.00780 0.02066 
 
 
Table 5.5 Hanes-Woolf values for the rChbL mutants.  
Hanes-  W63A    K545A    D551A    D648A    W689Y 
Woolf       
Vmax (μM) 333  5649  6925  5851  276  
Km (mM) 0.165  0.106  0.05  0.541  0.51 
kcat (s
-1
) 3.30x10
5
 5.59x10
7
 6.86x10
7
 5.79x10
6
 2.73x10
5
 
kcat/Km  1.99x10
6
 5.25x10
8
 1.37x10
9
 1.07x10
7
 5.36x10
5
 
(mM
-1
.s
-1
)  
SD (±)  0.02066 0.04327 0.07082 0.00780 0.02066 
 
 
 
 
 
 
 
 
 
 
 
 
5.10.2 Characterisation of the rChbL mutants’ properties 
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The properties of the rChbL mutants were examined in the following section. The 
stability of the mutants at various temperatures was examined in Figure 5.53 while the 
stability of the mutants at various pH values was examined in Figure 5.54.  
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Fig 5.53: The effect of temperature on the catalytic activity of the rChbL 
mutants. The Chb activity assay was performed as per Section 2.26 over a range of 
different temperatures, from 4
o
C to 60
o
C. The rate, V (mM PNP/min/mL enzyme), 
was plotted against temperature (
o
C). Experiment is representative of three individual 
experiments. Error bars represent the standard deviation of three replicates.  
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Fig 5.54: The effect of pH on the catalytic activity of the rChbL mutants. The 
Chb activity assay was performed as per Section 2.26 over a wide pH range, from 4.0 
to 12.0. The rate, V (mM PNP/min/mL enzyme), was plotted against pH. Experiment 
is representative of three individual experiments. Error bars represent the standard 
deviation of three replicates.  
 
The temperature profile of the rChbL mutants was similar to that of the rChbL 
enzyme. There was relatively little activity at 4
o
C. As the temperature increased so too 
did the rate of catalytic activity. The optimum rate of catalytic activity was reached 
just before 45
o
C, after which the rate steadily declined. There was very little catalytic 
activity observed at 60
o
C. The pH profiles of the mutants were slightly different than 
that of the rChbL enzyme. While the catalytic activity of the rChbL enzyme peaked at 
pH 8.0 and declined rapidly after, the mutants with increased catalytic activity 
(K545A and D551A) were also more stable at higher pH values. They retained the 
majority of their catalytic activity at pH 9.0 and half of their catalytic activity at pH 
10.0. Catalytic activity only sharply declined at pHs higher than 10.0. There was very 
little catalytic activity observed from the reduced activity mutants, which meant that 
the optimum pH and temperature for catalytic activity were unable to be determined.  
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Substrate specificity studies were carried out using a range of PNP-linked sugar 
substrates including β-GlcNAc, β- and α-glucose, β-galactose and sialic acid (see 
Figures 5.55 and 5.56). Following these experiments sugar inhibition studies on PNP-
GlcNAc cleavage was also carried out using a range of free sugars. The specificity 
studies and sugar inhibition studies were only carried out on the mutants with 
observed increases in activity, K545A and D551A, as the rate of catalytic activity of 
the other mutants was too low. 
 
It can be clearly observed from Figures 5.55 and 5.56 that the specificity of the rChbL 
mutants had not differed from the rChbL enzyme (see Figure 3.30). The GlcNAc 
substrate was the only substrate cleaved; there was relatively no cleavage of any of 
the other substrates examined.  
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Fig 5.55: Specificity of the rChbL mutant K545A. The Chb activity assay was 
performed as per Section 2.26 against a wide range of PNP-linked sugar substrates. 
The rate, V (mM PNP/min/mL enzyme), was plotted substrate concentration (mM). 
Experiment is representative of three individual experiments. Error bars represent the 
standard deviation of three replicates.  
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Fig 5.56: Specificity of the rChbL mutant D551A. The Chb activity assay was 
performed as per Section 2.26 against a wide range of PNP-linked sugar substrates. 
The rate, V (mM PNP/min/mL enzyme), was plotted substrate concentration (mM). 
Experiment is representative of three individual experiments. Error bars represent the 
standard deviation of three replicates.  
 
The pattern of inhibition by free sugars was similar between rChbL mutants K545A 
(see Figure 5.57), D551A (see Figure 5.58) and rChbL itself (see Figure 3.31). While 
fucose, xylose and galactose caused no inhibition, lactose, mannose, glucose and 
GlcNAc all caused inhibition to some extent. As with rChbL the most inhibition was 
observed with GlcNAc, while mannose caused the second highest level of inhibition. 
As observed for rChbL, lactose was the third best inhibitor for both mutants, K545A 
and D551A, with galactose the weakest of the inhibiting sugars. 
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Fig 5.57: The inhibitory effect of free sugars on the rate of rChbL mutant K545A 
catalytic activity on PNP-GlcNAc. The Chb activity assay was performed as per 
Section 2.26 with PNP-GlcNAc. The K545A mutant enzyme was used at a 
concentration of 1 μg/mL and incubated with increasing concentrations of the 
inhibiting sugar for 30 minutes at 37
o
C prior to addition to the plate. The rate, V (mM 
PNP/min/mL enzyme), was plotted substrate concentration (mM). Experiment is 
representative of three individual experiments. Error bars represent the standard 
deviation of three replicates.  
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Fig 5.58: The inhibitory effect of free sugars on the rate of rChbL mutant D551A 
catalytic activity on PNP-GlcNAc. The Chb activity assay was performed as per 
Section 2.26 with PNP-GlcNAc. The D551A mutant enzyme was used at a 
concentration of 1 μg/mL and incubated with increasing concentrations of the 
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inhibiting sugar for 30 minutes at 37
o
C prior to addition to the plate. The rate, V (mM 
PNP/min/mL enzyme), was plotted substrate concentration (mM). Experiment is 
representative of three individual experiments. Error bars represent the standard 
deviation of three replicates.  
 
Lineweaver-Burk plots were generated to describe the inhibition occurring between 
the rChbL mutants and the free sugars GlcNAc, glucose, mannose and lactose (see 
Figures 5.59 and 5.60). Tables 5.7 and 5.8 were generated from the results by the 
calculating 1/V intercept and the slope. 
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Fig 5.59: Lineweaver-Burk plots of the inhibition occurring with the K545A rChbL mutant and a) GlcNAc, b) glucose, c) mannose and 
d) lactose. The Chb activity was performed as described in Section 2.26. Increasing concentrations of PNP-GlcNAc were incubated with a 
constant concentration of enzyme (1 μg/mL) and either 25 mM or 50 mM inhibiting sugar. The reciprocal rate of the reaction was plotted against 
the reciprocal of the substrate concentration. Experiment is representative of three individual experiments. Error bars represent the standard 
deviation of three replicates.  
a) b) 
d) c) 
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Fig 5.60: Lineweaver-Burk plots of the inhibition occurring with the D551A rChbL mutant and a) GlcNAc, b) glucose, c) mannose and 
d) lactose. The Chb activity was performed as described in Section 2.26. Increasing concentrations of PNP-GlcNAc were incubated with a 
constant concentration of enzyme (1 μg/mL) and either 25 mM or 50 mM inhibiting sugar. The reciprocal rate of the reaction was plotted against 
the reciprocal of the substrate concentration. Experiment is representative of three individual experiments. Error bars represent the standard 
deviation of three replicates.  
a) 
b) 
c) d) 
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Table 5.6 Kinetic values describing the inhibition occurring between the rChbL 
mutant K545A- PNP-GlcNAc reaction and GlcNAc, glucose, mannose and 
lactose. 
   1/V intercept  Slope  
GlcNAc (No sugar) 0.0797   0.0973 
GlcNAc (25 mM) 0.1223   1.2092  
GlcNAc (50 mM) 0.0605   1.9734 
Glucose (No sugar) 0.0797   0.0973   
Glucose (25 mM) 0.1862   0.2712 
Glucose (50 mM) 0.1839   0.384 
Mannose (No sugar) 0.0797   0.0973 
Mannose (25 mM) 0.2338   0.2237   
Mannose (50 mM) 0.3002   0.2374  
Lactose (No sugar) 0.0797   0.0973  
Lactose (25 mM) 0.2853   0.1533 
Lactose (50 mM) 0.4135   0.2195 
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Table 5.7 Kinetic values describing the inhibition occurring between the rChbL 
mutant D551A- PNP-GlcNAc reaction and GlcNAc, glucose, mannose and 
lactose. 
   1/V intercept  Slope  
GlcNAc (No sugar) 0.0464   0.1477 
GlcNAc (25 mM) 0.2128   1.0289 
GlcNAc (50 mM) 0.1241   2.1677 
Glucose (No sugar) 0.0464   0.1477  
Glucose (25 mM) 0.2244   0.1509 
Glucose (50 mM) 0.2493   0.2190 
Mannose (No sugar) 0.0464   0.1477 
Mannose (25 mM) 0.199   0.3454   
Mannose (50 mM) 0.264   0.4901  
Lactose (No sugar) 0.0464   0.1477 
Lactose (25 mM) 0.2854   0.1739 
Lactose (50 mM) 0.3851   0.2108 
 
 
It can be observed from Tables 5.7 and 5.8 that the patterns of inhibition due to the 
presence of inhibiting sugars are the same for each rChbL mutant, K545A and 
D551A. However, they differ slightly from those of the original rChbL enzyme. N-
acetylglucosamine (GlcNAc) again inhibits both mutants in a competitive fashion, 
similarly to the rChbL enzyme. However, mannose does not inhibit the mutant 
enzymes competitively; instead inhibition occurs in a non-competitive manner. As 
with the rChbL enzyme, glucose and lactose inhibit the catalytic reaction in a non-
competitive manner.  
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5.11 Construction of a double rChbL mutant, K545A D551A 
 
As was the case with the mutations to the rChb CBP, two of the mutations had 
positive effects on the protein, increasing its ability to bind to GlcNAc epitopes. In 
this case, both mutations K545A and D551A increased the activity of the enzyme. 
These mutations were combined in one single mutant, using PCR whole vector 
amplification, to create the double mutant rChbL K545A D551A. The structural 
implications of the mutations were modelled using Pymol (see Figure 5.61). The 
double mutant was constructed using the primers shown in Figure 5.62 and the 
resultant construct was named pQE60_Chb_545A/551A. The double mutant protein 
was called rChbL K545A D551A. The properties of the new double mutant are shown 
in Table 5.9.  
 
a)                                                                  b) 
   
Fig 5.61: Binding pocket of a) wtChbL and b) rChbL K545A D551A. The 
catalytic site is highlighted in blue, D539 and E540, and residues 545 and 551 are 
highlighted in green. The image was generated using Pymol software.  
 
CCT TCA  CTT CGC  GCG TTA TAG GCA AAC GGA GCG GGA TTC CAG                                                                               
GGA GAT GAA GCG AAG AAT ATC CGT TTG GGA GAC GGA TTC CAG  
GAT AAA AAT GGT CCT ATC 
GAT AAA AAT GGT CCT ATC 
 
Fig 5.62: Primers used for the construction of rChbL double mutant K545A 
D551A. Outline of the position of the primers used for the mutation of the rChbL 
enzyme at residues 545 and 551. The forward primer 545A551A_chb_F is shown in 
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red and the reverse primer 545A551A_chb_R is shown in green. The mutated residues 
are underlined and in bold. 
 
 Table 5.8 Properties of the double mutant rChbL K545A D551A.  
                                  Molecular Weight (kDa) Extinction Coefficient            pI 
rChbL   99.99    1.601              6.53 
K545A D551A 99.86    1.602              6.53 
 
5.12 Expression and purification of the double mutant rChbL K545A 
D551A 
 
Following the successful construction of the double mutant construct rChbL K545A 
D551A, the plasmid was transformed into E. coli JM109 cells for stable storage of the 
plasmid DNA and E. coli KRX cells for expression of the mutant protein. The culture 
conditions, already optimised for the expression of the rChbL enzyme (see Section 
3.6), were used for the expression of the double mutant protein. The rChbL double 
mutant protein was expressed in E. coli KRX cells, in TB, at 30
o
C and induced with 
100 μM IPTG. The expression of the protein to both the insoluble cellular fraction and 
the culture media were examined (see Figure 5.64). The protein was then purified via 
IMAC as previously described (see Section 2.19.1) and buffer exchanged using FPLC 
(see Section 2.20). The catalytic activity of the new enzyme was then examined. 
 
It can be observed from the following figures (5.63 and 5.64) that expression and 
purification of the rChbL double mutant K545A D551A was similar to that of the 
rChbL enzyme and the other rChbL mutants previously described (see Section 5.9). 
There was protein expressed in the cellular fraction and to the culture media. The 
protein from the cellular lysate was found in the insoluble fraction as before. The 
protein began appearing in the culture media two hours post-induction. Similar levels 
of protein were observed in the culture media at five hours and sixteen hours post 
induction. The protein was collected after five hours incubation. The protein was 
purified via IMAC as before and was able to withstand a 20 mM imidazole wash, 
after which it was eluted with 250 mM imidazole. The protein was buffered 
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exchanged using FPLC and the average protein yield was approximately 6 mg/250 
mL culture.    
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Fig 5.63: a) Analysis of the growth rate of the rChbL double mutant K545A D551A b) and c) Time-course analysis of rChbL double 
mutant K545A D551A expression culture samples from the culture media (b) and the cellular fraction (c). a) Recombinant protein 
expression was induced at OD600nm = 0.5. 1 mL samples were taken from the cultures every hour for five hours, following induction and an 
overnight sample was taken 16 hours post induction. Absorbance readings were taken at the different time-points. The logAbs was plotted against 
time (hours).  
b) and c) Recombinant protein expression was induced at OD600nm = 0.5. 5 mL samples were taken from the culture every hour for five hours, 
following induction and an overnight sample was taken 16 hours post induction. Cellular fraction samples (see Section 2.15) and culture media 
samples (see Section 2.16) were obtained. The samples were then analysed by 12.5% SDS-PAGE. Lane 1, Protein ladder; Lane 2, T=0; Lane 3, 
T=1 hour; Lane 4, T=2 hours; Lane 5, T=3 hours; Lane 6, T=4 hours; Lane 7, T=5 hours; Lane 8, Overnight (T=16 hours).
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Fig 5.64: Purification of the rChbL double mutant K545A D551A from the 
culture media fraction. The culture media was collected after cell harvest from the 
rChbL double mutant expression cultures. These were then run over separate IMAC 
columns, washed with 40 mM imidazole and eluted with 250 mM imidazole. 
Fractions were run on 12.5% SDS gels. Lane 1, Protein ladder; Lane 2, Lysate; Lane 
3, Flow through; Lane 4, Wash; Lane 5, Elution one; Lane 6, Elution two; Lane 7, 
Buffer-exchanged sample.  
 
5.13 Characterisation of the rChbL double mutant K545A D551A 
 
The properties of the rChbL double mutant K545A D551A were examined in the 
following section. The effect of the combination of the mutations on the catalytic 
activity of the rChbL double mutant was examined (see Figure 5.65) along with their 
effects on the specificity of the enzyme (see Figure 5.66) and free sugar inhibition 
(see Figures 5.69 and 5.70). The effect on the physical properties of the enzyme such 
as its optimum temperature (see Figure 5.67) and its optimum pH (see Figure 5.68) 
were also examined.   
 
5.13.1 Preliminary kinetic characterisation of the rChbL double mutant K545A 
D551A 
 
Whether the mutations acted additively to further increase the catalytic rate of the 
rChbL enzyme or inhibited each other cancelling their positive effects on the catalytic 
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rate was examined. The catalytic rate of activity was again measured using two plots; 
Michaelis Menten and Hanes-Woolf. The results are shown in Figure 5.65 and Table 
5.10. 
 
The K545A and D551A mutations were found to act additively when combined in the 
rChbL enzyme. The Vmax of the rChbL double mutant was almost two-fold greater 
compared with the single rChbL mutants (see Table 5.10). The Km was slightly lower 
than the single rChbL mutants suggesting a greater affinity for the substrate.  The kcat 
and kcat/Km values were one to two orders of magnitude higher in the rChbL double 
mutant than the single rChbL mutants.   
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Fig 5.65: Kinetic analysis of the rChbL double mutant K545A D551A. The Chb 
activity assay was performed as per Section 2.26 over a range of substrate 
concentrations from 0 to 10 mM. The rate, V (mM PNP/min/mL enzyme), was plotted 
against substrate concentration (S). Experiment is representative of three individual 
experiments. Error bars represent the standard deviation of three replicates.  
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Table 5.9 Michaelis Menten and Hanes-Woolf values for the double mutant 
rChbL K545A D551A. 
Rate Constants Michaelis Menten Hanes-Woolf 
Vmax (μM)  11778   11601 
Km (mM)  0.18   0.05 
kcat (s
-1
)  1.17x10
8
  1.15x10
8
 
kcat/Km (mM
-1
.s
-1
) 6.48x10
8
  2.30x10
9 
SD (±)   0.0953   0.0953 
 
5.13.2 Characterisation of the properties of the rChbL double mutant K545A 
D551A. 
 
The effect of temperature and pH on the catalytic activity of the rChbL double mutant 
K45A D551A was examined using the Chb activity assay as outlined previously (see 
Section 2.26) and the results compared with those of the wild type rChbL and the 
single mutants K45A and D551A. 
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Fig 5.66: The effect of temperature on the catalytic activity of the rChbL double 
mutant K545A D551A. The Chb activity assay was performed as per Section 2.26 
over a range of different temperatures, from 4
o
C to 60
o
C. The rate, V (mM 
PNP/min/mL enzyme), was plotted against temperature (
o
C). Experiment is 
representative of three individual experiments. Error bars represent the standard 
deviation of three replicates.  
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Fig 5.67: The effect of pH on the catalytic activity of the rChbL double mutant 
K545A D551A compared with the rChbL enzyme. The Chb activity assay was 
performed as per Section 2.26 over a wide pH range, from 4.0 to 12.0. The rate, V 
(mM PNP/min/mL enzyme), was plotted against pH. Experiment is representative of 
three individual experiments. Error bars represent the standard deviation of three 
replicates.  
 
The temperature profile of the rChbL double mutant was similar to that of the rChbL 
single mutants in that there was no activity observed at 4
o
C and the rate of activity 
had greatly declined at 60
o
C (see Figure 5.66). The optimum rate of activity was 
observed at approximately 45
oC. It can be observed that the double mutants’ rate of 
activity was three times higher than the rChbL at its optimum temperature. The rChbL 
double mutant was also more stable than the rChbL at alkaline pH. The rate of activity 
only slightly declined at pH 9.0 and 10.0. The rate of activity was low at pH 12.0. The 
rChbL double mutants’ rate of activity was also lower at acidic pH. The optimum pH 
was 8.0.  
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Fig 5.68: Specificity of the rChbL double mutant K545A D551A. The Chb activity 
assay was performed as per Section 2.26 against a wide range of PNP-linked sugar 
substrates. The rate, V (mM PNP/min/mL enzyme), was plotted substrate 
concentration (S). Experiment is representative of three individual experiments. Error 
bars represent the standard deviation of three replicates.  
 
From Figure 5.68 it can be observed that the rChbL double mutant is specific for its 
substrate. There was only activity observed against β-GlcNAc, no activity was 
observed against any of the other substrates tested.  
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Fig 5.69: The inhibitory effect of free sugars on the rate of rChbL double mutant 
K545A D551A catalytic activity on PNP-GlcNAc. The Chb activity assay was 
performed as per Section 2.26 with PNP-GlcNAc. The K545A D551A double mutant 
enzyme was used at a concentration of 1 μg/mL and incubated with increasing 
concentrations of the inhibiting sugar for 30 minutes at 37
o
C prior to addition to the 
plate. The rate, V (mM PNP/min/mL enzyme), was plotted substrate concentration 
(S). Experiment is representative of three individual experiments. Error bars represent 
the standard deviation of three replicates.  
 
The rChbL double mutant was inhibited by the same sugars as the rChbL enzyme and 
rChbL single mutants (see Figure 5.69). GlcNAc and lactose free sugars largely 
inhibited the enzymes activity on its substrate while glucose and mannose also 
inhibited activity, however to a lesser degree. There was little to no inhibition 
observed with galactose, fucose and xylose. How the sugars inhibited catalytic 
activity was investigated in Figure 5.70.  
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Fig 5.70: Lineweaver-Burk plots of the inhibition occurring with the K545A rChbL mutant and a) GlcNAc, b) glucose, c) mannose and 
d) lactose. The Chb activity was performed as described in Section 2.26. Increasing concentrations of PNP-GlcNAc were incubated with a 
constant concentration of enzyme (1 μg/mL) and either 25 mM or 50 mM inhibiting sugar. The reciprocal rate of the reaction was plotted against 
the reciprocal of the substrate concentration. Experiment is representative of three individual experiments. Error bars represent the standard 
deviation of three replicates.  
a) b) 
c) d) 
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Table 5.10 Kinetic values describing the inhibition occurring between the rChbL 
double mutant K545A D551A-PNP-GlcNAc reaction and GlcNAc, glucose, 
mannose and lactose.  
   1/V intercept  Slope  
GlcNAc (No sugar) 0.002   0.1785 
GlcNAc (25 mM) 0.1631   0.4007 
GlcNAc (50 mM) 0.0194   2.0648 
Glucose (No sugar) 0.002   0.1785 
Glucose (25 mM) 0.1069   0.1724 
Glucose (50 mM) 0.1117   0.2425 
Mannose (No sugar) 0.002   0.1785 
Mannose (25 mM) 0.1394   0.342   
Mannose (50 mM) 0.173   0.3795 
Lactose (No sugar) 0.002   0.1785 
Lactose (25 mM) 0.2582   0.5681 
Lactose (50 mM) 0.536   0.8692 
 
The inhibition pattern produced by the different free sugars for the rChbL double 
mutant was similar to that of the rChbL single mutants (K545A and D551A). From 
Table 5.11 it can be observed that GlcNAc inhibited the catalytic reaction in a 
competitive fashion while the three other sugars (glucose, mannose and lactose) 
inhibited the reaction in a non-competitive manner. This was different to the original 
rChbL enzyme that was competitively inhibited by both GlcNac and mannose. 
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5.14 Discussion 
 
This chapter aimed to improve the binding ability of the rChb CBP thereby allowing it 
to successfully bind glycoproteins in an ELLA format. This aim was achieved through 
site-directed mutagenesis of residues around the binding pocket of the rChb CBP. 
Three of the mutations, W63A, D648A and W689Y, inhibited binding, suggesting an 
important structural role of these residues. Two of these mutations, K545A and 
D551A, improved the binding ability of the rChb CBP and when combined they 
worked additively to increase binding of rChb CBP to GlcNAc residues. Alongside 
this work, these mutations were also carried out on the rChbL enzyme, to investigate 
the role of these residues in the catalytic activity of the enzyme. While three of these 
mutations, W63A, D648A and W689Y, destroyed the catalytic activity from the 
rChbL enzyme, highlighting their importance in catalysis, two of the mutations, 
K545A D551A, increased the catalytic activity of the rChbL enzyme. When 
combined these mutations acted synergistically and again increased the catalytic 
activity of the rChbL enzyme.  
 
Previous studies (Tews et al., 1996) have investigated the structure of the S. 
marcescens chitobiase and proposed functions for certain residues proximal to the 
binding pocket and active site. While these residues were discovered to play a role in 
substrate binding and the problem being addressed in this chapter was the inability of 
the rChb CBP to bind glycoproteins, the issue with the rChb CBP was believed to be 
due to steric hindrance rather than a lack of substrate binding in the active site. The 
carbohydrate binding protein constructed in this study was initially an enzyme. 
Enzymes are extremely specific for their substrate, with the active site usually 
occupying a deep cleft in the protein structure (Mathews and van Holde, 1991). The 
position of the active site would not be an issue for chitobiose, the natural substrate of 
the chitobiase enzyme, as it is a small sugar composed of two N-acetylglucosamine 
residues. The difficulties arose however, when examining the binding of the rChb 
CBP to N-acetylglucosamine residues on glycoproteins. While the small chitobiose 
sugar is able to enter the deep crater, the N-acetylglucosamine residues are attached to 
a much larger glycoprotein which presumably inhibits binding of the GlcNAc 
residues. 
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Structural modelling of the active site/binding pocket suggested several over-hanging 
residues that may have been inhibiting binding to the N-acetylglucosamine residues 
on the glycoproteins. Alanine scanning was carried out on these residues. Alanine 
scanning is the most common method of mutagenesis to decipher the functional 
relevance of protein residues (Morrison and Weiss, 2001). The substitution of alanine 
in place of the residue of interest voids the side chain and thus the role of that 
particular residue can be deduced. Alanine substitutions allow the protein to retain its 
conformation and structural integrity unlike substitutions with another simple amino 
acid such as glycine, which could introduce flexibility into the structure (Morrison 
and Weiss, 2001; Cunningham and Wells, 1989). Cunningham and Wells (1989) 
carried out alanine scanning when looking at the binding between human growth 
hormone and its receptors on the human liver. Residues contained on portions of the 
protein proposed to be involved in receptor recognition were mutated to alanine. 
When a lower binding affinity was observed, the residues in question were identified 
as having a role in receptor recognition. A study investigating the functional residues 
in a protein kinase by Gibbs and Zoller (1991) also used the alanine scanning 
approach. They identified several charged amino acids in the catalytic site of the 
enzyme and subsequently mutated to them to alanine. The activity of the resultant 
mutants was tested and residues were proposed that may have a role in catalysis and 
substrate binding.   
 
This present study also used alanine scanning mutagenesis, however, rather than using 
alanine substitution to study the functional relevance of the residues in question, 
alanine was substituted as it is a small amino acid that allows the protein to retain its 
structure (Morrison and Weiss, 2001). As previously mentioned in the introduction, 
the structure and function of an enzyme are intrinsically linked. The mutagenesis of 
any residue has the risk of altering the structure of the enzyme and rendering it 
inactive. All mutations were carried out on residues proximal to the active site. 
Alanine was chosen to minimise structural alteration and preserve the active site.   
 
The expression and purification of both the rChbL enzyme mutants and the rChb CBP 
mutants did not greatly vary from that of the native rChbL enzyme. All mutant 
proteins were still expressed to the culture media, appearing two hours post-induction. 
Purification was carried out in the same manner as the rChbL. The mutant proteins 
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were also buffer-exchanged using FPLC rather than centrifugal concentrators 
(vivaspins). This was because of the low protein yields obtained for the native rChbL, 
due to its binding to the cellulose membrane. Similar yields of recombinant protein 
were obtained for all mutants in comparison with the native rChbL.  
 
The initial aim of this chapter was the mutagenesis of the rChb CBP to generate a 
protein capable of binding glycoproteins in the ELLA format. Through site-specific 
mutagenesis the following mutations were made: W63A, K545A, D551A, D648A and 
W689Y. From Figure 5.9 it can be seen that these mutations successfully opened up 
the active site, however there were a variety of consequences. Mutants W63A, D648A 
and W689Y did not increase the binding between the rChb CBP and GlcNAc, 
whether it was on a glycoprotein or in the BSA-conjugated format. However, while 
mutants K545A and D551A only showed a slight increase in their ability to bind 
GlcNAc on glycoproteins, there was double the signal observed when they were 
tested against BSA-GlcNAc. An increased signal was also observed when they were 
tested against bovine mucin. When these mutations were combined in the double 
mutant K545A D551A they worked in an additive fashion and the signals observed 
from the rChb CBP when tested against BSA-GlcNAc and bovine mucin were 
increased again, this time the signal received against BSA-GlcNAc was three times 
higher than that observed for the rChb CBP. Disappointingly, binding to GlcNAc on 
glycoproteins was not greatly enhanced. It was thought that the high level display of 
GlcNAc on the BSA-conjugate boosted the signal from the rChb CBP mutants. The 
glycans present on bovine mucin are O-linked. While N-linked glycans tend to have 
branched structures, such as bi-antennary and tri-antennary structures, the terminal 
ends of O-linked glycans are primarily non-branched. This may be the reason the 
rChb CBP mutants were capable of binding to the bovine mucin and not the N-linked 
glycoproteins. The bi-antennary structure of the asialo agalacto fetuin glycoprotein 
may have inhibited binding. The high signal obtained from GSLII is because it is a 
dimeric protein compared to the monomeric rChb CBP. Increasing the valency of the 
rChbL may improve its affinity for GlcNAc substrates. Green fluorescent protein 
(GFP) is a dimeric protein. Fusion to this protein may increase the binding of the rChb 
CBP to GlcNAc residues by allowing it to work as a dimer. However, the mutations 
have shown however that there is the possibility of turning this rChb CBP into a lectin 
for glycoprotein analysis with further mutagenesis. 
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Mutant K545A removed a lysine from the binding pocket of the rChb CBP. This 
lysine molecule is susceptible to the addition of a biotin molecule during 
biotinylation. The presence of a biotin in this position was proposed to cause 
interference with binding. Removal of this lysine meant removal of the potential for 
the acceptance of a biotin molecule in this position within the binding pocket. It was 
hypothesized that mutation of K545 also increased the space in the binding pocket, 
allowing the glycoprotein more room. D551 is directly above K545 and mutation of 
this residue was also hypothesized to increase the space in the active site. As this 
residue was protruding over the binding pocket it may have been hindering binding of 
the glycoprotein. Mutagenesis of this residue removed this interference. While the 
mutations improved the binding abilities of the rChb CBP they were still insufficient 
in producing a carbohydrate binding protein for the analysis of glycoproteins. 
However, this study shows the potential of the generation of new carbohydrate 
binding proteins through the mutagenesis of enzymes.  
 
In a review on enzyme design by Toscano et al., (2007), they state that “enzyme 
active sites provide highly optimized microenvironments for the catalysis of 
biologically useful chemical transformations. Consequently, changes at these centres 
can have large effects on enzyme activity.” The mutations carried out on the rChbL 
enzyme were all proximal to the active site and confirmed this statement. The 
mutations caused relatively large changes in the catalytic activity of the enzyme to be 
observed. Mutations W63A, D648A and W689Y caused a considerable decrease in 
catalytic activity. These mutations succeeded in opening the active site of the enzyme. 
This was the aim for the carbohydrate binding protein but obviously this was 
detrimental for the catalytic activity of the rChbL mutant enzymes. It was 
hypothesized that mutation of residues, W63A and D648A, disrupted the active site 
conformation in some way causing the enzyme to lose activity. The tryptophan at 
position 689 functions in holding the chitobiose substrate in position during catalysis. 
Mutation of this residue to a tyrosine did not allow it to carry out its function. While it 
was hypothesized that mutation of this residue to tyrosine may open up the binding 
pocket while still providing the same support to the substrate due to the tyrosine ring 
structure, this was not the case. These mutations reduced catalytic activity by 
decreasing the velocity (Vmax) of the rChbL enzyme while also decreasing its affinity 
 261 
for its substrate. As the rate of catalytic activity was so low it was difficult to assess 
their specificity, temperature and pH tolerance.   
 
While mutations to residues W63A, D648A and W689Y on the rChbL enzyme had 
detrimental effects on catalytic activity, the opposite was the case for mutations to 
residues K545A and D551A. Their changes to the structure of the active site were 
obviously not deleterious. The lysine at position 545 covers the catalytically important 
residues, D539 and E540. By substituting the lysine for an alanine the catalytic 
residues may have been more accessible for the substrate. This was confirmed as the 
Km of the rChbL mutant was decreased compared with the native rChbL. The mutant 
had a higher affinity for its substrate. The velocity, turnover number and specificity 
were also increased.  
 
The aspartic acid at position 551 was protruding over the active site. It was directly 
above residue K545. By mutating this residue to a smaller alanine residue it was again 
believed that it was easier for the substrate to reach the catalytic residues. This was 
confirmed by the reduction in Km and increase in Vmax. The velocity of the mutant 
rChbL was increased, while the affinity for the substrate was also increased. The 
turnover number and specificity of the mutant enzyme were also increased. When 
combining advantageous mutations the outcome is not necessarily also advantageous. 
Situations can arise where the advantageous effects are inhibited; if the mutations are 
in direct or indirect contact with one another or if one of the mutations causes a 
change in the mechanism of the reaction (Wells, 1990). However, in this case the 
combination of mutations K545A and D551A had an additive effect on the rate of 
catalytic activity of the rChbL enzyme. The velocity of the double mutant was almost 
double that of the single mutants while the affinity for its substrate was also increased. 
The turnover number and specificity were also increased.    
 
In 2005, Morley and Kazlauskas examined the relationship between the distance of a 
mutation to the active site of an enzyme and the improvement of certain properties 
including selectivity, catalytic activity and thermal stability. They revealed that 
mutations closer to the active site of the enzyme were often more advantageous in 
increasing the specificity of the enzyme than those further away. Otten et al., (2004) 
discovered that an aspargine at position 266, which was 7.1Å from the active site, was 
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critical for substrate specificity. Similarly, Cheon et al., (2004) discovered that the 
site-specific mutation of a phenylalanine at position 159 (11.3Å from the active site) 
increased substrate specificity 200-fold. This was also the case for the rChbL enzyme 
mutants, K545A, D551A and the double mutant K545A D551A. The specificity of 
the enzyme is measured by kcat/Km (Hedstrom, 2001). This figure was increased from 
a magnitude of 10
5
 to 10
7
-10
8
. When examining the relationship between the distance 
of the mutation from the active site and properties such as an increased catalytic rate 
and increased thermal stability, Morley and Kazlauskas (2005) concluded that there 
was no relationship between the distance of the mutation from the active site and an 
improvement in these characteristics. Many studies reported increases in activity 
when residues close to the active site were mutated such as Ducros et al., (2003) who 
recorded a 35-fold increase in catalytic activity when they mutated a glutamic acid 9Å 
from the active site. Alternatively however, many other studies reported increases in 
catalytic activity from mutations at a much greater distance from the active site such 
as Whittle and Shanklin (2001) who mutated a histidine 19Å from the active site and 
recorded a 31-fold increase in activity. This study reported an increased catalytic rate 
when residues close to the active site were mutated.  
 
Interestingly, the mutations that increased catalytic activity (K545A and D551A) also 
increased the pH stability of the mutant rChbL enzyme in comparison with the 
wildtype. The single mutants and double mutant were more stable at pH 9.0 and 10.0 
than the native rChbL, only losing activity at pH 12.0. The advantageous mutations 
were made to residues in the active site. Two charged residues, a lysine (545) and an 
aspartic acid (551) were mutated to the uncharged amino acid, alanine. This may have 
altered the charge of the catalytic environment, increasing the positive charge in the 
active site. This difference in charge may have affected the breakdown of the PNP-
GlcNAc substrate in some way. The increase in activity at more alkaline pH may also 
be due to the general increase in catalysis.  
 
The mutants K545A, D551A and the double mutant K545A D551A were all inhibited 
by the same free sugars as the original rChbL. N-acetylglucosamine (GlcNAc), 
glucose, mannose and lactose all inhibited the catalytic reaction between the rChbL 
mutants and the PNP-GlcNAc substrate. However the mechanism in which they 
inhibited the reaction was different in certain cases. Again, GlcNAc inhibited all 
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reactions in a competitive manner, the GlcNAc sugar bound in the active site 
occupying the place of the PNP-GlcNAc substrate. Lactose also inhibited the catalytic 
reaction in the same non-competitive manner. However, mannose switched from a 
competitive inhibitor to a non-competitive inhibitor. It was believed that the changes 
to the binding pocket did not allow the binding of mannose. It no longer accepted the 
structural variation of the axial –OH at C-2 that mannose contains rather than the 
equatorial N-acetyl group that N-acetylglucosamine contains. Glucose was found to 
inhibit the rChbL enzyme in a non-competitive manner rather than an un-competitive 
manner. Previous studies have shown mutagenesis of glycosidases changing the 
specificity of the enzyme. In a study by Corbett et al., (2001) it was reported that site-
directed mutagenesis altered the binding specificity of a β-glycosidase from 
Sulfolobus solfataricus. A single mutation (M439C) led to enhanced activity on 
xylose substrates while activity on fucose substrates was decreased. The activity on 
glucose substrates was not impaired by this mutation. Mutagenesis of the rChbL 
enzyme did not alter the specificity of the enzyme; it still only catalysed the cleavage 
of PNP-GlcNAc. However, the inhibition study implied that the rChbL mutants were 
more specific than the original rChbL due to the fact that only GlcNAc was able to 
competitively inhibit the catalytic reaction. No other sugars were able to enter the 
active site. This result was supported by the fact (previously mentioned) that the 
mutants had an increased specificity for the PNP-GlcNAc substrate as highlighted by 
an increase in kcat/Km values.   
 
The work described in this chapter was successful in creating new rChbL enzyme 
mutants and rChb CBP mutants. The changes to the binding abilities of the rChb CBP 
mutants were insufficient for them to be used as a carbohydrate binding protein for 
glycoanalysis, however they did show potential for further development of these rChb 
CBP mutants. Perhaps further mutagenesis would increase the binding potential. The 
increases in catalytic activity of the rChbL enzyme mutants and increased stability at 
higher pH make them promising candidates as commercial biocatalysts. This will be 
discussed further in the final discussion. 
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Chapter 6 
 
Interactions with Chitin
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6.1 Overview 
 
Hydrolysis of the synthetic substrate PNP-GlcNAc allowed the study of the kinetics 
of the rChbL enzyme and its mutants. However, this substrate does not reflect the 
activity of the rChbL in its natural environment. The natural substrate of rChbL is 
chitobiose, a dimer of GlcNAc, which is a major product of chitin degradation. There 
are two main forms of chitin found in nature: α- and β-chitin (Rinaudo, 2006). 
Deacetylation of chitin results in the polymer chitosan. Various forms of chitosan 
exist that simply differ in the degree of deacetylation. Cellulose is a similar 
polysaccharide consisting of β1-4 linked D-glucose units. These polysaccharides 
differ at the C-2 position where chitin has an N-acetyl group and cellulose does not 
(Dutta et al., 2004). Insoluble substrate assays were utilized to examine the 
interactions between the rChbL enzyme, CBP and these polysaccharides.  
 
The second aim of this chapter was to investigate the interaction of various length 
chito-oligosaccharides with the rChbL enzyme. Firstly, the ability of each chito-
oligosaccharide to inhibit the rChbL-PNP-GlcNAc reaction was examined to 
determine the preference of rChbL for each chito-oligosaccharide (see Section 6.4). 
The breakdown of these chito-oligosaccharides to GlcNAc by rChbL was then 
investigated using High Performance Liquid Chromatography (HPLC) and will be 
further explained in Section 6.5.  
 
6.2 rChbL Insoluble Substrate Assays  
 
The rChbL insoluble substrate assays were carried out at 4
o
C to minimise the 
occurrence of catalytic activity (see Figure 3.23). The aim was to study the interaction 
between the enzyme and various insoluble substrates, not its catalytic activity on the 
insoluble substrates. The assays were carried out as described in Section 2.29.1, 
analysed by SDS-PAGE (see Section 2.21) and silver stained to visualise the results 
(see Table 2.6). Briefly once rChbL was mixed with each substrate the levels of 
unbound protein in the culture media were monitored. The rChbL enzyme and all 
rChbL enzyme mutants were tested against α-chitin, β-chitin, chitosan and cellulose.  
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a)    b)     
    
Fig 6.1: Insoluble substrate assay using the rChbL enzyme with a) α-chitin, b) β-
chitin, c) chitosan and d) cellulose. The rChbL enzyme sample was continuously 
mixed with the substrate and samples were taken at various time-points as described 
in Section 2.29.1. The samples were analysed on SDS-PAGE (see Section 2.21) and 
visualised using silver nitrate staining (see Table 2.6). Lane 1, Protein Ladder; Lane 2, 
rChbL sample; Lane 3, 5 minutes incubation; Lane 4, 15 minutes incubation; Lane 5, 
30 minutes incubation; Lane 6, 1 hour incubation.  
 
 
 
 
 
 
 
 
c) d) 
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   a)            b)             c) 
    
Fig 6.2: Interactions between the rChbL mutants and α-chitin; a) W63A, b) 
K545A, c) D551A, d) D648A, e) W689Y and f) K545A D551A. The rChbL mutant 
enzyme samples were continuously mixed with the α-chitin substrate and samples 
were taken at various time-points as described in Section 2.29.1. The samples were 
analysed by SDS-PAGE (see Section 2.21) and visualised using silver nitrate staining 
(see Table 2.6). Lane 1, Protein Ladder; Lane 2, rChbL sample; Lane 3, 5 minutes 
incubation; Lane 4, 15 minutes incubation; Lane 5, 30 minutes incubation; Lane 6, 1 
hour incubation. 
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a)            b)                                          c) 
 
Fig 6.3: Interactions between the rChbL mutants and β-chitin; a) W63A, b) 
K545A, c) D551A, d) D648A, e) W689Y and f) K545A D551A. The rChbL mutant 
enzyme samples were continuously mixed with the β-chitin substrate and samples 
were taken at various time-points as described in Section 2.29.1. The samples were 
analysed by SDS-PAGE (see Section 2.21) and visualised using silver nitrate staining 
(see Table 2.6). Lane 1, Protein Ladder; Lane 2, rChbL sample; Lane 3, 5 minutes 
incubation; Lane 4, 15 minutes incubation; Lane 5, 30 minutes incubation; Lane 6, 1 
hour incubation. 
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    a)          b)            c) 
 
 
Fig 6.4: Interactions between the rChbL mutants and chitosan; a) W63A, b) 
K545A, c) D551A, d) D648A, e) W689Y and f) K545A D551A. The rChbL mutant 
enzyme samples were continuously mixed with the chitosan substrate and samples 
were taken at various time-points as described in Section 2.29.1. The samples were 
analysed by SDS-PAGE (see Section 2.21) and visualised using silver nitrate staining 
(see Table 2.6). Lane 1, Protein Ladder; Lane 2, rChbL sample; Lane 3, 5 minutes 
incubation; Lane 4, 15 minutes incubation; Lane 5, 30 minutes incubation; Lane 6, 1 
hour incubation. 
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    a)         b)            c) 
 
Fig 6.5: Interactions between the rChbL mutants and cellulose; a) W63A, b) 
K545A, c) D551A, d) D648A, e) W689Y and f) K545A D551A. The rChbL mutant 
enzyme samples were continuously mixed with the cellulose substrate and samples 
were taken at various time-points as described in Section 2.29.1. The samples were 
analysed by SDS-PAGE (see Section 2.21) and visualised using silver nitrate staining 
(see Table 2.6). Lane 1, Protein Ladder; Lane 2, rChbL sample; Lane 3, 5 minutes 
incubation; Lane 4, 15 minutes incubation; Lane 5, 30 minutes incubation; Lane 6, 1 
hour incubation. 
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Table 6.1 Summary of the interactions between the rChbL enzyme and rChbL 
enzyme mutants with α-chitin, β-chitin, chitosan and cellulose.  
    α-Chitin β-Chitin Chitosan Cellulose 
rChbL        √      x      x      x 
W63A        √      x      x      x 
K545A       √          x      x      x 
D551A       √      x      x      x 
D648A       √      x      x      x 
W689Y       √      √      x      x 
K545A D551A      √      x      x      x 
 
The rChbL enzyme bound to α-chitin with a high affinity (see Figure 6.1). All rChbL 
was bound to α-chitin after five minutes. There was possibly binding to β-chitin 
occurring, although to a very small degree compared with α-chitin. Binding to 
chitosan by the rChbL was not observed. Binding to cellulose was also not observed.  
 
Binding to α-chitin was observed for all rChbL mutants (see Figure 6.2). The lowest 
affinity was observed for the W689Y mutant.  The affinity of the rest of the mutants 
for α-chitin was similar to the native rChbL enzyme. The rChbL mutant W689Y 
bound to β-chitin with a relatively high affinity (see Figure 6.3). The majority of the 
W689Y mutant enzyme was bound after 5 minutes. There was possibly a small 
amount of binding to β-chitin observed for all the other rChbL mutants, but to a much 
lesser extent, similar to that of the native rChbL. It can be observed from Figures 6.4 
and 6.5 that there was no binding to chitosan or cellulose occurring for any of the 
rChbL mutants. The amount of rChbL mutant enzyme present was similar at all time-
points. This was similar to the native rChbL enzyme. 
 
 6.3 rChb CBP Insoluble Substrate Assays 
 
The insoluble substrate assays were repeated using the catalytically inactive rChb 
CBP. In this instance the reactions were allowed to proceed at the optimum 
temperature of 45°C (see Figure 3.23). It was expected that the enzyme, rChbL, and 
carbohydrate binding protein, rChb CBP, should have the same binding pattern and 
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the temperature difference between both sets of experiments could be used to examine 
binding at both high and low temperatures, as well as the speed of the reactions. Low 
affinity binding would occur more slowly at 4°C and may be overlooked during 
assays carried out at the optimum temperature of 45°C. The assays were carried out as 
described in Section 2.29.2, and unbound protein samples was analysed by SDS-
PAGE (see Section 2.21). Silver staining was used to visualise the results (see Table 
2.6). rChb CBP and all of the rChb CBP mutants were tested against the various 
insoluble substrates, as above.  
 
a)      b)     
   
Fig 6.6: Interactions between the rChb CBP with a) α-chitin, b) β-chitin, c) 
chitosan and d) cellulose. The rChb CBP sample was continuously mixed with the 
substrate and samples were taken at various time-points as described in Section 
2.29.2. The samples were analysed by SDS-PAGE (see Section 2.21) and visualised 
using silver nitrate staining (see Table 2.6). Lane 1, Protein Ladder; Lane 2, rChbL 
sample; Lane 3, 5 minutes incubation; Lane 4, 15 minutes incubation; Lane 5, 30 
minutes incubation; Lane 6, 1 hour incubation. 
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   a)     b)         c) 
 
Fig 6.7: Interactions between the rChb CBP mutants and α-chitin; a) W63A, b) 
K545A, c) D551A, d) D648A, e) W689Y and f) K545A D551A. The rChbL CBP 
mutant samples were continuously mixed with the α-chitin substrate and samples 
were taken at various time-points as described in Section 2.29.1. The samples were 
analysed by SDS-PAGE (see Section 2.21) and visualised using silver nitrate staining 
(see Table 2.6). Lane 1, Protein Ladder; Lane 2, rChbL sample; Lane 3, 5 minutes 
incubation; Lane 4, 15 minutes incubation; Lane 5, 30 minutes incubation; Lane 6, 1 
hour incubation. 
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     a)          b)          c) 
      
Fig 6.8: Interactions between the rChb CBP mutants and β-chitin; a) W63A, b) 
K545A, c) D551A, d) D648A, e) W689Y and f) K545A D551A. The rChbL CBP 
mutant samples were continuously mixed with the β-chitin substrate and samples 
were taken at various time-points as described in Section 2.29.1. The samples were 
analysed on SDS-PAGE (see Section 2.21) and visualised using silver nitrate staining 
(see Table 2.6). Lane 1, Protein Ladder; Lane 2, rChbL sample; Lane 3, 5 minutes 
incubation; Lane 4, 15 minutes incubation; Lane 5, 30 minutes incubation; Lane 6, 1 
hour incubation. 
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   a)        b)          c) 
   
Fig 6.9: Interactions between the rChb CBP mutants and chitosan; a) W63A, b) 
K545A, c) D551A, d) D648A, e) W689Y and f) K545A D551A. The rChbL CBP 
mutant samples were continuously mixed with the chitosan substrate and samples 
were taken at various time-points as described in Section 2.29.1. The samples were 
analysed by SDS-PAGE (see Section 2.21) and visualised using silver nitrate staining 
(see Table 2.6). Lane 1, Protein Ladder; Lane 2, rChb CBP sample; Lane 3, 5 minutes 
incubation; Lane 4, 15 minutes incubation; Lane 5, 30 minutes incubation; Lane 6, 1 
hour incubation. 
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a)       b)         c) 
 
Fig 6.10: Interactions between the rChb CBP mutants and cellulose; a) W63A, b) 
K545A, c) D551A, d) D648A, e) W689Y and f) K545A D551A. The rChbL CBP 
mutant samples were continuously mixed with the cellulose substrate and samples 
were taken at various time-points as described in Section 2.29.1. The samples were 
analysed on SDS-PAGE (see Section 2.21) and visualised using silver nitrate staining 
(see Table 2.6). Lane 1, Protein Ladder; Lane 2, rChbL sample; Lane 3, 5 minutes 
incubation; Lane 4, 15 minutes incubation; Lane 5, 30 minutes incubation; Lane 6, 1 
hour incubation. 
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Table 6.2 Summary of the interactions between the rChb CBP and rChb CBP 
mutants with α-chitin, β-chitin, chitosan and cellulose.  
    α-Chitin β-Chitin Chitosan Cellulose 
rChb CBP       √      √      √         √ 
W63A        √      √      √      √ 
K545A       √      √      √      √ 
D551A       √      √      √      √ 
D648A       √      √      √      √ 
W689Y       √      √      √      √ 
K545A D551A      √      √      √      √ 
 
Figure 6.6 demonstrates the effect temperature played on the binding capabilities of 
the rChbL protein. Here the rChb CBP was tested at 45
o
C and the binding patterns 
against the insoluble substrates observed were slightly different to those of the rChbL 
enzyme (see Figure 6.1). The rChb CBP was again observed to bind to α-chitin with 
high specificity, all the protein was bound to the insoluble substrate after 5 minutes. 
Definite binding to β-chitin was observed for the rChb CBP. Binding to chitosan and 
cellulose was observed, in contrast with the rChbL enzyme. 
 
Binding to α-chitin was observed for all the rChb CBP mutants (see Figure 6.7). It 
was observed that each rChb CBP mutant bound to α-chitin with a similar affinity. All 
CBP was bound to the insoluble substrate after 5 minutes. 
 
Figure 6.8 demonstrates that the rChb CBP mutants bound to β-chitin with a high 
affinity, there was no protein remaining in the culture media following 5 minutes of 
incubation. Binding to chitosan was observed for all the rChb CBP mutants, although 
to different extents. The highest affinity was observed for mutants D648A and 
W689Y, followed by K54A D551A. The remaining mutants had similar levels of 
affinity with almost no unbound protein detectable following 1 hour of incubation 
(see Figure 6.9). Figure 6.10 demonstrates the ability of the rChb CBP to also bind 
cellulose, in contrast with the native rChbL and the mutant enzymes. All rChb CBPs 
had the ability to bind cellulose, W689Y with the highest affinity.  The W689Y 
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mutant had no unbound protein detectable following 5 mins of incubation at 37°C. 
D551A appeared to have the lowest affinity for cellulose.  
 
6.4 Investigation into the inhibitory effects of the various length 
chito-oligosaccharides on rChbL catalytic activity 
 
Section 6.3 examined the specificity of the chitobiase against the bulky chitin, 
chitosan and cellulose substrates and concluded that the rChbL had the highest 
affinity for α-chitin. This section looks more closely at the specificity of the rChbL 
enzyme and the active rChbL mutants by examining the effect of shorter chitin chains, 
known as chito-oligosaccharides, on rChbL activity. Chito-oligosaccharides produced 
by the depolymerisation of chitin were used in this study. Various length chito-
oligosaccharides were used; chitobiose (2 GlcNAc residues), chitotriose (3), 
chitotetraose (4), chitopentaose (5), chitohexaose (6) and chitoheptaose (7). The 
inhibitory effect of each chito-oligosaccharide on the native rChbL enzyme and 
rChbL mutant enzymes catalytic activity was examined (see Figure 6.11).  
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Fig 6.11: Inhibition of the rChbL and rChbL mutants’ catalytic activity on PNP 
GlcNAc by various length chito-oligosaccharides. The Chb activity assay was 
carried out as described in Section 2.26. 1 μg/mL of enzyme was incubated with 10 
mM of various length chito-oligosaccharides at 37
o
C for 30 minutes before addition to 
the plate. The rate, V (mM PNP released/min/mL enzyme), of the reaction was 
plotted. Experiment is representative of three individual experiments. Error bars 
represent the standard deviation of three replicates.  
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Figure 6.11 demonstrates that all chito-oligosaccharides examined were able to 
significantly inhibit rChbL catalytic activity. The inhibition observed for each of the 
chito-oligosaccharides was relatively similar to one another. The native rChbL was 
inhibited by all chito-oligosaccharides tested. The highest level of inhibition was 
observed with chitobiose and the lowest level of inhibition was observed with 
chitoheptaose, however these values were relatively similar. The rChbL mutant 
enzymes followed a similar inhibition pattern. The highest level of inhibition for the 
K545A, D551A and K545A D551A mutants was observed with chitobiose, similarly 
to the native rChbL. The least inhibition for all the mutants was, again, observed with 
chitoheptaose. However, all signals were relatively similar indicating that the rChbL 
mutants were also inhibited by all the various length chito-oligosaccharides examined.  
These chito-oligosaccharides were potent inhibitors of rChbL activity; even when 
used at the low concentration of 10 mM, they reduced catalytic activity by over 90%.  
 
6.5 Analysis of the breakdown of various length chito-
oligosaccharides using High Performance Liquid Chromatography 
(HPLC) 
 
The hydrolysis of various length chito-oligosaccharides by the rChbL enzyme was 
analyzed using High Performance Liquid Chromatography (HPLC). A C-18 silica 
reversed phase monolith column was used. C-18 is an octadecyl carbon chain bonded 
silica which makes the stationary phase hydrophobic. The mobile phase used 
(ammonium acetate) was polar and therefore the hydrophobic stationary phase 
allowed hydrophobic molecules to adsorb to the column. While sugars are generally 
hydrophilic, they do possess hydrophobic residues such as valine, leucine and proline. 
The ring structures of tryptophan, phenylalanine and tyrosine are also hydrophobic. 
These residues can give the sugar hydrophobic areas which presumably bound to the 
column. The sugar molecules were eluted by increasing the concentration of organic 
non-polar solvent (acetonitrile) in the mobile phase. Standards used were N-
acetylglucosamine, chitobiose and chitohexaose. The hydrolysis of the chito-
oligosaccharides was carried out as described in Section 2.30.2. Sugars are difficult to 
detect and need to be derivatised to add UV absorptive groups to their structure. 
Anthranillic acid was chosen for this purpose. It labels the sugars with secondary 
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amines (UV-absorbing groups) through reductive amination. All samples and 
standards had to be derivatised prior to addition to the column. They were labelled 
with the use of anthranillic acid as described in Section 2.30.3. HPLC analysis was 
carried out as described in Section 2.30.1. 
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6.5.1 Optimisation of HPLC separation conditions 
 
Conditions for the separation of the various length sugars had to be optimised. The 
gradient of polar mobile phase to organic solvent was optimised to ensure a good 
resolution of each sugar (see Figure 6.12). The separation was run multiple times to 
ensure uniform elution of the sugars (see Table 6.3). The wavelength at which the 
highest signal for each sugar was obtained was determined (see Figure 6.13). The 
optimal volume of sugar sample to inject on the column was also ascertained (see 
Figure 6.14). Finally a standard curve of GlcNAc concentration was obtained for the 
quantification of chito-oligosaccharide hydrolysis to GlcNAc by the rChbL enzyme 
(see Figure 6.15). 
 
a)       b) 
                                             
Fig 6.12: Optimised gradient for separation of GlcNAc, chitobiose and 
chitohexaose. The separation was run as described in Section 2.30. The gradient of 
polar mobile phase to organic solvent was adjusted. Various run-times and 
concentrations were examined.  
 
Various run lengths and concentration gradients of mobile phases were used to ensure 
optimal separation of the sugars. Mobile phase A was sodium acetate while mobile 
phase B was the organic solvent, acetonitrile. GlcNAc was always resolved from the 
other sugars, however it was difficult to resolve the chitobiose and longer length 
chito-oligosaccharides. Figure 6.12 shows the separation of the GlcNAc, chitobiose 
and chitohexaose sugars. The separation of chitobiose and all the other length sugars 
was almost identical. Timing did not permit a separation to be optimised that 
separated out each sugar. The gradient program chosen was: 0-12 minutes (2% 
GlcNAc 
GlcNAc 
Biose 
Hexaose 
Biose 
Hexaose 
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Mobile phase B), 12-27 minutes (2-10% Mobile phase B), 27-35 minutes (10-2% 
Mobile phase B) and 35-40 minutes (2% Mobile phase B). It showed the optimum 
resolution between the three sugars.  
 
Table 6.3 Retention times of the various sugars on multiple runs showing 
consistent separations. 
Separation Deriv. Agent  GlcNAc Chitobiose Chitohexaose 
1  19.336   26.449  30.507  31.827  
2  19.333   26.470  30.580  31.907 
3  19.432   26.553  30.616  31.922 
4  19.399   26.542  30.611  31.922 
5  19.342   26.547  30.488  31.656 
6  19.200   26.158  30.195  31.486 
7  19.179   25.883  29.938  31.221 
8  19.234   25.948  29.967  31.189 
9  19.176   25.773  29.721  30.956 
10  19.158   25.642  29.562  30.785 
 
The retention times of the sugars were shown to be uniform over multiple runs. The 
standard deviation of the GlcNAc retention time was calculated to be 0.358424, while 
the standard deviation of chitobiose was 0.397155 and chitohexaose was 0.481977.  
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Fig 6.13: Optimisation of the wavelength used for the separation of sugars. The 
separation was run as described in Section 2.30 at various wavelengths; 230 nm, 240 
nm, 250 nm, 260 nm, 270 nm and 280 nm.  
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Fig 6.14: Optimisation of the injection volume used for the separation of sugars. 
The separation was run as described in Section 2.30 Increasing injection volumes 
were applied; 1μL, 2μL, 3μL and 4μL.  
 
The optimal wavelength for detection of the sugars was determined to be 240nm (see 
Figure 6.14) while detection of the sugars after a 3 μL and 4 μL injection were 
relatively similar. A 3 μL injection was chosen as 4 μL caused the peaks to slightly 
shift. 
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Fig 6.15: GlcNAc standard curve. Increasing concentrations of GlcNAc (from 0 to 
10 mM) were derivatised as described in Section 2.30.3 and then analysed as 
described in Section 2.30. 
 
6.5.2 Examination of the hydrolysis of chito-oligosaccharides by the rChbL 
enzyme 
 
As the insoluble substrate binding and chito-oligosaccharide inhibition profiles of the 
rChbL enzyme and rChbL enzyme mutants were found to be similar (see Section 6.2), 
only the study of the hydrolysis of chito-oligosaccharides by the native rChbL enzyme 
was deemed necessary. The hydrolysis of these chito-oligosaccharides to GlcNAc was 
examined. The hydrolysis of chitobiose, chitotriose, chitotetraose, chitopentaose, 
chitohexaose and chitoheptaose by the rChbL enzyme over various time-points was 
carried out as described in Section 2.30.2. The samples were then derivatised as 
described in Section 2.30.3 and were separated via HPLC as described in Section 
2.30. The results are shown in Figures 6.16 to 6.21 and Table 6.4. 
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a)           b) 
 
c)           d) 
 
Fig 6.16: HPLC analysis of the hydrolysis of chitobiose by the rChbL enzyme 
over a time-course. a) No rChbL, b) 1 hour incubation with rChbL, c) 3 hours 
incubation with rChbL and d) 24 hours incubation with rChbL. The hydrolysis of 
chitobiose was carried out as described in Section 2.30.2 and the resultant samples 
were derivatised as described in Section 2.30.3. The samples were then run as 
described in Section 2.30. The peaks were identified by the separation shown in 
Figure 6.12 and the amount of GlcNAc released was calculated using the standard 
curve generated in Figure 6.15.  
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a)                                                                 b) 
 
c)               d) 
 
Fig 6.17: HPLC analysis of the hydrolysis of chitotriose by the rChbL enzyme 
over a time-course. a) No rChbL, b) 1 hour incubation with rChbL, c) 3 hours 
incubation with rChbL and d) 24 hours incubation with rChbL. The hydrolysis of 
chitotriose was carried out as described in Section 2.30.2 and the resultant samples 
were derivatised as described in Section 2.30.3. The samples were then run as 
described in Section 2.30. The peaks were identified by the separation shown in 
Figure 6.12 and the amount of GlcNAc released was calculated using the standard 
curve generated in Figure 6.15.  
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a)                                                                 b) 
      
c)             d)                                                     
 
Fig 6.18: HPLC analysis of the hydrolysis of chitotetraose by the rChbL enzyme 
over a time-course. a) No rChbL, b) 1 hour incubation with rChbL, c) 3 hours 
incubation with rChbL and d) 24 hours incubation with rChbL. The hydrolysis of 
chitotetraose was carried out as described in Section 2.30.2 and the resultant samples 
were derivatised as described in Section 2.30.3. The samples were then run as 
described in Section 2.30. The peaks were identified by the separation shown in 
Figure 6.12 and the amount of GlcNAc released was calculated using the standard 
curve generated in Figure 6.15.  
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a)                                                                b) 
 
c)             d) 
 
Fig 6.19: HPLC analysis of the hydrolysis of chitopentaose by the rChbL enzyme 
over a time-course. a) No rChbL, b) 1 hour incubation with rChbL, c) 3 hours 
incubation with rChbL and d) 24 hours incubation with rChbL. The hydrolysis of 
chitopentaose was carried out as described in Section 2.30.2 and the resultant samples 
were derivatised as described in Section 2.30.3. The samples were then run as 
described in Section 2.30. The peaks were identified by the separation shown in 
Figure 6.12 and the amount of GlcNAc released was calculated using the standard 
curve generated in Figure 6.15.  
 
 
 
 
 
 
 
GlcNAc 
GlcNAc 
GlcNAc 
GlcNAc 
Pentaose 
Pentaose Pentaose 
Pentaose 
 289 
a)                                                                b) 
 
c)             d) 
 
Fig 6.20: HPLC analysis of the hydrolysis of chitohexaose by the rChbL enzyme 
over a time-course. a) No rChbL, b) 1 hour incubation with rChbL, c) 3 hours 
incubation with rChbL and d) 24 hours incubation with rChbL. The hydrolysis of 
chitohexaose was carried out as described in Section 2.30.2 and the resultant samples 
were derivatised as described in Section 2.30.3. The samples were then run as 
described in Section 2.30. The peaks were identified by the separation shown in 
Figure 6.12 and the amount of GlcNAc released was calculated using the standard 
curve generated in Figure 6.15.  
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a)                                                                 b) 
 
c)             d) 
 
Fig 6.21: HPLC analysis of the hydrolysis of chitoheptaose by the rChbL enzyme 
over a time-course. a) No rChbL, b) 1 hour incubation with rChbL, c) 3 hours 
incubation with rChbL and d) 24 hours incubation with rChbL. The hydrolysis of 
chitoheptaose was carried out as described in Section 2.30.2 and the resultant samples 
were derivatised as described in Section 2.30.3. The samples were then run as 
described in Section 2.30. The peaks were identified by the separation shown in 
Figure 6.12 and the amount of GlcNAc released was calculated using the standard 
curve generated in Figure 6.15.  
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Table 6.4 The millimolar concentration of GlcNAc released from the hydrolysis 
of the chito-oligosaccharides by rChbL. 
   0 hour  1 hour  3 hour  24 hour 
Chitobiose  0.237  0.282  2.721  3.102 
Chitotriose  0  0.078  1.466  5.450   
Chitotetraose  0.670  0.808  2.223  7.244  
Chitopentaose 0.633  0.707  2.244  7.684 
Chitohexaose  0.505  1.707  4.848  4.811 
Chitoheptaose 0  0  2.218  5.596 
 
The hydrolysis of all chito-oligosaccharides by the rChbL enzyme released GlcNAc, 
each to varying degrees (see Figures 6.16 to 6.21). The large peak observed around 20 
minutes was the excess derivatisation agent present in the sample. The highest levels 
of GlcNAc were generated through the hydrolysis of chitotetraose and chitopentaose. 
Less GlcNAc was released from the longer length chito-oligosaccharide, 
chitoheptaose. The hydrolysis of chitobiose proceeded at the fastest rate, with the 
majority of chitobiose hydrolysed to GlcNAc after 3 hours. The hydrolysis of 
chitohexaose also proceeded quickly, again with the majority of chitohexaose 
hydrolysed to GlcNAc after 3 hours. The hydrolysis of chitotetraose, chitopentaose 
and chitoheptaose proceeded at a slower rate. 
 
Chitobiose was completely hydrolysed to GlcNAc after 24 hours. No other products 
were observed. Not all the chitotriose was hydrolysed to GlcNAc after the 24 hours. 
The presence of a double peak after 24 hours suggests that the chitotriose was broken 
down into smaller length chito-oligosaccharide chains, as well as GlcNAc. This was 
presumably chitobiose, the only chito-oligosaccharide smaller than chitotriose but 
larger than GlcNAc.  
 
The majority of chitotetraose was hydrolysed to GlcNAc. Some intermediate 
hydrolytic products were observed after three hours, presumably chitobiose or 
chitotriose. The hydrolysis of chitopentaose proceeded at a relatively slow rate. 
Again, the majority of chitopentaose was hydrolysed to GlcNAc, with a small amount 
of intermediate product observed. The chitohexaose was completely hydrolysed to 
yield only GlcNAc after 24 hours. Intermediate hydrolytic products were present at 
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earlier time-points, presumably the lower length chito-oligosaccharides. The majority 
of chitoheptaose was hydrolysed to GlcNAc after 24 hours. Again, lower length chito-
oligosaccharides were present.  
 
6.6 Discussion 
 
A chitin-binding assay protocol described by Suginta et al., (2007) was used to study 
the binding patterns of rChbL to various insoluble substrates. This assay has been 
used previously to examine the effect of certain mutations on the specificity of a 
chitinase from Vibrio carchariae. Although the optimum temperature for the catalytic 
activity of rChbL has been demonstrated to be 45°C (see Figure 3.23) this assay was 
carried out at 4°C in order to minimise any catalytic activity. Quantification of 
unbound protein in the culture media by spectroscopy was impossible due to signal 
disruption caused by particulate insoluble matter. As chitin and its derivatives are 
insoluble substances it is necessary to visualise unbound and bound protein using 
SDS-PAGE analysis. The binding patterns of the rChbL enzyme and rChbL enzyme 
mutants yielded some interesting results.  
 
The binding patterns of rChbL and its mutants were very similar with only one 
exception, mutant W689Y. All of the enzymes bound to α-chitin with high affinity. 
No unbound enzyme was detected in the culture media following five minutes of 
incubation and the bound enzyme was not removed even with lengthy boiling. On the 
other hand, there was very little, if any, binding observed to β-chitin for all but one 
mutant. Mutant W689Y was found to bind to β-chitin with a relatively high affinity 
compared with the native rChbL enzyme. The point mutation may have slightly 
changed the structure of the active site allowing the binding of β-chitin.  
 
The predominant form of chitin found in nature is α-chitin. β-chitin is much rarer as it 
is only found in squid pens. P. luminescens is an insect pathogen. Although it is not 
known what role chitin-degrading enzymes may play in this process, high affinity 
binding of rChbL to α-chitin was expected. The difference in the structures of α-chitin 
and β-chitin may also explain the difference in binding and affinity. The structures of 
α-chitin and β-chitin are described thoroughly in the introduction. The chains of N-
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acetylglucosamine residues are organised in a parallel fashion in α-chitin while they 
are organised in an anti-parallel fashion in β-chitin. The parallel sheets of α-chitin are 
held together by strong hydrogen bonds while the anti-parallel sheets of β-chitin are 
only held together by weaker hydrogen bonds (Jang et al., 2004). Perhaps the rChbL 
enzyme has a high affinity for the tightly organised structure of α-chitin rather the 
more loosely packed together β-chitin. The distribution of charge may also play a role 
here. The active site of the rChbL is found in a deep cleft in the enzyme structure. The 
organised α–chitin structure may enter the active site with more ease than the loosely 
packed β–chitin.  
 
Binding of rChbL and its mutants to chitosan and cellulose was not observed 
following incubation at 4
o
C for one hour. While chitosan is a deacetylated form of 
chitin, cellulose differs from chitin due to the absence of an N-acetyl group at the C-2 
position. These variations in structure obviously play a role in the ability of rChbL to 
bind to these substrates with a comparable affinity to α-chitin binding.  
 
Although it was necessary to perform the rChbL insoluble substrate binding assays at 
4
o
C to prevent catalytic activity the low temperature may also have inhibited binding 
to the substrates. The results demonstrated however that α-chitin was the preferred 
substrate of the rChbL enzyme, while the W689Y mutant was capable of binding to 
both α- and β-chitin.  
 
The advantage of using the catalytically inactive rChb CBP was that insoluble 
substrate assays could be carried out at the proteins optimum temperature without the 
worry of catalytic activity occurring. In comparison at 45°C, the rChb protein was not 
as selective as rChbL; it bound to all insoluble substrates tested. High affinity binding 
to α-chitin and β-chitin was observed, while binding to chitosan and cellulose was 
observed, albeit with a lower affinity. It was concluded that while rChb CBP bound to 
all of the insoluble substrates tested, it did have a preference for α-chitin. Similar 
results may also have been observed for the catalytically active rChb had the reaction 
been monitored for a longer period of time at 4°C. The binding of chitinases to chitin 
was examined by Suginta et al., (2007). They also mutated various residues in the 
active site of their chitinase and reported no difference in the binding affinities 
towards chitin. 
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While analysis of the binding affinities of the rChbL enzyme was useful and gave 
insight into its affinity for the different forms of chitin, it gave no indication as to the 
catalytic action of the enzyme on chitin. As stated previously rChbL is analogous to 
the S. marcescens chitobiase Chb. Chitobiases such as Chb are capable of cleaving 
chitobiose into GlcNAc monomers and do not break down chitin into smaller chito-
oligosaccharides. In order to determine the hydrolytic action of rChbL HPLC analysis 
was employed to study the break-down of varying length chito-oligosaccharides by 
rChb. First, the inhibitory effect of the chito-oligosaccharides on activity was 
examined using the PNP-GlcNAc assay. This experiment revealed that all of the 
chito-oligosaccharides were potent inhibitors, inhibiting the reaction by 90%. There 
was very little difference in the levels of inhibition by each chito-oligosaccharide 
observed. This result demonstrated that rChbL was able to bind to each chito-
oligosaccharide. Again, however, binding a substrate was not the same as hydrolysing 
it.  
 
There are many studies that describe the hydrolysis of chito-oligosaccharides by 
various chitinases and chitobiases and the resulting analysis of the reaction products. 
The methods typically used for this analysis are either TLC or HPLC. The 
examination of chito-oligosaccharides by HPLC has been extensively described in the 
literature and was the method of choice in this study. Van Eikeren and McLaughlin 
(1977) described the use of a carbohydrate column and an eluent gradient of 70:30 
acetonitrile:water. More recently Chang and Fu (2000) optimised this 
acetonitrile:water gradient going from 80:20 to 60:40. The derivatisation and 
separation protocols used in this work were taken and adapted from work by Alwael 
et al., (2011). Alwael et al. devised a HPLC method for the determination of 
monosaccharides in complex samples originating from the production of 
biopharmaceuticals. Samples such as cell-culture media and fermentation broths were 
tested for the presence of sugars such as glucose, glucosamine, galactose, 
galactosamine, mannose, mannosamine, fucose and sialic acid. Monosaccharides must 
be labelled for detection on a HPLC system due to the absence of UV absorbing 
groups in their structure. The monosaccharides were derivatised using anthranillic 
acid before injection onto the column. This added a secondary amine group through 
reductive amination to the sugar which is a UV absorbing group. However, the 
presence of N-acetyl groups on sugars can cause lower rates of reductive amination as 
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their reducing ends are known to be less reactive and therefore lower yields of 
secondary amines and lower UV signals are observed (Rustighi et al., 2009). Alwael 
et al., (2011) did not include any sugars with N-acetyl groups in their study. Rustighi 
et al., (2009) compared the derivatisation efficiency of various sugars with and 
without N-acetyl groups using three different chemicals dyes; 4-aminobenzonitrile, 2-
aminopyridine and 2-aminobenzoic acid (anthranillic acid). The resultant samples 
were analysed by capillary electrophoresis (CE) with UV detection.  They found that 
the optimal dye for monosaccharide detection was anthranillic acid; this dye allowed 
for the most sensitive detection of the sugars containing N-acetyl groups.  
 
Suginta et al., (2010) studied the hydrolysis of various length chito-oligosaccharides 
by an N-acetylglucosaminidase from Vibrio harveyi 650 using HPLC. They 
discovered that this N-acetylglucosamindase hydrolysed all chito-oligosaccharides 
tested but had a slight preference for chitotetraose, followed by chitotriose, while its 
least favourite chito-oligosaccharide was chitobiose. TLC analysis showed that the N-
acetylglucosamindase was exo-acting, cleaving GlcNAc from the end of each chito-
oligosaccharide, the final product being only GlcNAc. Hoell et al., (2005) used HPLC 
to analyse chito-oligosaccharide hydrolysis by a novel chitinase from Trichoderma 
atroviride. This chitinase was found to be endo-acting. For example, the hydrolysis of 
chitohexaose yielded chitotetraose, chitotriose and chitobiose, but not GlcNAc.  
 
Analysis in this study revealed the rChbL enzyme was primarily exo-acting. The main 
hydrolytic product at all time-points was GlcNAc. It was hypothesized that the rChbL 
enzyme primarily cleaved GlcNAc from the non-reducing ends of the chito-
oligosaccharides. Its preferential substrate was deemed to be chitobiose as this was 
the reaction that proceeded the fastest. It also favoured chitotriose and chitohexaose 
over the other substrates. The hydrolysis of chitoheptaose proceeded at the slowest 
rate and this substrate was therefore deemed to be the least favoured by the rChbL 
enzyme. In the end it was concluded that rChbL was an exo-acting N-
acetylglucosaminindase (chitobiase), capable of cleaving single GlcNAc units from 
various length chito-oligosaccharides.  
 
This chapter succeeded in determining the binding specificities of rChbL and rChb 
CBP for various insoluble substrates as well as the hydrolytic capabilities of the N-
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acetylglucosaminidase rChbL. These results highlight the promise of rChbL as a 
commercial enzyme for the production of GlcNAc from chitin substrates.  
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Chapter 7 
 
 
 
Final Discussion, Conclusions and 
Recommendations 
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Chitin is a readily available bioresource, with between 10
10
-10
12
 metric tons produced 
annually. Chitin breakdown is a commercially lucrative process due to the economic 
value of its’ breakdown products such as chito-oligosaccharides and N-
acetylglucosamine (Gortari and Hours, 2013). These products have uses in areas such 
as the food industry, pharmaceutical industry, cosmetic industry and textile industry. 
As previously discussed chemical methods have been widely used for chitin 
breakdown, however these have many disadvantages including non-specific products 
and the generation of toxic waste. There is a general movement towards the biological 
hydrolysis of chitin biowaste, this can be carried out through microbial fermentation 
or enzymatic hydrolysis (Gortari and Hours, 2013). This study is interested in the 
enzymatic hydrolysis of chitin with the use of enzymes such as chitinases and 
chitobiases. The hydrolysis of chitin by chitinolytic enzymes from various sources is 
difficult to compare due to the different processes and parameters employed. The 
source of chitin differs, along with how the waste is pre-treated, the temperature/pH 
of the process and how the supplements added. Enzymes from various sources such as 
Serratia marcescens, Streptococcus pneumoniae and Vibrio harveyi have all been 
employed for chitin breakdown (Gortari and Hours, 2013; Suginta et al., 2010; Tews 
et al. 1996).  
 
This study described the cloning, expression and purification of a chitobiase enzyme 
from P. luminescens with the final aim of a creating an enzyme for commercial chitin 
breakdown. The enzyme was cloned from the chb gene from P. luminescens and 
expressed in a bacterial expression system (E. coli). The addition of a His6 tag to the 
recombinant enzyme allowed the use of affinity purification. This 
expression/purification system enabled the fast production of relatively high yields of 
pure enzyme (rChbL). The purified enzyme was then characterised, its kinetic 
properties were investigated and compared with a commercial chitobiase using a 
modified assay. The major issue encountered was the identification of the best 
fraction from which to harvest the recombinant protein. The protein was initially 
found in the insoluble cellular fraction, namely the periplasmic fraction. On further 
investigation it was noted that a portion of the protein was being exported to the 
culture media. The recombinant protein was expressed with its’ signal peptide 
however this is a signal peptide recognised by P. luminescens. Efforts to increase the 
amount of secreted recombinant protein could include the addition of a signal peptide 
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recognised by E. coli such as pelB. This signal peptide directs the protein to the 
periplasmic space where it is cleaved and secreted. This would possibly increase the 
recombinant protein yields obtained.  
A recombinant chitobiase enzyme was generated that had comparable activity to an 
already commercially available recombinant chitobiase enzyme from Xanthomonas 
manihotis available from New England Biolabs. Sigma Aldrich also advertises a 
recombinant chitobiase from a microbial source, from Streptococcus pneumoniae. 
This highlights that there is a market for these products. The rChbL from this study 
could be less costly to produce due to the engineered recombinant purification tag 
which leads to less downstream processing and therefore less cost. The fact that it can 
also be obtained directly from the culture media reduces production costs.  
 
A catalytically inactive chitobiase protein (rChb CBP) was generated to establish 
whether the homologous residues in the S. marcescens enzyme were also the catalytic 
residues in the P. luminescens enzyme. The catalytically active residues were mutated 
and the catalytic activity was shown to be removed from the enzyme. The 
carbohydrate-binding properties of the new carbohydrate-binding protein were 
examined against terminal GlcNAc residues on a variety of glycoproteins as well as a 
synthetic BSA-GlcNAc conjugate and an O-linked glycan, bovine serum mucin. 
Binding was examined using various ELLA formats, however no interaction between 
the rChb CBP and GlcNAc was observed. The immobilisation of the rChb CBP to a 
sepharose matrix was completed successfully, however binding to GlcNAc was still 
not observed. Detection of binding between the rChb CBP and GlcNAc was the major 
issue encountered in this chapter. While the His6 tag allowed for the purification of 
the recombinant protein it did not allow detection in an ELLA format. The addition of 
a linker to extend the His6 tag from the protein did not enable detection in the ELLA 
format but did improve purification of the protein. Biotinylation of the protein 
enabled detection but it was noted that there were potential biotinylation sites in the 
binding pocket of the protein that could interfere with potential binding of GlcNAc 
residues. Further work could be carried out to enable better detection of the rChb CBP 
in the ELLA format. A possible way to do this would be the addition of a His patch. 
While the His tag was at the C-terminus of the protein and was possibly hidden by the 
tertiary protein structure a His patch may be engineered so that it would be present on 
the protein surface. However, this may cause issues with protein folding and structure 
 300 
and ultimately affect its binding. Alternatively, the His6 tag may be engineered at the 
N-terminus of the protein. While not ideal in this case due to the cleavage of the 
signal peptide and consequent removal of the His6 tag, it would be possible to 
engineer the tag after the signal peptide sequence.   
 
The next objective was to improve the binding ability of the rChb CBP through site-
directed mutagenesis. Residues were chosen around the active site that were proposed 
to be interfering with the binding of the bulky glycoprotein structure. Five single 
mutants were successfully cloned, expressed and purified. Two mutations (K545A 
and D551) resulted in binding to a BSA-GlcNAc conjugate being observed, while the 
combination of these mutations in a single mutant increased the signal observed 
again. This reinforced the hypothesis that the rChb CBP was unable to bind to the 
GlcNAc residues on glycoproteins due to its binding pocket being located deep inside 
the enzyme and denying access to the large glycoprotein. The binding of the BSA-
GlcNAc conjugate was a positive result, and the slight increase in binding to bovine 
serum mucin and asialo agalacto fetuin demonstrated that there was potential to 
generate a carbohydrate binding protein for glycoanalysis. However the overall aim of 
creating a carbohydrate-binding protein capable of binding GlcNAc residues on 
glycoproteins was not achieved. Further mutagenesis may be carried out on the 
binding pocket of the rChb CBP to make it more accessible for glycoprotein binding. 
The rChb CBP double mutant (K545A D551A) may be used as a starting point and 
further mutagenesis of the surrounding residues to alanine carried out as this 
technique was successful in this study. Random mutagenesis of these and surrounding 
residues could also generate interesting results. Currently the only N-
acetylglucosamine binding protein available on the market is GSLII, available from 
Vector Labs. As N-acetylglucosamine is part of the core N-glycan structure and 
present on almost all glycoproteins there is a large gap in the glycoanalysis market for 
a protein with N-acetylglucosamine binding capabilities. The issue with GSLII is that 
it is obtained from plant origin so there are issues encountered with purity, batch-
batch-to batch variation and supply. The generation of a recombinant N-
acetylglucosamine binding protein would be commercially valuable as there would be 
a constant supply with no batch-to-batch variation. Carbohydrate-binding proteins are 
critical for the biopharmaceutical industry as they are used for glycoanalysis to 
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examine the various glycoforms of its protein therapeutics. It is a critical quality 
control measure. 
We also investigated what effect the site specific mutations had on the rChbL enzyme 
due to their proximity to the active site. Again, five single mutants were successfully 
cloned, expressed and purified. Interestingly, the mutations that increased the binding 
abilities of the rChb CBP (K545A and D551A) also increased the catalytic activity of 
the rChbL enzyme. The combination of these mutations in a single mutant acted 
additively and significantly increased the catalytic activity of the rChbL double 
mutant threefold in comparison with the native rChbL. The mutants with increased 
catalytic activity also demonstrated an increased stability over a wider pH range and 
higher temperatures, all properties that are of interest in the generation of an enzyme 
for commercial/industrial use. The increased activity of these mutants highlighted that 
they could be a more cost effective product than those already available, due to their 
higher levels of activity. Also activity at wider pH ranges and temperatures is 
important due to the fact that chitin hydrolysis can involve the use of acids/bases and 
high temperatures.  
 
Finally the activity of rChbL against natural substrates was investigated. At 4
o
C it was 
shown to bind both α–chitin and β–chitin, but not cellulose and chitosan. The rChb 
CBP was used to examine its interactions with these insoluble substrates at a higher 
temperature (45
o
C), as 4
o
C is not very industrially relevant. Binding to all insoluble 
substrates was observed at this higher temperature. The use of the lower temperature 
allowed the relative affinity of the rChbL for the insoluble substrates to be 
determined. The rChbL had a higher affinity for α–chitin and β–chitin than chitosan 
and cellulose. The study of the interaction of the rChbL with different length chito-
oligosaccharides generated some interesting results. The enzyme was inhibited by all 
length chito-oligosaccharides. It also hydrolysed all length chito-oligosaccharides to 
GlcNAc after 24 hour incubation. The study of the ability of the rChbL site specific 
mutants to hydrolyse the different length chito-oligosaccharides would be an 
interesting future study. The development of a separation of all the different length 
sugars would also be worthwhile. This would enable the various breakdown products 
to be identified and provide a more thorough insight into the preferences of the rChbL 
enzyme and its mechanism of action. This work so far has allowed us to conclude that 
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the enzyme is probably an exo-acting N-acetylglucosaminidase cleaving GlcNAc 
from the terminal end of chito-oligosaccharides.  
 
While the rChb CBP is not a viable option for use in glycoanalysis, this work has 
provided a potential principle for the generation of carbohydrate-binding protein for 
glycoanalysis. Enzymes are extremely specific in the substrates they bind which can 
be exploited for the field of glycoanalysis. Enzymes of a substrate specificity of 
interest may be catalytically inactivated and used as novel carbohydrate-binding 
proteins. There is a lack of commercial GlcNAc binders available for glycoanalysis, 
with only GSLII available. Other chitobiases or chitin hydrolysing enzymes could be 
catalytically inactivated in the search for a GlcNAc binding protein that could be 
produced recombinantly to ensuring a constant, consistent supply.   
 
The rChbL enzyme has proven itself as a possible candidate for commercial use. 
Industrially enzymes need to be able to perform at fast rates, at relatively high 
temperatures and over a broad pH range to account for fluctuations that occur over the 
duration of the process. The rChbL double mutant particularly, has many of these 
characteristics. It catalysed the hydrolysis of PNP-GlcNAc three times faster than a 
commercially available chitobiase; it has proven to be active at 45
o
C and has optimal 
activity over a wide pH range, from pH 6-10. The fact that the rChbL enzyme retained 
some of its catalytic activity after immobilisation to a sepharose matrix is a major 
advantage, which could possibly be improved by using different immobilisation 
techniques. The enzymatic hydrolysis of substances, including chitin, is being carried 
out in bioreactors using immobilised enzymes. This allows the re-use of the enzyme 
and the continuous removal of product.  
The rChbL has potential uses in the breakdown of chitin and chito-oligosaccharides. 
Used in conjunction with endo-acting chitinases it would be of possible use in the 
hydrolysis of chitin and chito-oligosaccharides to N-acetylglucosamine. This is useful 
for the production of N-acetylglucosamine which has many uses as previously 
described (see Section 1.1.3.3). It could also be used for the breakdown of chitin 
biomass.  
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